1	J	NNP	O	J	nn	3	SENT_1	[p1l52t82r65b106],
2	Hum	NNP	PERSON	Hum	nn	3	SENT_1	[p1l78t82r148b106],
3	Genet	NNP	PERSON	Genet	dep	7	SENT_1	[p1l161t81r244b106],
4	(	CD	NUMBER	(	dep	3	SENT_1	[p1l258t81r349b112],
5	2008	CD	DATE	2008	dep	7	SENT_1	[p1l258t81r349b112],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l258t81r349b112],
7	532899-904	CD	NUMBER	532899-904	dep	9	SENT_1	[p1l363t81r530b107],
8	DOI	NNP	O	DOI	dep	7	SENT_1	[p1l52t124r114b149],
9	10.1007	CD	NUMBER	10.1007	_	0	SENT_1	[p1l130t124r528b149],
10	/	:	O	/	punct	9	SENT_1	[p1l130t124r528b149],
11	s10038	CD	NUMBER	s10038	num	12	SENT_1	[p1l130t124r528b149],
12	—	NN	O	—	dep	9	SENT_1	[p1l130t124r528b149],
13	008	CD	NUMBER	008	dep	12	SENT_1	[p1l130t124r528b149],
14	—	CD	NUMBER	—	number	15	SENT_1	[p1l130t124r528b149],
15	0324	CD	DATE	0324	num	17	SENT_1	[p1l130t124r528b149],
16	—	CD	NUMBER	—	number	17	SENT_1	[p1l130t124r528b149],
17	9	CD	NUMBER	9	dep	13	SENT_1	[p1l130t124r528b149],

1	Pharmacokinetic	JJ	MISC	pharmacokinetic	amod	2	SENT_2	[p1l53t340r535b387],
2	interaction	NN	O	interaction	_	0	SENT_2	[p1l558t340r867b387],
3	between	IN	O	between	_	0	SENT_2	[p1l889t341r1120b387],
4	pravastatin	NN	O	pravastatin	prep_between	2	SENT_2	[p1l1142t340r1465b400],
5	and	CC	O	and	_	0	SENT_2	[p1l1488t341r1592b387],
6	olmesartan	NN	O	olmesartan	conj_and	4	SENT_2	[p1l1615t341r1930b387],
7	in	IN	O	in	dep	2	SENT_2	[p1l53t414r107b460],
8	relation	NN	O	relation	pobj	7	SENT_2	[p1l131t414r351b461],
9	to	TO	O	to	dep	2	SENT_2	[p1l375t418r428b461],
10	SLCOIBI	NNP	O	SLCOIBI	nn	11	SENT_2	[p1l451t414r726b462],
11	polymorphism	NN	O	polymorphism	pobj	9	SENT_2	[p1l754t414r1165b474],

1	Suttasinee	NNP	PERSON	Suttasinee	nn	2	SENT_3	[p1l53t549r233b579],
2	Suwannakul	NNP	PERSON	Suwannakul	dep	22	SENT_3	[p1l250t549r469b579],
3	-	:	O	-	_	0	SENT_3	[p1l484t560r492b567],
4	Ichiro	NNP	PERSON	Ichiro	nn	15	SENT_3	[p1l507t549r614b579],
5	Ieiri	NNP	PERSON	Ieiri	nn	15	SENT_3	[p1l629t549r704b579],
6	-	:	O	-	_	0	SENT_3	[p1l720t560r728b567],
7	Miyuki	NNP	PERSON	Miyuki	nn	10	SENT_3	[p1l742t549r871b587],
8	Kimura	NNP	PERSON	Kimura	nn	10	SENT_3	[p1l887t549r1026b579],
9	Kiyoshi	NNP	PERSON	Kiyoshi	nn	10	SENT_3	[p1l1042t560r1049b567, p1l53t601r187b639],
10	Kawabata	NNP	PERSON	Kawabata	dep	15	SENT_3	[p1l203t601r384b631],
11	-	:	O	-	_	0	SENT_3	[p1l400t612r407b619],
12	Hiroyuki	NNP	PERSON	Hiroyuki	nn	13	SENT_3	[p1l422t601r583b639],
13	Kusuhara	NNP	PERSON	Kusuhara	dep	10	SENT_3	[p1l599t601r775b631],
14	-	:	O	-	_	0	SENT_3	[p1l790t612r798b619],
15	Takeshi	NNP	PERSON	Takeshi	dep	2	SENT_3	[p1l813t601r952b631],
16	Hirota	NNP	PERSON	Hirota	nn	18	SENT_3	[p1l967t601r1085b631],
17	Shin	NNP	PERSON	Shin	nn	18	SENT_3	[p1l1100t612r1107b619, p1l10t669r174b731],
18	Irie	NNP	PERSON	Irie	dep	15	SENT_3	[p1l206t669r338b730],
19	-	:	O	-	_	0	SENT_3	[p1l372t692r386b707],
20	Yuichi	NNP	PERSON	Yuichi	nn	21	SENT_3	[p1l418t669r661b730],
21	Sugiyama	NNP	PERSON	Sugiyama	dep	2	SENT_3	[p1l695t669r1058b747],
22	°	VBD	O	°	_	0	SENT_3	[p1l1090t692r1105b707],
23	Shun	NNP	O	Shun	nn	24	SENT_3	[p1l1139t669r1327b731],
24	Higuchi	NNP	PERSON	Higuchi	nsubj	22	SENT_3	[p1l1358t669r1650b747],

1	Received	VBN	O	receive	_	0	SENT_4	[p1l8t904r297b956],
2	:	:	O	:	_	0	SENT_4	[p1l8t904r297b956],
3	20	CD	DATE	20	num	4	SENT_4	[p1l330t904r400b956],
4	February	NNP	DATE	February	dobj	1	SENT_4	[p1l427t904r691b971],
5	2008	CD	DATE	2008	num	4	SENT_4	[p1l719t904r898b956],
6	/	:	O	/	punct	7	SENT_4	[p1l719t904r898b956],
7	Accepted	JJ	O	accepted	dep	4	SENT_4	[p1l911t904r1204b971],
8	:	:	O	:	_	0	SENT_4	[p1l911t904r1204b971],
9	7	CD	DATE	7	dep	7	SENT_4	[p1l1237t905r1269b955],
10	July	NNP	DATE	July	tmod	9	SENT_4	[p1l1297t904r1418b971],
11	2008	CD	DATE	2008	num	10	SENT_4	[p1l1447t904r1625b956],
12	/	:	O	/	punct	7	SENT_4	[p1l1447t904r1625b956],
13	Published	VBN	O	publish	partmod	4	SENT_4	[p1l1638t904r1927b956],
14	online	NN	O	online	prep	13	SENT_4	[p1l1955t904r2152b956],
15	:	:	O	:	_	0	SENT_4	[p1l1955t904r2152b956],
16	©	CD	NUMBER	©	dobj	1	SENT_4	[p1l10t990r62b1042],
17	The	DT	O	the	det	19	SENT_4	[p1l91t990r204b1041],
18	Japan	NNP	ORGANIZATION	Japan	nn	19	SENT_4	[p1l230t991r397b1057],
19	Society	NNP	ORGANIZATION	Society	dep	16	SENT_4	[p1l426t990r643b1057],
20	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l671t990r734b1041],
21	Human	JJ	ORGANIZATION	human	amod	22	SENT_4	[p1l757t991r972b1041],
22	Genetics	NNP	ORGANIZATION	Genetics	prep_of	19	SENT_4	[p1l999t990r1253b1042],
23	and	CC	O	and	_	0	SENT_4	[p1l1283t990r1387b1041],
24	Springer	NNP	PERSON	Springer	conj_and	4	SENT_4	[p1l1415t990r1666b1057],
25	2008	CD	DATE	2008	num	24	SENT_4	[p1l1693t990r1835b1042],

1	Abstract	JJ	O	abstract	amod	3	SENT_5	[p1l8t1214r330b1276],
2	The	DT	O	the	det	3	SENT_5	[p1l418t1215r551b1275],
3	impact	NN	O	impact	nsubjpass	22	SENT_5	[p1l581t1215r818b1293],
4	of	IN	O	of	_	0	SENT_5	[p1l847t1215r922b1275],
5	SLCOIBI	NNP	O	SLCOIBI	nn	6	SENT_5	[p1l946t1216r1290b1276],
6	polymorphism	NN	O	polymorphism	prep_of	3	SENT_5	[p1l1325t1215r1832b1293],
7	on	IN	O	on	_	0	SENT_5	[p1l1861t1234r1945b1275],
8	the	DT	O	the	det	9	SENT_5	[p1l1974t1215r2078b1275],
9	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	6	SENT_5	[p1l7t1322r619b1400],
10	of	IN	O	of	_	0	SENT_5	[p1l641t1322r716b1383],
11	olmesartan	NN	O	olmesartan	prep_of	9	SENT_5	[p1l731t1322r1110b1383],
12	and	CC	O	and	_	0	SENT_5	[p1l1131t1322r1253b1383],
13	on	IN	O	on	_	0	SENT_5	[p1l1273t1342r1356b1382],
14	the	DT	O	the	det	16	SENT_5	[p1l1375t1322r1479b1383],
15	pharmacokinetic	JJ	O	pharmacokinetic	amod	16	SENT_5	[p1l1499t1322r2077b1400],
16	interaction	NN	O	interaction	prep_on	6	SENT_5	[p1l8t1429r380b1490],
17	between	IN	O	between	_	0	SENT_5	[p1l409t1429r698b1490],
18	pravastatin	NN	O	pravastatin	prep_between	16	SENT_5	[p1l729t1429r1109b1507],
19	and	CC	O	and	_	0	SENT_5	[p1l1142t1429r1264b1490],
20	olmesartan	NN	O	olmesartan	prep_between	16	SENT_5	[p1l1296t1429r1675b1490],
21	was	VBD	O	be	auxpass	22	SENT_5	[p1l1706t1449r1836b1490],
22	investigated	VBN	O	investigate	_	0	SENT_5	[p1l1869t1429r2076b1490, p1l8t1536r261b1614],
23	.	.	O	.	_	0	SENT_5	[p1l1869t1429r2076b1490, p1l8t1536r261b1614],

1	On	IN	O	on	_	0	SENT_6	[p1l295t1537r397b1597],
2	day	NN	DURATION	day	prep_on	8	SENT_6	[p1l426t1536r548b1614],
3	1	CD	NUMBER	1	num	2	SENT_6	[p1l585t1537r636b1607],
4	,	,	O	,	_	0	SENT_6	[p1l585t1537r636b1607],
5	ten	CD	NUMBER	ten	num	7	SENT_6	[p1l667t1545r772b1596],
6	healthy	JJ	O	healthy	amod	7	SENT_6	[p1l800t1536r1054b1614],
7	volunteers	NNS	O	volunteer	nsubj	8	SENT_6	[p1l1083t1536r1442b1597],
8	took	VBD	O	take	_	0	SENT_6	[p1l1472t1536r1626b1596],
9	an	DT	O	a	det	15	SENT_6	[p1l1654t1555r1732b1596],
10	oral	JJ	O	oral	amod	15	SENT_6	[p1l1762t1536r1893b1596],
11	dose	NN	O	dose	nn	15	SENT_6	[p1l1923t1536r2078b1596],
12	(	NN	O	(	nn	15	SENT_6	[p1l11t1643r121b1717],
13	10	CD	NUMBER	10	num	15	SENT_6	[p1l11t1643r121b1717],
14	mg	NN	O	mg	nn	15	SENT_6	[p1l153t1643r288b1721],
15	)	NN	O	)	dobj	8	SENT_6	[p1l153t1643r288b1721],
16	of	IN	O	of	_	0	SENT_6	[p1l319t1643r394b1703],
17	pravastatin	NN	O	pravastatin	prep_of	15	SENT_6	[p1l413t1643r812b1721],
18	.	.	O	.	_	0	SENT_6	[p1l413t1643r812b1721],

1	After	IN	O	after	_	0	SENT_7	[p1l843t1643r1027b1703],
2	a	DT	O	a	det	5	SENT_7	[p1l1054t1662r1089b1703],
3	3-day	JJ	DURATION	3-day	amod	5	SENT_7	[p1l1118t1643r1310b1721],
4	washout	NN	O	washout	nn	5	SENT_7	[p1l1338t1643r1626b1703],
5	period	NN	O	period	prep_after	9	SENT_7	[p1l1651t1643r1891b1721],
6	,	,	O	,	_	0	SENT_7	[p1l1651t1643r1891b1721],
7	each	DT	O	each	nsubj	9	SENT_7	[p1l1922t1643r2078b1703],
8	subject	JJ	O	subject	advmod	9	SENT_7	[p1l11t1750r253b1828],
9	received	VBN	O	receive	_	0	SENT_7	[p1l273t1750r568b1810],
10	olmesartan	NN	O	olmesartan	nn	11	SENT_7	[p1l589t1750r969b1810],
11	medoxomil	NN	O	medoxomil	nsubj	15	SENT_7	[p1l989t1750r1384b1810],
12	(	CD	NUMBER	(	number	13	SENT_7	[p1l1408t1750r1518b1824],
13	10	CD	NUMBER	10	num	15	SENT_7	[p1l1408t1750r1518b1824],
14	mg	NN	O	mg	nn	15	SENT_7	[p1l1550t1750r1685b1828],
15	)	NN	O	)	xcomp	9	SENT_7	[p1l1550t1750r1685b1828],
16	for	IN	O	for	_	0	SENT_7	[p1l1709t1750r1809b1810],
17	3	CD	DURATION	3	num	18	SENT_7	[p1l1831t1750r1865b1810],
18	days	NNS	NUMBER	day	prep_for	15	SENT_7	[p1l1901t1750r2074b1828],
19	.	.	O	.	_	0	SENT_7	[p1l1901t1750r2074b1828],

1	On	IN	O	on	_	0	SENT_8	[p1l10t1857r112b1917],
2	day	NN	DURATION	day	prep_on	6	SENT_8	[p1l132t1857r254b1935],
3	8	CD	NUMBER	8	num	2	SENT_8	[p1l278t1857r334b1928],
4	,	,	O	,	_	0	SENT_8	[p1l278t1857r334b1928],
5	they	PRP	O	they	nsubj	6	SENT_8	[p1l357t1857r504b1935],
6	received	VBD	O	receive	dep	38	SENT_8	[p1l524t1857r819b1917],
7	olmesartan	NN	O	olmesartan	nn	8	SENT_8	[p1l840t1857r1219b1917],
8	medoxomil	NN	O	medoxomil	dobj	6	SENT_8	[p1l1239t1857r1633b1917],
9	(	CD	NUMBER	(	number	10	SENT_8	[p1l1656t1857r1766b1931],
10	10	CD	NUMBER	10	num	12	SENT_8	[p1l1656t1857r1766b1931],
11	mg	NN	O	mg	nn	12	SENT_8	[p1l1798t1857r1933b1935],
12	)	NN	O	)	dep	8	SENT_8	[p1l1798t1857r1933b1935],
13	and	CC	O	and	_	0	SENT_8	[p1l1957t1857r2079b1917],
14	pravastatin	NN	O	pravastatin	dobj	6	SENT_8	[p1l7t1964r389b2042],
15	(	CD	NUMBER	(	number	16	SENT_8	[p1l453t1964r563b2038],
16	10	CD	NUMBER	10	num	18	SENT_8	[p1l453t1964r563b2038],
17	mg	NN	O	mg	nn	18	SENT_8	[p1l594t1965r729b2042],
18	)	NN	O	)	dep	14	SENT_8	[p1l594t1965r729b2042],
19	concurrently	RB	O	concurrently	advmod	6	SENT_8	[p1l795t1964r1250b2042],
20	,	,	O	,	_	0	SENT_8	[p1l795t1964r1250b2042],
21	and	CC	O	and	_	0	SENT_8	[p1l1317t1964r1439b2024],
22	pharmacokinetic	JJ	O	pharmacokinetic	amod	23	SENT_8	[p1l1499t1964r2077b2042],
23	proﬁles	NNS	O	proﬁles	nsubjpass	25	SENT_8	[p1l7t2071r264b2149],
24	were	VBD	O	be	auxpass	25	SENT_8	[p1l287t2090r452b2131],
25	compared	VBN	O	compare	conj_and	6	SENT_8	[p1l474t2071r815b2149],
26	with	IN	O	with	_	0	SENT_8	[p1l834t2071r986b2131],
27	those	DT	O	those	prep_with	25	SENT_8	[p1l1006t2071r1187b2131],
28	in	IN	O	in	_	0	SENT_8	[p1l1207t2071r1272b2130],
29	each	DT	O	each	det	31	SENT_8	[p1l1293t2071r1450b2131],
30	single-dose	JJ	O	single-dose	amod	31	SENT_8	[p1l1472t2071r1862b2149],
31	phase	NN	O	phase	prep_in	27	SENT_8	[p1l1882t2071r2077b2149],
32	with	IN	O	with	_	0	SENT_8	[p1l9t2178r161b2239],
33	regard	NN	O	regard	prep_with	31	SENT_8	[p1l187t2178r408b2256],
34	to	TO	O	to	_	0	SENT_8	[p1l435t2187r499b2238],
35	the	DT	O	the	det	37	SENT_8	[p1l527t2178r631b2238],
36	SLCOIBI	NN	O	slcoibus	nn	37	SENT_8	[p1l659t2179r1002b2239],
37	genotypes	NNS	O	genotype	prep_to	25	SENT_8	[p1l1037t2187r1385b2256],
38	(	VBP	O	(	_	0	SENT_8	[p1l1417t2178r1744b2252],
39	*	CD	NUMBER	*	num	46	SENT_8	[p1l1417t2178r1744b2252],
40	1b	JJ	O	1b	amod	46	SENT_8	[p1l1417t2178r1744b2252],
41	/	:	O	/	punct	43	SENT_8	[p1l1417t2178r1744b2252],
42	*	CD	NUMBER	*	num	43	SENT_8	[p1l1417t2178r1744b2252],
43	lb	NN	O	lb	dep	40	SENT_8	[p1l1417t2178r1744b2252],
44	,	,	O	,	_	0	SENT_8	[p1l1417t2178r1744b2252],
45	*	CD	NUMBER	*	appos	43	SENT_8	[p1l1779t2178r2076b2249],
46	1b	NN	O	1b	dobj	38	SENT_8	[p1l1779t2178r2076b2249],
47	/	:	O	/	punct	48	SENT_8	[p1l1779t2178r2076b2249],
48	*	CD	NUMBER	*	dep	46	SENT_8	[p1l1779t2178r2076b2249],
49	l5	NN	O	l5	dep	48	SENT_8	[p1l1779t2178r2076b2249],
50	,	,	O	,	_	0	SENT_8	[p1l1779t2178r2076b2249],
51	and	CC	O	and	_	0	SENT_8	[p1l10t2285r132b2346],
52	*	NN	O	*	nn	53	SENT_8	[p1l163t2285r488b2360],
53	l5	NN	O	l5	conj_and	48	SENT_8	[p1l163t2285r488b2360],
54	/	:	O	/	punct	48	SENT_8	[p1l163t2285r488b2360],
55	*	CD	NUMBER	*	num	57	SENT_8	[p1l163t2285r488b2360],
56	l5	NN	O	l5	nn	57	SENT_8	[p1l163t2285r488b2360],
57	)	NN	O	)	nsubj	38	SENT_8	[p1l163t2285r488b2360],
58	.	.	O	.	_	0	SENT_8	[p1l163t2285r488b2360],

1	In	IN	O	in	_	0	SENT_9	[p1l520t2287r590b2345],
2	the	DT	O	the	det	4	SENT_9	[p1l617t2285r720b2346],
3	single-dose	JJ	O	single-dose	amod	4	SENT_9	[p1l752t2285r1141b2363],
4	phase	NN	O	phase	prep_in	13	SENT_9	[p1l1169t2285r1384b2363],
5	,	,	O	,	_	0	SENT_9	[p1l1169t2285r1384b2363],
6	the	DT	O	the	det	8	SENT_9	[p1l1414t2285r1518b2346],
7	mean	NN	O	mean	nn	8	SENT_9	[p1l1546t2305r1733b2346],
8	Cmax	NN	O	cmax	nsubj	13	SENT_9	[p1l1764t2287r1929b2360],
9	and	CC	O	and	_	0	SENT_9	[p1l1957t2285r2079b2346],
10	AUC0_24	NN	O	auc0_24	nsubj	13	SENT_9	[p1l8t2393r318b2467],
11	of	IN	O	of	_	0	SENT_9	[p1l366t2392r441b2453],
12	olmesartan	NN	O	olmesartan	prep_of	8	SENT_9	[p1l481t2392r861b2453],
13	tended	VBD	O	tend	_	0	SENT_9	[p1l906t2392r1137b2453],
14	to	TO	O	to	aux	16	SENT_9	[p1l1182t2401r1247b2453],
15	be	VB	O	be	cop	16	SENT_9	[p1l1292t2392r1373b2453],
16	higher	JJR	O	higher	xcomp	13	SENT_9	[p1l1418t2392r1641b2470],
17	in	IN	O	in	_	0	SENT_9	[p1l1685t2392r1751b2452],
18	*	CD	NUMBER	*	num	19	SENT_9	[p1l1801t2392r2075b2453],
19	l5	NN	O	l5	prep_in	16	SENT_9	[p1l1801t2392r2075b2453],
20	/	:	O	/	punct	23	SENT_9	[p1l1801t2392r2075b2453],
21	*	CD	NUMBER	*	num	23	SENT_9	[p1l1801t2392r2075b2453],
22	l5	NN	O	l5	nn	23	SENT_9	[p1l1801t2392r2075b2453],
23	subjects	NNS	O	subject	dep	19	SENT_9	[p1l11t2499r285b2577],
24	than	IN	O	than	prep	23	SENT_9	[p1l325t2499r473b2559],
25	in	IN	O	in	pcomp	24	SENT_9	[p1l512t2499r578b2559],
26	*	CD	NUMBER	*	num	27	SENT_9	[p1l620t2499r897b2560],
27	lb	NN	O	lb	pobj	25	SENT_9	[p1l620t2499r897b2560],
28	/	:	O	/	punct	23	SENT_9	[p1l620t2499r897b2560],
29	*	CD	NUMBER	*	num	30	SENT_9	[p1l620t2499r897b2560],
30	lb	NN	O	lb	dep	23	SENT_9	[p1l620t2499r897b2560],
31	subjects	NNS	O	subject	dep	30	SENT_9	[p1l940t2499r1233b2577],
32	,	,	O	,	_	0	SENT_9	[p1l940t2499r1233b2577],
33	while	IN	O	while	mark	36	SENT_9	[p1l1275t2499r1466b2560],
34	the	DT	O	the	det	36	SENT_9	[p1l1505t2499r1609b2559],
35	mean	NN	O	mean	nn	36	SENT_9	[p1l1648t2518r1835b2559],
36	CL	NN	O	cl	dep	31	SENT_9	[p1l1875t2500r2083b2573],
37	,	,	O	,	_	0	SENT_9	[p1l1875t2500r2083b2573],
38	/	:	O	/	punct	23	SENT_9	[p1l1875t2500r2083b2573],
39	F	NN	O	f	dep	23	SENT_9	[p1l1875t2500r2083b2573],
40	(	CD	NUMBER	(	dep	39	SENT_9	[p1l11t2606r239b2680],
41	:	:	O	:	_	0	SENT_9	[p1l11t2606r239b2680],
42	|	CD	NUMBER	|	dep	39	SENT_9	[p1l11t2606r239b2680],
43	:	:	O	:	_	0	SENT_9	[p1l11t2606r239b2680],
44	SD	NN	O	sd	nn	45	SENT_9	[p1l11t2606r239b2680],
45	)	NN	O	)	dep	42	SENT_9	[p1l11t2606r239b2680],
46	in	IN	O	in	_	0	SENT_9	[p1l264t2606r330b2665],
47	*	CD	NUMBER	*	num	48	SENT_9	[p1l357t2606r631b2666],
48	l5	NN	O	l5	prep_in	19	SENT_9	[p1l357t2606r631b2666],
49	/	:	O	/	punct	55	SENT_9	[p1l357t2606r631b2666],
50	*	CD	NUMBER	*	num	52	SENT_9	[p1l357t2606r631b2666],
51	l5	NN	O	l5	nn	52	SENT_9	[p1l357t2606r631b2666],
52	subjects	NNS	O	subject	nsubj	55	SENT_9	[p1l660t2606r933b2684],
53	was	VBD	O	be	cop	55	SENT_9	[p1l958t2625r1087b2666],
54	signiﬁcantly	RB	O	signiﬁcantly	advmod	55	SENT_9	[p1l1114t2606r1539b2684],
55	lower	JJR	O	lower	parataxis	16	SENT_9	[p1l1563t2606r1759b2666],
56	than	IN	O	than	_	0	SENT_9	[p1l1780t2606r1928b2666],
57	that	DT	O	that	prep_than	55	SENT_9	[p1l1950t2606r2080b2666],
58	in	IN	O	in	_	0	SENT_9	[p1l8t2713r74b2772],
59	*	CD	NUMBER	*	num	60	SENT_9	[p1l108t2713r384b2773],
60	lb	NN	O	lb	prep_in	57	SENT_9	[p1l108t2713r384b2773],
61	/	:	O	/	punct	55	SENT_9	[p1l108t2713r384b2773],
62	*	CD	NUMBER	*	num	64	SENT_9	[p1l108t2713r384b2773],
63	1b	JJ	O	1b	amod	64	SENT_9	[p1l108t2713r384b2773],
64	subjects	NNS	O	subject	dobj	16	SENT_9	[p1l418t2713r710b2791],
65	.	.	O	.	_	0	SENT_9	[p1l418t2713r710b2791],

1	No	DT	O	no	det	4	SENT_10	[p1l745t2714r847b2773],
2	statistically	RB	O	statistically	advmod	3	SENT_10	[p1l881t2712r1273b2791],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_10	[p1l1307t2712r1664b2791],
4	differences	NNS	O	difference	nsubjpass	6	SENT_10	[p1l1695t2713r2077b2773],
5	were	VBD	O	be	auxpass	6	SENT_10	[p1l9t2839r174b2880],
6	observed	VBN	O	observe	_	0	SENT_10	[p1l202t2820r513b2880],
7	in	IN	O	in	_	0	SENT_10	[p1l538t2820r604b2879],
8	any	DT	O	any	det	10	SENT_10	[p1l632t2839r752b2898],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	10	SENT_10	[p1l778t2820r1356b2898],
10	parameters	NNS	O	parameter	prep_in	6	SENT_10	[p1l1383t2829r1763b2898],
11	between	IN	O	between	_	0	SENT_10	[p1l1789t2820r2079b2880],
12	single-dose	JJ	O	single-dose	amod	15	SENT_10	[p1l11t2927r401b3005],
13	and	CC	O	and	_	0	SENT_10	[p1l444t2927r566b2987],
14	co-administration	JJ	O	co-administration	conj_and	12	SENT_10	[p1l606t2927r1218b2987],
15	phases	NNS	O	phase	prep_between	10	SENT_10	[p1l1258t2927r1486b3005],
16	for	IN	O	for	_	0	SENT_10	[p1l1528t2927r1628b2987],
17	both	DT	O	both	preconj	18	SENT_10	[p1l1665t2927r1819b2987],
18	pravastatin	NN	O	pravastatin	prep_for	6	SENT_10	[p1l1858t2946r2076b3005, p1l11t3034r195b3094],
19	and	CC	O	and	_	0	SENT_10	[p1l227t3034r350b3094],
20	RMS-416	NN	O	rms-416	conj_and	18	SENT_10	[p1l379t3034r736b3095],
21	.	.	O	.	_	0	SENT_10	[p1l379t3034r736b3095],

1	These	DT	O	these	det	2	SENT_11	[p1l771t3034r976b3094],
2	results	NNS	O	result	nsubj	3	SENT_11	[p1l1007t3034r1230b3094],
3	suggest	VBP	O	suggest	_	0	SENT_11	[p1l1266t3043r1521b3112],
4	that	IN	O	that	complm	6	SENT_11	[p1l1550t3034r1681b3094],
5	OATP1Bl	NN	O	oatp1bl	nsubj	6	SENT_11	[p1l1712t3035r2071b3094],
6	plays	VBZ	O	play	ccomp	3	SENT_11	[p1l7t3141r188b3219],
7	a	DT	O	a	det	8	SENT_11	[p1l218t3160r254b3201],
8	role	NN	O	role	dobj	6	SENT_11	[p1l278t3141r411b3201],
9	in	IN	O	in	_	0	SENT_11	[p1l438t3141r504b3200],
10	the	DT	O	the	det	11	SENT_11	[p1l530t3141r633b3201],
11	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	8	SENT_11	[p1l660t3141r1271b3219],
12	of	IN	O	of	_	0	SENT_11	[p1l1301t3141r1376b3201],
13	olmesartan	NN	O	olmesartan	prep_of	8	SENT_11	[p1l1397t3141r1795b3212],
14	,	,	O	,	_	0	SENT_11	[p1l1397t3141r1795b3212],
15	and	CC	O	and	_	0	SENT_11	[p1l1827t3141r1949b3201],
16	the	DT	O	the	dobj	6	SENT_11	[p1l1974t3141r2078b3201],

1	S.	NNP	PERSON	S.	nn	2	SENT_12	[p1l10t3409r61b3460],
2	Suwannakul	NNP	PERSON	Suwannakul	_	0	SENT_12	[p1l94t3408r454b3460],
3	-	:	O	-	_	0	SENT_12	[p1l487t3436r495b3445],
4	I.	NN	PERSON	i.	dep	2	SENT_12	[p1l526t3410r563b3460],
5	Ieiri	NNP	PERSON	Ieiri	nn	6	SENT_12	[p1l593t3408r714b3460],
6	OZ	NNP	O	OZ	dep	4	SENT_12	[p1l744t3405r870b3472],
7	)	SYM	O	)	dep	14	SENT_12	[p1l744t3405r870b3472],
8	-	:	O	-	_	0	SENT_12	[p1l904t3436r912b3445],
9	T.	FW	PERSON	t.	nn	10	SENT_12	[p1l943t3410r1001b3460],
10	Hirota	FW	PERSON	hirota	dep	14	SENT_12	[p1l1032t3408r1219b3460],
11	-	:	O	-	_	0	SENT_12	[p1l1251t3436r1259b3445],
12	S.	NNP	ORGANIZATION	S.	dep	10	SENT_12	[p1l1292t3409r1343b3460],
13	Higuchi	NNP	ORGANIZATION	Higuchi	nn	14	SENT_12	[p1l1374t3408r1609b3475],
14	Department	NNP	ORGANIZATION	Department	dep	2	SENT_12	[p1l8t3496r356b3561],
15	of	IN	ORGANIZATION	of	_	0	SENT_12	[p1l383t3494r446b3546],
16	Clinical	JJ	ORGANIZATION	clinical	amod	17	SENT_12	[p1l469t3494r700b3546],
17	Pharmacokinetics	NNS	ORGANIZATION	pharmacokinetic	prep_of	14	SENT_12	[p1l728t3494r1267b3555],
18	,	,	O	,	_	0	SENT_12	[p1l728t3494r1267b3555],
19	Graduate	NNP	ORGANIZATION	Graduate	nn	20	SENT_12	[p1l9t3581r277b3633],
20	School	NNP	ORGANIZATION	School	appos	17	SENT_12	[p1l306t3581r506b3633],
21	of	IN	ORGANIZATION	of	_	0	SENT_12	[p1l534t3581r598b3633],
22	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	23	SENT_12	[p1l619t3581r1074b3633],
23	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	20	SENT_12	[p1l1103t3581r1373b3642],
24	,	,	O	,	_	0	SENT_12	[p1l1103t3581r1373b3642],

1	Kyushu	NNP	ORGANIZATION	Kyushu	nn	2	SENT_13	[p2l9t19r235b86],
2	University	NNP	ORGANIZATION	University	_	0	SENT_13	[p2l262t19r587b86],
3	,	,	O	,	_	0	SENT_13	[p2l262t19r587b86],
4	3-1-1	CD	NUMBER	3-1-1	appos	2	SENT_13	[p2l619t20r790b80],
5	,	,	O	,	_	0	SENT_13	[p2l619t20r790b80],
6	Maidashi	NNP	LOCATION	Maidashi	appos	2	SENT_13	[p2l819t19r1107b80],
7	,	,	O	,	_	0	SENT_13	[p2l819t19r1107b80],
8	Higashi-ku	NN	O	higashi-ku	appos	2	SENT_13	[p2l8t105r350b172],
9	,	,	O	,	_	0	SENT_13	[p2l8t105r350b172],
10	Fukuoka	NNP	LOCATION	Fukuoka	appos	2	SENT_13	[p2l379t106r636b157],
11	812-8582	CD	NUMBER	812-8582	num	10	SENT_13	[p2l664t105r958b166],
12	,	,	O	,	_	0	SENT_13	[p2l664t105r958b166],
13	Japan	NNP	LOCATION	Japan	appos	2	SENT_13	[p2l987t107r1154b172],
14	e	SYM	O	e	dep	16	SENT_13	[p2l9t192r211b243],
15	—	CD	NUMBER	—	num	16	SENT_13	[p2l9t192r211b243],
16	mail	NN	O	mail	rcmod	13	SENT_13	[p2l9t192r211b243],
17	:	:	O	:	_	0	SENT_13	[p2l9t192r211b243],
18	ieiri-ttr@umin.ac.jp	NN	O	ieiri-ttr@umin.ac.jp	dep	13	SENT_13	[p2l243t192r830b258],

1	M.	NNP	PERSON	M.	nn	2	SENT_14	[p2l8t366r86b416],
2	Kimura	NNP	PERSON	Kimura	_	0	SENT_14	[p2l117t364r341b416],
3	-	:	O	-	_	0	SENT_14	[p2l372t392r380b400],
4	S.	NNP	O	S.	nn	6	SENT_14	[p2l413t365r465b416],
5	Irie	NNP	O	Irie	nn	6	SENT_14	[p2l495t365r595b416],
6	Kyushu	NNP	ORGANIZATION	Kyushu	dep	2	SENT_14	[p2l9t450r235b517],
7	Clinical	JJ	ORGANIZATION	clinical	amod	14	SENT_14	[p2l263t450r494b502],
8	Pharmacology	NNP	ORGANIZATION	Pharmacology	nn	14	SENT_14	[p2l521t450r946b517],
9	Research	NNP	ORGANIZATION	Research	nn	14	SENT_14	[p2l973t450r1242b502],
10	Clinic	NNP	ORGANIZATION	Clinic	nn	14	SENT_14	[p2l1270t450r1464b511],
11	,	,	O	,	_	0	SENT_14	[p2l1270t450r1464b511],
12	Fukuoka	NNP	LOCATION	Fukuoka	appos	14	SENT_14	[p2l8t536r280b597],
13	,	,	O	,	_	0	SENT_14	[p2l8t536r280b597],
14	Japan	NNP	LOCATION	Japan	dep	6	SENT_14	[p2l309t538r475b603],

1	K.	NNP	PERSON	K.	nn	6	SENT_15	[p2l9t710r74b760],
2	Kawabata	NNP	PERSON	Kawabata	nn	6	SENT_15	[p2l105t709r399b760],
3	Daiichi-Sankyo	NNP	PERSON	Daiichi-Sankyo	nn	6	SENT_15	[p2l8t795r469b862],
4	RD	NNP	ORGANIZATION	RD	nn	6	SENT_15	[p2l497t797r596b846],
5	Associe	NNP	ORGANIZATION	Associe	nn	6	SENT_15	[p2l623t795r854b847],
6	Co.	NNP	ORGANIZATION	Co.	_	0	SENT_15	[p2l882t796r1000b856],
7	,	,	O	,	_	0	SENT_15	[p2l882t796r1000b856],
8	Ltd	NNP	ORGANIZATION	Ltd	nn	12	SENT_15	[p2l1029t795r1145b856],
9	,	,	O	,	_	0	SENT_15	[p2l1029t795r1145b856],
10	Tokyo	NNP	LOCATION	Tokyo	appos	12	SENT_15	[p2l1175t795r1381b862],
11	,	,	O	,	_	0	SENT_15	[p2l1175t795r1381b862],
12	Japan	NNP	LOCATION	Japan	appos	6	SENT_15	[p2l1410t797r1577b862],

1	H.	NNP	PERSON	H.	nn	2	SENT_16	[p2l8t969r74b1019],
2	Kusuhara	NNP	PERSON	Kusuhara	_	0	SENT_16	[p2l105t968r386b1019],
3	-	:	O	-	_	0	SENT_16	[p2l416t996r425b1004],
4	Y.	NNP	ORGANIZATION	Y.	nn	6	SENT_16	[p2l456t969r521b1019],
5	Sugiyama	NNP	ORGANIZATION	Sugiyama	nn	6	SENT_16	[p2l554t968r846b1035],
6	Department	NNP	ORGANIZATION	Department	dep	2	SENT_16	[p2l8t1055r356b1120],
7	of	IN	ORGANIZATION	of	_	0	SENT_16	[p2l383t1054r447b1105],
8	Molecular	JJ	ORGANIZATION	molecular	amod	9	SENT_16	[p2l468t1054r772b1105],
9	Pharmacokinetics	NNS	ORGANIZATION	pharmacokinetic	prep_of	6	SENT_16	[p2l797t1054r1336b1115],
10	,	,	O	,	_	0	SENT_16	[p2l797t1054r1336b1115],
11	Graduate	NNP	ORGANIZATION	Graduate	nn	12	SENT_16	[p2l9t1140r277b1192],
12	School	NNP	ORGANIZATION	School	appos	9	SENT_16	[p2l306t1140r506b1192],
13	of	IN	ORGANIZATION	of	_	0	SENT_16	[p2l534t1140r598b1192],
14	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	15	SENT_16	[p2l619t1140r1074b1192],
15	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	12	SENT_16	[p2l1103t1140r1373b1201],
16	,	,	O	,	_	0	SENT_16	[p2l1103t1140r1373b1201],
17	The	DT	ORGANIZATION	the	det	18	SENT_16	[p2l8t1226r120b1278],
18	University	NNP	ORGANIZATION	University	appos	9	SENT_16	[p2l148t1226r457b1293],
19	of	IN	ORGANIZATION	of	_	0	SENT_16	[p2l485t1226r549b1278],
20	Tokyo	NNP	ORGANIZATION	Tokyo	nn	24	SENT_16	[p2l570t1226r777b1293],
21	,	,	O	,	_	0	SENT_16	[p2l570t1226r777b1293],
22	Tokyo	NNP	LOCATION	Tokyo	appos	24	SENT_16	[p2l806t1226r1012b1293],
23	,	,	O	,	_	0	SENT_16	[p2l806t1226r1012b1293],
24	Japan	NNP	LOCATION	Japan	prep_of	18	SENT_16	[p2l1041t1227r1208b1293],
25	19	CD	DATE	19	num	24	SENT_16	[p2l6t1336r70b1388],
26	July	NNP	DATE	July	tmod	24	SENT_16	[p2l98t1335r221b1403],
27	2008	CD	DATE	2008	num	26	SENT_16	[p2l249t1335r394b1388],

1	co-administration	NN	O	co-administration	nsubj	6	SENT_17	[p2l45t1562r667b1624],
2	of	IN	O	of	_	0	SENT_17	[p2l706t1562r782b1624],
3	olmesartan	NN	O	olmesartan	prep_of	1	SENT_17	[p2l815t1562r1201b1624],
4	does	VBZ	O	do	aux	6	SENT_17	[p2l1239t1562r1396b1624],
5	not	RB	O	not	neg	6	SENT_17	[p2l1435t1571r1546b1624],
6	affect	VB	O	affect	_	0	SENT_17	[p2l1585t1562r1784b1624],
7	the	DT	O	the	det	8	SENT_17	[p2l1821t1562r1926b1624],
8	pharmacokinetics	NNS	O	pharmacokinetic	dobj	6	SENT_17	[p2l1964t1562r2146b1642, p2l44t1672r508b1734],
9	of	IN	O	of	_	0	SENT_17	[p2l556t1672r631b1734],
10	pravastatin	NN	O	pravastatin	prep_of	8	SENT_17	[p2l669t1672r1057b1752],
11	or	CC	O	or	_	0	SENT_17	[p2l1102t1692r1174b1734],
12	its	PRP$	O	its	poss	13	SENT_17	[p2l1216t1672r1296b1734],
13	metabolite	NN	O	metabolite	dobj	6	SENT_17	[p2l1342t1672r1734b1746],
14	,	,	O	,	_	0	SENT_17	[p2l1342t1672r1734b1746],
15	RMS-416	NN	O	rms-416	appos	13	SENT_17	[p2l1781t1672r2146b1746],
16	,	,	O	,	_	0	SENT_17	[p2l1781t1672r2146b1746],
17	although	IN	O	although	mark	23	SENT_17	[p2l46t1782r352b1862],
18	larger	JJR	O	larger	amod	19	SENT_17	[p2l380t1782r585b1862],
19	scale	NN	O	scale	nsubjpass	23	SENT_17	[p2l615t1782r786b1844],
20	clinical	JJ	O	clinical	amod	21	SENT_17	[p2l815t1782r1073b1844],
21	studies	NNS	O	study	dep	19	SENT_17	[p2l1105t1782r1343b1844],
22	are	VBP	O	be	auxpass	23	SENT_17	[p2l1374t1802r1478b1844],
23	needed	VBN	O	need	advcl	6	SENT_17	[p2l1505t1782r1755b1844],
24	to	TO	O	to	aux	25	SENT_17	[p2l1782t1792r1847b1844],
25	conﬁrm	VB	O	conﬁrm	xcomp	23	SENT_17	[p2l1877t1782r2150b1844],
26	these	DT	O	these	det	27	SENT_17	[p2l44t1892r223b1954],
27	observations	NNS	O	observation	nsubj	28	SENT_17	[p2l244t1892r685b1954],
28	due	JJ	O	due	xcomp	25	SENT_17	[p2l706t1892r830b1954],
29	to	TO	O	to	_	0	SENT_17	[p2l849t1902r914b1954],
30	the	DT	O	the	det	33	SENT_17	[p2l933t1892r1038b1954],
31	small	JJ	O	small	amod	33	SENT_17	[p2l1061t1892r1247b1954],
32	sample	NN	O	sample	nn	33	SENT_17	[p2l1269t1892r1513b1972],
33	size	NN	O	size	prep_to	28	SENT_17	[p2l1536t1892r1667b1954],
34	in	IN	O	in	_	0	SENT_17	[p2l1686t1892r1753b1953],
35	the	DT	O	the	det	37	SENT_17	[p2l1771t1892r1876b1954],
36	present	JJ	DATE	present	amod	37	SENT_17	[p2l1894t1902r2150b1972],
37	study	NN	O	study	prep_in	33	SENT_17	[p2l47t2002r250b2082],
38	.	.	O	.	_	0	SENT_17	[p2l47t2002r250b2082],

1	Keywords	NNPS	O	Keywords	_	0	SENT_18	[p2l45t2223r424b2301],
2	Olmesartan	NNP	O	Olmesartan	dep	1	SENT_18	[p2l517t2223r921b2285],
3	-	:	O	-	_	0	SENT_18	[p2l952t2256r962b2266],
4	Pravastatin	NN	O	pravastatin	dep	1	SENT_18	[p2l991t2223r1383b2284],
5	-	:	O	-	_	0	SENT_18	[p2l1414t2256r1423b2266],
6	Pharmacokinetics	NNP	O	Pharmacokinetics	nn	7	SENT_18	[p2l1453t2222r2079b2284],
7	Interaction	NN	O	interaction	dep	4	SENT_18	[p2l2112t2256r2121b2266, p2l44t2332r426b2394],
8	-	:	O	-	_	0	SENT_18	[p2l465t2365r474b2375],
9	OATP1B1	NN	O	oatp1b1	dep	7	SENT_18	[p2l513t2333r878b2394],
10	-	:	O	-	_	0	SENT_18	[p2l924t2366r934b2375],
11	SLCOIBI	NN	O	slcoibus	dep	9	SENT_18	[p2l971t2333r1321b2394],
12	-	:	O	-	_	0	SENT_18	[p2l1365t2366r1375b2375],
13	Polymorphisms	NNS	O	polymorphism	dep	4	SENT_18	[p2l1412t2332r1962b2412],

1	Introduction	NN	O	introduction	_	0	SENT_19	[p2l44t2571r522b2633],

1	As	IN	O	as	mark	6	SENT_20	[p2l44t2793r138b2854],
2	hyperlipemia	NN	O	hyperlipemia	nsubj	6	SENT_20	[p2l172t2792r639b2872],
3	and	CC	O	and	_	0	SENT_20	[p2l674t2792r798b2854],
4	hypertension	NN	O	hypertension	conj_and	2	SENT_20	[p2l830t2792r1286b2872],
5	often	RB	O	often	advmod	6	SENT_20	[p2l1321t2792r1499b2854],
6	occur	VBP	O	occur	advcl	24	SENT_20	[p2l1534t2812r1728b2854],
7	together	RB	O	together	advmod	6	SENT_20	[p2l1760t2792r2050b2872],
8	in	IN	O	in	_	0	SENT_20	[p2l2082t2792r2149b2853],
9	the	DT	O	the	det	11	SENT_20	[p2l44t2902r150b2963],
10	same	JJ	O	same	amod	11	SENT_20	[p2l185t2921r361b2963],
11	patients	NNS	O	patient	prep_in	6	SENT_20	[p2l392t2902r686b2982],
12	,	,	O	,	_	0	SENT_20	[p2l392t2902r686b2982],
13	the	DT	O	the	det	15	SENT_20	[p2l721t2902r826b2963],
14	combination	NN	O	combination	nn	15	SENT_20	[p2l859t2902r1299b2963],
15	therapy	NN	O	therapy	nsubjpass	24	SENT_20	[p2l1331t2902r1592b2982],
16	of	IN	O	of	_	0	SENT_20	[p2l1627t2902r1702b2963],
17	lipidlowering	VBG	O	lipidlower	amod	18	SENT_20	[p2l1728t2902r2146b2982, p2l44t3012r154b3092],
18	drug	NN	O	drug	prep_of	15	SENT_20	[p2l196t3012r353b3092],
19	and	CC	O	and	_	0	SENT_20	[p2l397t3012r521b3073],
20	antihypertensive	JJ	O	antihypertensive	amod	21	SENT_20	[p2l562t3012r1143b3092],
21	drug	NN	O	drug	conj_and	18	SENT_20	[p2l1185t3012r1342b3092],
22	is	VBZ	O	be	auxpass	24	SENT_20	[p2l1384t3012r1438b3073],
23	frequently	RB	O	frequently	advmod	24	SENT_20	[p2l1481t3012r1842b3092],
24	used	VBN	O	use	_	0	SENT_20	[p2l1882t3012r2042b3073],
25	in	IN	O	in	_	0	SENT_20	[p2l2082t3012r2149b3073],
26	clinical	JJ	O	clinical	amod	27	SENT_20	[p2l45t3122r303b3183],
27	situations	NNS	O	situation	prep_in	24	SENT_20	[p2l334t3122r686b3183],
28	.	.	O	.	_	0	SENT_20	[p2l334t3122r686b3183],

1	Pravastatin	NNP	O	Pravastatin	nsubj	4	SENT_21	[p2l716t3122r1108b3183],
2	is	VBZ	O	be	cop	4	SENT_21	[p2l1135t3122r1189b3183],
3	an	DT	O	a	det	4	SENT_21	[p2l1220t3141r1299b3183],
4	inhibitor	NN	O	inhibitor	_	0	SENT_21	[p2l1326t3122r1631b3183],
5	of	IN	O	of	_	0	SENT_21	[p2l1657t3122r1733b3183],
6	3	CD	NUMBER	3	number	7	SENT_21	[p2l1757t3122r2146b3202, p2l47t3232r638b3312],
7	—	CD	NUMBER	—	num	11	SENT_21	[p2l1757t3122r2146b3202, p2l47t3232r638b3312],
8	hydroXy3-methylglutaryl	NN	O	hydroxy3-methylglutaryl	nn	11	SENT_21	[p2l1757t3122r2146b3202, p2l47t3232r638b3312],
9	coenzyme	NN	O	coenzyme	nn	11	SENT_21	[p2l669t3251r1024b3312],
10	A	NN	O	a	nn	11	SENT_21	[p2l1055t3233r1117b3293],
11	reductase	NN	O	reductase	prep_of	4	SENT_21	[p2l1145t3232r1478b3294],
12	used	VBN	O	use	partmod	11	SENT_21	[p2l1507t3232r1668b3294],
13	for	IN	O	for	_	0	SENT_21	[p2l1697t3232r1799b3294],
14	the	DT	O	the	det	15	SENT_21	[p2l1828t3232r1933b3294],
15	treatment	NN	O	treatment	prep_for	12	SENT_21	[p2l1964t3241r2146b3294, p2l44t3351r220b3404],
16	of	IN	O	of	_	0	SENT_21	[p2l252t3342r328b3404],
17	hypercholesterolemia	NN	O	hypercholesterolemia	prep_of	15	SENT_21	[p2l353t3342r1132b3422],
18	.	.	O	.	_	0	SENT_21	[p2l353t3342r1132b3422],

1	Although	IN	O	although	mark	6	SENT_22	[p2l1168t3342r1500b3422],
2	pravastatin	NN	O	pravastatin	nsubjpass	6	SENT_22	[p2l1531t3342r1918b3422],
3	is	VBZ	O	be	auxpass	6	SENT_22	[p2l1950t3342r2005b3404],
4	not	RB	O	not	neg	6	SENT_22	[p2l2038t3351r2150b3404],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_22	[p2l47t3452r479b3532],
6	metabolized	VBN	O	metabolize	advcl	18	SENT_22	[p2l513t3452r945b3514],
7	by	IN	O	by	_	0	SENT_22	[p2l976t3452r1063b3532],
8	cytochrome	NN	O	cytochrome	nn	9	SENT_22	[p2l1097t3452r1512b3532],
9	P450	NN	O	p450	agent	6	SENT_22	[p2l1546t3452r1724b3514],
10	(	CD	NUMBER	(	num	13	SENT_22	[p2l1761t3452r1982b3528],
11	CYP	NN	O	cyp	nn	13	SENT_22	[p2l1761t3452r1982b3528],
12	)	NN	O	)	nn	13	SENT_22	[p2l1761t3452r1982b3528],
13	isoenzymes	NNS	O	isoenzyme	dep	9	SENT_22	[p2l2019t3452r2146b3514, p2l45t3582r371b3642],
14	,	,	O	,	_	0	SENT_22	[p2l2019t3452r2146b3514, p2l45t3582r371b3642],
15	cumulative	JJ	O	cumulative	amod	16	SENT_22	[p2l405t3562r796b3624],
16	evidence	NN	O	evidence	nsubj	18	SENT_22	[p2l828t3562r1139b3624],
17	has	VBZ	O	have	aux	18	SENT_22	[p2l1171t3562r1284b3624],
18	suggested	VBN	O	suggest	_	0	SENT_22	[p2l1320t3562r1664b3642],
19	that	IN	O	that	complm	24	SENT_22	[p2l1694t3562r1825b3624],
20	multiple	JJ	O	multiple	amod	22	SENT_22	[p2l1854t3562r2148b3642],
21	membrane	NN	O	membrane	nn	22	SENT_22	[p2l44t3672r416b3734],
22	transporters	NNS	O	transporter	nsubjpass	24	SENT_22	[p2l476t3681r890b3752],
23	are	VBP	O	be	auxpass	24	SENT_22	[p2l953t3692r1056b3734],
24	involved	VBN	O	involve	ccomp	18	SENT_22	[p2l1117t3672r1426b3734],
25	in	IN	O	in	_	0	SENT_22	[p2l1485t3672r1552b3733],
26	the	DT	O	the	det	27	SENT_22	[p2l1611t3672r1717b3734],
27	absorption	NN	O	absorption	prep_in	24	SENT_22	[p2l1779t3672r2149b3752],

1	(	NNP	O	(	nn	2	SENT_23	[p3l47t22r448b102],
2	Kobayashi	NNP	PERSON	Kobayashi	_	0	SENT_23	[p3l47t22r448b102],
3	et	FW	O	et	nn	4	SENT_23	[p3l493t31r556b83],
4	al.	FW	O	al.	dep	2	SENT_23	[p3l601t22r678b84],
5	2003	CD	DATE	2003	num	6	SENT_23	[p3l728t22r948b98],
6	)	CD	NUMBER	)	dep	4	SENT_23	[p3l728t22r948b98],
7	,	,	O	,	_	0	SENT_23	[p3l728t22r948b98],
8	hepatobiliary	JJ	O	hepatobiliary	amod	9	SENT_23	[p3l995t22r1460b102],
9	excretion	NN	O	excretion	appos	6	SENT_23	[p3l1505t22r1832b83],
10	(	CD	NUMBER	(	dep	2	SENT_23	[p3l1879t22r2147b98],
11	Hirano	NNP	PERSON	Hirano	dep	10	SENT_23	[p3l1879t22r2147b98],
12	et	FW	O	et	nn	13	SENT_23	[p3l45t141r107b193],
13	al.	FW	O	al.	dep	2	SENT_23	[p3l131t132r209b193],
14	2005	CD	DATE	2005	dep	13	SENT_23	[p3l237t132r432b204],
15	;	:	O	;	_	0	SENT_23	[p3l237t132r432b204],
16	Kivisto	NNP	PERSON	Kivisto	dep	13	SENT_23	[p3l459t132r714b193],
17	et	FW	O	et	nn	18	SENT_23	[p3l740t141r802b193],
18	al.	FW	O	al.	dep	16	SENT_23	[p3l826t132r903b193],
19	2005	CD	DATE	2005	dep	16	SENT_23	[p3l932t132r1126b204],
20	;	:	O	;	_	0	SENT_23	[p3l932t132r1126b204],
21	Nakai	NNP	PERSON	Nakai	dep	13	SENT_23	[p3l1153t132r1361b193],
22	et	FW	O	et	nn	23	SENT_23	[p3l1385t141r1448b193],
23	al.	FW	O	al.	dep	21	SENT_23	[p3l1471t132r1549b193],
24	2001	CD	DATE	2001	num	25	SENT_23	[p3l1578t132r1799b207],
25	)	CD	NUMBER	)	dep	2	SENT_23	[p3l1578t132r1799b207],
26	,	,	O	,	_	0	SENT_23	[p3l1578t132r1799b207],
27	and	CC	O	and	_	0	SENT_23	[p3l1827t132r1951b193],
28	renal	JJ	O	renal	amod	29	SENT_23	[p3l1973t132r2148b193],
29	excretion	NN	O	excretion	conj_and	25	SENT_23	[p3l45t241r372b302],
30	(	CD	NUMBER	(	num	31	SENT_23	[p3l415t241r803b321],
31	Hasegawa	NNP	PERSON	Hasegawa	dep	2	SENT_23	[p3l415t241r803b321],
32	et	FW	O	et	nn	33	SENT_23	[p3l842t250r904b302],
33	al.	FW	O	al.	dep	31	SENT_23	[p3l943t241r1021b302],
34	2002	CD	DATE	2002	num	35	SENT_23	[p3l1067t241r1266b317],
35	)	NN	O	)	dep	2	SENT_23	[p3l1067t241r1266b317],
36	of	IN	O	of	_	0	SENT_23	[p3l1309t240r1385b302],
37	pravastatin	NN	O	pravastatin	prep_of	35	SENT_23	[p3l1417t241r1822b321],
38	.	.	O	.	_	0	SENT_23	[p3l1417t241r1822b321],

1	Organic	NNP	O	Organic	nn	2	SENT_24	[p3l1867t241r2147b321],
2	anion	NN	O	anion	nsubj	16	SENT_24	[p3l46t351r239b413],
3	transporting	VBG	O	transport	partmod	2	SENT_24	[p3l327t351r752b431],
4	polypeptide	NN	O	polypeptide	nn	6	SENT_24	[p3l840t351r1257b431],
5	(	CD	NUMBER	(	num	6	SENT_24	[p3l1349t352r1629b427],
6	OATP	NN	O	oatp	dobj	3	SENT_24	[p3l1349t352r1629b427],
7	)	CD	NUMBER	)	num	10	SENT_24	[p3l1349t352r1629b427],
8	1B1	NN	O	1b1	nn	10	SENT_24	[p3l1729t352r1858b412],
9	(	NN	O	(	nn	10	SENT_24	[p3l1957t352r2148b431],
10	gene	NN	O	gene	tmod	3	SENT_24	[p3l1957t352r2148b431],
11	SLCOIBI	NNP	O	SLCOIBI	dep	10	SENT_24	[p3l44t462r427b537],
12	)	CD	NUMBER	)	num	11	SENT_24	[p3l44t462r427b537],
13	is	VBZ	O	be	cop	16	SENT_24	[p3l464t461r519b523],
14	an	DT	O	a	det	16	SENT_24	[p3l557t480r636b523],
15	uptake	NN	O	uptake	nn	16	SENT_24	[p3l671t461r904b541],
16	transporter	NN	O	transporter	_	0	SENT_24	[p3l940t470r1323b541],
17	expressed	VBN	O	express	partmod	16	SENT_24	[p3l1357t461r1703b541],
18	at	IN	O	at	_	0	SENT_24	[p3l1739t470r1800b523],
19	the	DT	O	the	det	21	SENT_24	[p3l1833t461r1939b523],
20	sinusoidal	JJ	O	sinusoidal	amod	21	SENT_24	[p3l1978t461r2146b523, p3l47t571r252b633],
21	membrane	NN	O	membrane	prep_at	17	SENT_24	[p3l289t571r660b633],
22	of	IN	O	of	_	0	SENT_24	[p3l698t571r774b633],
23	hepatocytes	NNS	O	hepatocyte	prep_of	21	SENT_24	[p3l803t571r1239b651],
24	,	,	O	,	_	0	SENT_24	[p3l803t571r1239b651],
25	mediating	VBG	O	mediate	xcomp	17	SENT_24	[p3l1278t571r1630b651],
26	the	DT	O	the	det	27	SENT_24	[p3l1666t571r1771b633],
27	uptake	NN	O	uptake	dobj	25	SENT_24	[p3l1808t571r2041b651],
28	of	IN	O	of	_	0	SENT_24	[p3l2078t571r2154b633],
29	various	JJ	O	various	amod	33	SENT_24	[p3l44t681r300b743],
30	endogenous	JJ	O	endogenous	amod	33	SENT_24	[p3l349t681r766b761],
31	and	CC	O	and	_	0	SENT_24	[p3l815t681r939b743],
32	exogenous	JJ	O	exogenous	amod	33	SENT_24	[p3l985t701r1358b761],
33	substances	NNS	O	substance	prep_of	27	SENT_24	[p3l1409t681r1779b743],
34	from	IN	O	from	_	0	SENT_24	[p3l1828t681r1998b743],
35	the	DT	O	the	det	37	SENT_24	[p3l2043t681r2148b743],
36	blood	NN	O	blood	nn	37	SENT_24	[p3l43t791r244b853],
37	circulation	NN	O	circulation	prep_from	25	SENT_24	[p3l269t791r646b853],
38	into	IN	O	into	_	0	SENT_24	[p3l671t791r806b853],
39	hepatocytes	NNS	O	hepatocyte	prep_into	25	SENT_24	[p3l832t791r1247b871],
40	in	IN	O	in	_	0	SENT_24	[p3l1274t791r1341b852],
41	a	DT	O	a	det	43	SENT_24	[p3l1367t811r1404b853],
42	sodium	NN	O	sodium	nn	43	SENT_24	[p3l1431t791r2149b871],
43	—	NN	O	—	prep_in	39	SENT_24	[p3l1431t791r2149b871],
44	independent	JJ	O	independent	amod	45	SENT_24	[p3l1431t791r2149b871],
45	manner	NN	O	manner	dep	43	SENT_24	[p3l44t921r325b963],
46	.	.	O	.	_	0	SENT_24	[p3l44t921r325b963],

1	Previous	JJ	O	previous	amod	2	SENT_25	[p3l373t901r677b963],
2	study	NN	O	study	nsubj	4	SENT_25	[p3l725t901r911b981],
3	has	VBZ	O	have	aux	4	SENT_25	[p3l953t901r1067b963],
4	suggested	VBN	O	suggest	_	0	SENT_25	[p3l1115t901r1459b981],
5	that	IN	O	that	complm	9	SENT_25	[p3l1501t901r1633b963],
6	OATP1B1	NN	O	oatp1b1	nsubjpass	9	SENT_25	[p3l1676t902r2042b963],
7	is	VBZ	O	be	auxpass	9	SENT_25	[p3l2092t901r2147b963],
8	predominantly	RB	O	predominantly	advmod	9	SENT_25	[p3l43t1011r558b1091],
9	involved	VBN	O	involve	ccomp	4	SENT_25	[p3l588t1011r896b1073],
10	in	IN	O	in	_	0	SENT_25	[p3l925t1011r991b1072],
11	hepatic	JJ	O	hepatic	amod	12	SENT_25	[p3l1020t1011r1272b1091],
12	uptake	NN	O	uptake	prep_in	9	SENT_25	[p3l1303t1011r1536b1091],
13	of	IN	O	of	prep	12	SENT_25	[p3l1568t1011r1643b1072],
14	pravastatin	NN	O	pravastatin	dep	18	SENT_25	[p3l1666t1011r2053b1091],
15	in	IN	O	in	_	0	SENT_25	[p3l2082t1011r2149b1072],
16	humans	NNS	O	human	prep_in	14	SENT_25	[p3l44t1121r315b1183],
17	(	CD	NUMBER	(	dep	18	SENT_25	[p3l378t1121r612b1197],
18	Nakai	NNP	PERSON	Nakai	dep	22	SENT_25	[p3l378t1121r612b1197],
19	et	FW	O	et	nn	20	SENT_25	[p3l673t1130r735b1182],
20	al.	FW	O	al.	dep	18	SENT_25	[p3l794t1121r872b1183],
21	2001	CD	DATE	2001	num	22	SENT_25	[p3l936t1121r1156b1197],
22	)	CD	NUMBER	)	dep	13	SENT_25	[p3l936t1121r1156b1197],
23	.	.	O	.	_	0	SENT_25	[p3l936t1121r1156b1197],

1	Several	JJ	O	several	amod	3	SENT_26	[p3l1221t1121r1482b1183],
2	single-nucleotide	JJ	O	single-nucleotide	amod	3	SENT_26	[p3l1543t1121r2148b1201],
3	polymorphisms	NNS	O	polymorphism	nsubj	4	SENT_26	[p3l43t1231r590b1311],
4	(	VBP	O	(	_	0	SENT_26	[p3l631t1231r878b1307],
5	SNPs	NNS	O	snp	dobj	4	SENT_26	[p3l631t1231r878b1307],
6	)	CD	NUMBER	)	nsubjpass	9	SENT_26	[p3l631t1231r878b1307],
7	have	VBP	O	have	aux	9	SENT_26	[p3l917t1231r1081b1292],
8	been	VBN	O	be	auxpass	9	SENT_26	[p3l1118t1231r1284b1292],
9	identiﬁed	VBN	O	identiﬁed	rcmod	5	SENT_26	[p3l1320t1231r1653b1292],
10	in	IN	O	in	_	0	SENT_26	[p3l1690t1231r1757b1292],
11	SLCOIBI	NNP	O	SLCOIBI	prep_in	9	SENT_26	[p3l1794t1231r2141b1293],
12	(	CD	NUMBER	(	num	11	SENT_26	[p3l47t1342r363b1416],
13	Nozawa	NNP	PERSON	Nozawa	tmod	9	SENT_26	[p3l47t1342r363b1416],
14	et	FW	O	et	nn	15	SENT_26	[p3l404t1350r466b1402],
15	al.	FW	O	al.	nsubjpass	27	SENT_26	[p3l509t1341r587b1402],
16	2002	CD	DATE	2002	dep	15	SENT_26	[p3l634t1342r828b1413],
17	;	:	O	;	_	0	SENT_26	[p3l634t1342r828b1413],
18	Tirona	NNP	O	Tirona	nsubjpass	27	SENT_26	[p3l874t1341r1110b1402],
19	et	FW	O	et	nn	20	SENT_26	[p3l1151t1351r1213b1402],
20	al.	FW	O	al.	dep	18	SENT_26	[p3l1257t1341r1334b1402],
21	2001	CD	DATE	2001	num	22	SENT_26	[p3l1382t1342r1603b1416],
22	)	CD	NUMBER	)	dep	18	SENT_26	[p3l1382t1342r1603b1416],
23	,	,	O	,	_	0	SENT_26	[p3l1382t1342r1603b1416],
24	and	CC	O	and	_	0	SENT_26	[p3l1651t1341r1775b1402],
25	some	DT	O	some	nsubjpass	27	SENT_26	[p3l1819t1361r2000b1402],
26	are	VBP	O	be	auxpass	27	SENT_26	[p3l2045t1361r2148b1402],
27	reported	VBN	O	report	rcmod	13	SENT_26	[p3l43t1450r338b1530],
28	to	TO	O	to	aux	30	SENT_26	[p3l424t1459r489b1512],
29	be	VB	O	be	auxpass	30	SENT_26	[p3l576t1450r657b1512],
30	associated	VBN	O	associate	xcomp	27	SENT_26	[p3l747t1450r1107b1512],
31	with	IN	O	with	_	0	SENT_26	[p3l1194t1450r1348b1512],
32	alterations	NNS	O	alteration	prep_with	30	SENT_26	[p3l1437t1450r1801b1512],
33	in	IN	O	in	_	0	SENT_26	[p3l1889t1450r1956b1511],
34	the	DT	O	the	prep_in	32	SENT_26	[p3l2043t1450r2148b1512],

1	Q	NNP	O	Q	nn	2	SENT_27	[p3l1786t1689r1862b1783],
2	Springer	NNP	O	Springer	_	0	SENT_27	[p3l1891t1712r2149b1786],

1	900	CD	NUMBER	900	num	2	SENT_28	[p3l53t1861r104b1887],
2	J	NN	O	j	_	0	SENT_28	[p3l1629t1862r1642b1887],
3	Hum	NNP	PERSON	Hum	nn	4	SENT_28	[p3l1655t1862r1725b1886],
4	Genet	NNP	PERSON	Genet	dep	2	SENT_28	[p3l1738t1861r1821b1887],
5	(	CD	NUMBER	(	num	6	SENT_28	[p3l1835t1861r1926b1892],
6	2008	CD	DATE	2008	dep	4	SENT_28	[p3l1835t1861r1926b1892],
7	)	CD	NUMBER	)	num	8	SENT_28	[p3l1835t1861r1926b1892],
8	532899-904	CD	NUMBER	532899-904	dep	2	SENT_28	[p3l1940t1861r2107b1887],

1	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_29	[p3l6t2030r640b2111],
2	of	IN	O	of	_	0	SENT_29	[p3l707t2030r784b2093],
3	certain	JJ	O	certain	amod	5	SENT_29	[p3l842t2030r1085b2093],
4	substrate	NN	O	substrate	nn	5	SENT_29	[p3l1151t2030r1465b2093],
5	drugs	NNS	O	drug	prep_of	1	SENT_29	[p3l1530t2030r1746b2111],
6	,	,	O	,	_	0	SENT_29	[p3l1530t2030r1746b2111],
7	including	VBG	O	include	_	0	SENT_29	[p3l1812t2030r2150b2111],
8	repaglinide	NN	O	repaglinide	nn	10	SENT_29	[p3l6t2141r411b2222],
9	(	CD	NUMBER	(	num	10	SENT_29	[p3l439t2141r688b2219],
10	Niemi	NNP	PERSON	Niemi	prep_including	1	SENT_29	[p3l439t2141r688b2219],
11	et	FW	O	et	nn	14	SENT_29	[p3l714t2151r778b2204],
12	al.	FW	O	al.	nn	14	SENT_29	[p3l803t2141r882b2204],
13	2005a	FW	O	2005a	nn	14	SENT_29	[p3l913t2141r1179b2219],
14	)	FW	O	)	dep	10	SENT_29	[p3l913t2141r1179b2219],
15	,	,	O	,	_	0	SENT_29	[p3l913t2141r1179b2219],
16	fexofenadine	NN	O	fexofenadine	nn	18	SENT_29	[p3l1207t2141r1674b2204],
17	(	CD	NUMBER	(	num	18	SENT_29	[p3l1703t2141r1952b2219],
18	Niemi	NNP	PERSON	Niemi	conj_and	10	SENT_29	[p3l1703t2141r1952b2219],
19	et	FW	O	et	nn	22	SENT_29	[p3l1979t2151r2042b2204],
20	al.	FW	O	al.	nn	22	SENT_29	[p3l2067t2141r2147b2204],
21	2005b	FW	O	2005b	nn	22	SENT_29	[p3l9t2252r279b2329],
22	)	FW	O	)	dep	18	SENT_29	[p3l9t2252r279b2329],
23	,	,	O	,	_	0	SENT_29	[p3l9t2252r279b2329],
24	pitavastatin	NN	O	pitavastatin	nn	26	SENT_29	[p3l315t2252r731b2333],
25	(	CD	NUMBER	(	num	26	SENT_29	[p3l768t2252r1032b2333],
26	Chung	NNP	PERSON	Chung	conj_and	10	SENT_29	[p3l768t2252r1032b2333],
27	et	FW	O	et	nn	28	SENT_29	[p3l1068t2261r1131b2314],
28	al.	FW	O	al.	dep	26	SENT_29	[p3l1166t2252r1245b2314],
29	2005	CD	DATE	2005	dep	26	SENT_29	[p3l1286t2252r1483b2326],
30	;	:	O	;	_	0	SENT_29	[p3l1286t2252r1483b2326],
31	Ieiri	NNP	O	Ieiri	conj_and	10	SENT_29	[p3l1521t2252r1668b2314],
32	et	FW	O	et	nn	33	SENT_29	[p3l1705t2261r1768b2314],
33	al.	FW	O	al.	dep	31	SENT_29	[p3l1803t2252r1882b2314],
34	2007	CD	DATE	2007	num	35	SENT_29	[p3l1922t2252r2148b2329],
35	)	CD	NUMBER	)	dep	31	SENT_29	[p3l1922t2252r2148b2329],
36	,	,	O	,	_	0	SENT_29	[p3l1922t2252r2148b2329],
37	and	CC	O	and	_	0	SENT_29	[p3l9t2363r136b2425],
38	pravastatin	NN	O	pravastatin	nn	40	SENT_29	[p3l177t2363r571b2444],
39	(	CD	NUMBER	(	num	40	SENT_29	[p3l617t2363r925b2444],
40	Mwinyi	NNP	PERSON	Mwinyi	conj_and	10	SENT_29	[p3l617t2363r925b2444],
41	et	FW	O	et	nn	42	SENT_29	[p3l970t2372r1033b2425],
42	al.	FW	O	al.	dep	40	SENT_29	[p3l1077t2363r1156b2425],
43	2004	CD	DATE	2004	dep	40	SENT_29	[p3l1204t2363r1402b2437],
44	;	:	O	;	_	0	SENT_29	[p3l1204t2363r1402b2437],
45	Niemi	NNP	PERSON	Niemi	dep	1	SENT_29	[p3l1448t2363r1671b2426],
46	et	FW	O	et	nn	47	SENT_29	[p3l1715t2372r1779b2425],
47	al.	FW	O	al.	dep	45	SENT_29	[p3l1822t2363r1900b2425],
48	2004	CD	DATE	2004	dep	45	SENT_29	[p3l1949t2363r2147b2437],
49	;	:	O	;	_	0	SENT_29	[p3l1949t2363r2147b2437],
50	Nishizato	NNP	O	Nishizato	dep	1	SENT_29	[p3l7t2473r350b2535],
51	et	FW	O	et	nn	52	SENT_29	[p3l430t2482r493b2535],
52	al.	FW	O	al.	dep	50	SENT_29	[p3l573t2473r652b2535],
53	2003	CD	DATE	2003	num	54	SENT_29	[p3l736t2473r960b2550],
54	)	CD	NUMBER	)	dep	50	SENT_29	[p3l736t2473r960b2550],
55	.	.	O	.	_	0	SENT_29	[p3l736t2473r960b2550],

1	Particularly	RB	O	particularly	advmod	20	SENT_30	[p3l1043t2473r1462b2554],
2	subjects	NNS	O	subject	nsubj	20	SENT_30	[p3l1544t2473r1828b2554],
3	having	VBG	O	have	partmod	2	SENT_30	[p3l1907t2472r2150b2554],
4	SLCOIB	NNP	O	SLCOIB	nsubj	9	SENT_30	[p3l7t2585r501b2648],
5	]	CD	NUMBER	]	num	4	SENT_30	[p3l7t2585r501b2648],
6	*	CD	NUMBER	*	num	8	SENT_30	[p3l7t2585r501b2648],
7	l5	NN	O	l5	nn	8	SENT_30	[p3l7t2585r501b2648],
8	allele	NN	O	allele	dep	4	SENT_30	[p3l593t2585r785b2648],
9	(	CD	NUMBER	(	xcomp	3	SENT_30	[p3l874t2585r1282b2666],
10	possessing	VBG	O	possess	partmod	9	SENT_30	[p3l874t2585r1282b2666],
11	both	DT	O	both	det	12	SENT_30	[p3l1369t2585r1529b2648],
12	388A	NN	O	388a	dobj	10	SENT_30	[p3l1617t2586r1937b2648],
13	>	JJR	O	>	amod	14	SENT_30	[p3l1617t2586r1937b2648],
14	G	NN	O	g	dep	12	SENT_30	[p3l1617t2586r1937b2648],
15	and	CC	O	and	_	0	SENT_30	[p3l2025t2585r2151b2648],
16	521T	NN	O	521t	conj_and	12	SENT_30	[p3l9t2696r342b2773],
17	>	JJR	O	>	amod	19	SENT_30	[p3l9t2696r342b2773],
18	C	NN	O	c	nn	19	SENT_30	[p3l9t2696r342b2773],
19	)	NN	O	)	dep	16	SENT_30	[p3l9t2696r342b2773],
20	showed	VBD	O	show	_	0	SENT_30	[p3l370t2696r639b2759],
21	elevated	JJ	O	elevated	amod	23	SENT_30	[p3l662t2696r960b2759],
22	systemic	JJ	O	systemic	amod	23	SENT_30	[p3l986t2696r1293b2777],
23	exposure	NN	O	exposure	dobj	20	SENT_30	[p3l1319t2716r1639b2777],
24	of	IN	O	of	_	0	SENT_30	[p3l1664t2696r1741b2759],
25	pravastatin	NN	O	pravastatin	prep_of	23	SENT_30	[p3l1756t2696r2151b2777],
26	as	IN	O	as	_	0	SENT_30	[p3l9t2827r78b2870],
27	compared	VBN	O	compare	prepc_as	20	SENT_30	[p3l121t2807r475b2888],
28	to	TO	O	to	pcomp	27	SENT_30	[p3l514t2817r581b2870],
29	subjects	NNS	O	subject	pobj	28	SENT_30	[p3l626t2807r908b2888],
30	without	IN	O	without	prep	28	SENT_30	[p3l951t2807r1225b2870],
31	this	DT	O	this	det	32	SENT_30	[p3l1265t2807r1391b2870],
32	allele	NN	O	allele	dep	36	SENT_30	[p3l1435t2807r1627b2870],
33	(	CD	NUMBER	(	dep	32	SENT_30	[p3l1671t2807r1920b2884],
34	Niemi	NNP	PERSON	Niemi	dep	36	SENT_30	[p3l1671t2807r1920b2884],
35	et	FW	O	et	nn	36	SENT_30	[p3l1963t2817r2026b2870],
36	al.	FW	O	al.	dep	43	SENT_30	[p3l2067t2807r2147b2870],
37	2004	CD	DATE	2004	dep	36	SENT_30	[p3l8t2919r206b2993],
38	;	:	O	;	_	0	SENT_30	[p3l8t2919r206b2993],
39	Nishizato	NNP	O	Nishizato	dep	37	SENT_30	[p3l260t2918r603b2981],
40	et	FW	O	et	nn	41	SENT_30	[p3l655t2928r719b2981],
41	al.	FW	O	al.	dep	39	SENT_30	[p3l770t2918r849b2981],
42	2003	CD	DATE	2003	num	43	SENT_30	[p3l906t2919r1130b2996],
43	)	CD	NUMBER	)	dep	30	SENT_30	[p3l906t2919r1130b2996],
44	.	.	O	.	_	0	SENT_30	[p3l906t2919r1130b2996],

1	In	IN	O	in	_	0	SENT_31	[p3l1185t2920r1258b2980],
2	contrast	NN	O	contrast	prep_in	6	SENT_31	[p3l1309t2928r1610b2992],
3	,	,	O	,	_	0	SENT_31	[p3l1309t2928r1610b2992],
4	some	DT	O	some	det	5	SENT_31	[p3l1668t2938r1851b2981],
5	reports	NNS	O	report	nsubj	6	SENT_31	[p3l1902t2928r2149b2999],
6	indicated	VBD	O	indicate	_	0	SENT_31	[p3l7t3029r336b3092],
7	that	IN	O	that	_	0	SENT_31	[p3l382t3029r516b3092],
8	SLCOIBI	NNP	O	SLCOIBI	prep_that	6	SENT_31	[p3l560t3030r916b3093],
9	*	CD	NUMBER	*	num	8	SENT_31	[p3l934t3029r1056b3092],
10	1	CD	NUMBER	1	num	11	SENT_31	[p3l934t3029r1056b3092],
11	]	NN	O	]	dobj	6	SENT_31	[p3l934t3029r1056b3092],
12	?	.	O	?	_	0	SENT_31	[p3l934t3029r1056b3092],

1	allele	NN	O	allele	nsubj	8	SENT_32	[p3l1105t3029r1296b3092],
2	(	CD	NUMBER	(	num	1	SENT_32	[p3l1345t3029r1752b3110],
3	possessing	VBG	O	possess	partmod	1	SENT_32	[p3l1345t3029r1752b3110],
4	388A	NN	O	388a	dobj	3	SENT_32	[p3l1802t3030r2148b3107],
5	>	JJR	O	>	amod	7	SENT_32	[p3l1802t3030r2148b3107],
6	G	NN	O	g	nn	7	SENT_32	[p3l1802t3030r2148b3107],
7	)	NN	O	)	dep	4	SENT_32	[p3l1802t3030r2148b3107],
8	showed	VBD	O	show	_	0	SENT_32	[p3l10t3140r280b3203],
9	enhanced	VBN	O	enhance	amod	11	SENT_32	[p3l314t3140r652b3202],
10	transport	NN	O	transport	nn	11	SENT_32	[p3l685t3149r1005b3221],
11	activity	NN	O	activity	dobj	8	SENT_32	[p3l1039t3140r1305b3221],
12	of	IN	O	of	_	0	SENT_32	[p3l1341t3140r1419b3202],
13	OATPIB1	NN	O	oatpib1	prep_of	11	SENT_32	[p3l1448t3140r1820b3203],
14	as	IN	O	as	prep	8	SENT_32	[p3l1864t3159r1932b3202],
15	compared	VBN	O	compare	_	0	SENT_32	[p3l1969t3159r2148b3202, p3l6t3251r205b3332],
16	with	IN	O	with	prepc_compared_with	8	SENT_32	[p3l241t3251r398b3313],
17	wild	JJ	O	wild	amod	19	SENT_32	[p3l434t3251r776b3332],
18	—	NN	O	—	nn	19	SENT_32	[p3l434t3251r776b3332],
19	type	NN	O	type	dep	31	SENT_32	[p3l434t3251r776b3332],
20	allele	NN	O	allele	dep	19	SENT_32	[p3l814t3251r1006b3313],
21	(	CD	NUMBER	(	num	20	SENT_32	[p3l1044t3251r1198b3328],
22	i.e.	FW	O	i.e.	dep	20	SENT_32	[p3l1044t3251r1198b3328],
23	,	,	O	,	_	0	SENT_32	[p3l1044t3251r1198b3328],
24	*	CD	NUMBER	*	num	26	SENT_32	[p3l1241t3251r1366b3313],
25	1a	NN	O	1a	nn	26	SENT_32	[p3l1241t3251r1366b3313],
26	allele	NN	O	allele	appos	22	SENT_32	[p3l1401t3251r1621b3328],
27	)	CD	NUMBER	)	number	28	SENT_32	[p3l1401t3251r1621b3328],
28	(	CD	NUMBER	(	dep	26	SENT_32	[p3l1662t3251r1933b3328],
29	Maeda	NNP	PERSON	Maeda	dep	31	SENT_32	[p3l1662t3251r1933b3328],
30	et	FW	O	et	nn	31	SENT_32	[p3l1968t3260r2031b3313],
31	al.	FW	O	al.	dep	38	SENT_32	[p3l2067t3251r2147b3313],
32	2006	CD	DATE	2006	dep	31	SENT_32	[p3l9t3362r206b3436],
33	;	:	O	;	_	0	SENT_32	[p3l9t3362r206b3436],
34	Mwinyi	NNP	PERSON	Mwinyi	dep	32	SENT_32	[p3l239t3362r521b3443],
35	et	FW	O	et	nn	36	SENT_32	[p3l552t3371r615b3424],
36	al.	FW	O	al.	dep	34	SENT_32	[p3l646t3362r725b3424],
37	2004	CD	DATE	2004	num	38	SENT_32	[p3l760t3362r984b3439],
38	)	CD	NUMBER	)	dep	8	SENT_32	[p3l760t3362r984b3439],
39	.	.	O	.	_	0	SENT_32	[p3l760t3362r984b3439],

1	Olmesartan	JJ	O	olmesartan	amod	2	SENT_33	[p3l111t3473r523b3536],
2	medoxomil	NN	O	medoxomil	nsubj	8	SENT_33	[p3l576t3473r984b3536],
3	is	VBZ	O	be	cop	8	SENT_33	[p3l1037t3473r1092b3536],
4	an	DT	O	a	det	8	SENT_33	[p3l1148t3493r1229b3536],
5	angiotensin	NN	O	angiotensin	nn	8	SENT_33	[p3l1283t3473r1695b3554],
6	II	CD	NUMBER	ii	num	8	SENT_33	[p3l1748t3475r1805b3535],
7	receptor	NN	O	receptor	nn	8	SENT_33	[p3l1856t3483r2153b3554],
8	blocker	NN	O	blocker	_	0	SENT_33	[p3l6t3584r277b3647],
9	used	VBN	O	use	partmod	8	SENT_33	[p3l302t3584r466b3647],
10	for	IN	O	for	_	0	SENT_33	[p3l493t3584r597b3647],
11	the	DT	O	the	det	12	SENT_33	[p3l622t3584r730b3647],
12	treatment	NN	O	treatment	prep_for	9	SENT_33	[p3l758t3594r1098b3647],
13	of	IN	O	of	_	0	SENT_33	[p3l1125t3584r1203b3647],
14	hypertension	NN	O	hypertension	prep_of	12	SENT_33	[p3l1224t3584r1705b3665],
15	.	.	O	.	_	0	SENT_33	[p3l1224t3584r1705b3665],

1	Olmesartan	JJ	O	olmesartan	amod	2	SENT_34	[p3l1739t3584r2151b3647],
2	medoxomil	NN	O	medoxomil	nsubj	6	SENT_34	[p3l7t3695r415b3758],
3	is	VBZ	O	be	cop	6	SENT_34	[p3l442t3695r497b3758],
4	completely	RB	O	completely	advmod	6	SENT_34	[p3l526t3695r924b3776],
5	de	IN	O	de	amod	6	SENT_34	[p3l952t3695r1395b3758],
6	—	CD	NUMBER	—	_	0	SENT_34	[p3l952t3695r1395b3758],
7	esteriﬁed	VBN	O	esteriﬁed	partmod	6	SENT_34	[p3l952t3695r1395b3758],
8	during	IN	O	during	_	0	SENT_34	[p3l1422t3695r1652b3776],
9	absorption	NN	O	absorption	prep_during	7	SENT_34	[p3l1681t3695r2058b3776],
10	to	TO	O	to	aux	11	SENT_34	[p3l2083t3704r2149b3758],
11	form	VB	O	form	xcomp	7	SENT_34	[p4l8t21r181b84],
12	olmesartan	NN	O	olmesartan	dobj	11	SENT_34	[p4l227t22r639b96],
13	,	,	O	,	_	0	SENT_34	[p4l227t22r639b96],
14	a	DT	O	a	det	17	SENT_34	[p4l690t41r727b84],
15	pharmacologically	RB	O	pharmacologically	advmod	16	SENT_34	[p4l771t22r1442b103],
16	active	JJ	O	active	amod	17	SENT_34	[p4l1491t22r1701b84],
17	metabolite	NN	O	metabolite	appos	6	SENT_34	[p4l1749t22r2148b96],
18	,	,	O	,	_	0	SENT_34	[p4l1749t22r2148b96],
19	which	WDT	O	which	nsubjpass	21	SENT_34	[p4l8t134r225b197],
20	is	VBZ	O	be	auxpass	21	SENT_34	[p4l284t134r340b197],
21	excreted	VBN	O	excrete	rcmod	6	SENT_34	[p4l402t134r706b197],
22	by	IN	O	by	prep	21	SENT_34	[p4l763t134r851b215],
23	hepatobiliary	NN	O	hepatobiliary	nn	26	SENT_34	[p4l909t134r1383b215],
24	and	CC	O	and	_	0	SENT_34	[p4l1446t134r1572b197],
25	renal	JJ	O	renal	nn	26	SENT_34	[p4l1630t134r1808b197],
26	systems	NNS	O	system	dep	31	SENT_34	[p4l1872t144r2149b215],
27	without	IN	O	without	_	0	SENT_34	[p4l8t245r282b308],
28	further	JJ	O	further	amod	29	SENT_34	[p4l305t245r549b308],
29	metabolism	NN	O	metabolism	prep_without	26	SENT_34	[p4l573t245r993b308],
30	(	CD	NUMBER	(	dep	31	SENT_34	[p4l1020t245r1238b323],
31	Laeis	NNP	O	Laeis	dep	35	SENT_34	[p4l1020t245r1238b323],
32	et	FW	O	et	nn	33	SENT_34	[p4l1266t255r1329b308],
33	al.	FW	O	al.	dep	31	SENT_34	[p4l1355t245r1434b308],
34	2001	CD	DATE	2001	num	35	SENT_34	[p4l1465t246r1689b323],
35	)	CD	NUMBER	)	dep	22	SENT_34	[p4l1465t246r1689b323],
36	.	.	O	.	_	0	SENT_34	[p4l1465t246r1689b323],

1	At	IN	O	at	quantmod	3	SENT_35	[p4l1718t246r1806b308],
2	least	JJS	O	least	mwe	1	SENT_35	[p4l1831t245r1994b308],
3	two	CD	NUMBER	two	num	5	SENT_35	[p4l2019t255r2150b308],
4	uptake	NN	O	uptake	nn	5	SENT_35	[p4l7t357r244b438],
5	transporters	NNS	O	transporter	nsubjpass	13	SENT_35	[p4l281t366r722b438],
6	,	,	O	,	_	0	SENT_35	[p4l281t366r722b438],
7	OATP1B1	NN	O	oatp1b1	appos	5	SENT_35	[p4l763t357r1135b420],
8	and	CC	O	and	_	0	SENT_35	[p4l1180t357r1306b419],
9	OATPIB3	NN	O	oatpib3	appos	5	SENT_35	[p4l1342t357r1741b431],
10	,	,	O	,	_	0	SENT_35	[p4l1342t357r1741b431],
11	have	VBP	O	have	aux	13	SENT_35	[p4l1780t357r1947b420],
12	been	VBN	O	be	auxpass	13	SENT_35	[p4l1982t357r2151b419],
13	demonstrated	VBN	O	demonstrate	_	0	SENT_35	[p4l8t468r492b530],
14	to	TO	O	to	aux	15	SENT_35	[p4l526t477r593b530],
15	account	VB	O	account	xcomp	13	SENT_35	[p4l632t477r909b530],
16	for	IN	O	for	_	0	SENT_35	[p4l944t468r1048b530],
17	hepatic	JJ	O	hepatic	amod	18	SENT_35	[p4l1081t468r1338b549],
18	uptake	NN	O	uptake	prep_for	15	SENT_35	[p4l1375t468r1612b549],
19	of	IN	O	of	_	0	SENT_35	[p4l1650t468r1727b530],
20	olmesartan	NN	O	olmesartan	prep_of	18	SENT_35	[p4l1758t468r2151b530],
21	(	CD	NUMBER	(	num	20	SENT_35	[p4l10t579r772b660],
22	Nakagomi	NNP	PERSON	Nakagomi	dep	20	SENT_35	[p4l10t579r772b660],
23	.	.	O	.	_	0	SENT_35	[p4l10t579r772b660],

1	—	NN	O	—	_	0	SENT_36	[p4l10t579r772b660],
2	.	.	O	.	_	0	SENT_36	[p4l10t579r772b660],

1	Hagihara	NNP	O	Hagihara	dep	3	SENT_37	[p4l10t579r772b660],
2	et	FW	O	et	nn	3	SENT_37	[p4l804t588r867b641],
3	al.	FW	O	al.	_	0	SENT_37	[p4l900t579r979b641],
4	2006	CD	DATE	2006	dep	3	SENT_37	[p4l1017t579r1214b653],
5	;	:	O	;	_	0	SENT_37	[p4l1017t579r1214b653],
6	Yamada	NNP	PERSON	Yamada	dep	8	SENT_37	[p4l1251t579r1550b641],
7	et	FW	O	et	nn	8	SENT_37	[p4l1581t588r1644b641],
8	al.	FW	O	al.	parataxis	3	SENT_37	[p4l1677t579r1756b641],
9	2007	CD	DATE	2007	num	10	SENT_37	[p4l1794t579r2018b656],
10	)	CD	NUMBER	)	dep	8	SENT_37	[p4l1794t579r2018b656],
11	.	.	O	.	_	0	SENT_37	[p4l1794t579r2018b656],

1	As	IN	O	as	mark	5	SENT_38	[p4l2054t579r2149b641],
2	pravastatin	NN	O	pravastatin	nsubj	5	SENT_38	[p4l6t690r401b771],
3	and	CC	O	and	_	0	SENT_38	[p4l423t690r550b753],
4	olmesartan	NN	O	olmesartan	conj_and	2	SENT_38	[p4l571t690r964b753],
5	share	VBP	O	share	csubj	9	SENT_38	[p4l987t690r1171b753],
6	some	DT	O	some	det	8	SENT_38	[p4l1196t710r1379b753],
7	transporter	NN	O	transporter	nn	8	SENT_38	[p4l1400t690r2152b771],
8	—	NN	O	—	dobj	5	SENT_38	[p4l1400t690r2152b771],
9	mediated	VBD	O	mediate	_	0	SENT_38	[p4l1400t690r2152b771],
10	transport	NN	O	transport	nn	11	SENT_38	[p4l7t810r326b882],
11	pathways	NNS	O	pathway	dobj	9	SENT_38	[p4l356t801r713b882],
12	,	,	O	,	_	0	SENT_38	[p4l356t801r713b882],
13	such	JJ	O	such	_	0	SENT_38	[p4l752t801r911b864],
14	as	IN	O	as	_	0	SENT_38	[p4l944t821r1013b864],
15	hepatic	JJ	O	hepatic	amod	16	SENT_38	[p4l1046t801r1303b882],
16	uptake	NN	O	uptake	prep_such_as	11	SENT_38	[p4l1337t801r1574b882],
17	via	IN	O	via	_	0	SENT_38	[p4l1608t801r1716b864],
18	OATPlBl	NNP	O	OATPlBl	prep_via	16	SENT_38	[p4l1748t801r2148b875],
19	,	,	O	,	_	0	SENT_38	[p4l1748t801r2148b875],
20	the	DT	O	the	det	23	SENT_38	[p4l7t912r114b975],
21	co	NN	O	co	nn	23	SENT_38	[p4l150t912r784b975],
22	—	NN	O	—	nn	23	SENT_38	[p4l150t912r784b975],
23	administration	NN	O	administration	appos	18	SENT_38	[p4l150t912r784b975],
24	of	IN	O	of	prep	23	SENT_38	[p4l819t912r896b975],
25	both	CC	O	both	dep	24	SENT_38	[p4l923t912r1082b975],
26	drugs	NNS	O	drug	conj	24	SENT_38	[p4l1117t912r1311b993],
27	may	MD	O	may	aux	29	SENT_38	[p4l1347t932r1499b993],
28	potentially	RB	O	potentially	advmod	29	SENT_38	[p4l1533t912r1917b993],
29	cause	VB	O	cause	rcmod	26	SENT_38	[p4l1954t932r2150b975],
30	drug	NN	O	drug	nn	33	SENT_38	[p4l8t1023r378b1104],
31	—	NN	O	—	nn	33	SENT_38	[p4l8t1023r378b1104],
32	drug	NN	O	drug	nn	33	SENT_38	[p4l8t1023r378b1104],
33	interactions	NNS	O	interaction	dobj	29	SENT_38	[p4l410t1023r848b1097],
34	,	,	O	,	_	0	SENT_38	[p4l410t1023r848b1097],
35	which	WDT	O	which	nsubj	38	SENT_38	[p4l883t1023r1100b1086],
36	may	MD	O	may	aux	38	SENT_38	[p4l1130t1043r1282b1104],
37	consequently	RB	O	consequently	advmod	38	SENT_38	[p4l1314t1023r1786b1104],
38	modulate	VB	O	modulate	rcmod	33	SENT_38	[p4l1817t1023r2150b1086],
39	the	DT	O	the	det	40	SENT_38	[p4l7t1134r114b1197],
40	pharmacokinetics	NNS	O	pharmacokinetic	dobj	38	SENT_38	[p4l142t1134r776b1215],
41	or	CC	O	or	_	0	SENT_38	[p4l807t1154r880b1197],
42	pharmacodynamics	NNS	O	pharmacodynamic	conj_or	40	SENT_38	[p4l906t1134r1604b1215],
43	of	IN	O	of	prep	24	SENT_38	[p4l1635t1134r1712b1197],
44	either	CC	O	either	dep	43	SENT_38	[p4l1735t1134r1939b1197],
45	drug	NN	O	drug	conj	43	SENT_38	[p4l1967t1134r2146b1215],
46	.	.	O	.	_	0	SENT_38	[p4l1967t1134r2146b1215],

1	Therefore	RB	O	therefore	advmod	7	SENT_39	[p4l7t1245r380b1319],
2	,	,	O	,	_	0	SENT_39	[p4l7t1245r380b1319],
3	this	DT	O	this	det	5	SENT_39	[p4l417t1245r543b1308],
4	exploratory	JJ	O	exploratory	amod	5	SENT_39	[p4l580t1245r992b1326],
5	study	NN	O	study	nsubjpass	7	SENT_39	[p4l1030t1245r1218b1326],
6	was	VBD	O	be	auxpass	7	SENT_39	[p4l1254t1265r1388b1308],
7	performed	VBN	O	perform	_	0	SENT_39	[p4l1423t1245r1797b1326],
8	to	TO	O	to	aux	9	SENT_39	[p4l1832t1255r1898b1308],
9	investigate	VB	O	investigate	xcomp	7	SENT_39	[p4l1933t1245r2148b1308, p4l7t1356r205b1437],
10	the	DT	O	the	det	12	SENT_39	[p4l238t1356r345b1418],
11	pharmacokinetic	JJ	O	pharmacokinetic	amod	12	SENT_39	[p4l377t1356r976b1437],
12	interaction	NN	O	interaction	dobj	9	SENT_39	[p4l1010t1356r1395b1418],
13	between	IN	O	between	_	0	SENT_39	[p4l1426t1356r1725b1419],
14	pravastatin	NN	O	pravastatin	prep_between	12	SENT_39	[p4l1756t1356r2151b1437],
15	and	CC	O	and	_	0	SENT_39	[p4l9t1467r136b1530],
16	olmesartan	NN	O	olmesartan	prep_between	12	SENT_39	[p4l167t1467r577b1530],
17	.	.	O	.	_	0	SENT_39	[p4l167t1467r577b1530],

1	In	IN	O	in	_	0	SENT_40	[p4l614t1468r686b1529],
2	addition	NN	O	addition	prep_in	23	SENT_40	[p4l719t1467r1028b1541],
3	,	,	O	,	_	0	SENT_40	[p4l719t1467r1028b1541],
4	since	IN	O	since	_	0	SENT_40	[p4l1067t1467r1246b1530],
5	the	DT	O	the	det	6	SENT_40	[p4l1278t1467r1385b1530],
6	effects	NNS	O	effect	prep_since	19	SENT_40	[p4l1417t1467r1652b1530],
7	of	IN	O	of	_	0	SENT_40	[p4l1687t1467r1764b1530],
8	SLCO	NNP	O	SLCO	prep_of	6	SENT_40	[p4l1789t1467r2044b1530],
9	]	CD	NUMBER	]	num	8	SENT_40	[p4l1789t1467r2044b1530],
10	B1	NN	O	b1	nn	11	SENT_40	[p4l2051t1467r2144b1529],
11	variant	NN	O	variant	nsubjpass	19	SENT_40	[p4l8t1578r256b1640],
12	on	IN	O	on	_	0	SENT_40	[p4l289t1597r375b1640],
13	olmesartan	NN	O	olmesartan	nn	14	SENT_40	[p4l408t1578r801b1640],
14	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	11	SENT_40	[p4l831t1578r1465b1659],
15	have	VBP	O	have	aux	19	SENT_40	[p4l1498t1578r1665b1640],
16	not	RB	O	not	neg	19	SENT_40	[p4l1699t1587r1812b1640],
17	yet	RB	O	yet	advmod	19	SENT_40	[p4l1843t1587r1952b1659],
18	been	VBN	O	be	auxpass	19	SENT_40	[p4l1982t1578r2150b1640],
19	reported	VBN	O	report	parataxis	23	SENT_40	[p4l6t1690r325b1771],
20	,	,	O	,	_	0	SENT_40	[p4l6t1690r325b1771],
21	we	PRP	O	we	nsubj	23	SENT_40	[p4l364t1710r465b1753],
22	also	RB	O	also	advmod	23	SENT_40	[p4l504t1690r643b1753],
23	evaluated	VBD	O	evaluate	_	0	SENT_40	[p4l682t1690r1026b1753],
24	the	DT	O	the	det	25	SENT_40	[p4l1061t1690r1169b1753],
25	contribution	NN	O	contribution	dobj	23	SENT_40	[p4l1206t1690r1644b1753],
26	of	IN	O	of	_	0	SENT_40	[p4l1681t1690r1758b1753],
27	SLCOIBI	NNP	O	SLCOIBI	nn	28	SENT_40	[p4l1789t1691r2144b1753],
28	variants	NNS	O	variant	prep_of	25	SENT_40	[p4l8t1801r289b1864],
29	to	TO	O	to	_	0	SENT_40	[p4l320t1811r387b1864],
30	the	DT	O	the	det	32	SENT_40	[p4l417t1801r524b1864],
31	pharmacokinetic	JJ	O	pharmacokinetic	amod	32	SENT_40	[p4l554t1801r1153b1882],
32	proﬁles	NNS	O	proﬁles	prep_to	23	SENT_40	[p4l1184t1801r1450b1882],
33	of	IN	O	of	_	0	SENT_40	[p4l1482t1801r1559b1864],
34	olmesartan	NN	O	olmesartan	prep_of	32	SENT_40	[p4l1584t1801r1995b1864],
35	.	.	O	.	_	0	SENT_40	[p4l1584t1801r1995b1864],

1	Materials	NNPS	O	Materials	_	0	SENT_41	[p4l7t2044r375b2107],
2	and	CC	O	and	_	0	SENT_41	[p4l409t2045r550b2107],
3	methods	NNS	O	method	conj_and	1	SENT_41	[p4l582t2045r904b2107],

1	Subjects	NNS	O	subject	_	0	SENT_42	[p4l10t2269r308b2350],
2	and	CC	O	and	_	0	SENT_42	[p4l344t2269r471b2331],
3	genotyping	NN	O	genotyping	conj_and	1	SENT_42	[p4l504t2269r905b2350],
4	of	IN	O	of	dep	1	SENT_42	[p4l940t2269r1017b2331],
5	SLCOIBI	NNP	O	SLCOIBI	pobj	4	SENT_42	[p4l1044t2269r1398b2332],

1	Ten	CD	NUMBER	ten	num	4	SENT_43	[p4l7t2494r145b2555],
2	healthy	JJ	O	healthy	amod	4	SENT_43	[p4l204t2493r467b2574],
3	male	JJ	O	male	amod	4	SENT_43	[p4l527t2493r699b2555],
4	volunteers	NNS	O	volunteer	nsubj	5	SENT_43	[p4l760t2493r1131b2555],
5	(	VBP	O	(	_	0	SENT_43	[p4l1195t2494r1343b2574],
6	age	NN	O	age	nn	7	SENT_43	[p4l1195t2494r1343b2574],
7	range	NN	O	range	dobj	5	SENT_43	[p4l1403t2512r1620b2574],
8	,	,	O	,	_	0	SENT_43	[p4l1403t2512r1620b2574],
9	20-26	CD	NUMBER	20-26	num	10	SENT_43	[p4l1685t2493r1904b2556],
10	years	NNS	NUMBER	year	appos	7	SENT_43	[p4l1938t2512r2147b2574],
11	;	:	O	;	_	0	SENT_43	[p4l1938t2512r2147b2574],
12	weight	NN	O	weight	nn	13	SENT_43	[p4l8t2604r251b2685],
13	range	NN	O	range	nsubj	19	SENT_43	[p4l306t2624r523b2685],
14	,	,	O	,	_	0	SENT_43	[p4l306t2624r523b2685],
15	49.7-96	CD	NUMBER	49.7-96	number	16	SENT_43	[p4l583t2604r937b2668],
16	.7	CD	NUMBER	.7	num	18	SENT_43	[p4l583t2604r937b2668],
17	kg	NN	O	kg	nn	18	SENT_43	[p4l972t2604r1088b2685],
18	)	NN	O	)	appos	13	SENT_43	[p4l972t2604r1088b2685],
19	participated	VBD	O	participate	parataxis	5	SENT_43	[p4l1146t2604r1572b2685],
20	in	IN	O	in	_	0	SENT_43	[p4l1628t2604r1696b2666],
21	this	DT	O	this	det	22	SENT_43	[p4l1752t2604r1877b2667],
22	study	NN	O	study	prep_in	19	SENT_43	[p4l1939t2604r2146b2685],
23	.	.	O	.	_	0	SENT_43	[p4l1939t2604r2146b2685],

1	They	PRP	O	they	nsubjpass	3	SENT_44	[p4l7t2715r189b2796],
2	were	VBD	O	be	auxpass	3	SENT_44	[p4l236t2735r407b2778],
3	grouped	VBN	O	group	_	0	SENT_44	[p4l455t2715r747b2796],
4	based	VBN	O	base	_	0	SENT_44	[p4l791t2715r995b2778],
5	on	IN	O	on	prepc_based_on	3	SENT_44	[p4l1041t2735r1127b2778],
6	their	PRP$	O	they	poss	8	SENT_44	[p4l1172t2715r1336b2778],
7	SLCOIBI	NN	O	slcoibus	nn	8	SENT_44	[p4l1381t2716r1736b2779],
8	genotypes	NNS	O	genotype	pobj	3	SENT_44	[p4l1789t2725r2149b2796],
9	into	IN	O	into	_	0	SENT_44	[p4l7t2826r144b2889],
10	three	CD	NUMBER	three	num	11	SENT_44	[p4l207t2826r385b2889],
11	groups	NNS	O	group	prep_into	8	SENT_44	[p4l449t2846r709b2907],
12	:	:	O	:	_	0	SENT_44	[p4l449t2846r709b2907],
13	SLCOIB1	NN	O	slcoib1	nn	15	SENT_44	[p4l777t2827r1435b2889],
14	*	CD	NUMBER	*	num	15	SENT_44	[p4l777t2827r1435b2889],
15	I5	NN	O	i5	dep	8	SENT_44	[p4l777t2827r1435b2889],
16	/	:	O	/	punct	20	SENT_44	[p4l777t2827r1435b2889],
17	*	CD	NUMBER	*	number	18	SENT_44	[p4l777t2827r1435b2889],
18	15	CD	NUMBER	15	num	20	SENT_44	[p4l777t2827r1435b2889],
19	(	NN	O	(	nn	20	SENT_44	[p4l1500t2827r1568b2903],
20	n	NN	O	n	dep	15	SENT_44	[p4l1500t2827r1568b2903],
21	=	JJ	O	=	amod	20	SENT_44	[p4l1604t2854r1665b2878],
22	4	CD	NUMBER	4	number	23	SENT_44	[p4l1701t2826r1793b2903],
23	)	CD	NUMBER	)	dep	21	SENT_44	[p4l1701t2826r1793b2903],
24	,	,	O	,	_	0	SENT_44	[p4l1701t2826r1793b2903],
25	*	CD	NUMBER	*	num	26	SENT_44	[p4l1863t2826r2147b2889],
26	1b	NN	O	1b	appos	20	SENT_44	[p4l1863t2826r2147b2889],
27	/	:	O	/	punct	20	SENT_44	[p4l1863t2826r2147b2889],
28	*	CD	NUMBER	*	num	31	SENT_44	[p4l1863t2826r2147b2889],
29	l5	NN	O	l5	nn	31	SENT_44	[p4l1863t2826r2147b2889],
30	(	NN	O	(	nn	31	SENT_44	[p4l10t2938r79b3015],
31	n	NN	O	n	dep	15	SENT_44	[p4l10t2938r79b3015],
32	=	JJ	O	=	amod	8	SENT_44	[p4l116t2966r176b2990],
33	2	CD	NUMBER	2	number	34	SENT_44	[p4l213t2938r303b3015],
34	)	CD	NUMBER	)	dep	32	SENT_44	[p4l213t2938r303b3015],
35	,	,	O	,	_	0	SENT_44	[p4l213t2938r303b3015],
36	and	CC	O	and	_	0	SENT_44	[p4l339t2937r465b3000],
37	*	NN	O	*	conj_and	3	SENT_44	[p4l499t2937r786b3000],
38	1b	NN	O	1b	dep	37	SENT_44	[p4l499t2937r786b3000],
39	/	:	O	/	punct	37	SENT_44	[p4l499t2937r786b3000],
40	*	CD	NUMBER	*	num	43	SENT_44	[p4l499t2937r786b3000],
41	1b	NN	O	1b	nn	43	SENT_44	[p4l499t2937r786b3000],
42	(	NN	O	(	nn	43	SENT_44	[p4l819t2938r889b3015],
43	n	NN	O	n	dep	37	SENT_44	[p4l819t2938r889b3015],
44	=	JJ	O	=	amod	46	SENT_44	[p4l925t2966r986b2990],
45	4	CD	NUMBER	4	tmod	44	SENT_44	[p4l1021t2938r1112b3015],
46	)	NN	O	)	dep	43	SENT_44	[p4l1021t2938r1112b3015],
47	.	.	O	.	_	0	SENT_44	[p4l1021t2938r1112b3015],

1	They	PRP	O	they	nsubjpass	3	SENT_45	[p4l1146t2937r1328b3018],
2	were	VBD	O	be	auxpass	3	SENT_45	[p4l1360t2957r1531b3000],
3	recruited	VBN	O	recruit	_	0	SENT_45	[p4l1561t2937r1881b3000],
4	from	IN	O	from	_	0	SENT_45	[p4l1911t2937r2084b3000],
5	a	DT	O	a	det	6	SENT_45	[p4l2115t2957r2152b3000],
6	population	NN	O	population	prep_from	3	SENT_45	[p4l6t3048r391b3129],
7	of	IN	O	of	_	0	SENT_45	[p4l469t3048r547b3111],
8	108	CD	NUMBER	108	num	11	SENT_45	[p4l627t3049r747b3111],
9	male	JJ	O	male	amod	11	SENT_45	[p4l828t3049r1000b3111],
10	Japanese	JJ	MISC	japanese	amod	11	SENT_45	[p4l1078t3050r1395b3129],
11	volunteers	NNS	O	volunteer	prep_of	6	SENT_45	[p4l1474t3048r1845b3111],
12	whose	WP$	O	whose	poss	13	SENT_45	[p4l1925t3048r2150b3111],
13	SLC	NNP	O	SLC	dobj	18	SENT_45	[p4l8t3161r163b3223],
14	01	CD	NUMBER	01	num	16	SENT_45	[p4l166t3160r262b3223],
15	BI	NNP	O	BI	nn	16	SENT_45	[p4l269t3160r362b3221],
16	genotype	NN	O	genotype	nsubjpass	18	SENT_45	[p4l394t3169r720b3240],
17	was	VBD	O	be	auxpass	18	SENT_45	[p4l746t3179r880b3222],
18	prescreened	VBN	O	prescreen	rcmod	11	SENT_45	[p4l905t3159r1335b3240],
19	after	IN	O	after	mark	24	SENT_45	[p4l1360t3159r1523b3222],
20	written	VBN	O	write	amod	22	SENT_45	[p4l1546t3159r1799b3222],
21	informed	JJ	O	informed	amod	22	SENT_45	[p4l1823t3159r2151b3222],
22	consent	NN	O	consent	nsubjpass	24	SENT_45	[p4l8t3279r282b3332],
23	was	VBD	O	be	auxpass	24	SENT_45	[p4l347t3289r481b3333],
24	obtained	VBN	O	obtain	advcl	18	SENT_45	[p4l550t3270r875b3332],
25	.	.	O	.	_	0	SENT_45	[p4l550t3270r875b3332],

1	The	DT	O	the	det	3	SENT_46	[p4l946t3270r1083b3332],
2	individual	JJ	O	individual	amod	3	SENT_46	[p4l1150t3270r1512b3332],
3	genotyping	NN	O	genotyping	nsubjpass	7	SENT_46	[p4l1581t3270r1981b3351],
4	for	IN	O	for	_	0	SENT_46	[p4l2049t3270r2153b3332],
5	SLCOIBI	NNP	O	SLCOIBI	prep_for	3	SENT_46	[p4l8t3383r362b3446],
6	was	VBD	O	be	auxpass	7	SENT_46	[p4l415t3402r549b3445],
7	determined	VBN	O	determine	dep	12	SENT_46	[p4l597t3382r1001b3445],
8	using	VBG	O	use	xcomp	7	SENT_46	[p4l1045t3382r1237b3464],
9	an	DT	O	a	det	11	SENT_46	[p4l1285t3402r1367b3445],
10	ABI	NNP	MISC	ABI	nn	11	SENT_46	[p4l1411t3383r1563b3445],
11	PRISM	NNP	O	PRISM	dobj	8	SENT_46	[p4l1609t3363r1926b3446],
12	®	VBD	O	®	_	0	SENT_46	[p4l1609t3363r1926b3446],
13	7000	CD	NUMBER	7000	num	15	SENT_46	[p4l1974t3383r2150b3446],
14	Sequence	NN	O	sequence	nn	15	SENT_46	[p4l10t3495r350b3576],
15	Detection	NN	O	detection	dobj	12	SENT_46	[p4l389t3495r737b3557],
16	System	NNP	O	System	nn	19	SENT_46	[p4l778t3495r1039b3576],
17	(	NNP	O	(	nn	19	SENT_46	[p4l1080t3495r1395b3576],
18	Applied	NNP	O	Applied	nn	19	SENT_46	[p4l1080t3495r1395b3576],
19	Biosystems	NNP	O	Biosystems	nsubj	12	SENT_46	[p4l1433t3495r1864b3576],
20	,	,	O	,	_	0	SENT_46	[p4l1433t3495r1864b3576],
21	Foster	NNP	PERSON	Foster	nn	23	SENT_46	[p4l1905t3496r2147b3569],
22	,	,	O	,	_	0	SENT_46	[p4l1905t3496r2147b3569],
23	CA	NNP	LOCATION	CA	appos	19	SENT_46	[p4l8t3607r156b3684],
24	)	CD	NUMBER	)	num	23	SENT_46	[p4l8t3607r156b3684],
25	with	IN	O	with	_	0	SENT_46	[p4l208t3606r365b3670],
26	TaqMan	NNP	O	TaqMan	nn	30	SENT_46	[p4l414t3588r768b3688],
27	®	NNP	O	®	nn	30	SENT_46	[p4l414t3588r768b3688],
28	SNP	NN	O	snp	nn	30	SENT_46	[p4l820t3607r980b3670],
29	genotyping	NN	O	genotyping	nn	30	SENT_46	[p4l1029t3606r1430b3688],
30	assays	NNS	O	assay	prep_with	23	SENT_46	[p4l1481t3627r1725b3688],
31	,	,	O	,	_	0	SENT_46	[p4l1481t3627r1725b3688],
32	as	IN	O	as	mark	33	SENT_46	[p4l1779t3627r1847b3670],
33	recommended	VBN	O	recommend	dep	19	SENT_46	[p4l1896t3627r2148b3670, p4l7t3718r291b3781],
34	by	IN	O	by	_	0	SENT_46	[p4l323t3718r410b3799],
35	the	DT	O	the	det	36	SENT_46	[p4l444t3718r550b3781],
36	manufacturer	NN	O	manufacturer	prep_by	33	SENT_46	[p4l585t3718r1081b3781],
37	.	.	O	.	_	0	SENT_46	[p4l585t3718r1081b3781],

1	The	DT	O	the	det	2	SENT_47	[p4l1119t3718r1257b3781],
2	accuracy	NN	O	accuracy	nsubjpass	6	SENT_47	[p4l1292t3738r1608b3799],
3	of	IN	O	of	_	0	SENT_47	[p4l1643t3718r1721b3781],
4	genotyping	NN	O	genotyping	prep_of	2	SENT_47	[p4l1749t3718r2150b3799],
5	was	VBD	O	be	auxpass	6	SENT_47	[p5l8t42r142b85],
6	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_47	[p5l176t22r538b85],
7	by	IN	O	by	_	0	SENT_47	[p5l567t22r654b103],
8	direct	JJ	O	direct	amod	9	SENT_47	[p5l686t22r890b85],
9	sequencing	NN	O	sequencing	agent	6	SENT_47	[p5l922t22r1340b103],
10	.	.	O	.	_	0	SENT_47	[p5l922t22r1340b103],

1	Each	DT	O	each	det	2	SENT_48	[p5l1375t22r1554b85],
2	subject	JJ	O	subject	poss	5	SENT_48	[p5l1587t22r1900b103],
3	’s	POS	O	’s	_	0	SENT_48	[p5l1587t22r1900b103],
4	health	NN	O	health	nn	5	SENT_48	[p5l1932t22r2151b85],
5	status	NN	O	status	nsubjpass	7	SENT_48	[p5l10t141r208b194],
6	was	VBD	O	be	auxpass	7	SENT_48	[p5l258t151r392b194],
7	ascertained	VBN	O	ascertain	_	0	SENT_48	[p5l443t132r846b194],
8	to	TO	O	to	aux	10	SENT_48	[p5l892t141r959b194],
9	be	VB	O	be	cop	10	SENT_48	[p5l1006t132r1089b194],
10	normal	JJ	O	normal	xcomp	7	SENT_48	[p5l1137t132r1389b194],
11	by	IN	O	by	_	0	SENT_48	[p5l1437t132r1524b213],
12	medical	JJ	O	medical	amod	13	SENT_48	[p5l1572t132r1856b194],
13	history	NN	O	history	prep_by	10	SENT_48	[p5l1902t132r2150b213],

1	@	IN	O	@	dep	6	SENT_49	[p5l6t375r83b470],
2	Springer	NNP	PERSON	Springer	nn	3	SENT_49	[p5l113t398r375b473],
3	interview	NN	O	interview	pobj	1	SENT_49	[p5l7t500r364b575],
4	,	,	O	,	_	0	SENT_49	[p5l7t500r364b575],
5	physical	JJ	O	physical	amod	6	SENT_49	[p5l403t500r701b581],
6	examination	NN	O	examination	_	0	SENT_49	[p5l740t500r1202b575],
7	,	,	O	,	_	0	SENT_49	[p5l740t500r1202b575],
8	electrocardiography	NN	O	electrocardiography	conj_and	6	SENT_49	[p5l1243t500r1980b581],
9	,	,	O	,	_	0	SENT_49	[p5l1243t500r1980b581],
10	and	CC	O	and	_	0	SENT_49	[p5l2022t500r2148b563],
11	routine	JJ	O	routine	amod	14	SENT_49	[p5l6t611r259b674],
12	clinical	JJ	O	clinical	amod	14	SENT_49	[p5l290t611r553b674],
13	laboratory	NN	O	laboratory	nn	14	SENT_49	[p5l583t611r950b692],
14	testing	NN	O	testing	conj_and	6	SENT_49	[p5l980t611r1235b692],
15	.	.	O	.	_	0	SENT_49	[p5l980t611r1235b692],

1	None	NN	O	none	nsubj	9	SENT_50	[p5l1270t613r1461b674],
2	was	VBD	O	be	aux	3	SENT_50	[p5l1492t631r1626b674],
3	receiving	VBG	O	receive	_	0	SENT_50	[p5l1656t611r1990b692],
4	any	DT	O	any	det	6	SENT_50	[p5l2022t631r2147b692],
5	continuous	JJ	O	continuous	amod	6	SENT_50	[p5l8t722r398b784],
6	medications	NNS	O	medication	dobj	3	SENT_50	[p5l464t722r894b784],
7	or	CC	O	or	_	0	SENT_50	[p5l962t741r1034b784],
8	habitually	RB	O	habitually	advmod	9	SENT_50	[p5l1096t722r1454b803],
9	abusing	VBG	O	abuse	conj_or	3	SENT_50	[p5l1520t722r1794b803],
10	alcohol	NN	O	alcohol	dobj	9	SENT_50	[p5l1861t722r2149b785],
11	/	:	O	/	punct	12	SENT_50	[p5l1861t722r2149b785],
12	drugs	NNS	O	drug	dep	10	SENT_50	[p5l8t833r222b914],
13	.	.	O	.	_	0	SENT_50	[p5l8t833r222b914],

1	They	PRP	O	they	nsubjpass	3	SENT_51	[p5l277t833r458b914],
2	were	VBD	O	be	auxpass	3	SENT_51	[p5l510t852r680b896],
3	required	VBN	O	require	_	0	SENT_51	[p5l730t833r1030b914],
4	to	TO	O	to	aux	5	SENT_51	[p5l1079t842r1146b895],
5	refrain	VB	O	refrain	xcomp	3	SENT_51	[p5l1196t833r1435b895],
6	from	IN	O	from	_	0	SENT_51	[p5l1485t833r1658b895],
7	alcohol	NN	O	alcohol	nn	10	SENT_51	[p5l1709t833r1969b895],
8	and	CC	O	and	_	0	SENT_51	[p5l2022t833r2148b895],
9	caffeine	NN	O	caffeine	nn	10	SENT_51	[p5l8t942r706b1024],
10	—	NN	O	—	prep_from	5	SENT_51	[p5l8t942r706b1024],
11	containing	VBG	O	contain	conj_and	11	SENT_51	[p5l8t942r706b1024],
12	beverages	NNS	O	beverage	dobj	11	SENT_51	[p5l783t943r1140b1024],
13	for	IN	O	for	_	0	SENT_51	[p5l1221t943r1324b1005],
14	2	CD	DURATION	2	num	15	SENT_51	[p5l1401t943r1442b1004],
15	days	NNS	NUMBER	day	prep_for	12	SENT_51	[p5l1476t943r1635b1024],
16	before	IN	O	before	_	0	SENT_51	[p5l1713t943r1942b1005],
17	and	CC	O	and	_	0	SENT_51	[p5l2022t943r2148b1005],
18	throughout	IN	O	throughout	_	0	SENT_51	[p5l7t1055r400b1136],
19	the	DT	O	the	det	20	SENT_51	[p5l437t1055r544b1118],
20	study	NN	O	study	prep_before	11	SENT_51	[p5l586t1055r792b1136],
21	.	.	O	.	_	0	SENT_51	[p5l586t1055r792b1136],

1	Drinking	VBG	O	drink	csubjpass	8	SENT_52	[p5l834t1055r1155b1136],
2	grapefruit	NN	O	grapefruit	nn	5	SENT_52	[p5l1195t1055r1548b1136],
3	or	CC	O	or	_	0	SENT_52	[p5l1586t1075r1658b1118],
4	orange	NN	O	orange	conj_or	2	SENT_52	[p5l1695t1075r1936b1136],
5	juice	NN	O	juice	dobj	1	SENT_52	[p5l1967t1055r2146b1136],
6	was	VBD	O	be	auxpass	8	SENT_52	[p5l8t1186r142b1229],
7	not	RB	O	not	neg	8	SENT_52	[p5l173t1175r287b1229],
8	permitted	VBN	O	permit	_	0	SENT_52	[p5l314t1166r659b1247],
9	during	IN	O	during	_	0	SENT_52	[p5l689t1166r919b1247],
10	the	DT	O	the	det	11	SENT_52	[p5l950t1166r1056b1229],
11	period	NN	O	period	prep_during	8	SENT_52	[p5l1085t1166r1314b1247],
12	of	IN	O	of	_	0	SENT_52	[p5l1344t1166r1421b1229],
13	study	NN	O	study	prep_of	11	SENT_52	[p5l1448t1166r1656b1247],
14	,	,	O	,	_	0	SENT_52	[p5l1448t1166r1656b1247],
15	and	CC	O	and	_	0	SENT_52	[p5l1690t1166r1816b1229],
16	standard	JJ	O	standard	amod	17	SENT_52	[p5l1848t1166r2149b1229],
17	meals	NNS	O	meal	nsubjpass	19	SENT_52	[p5l7t1277r213b1340],
18	were	VBD	O	be	auxpass	19	SENT_52	[p5l248t1297r419b1340],
19	served	VBN	O	serve	conj_and	8	SENT_52	[p5l456t1277r685b1340],
20	as	IN	O	as	_	0	SENT_52	[p5l720t1297r788b1340],
21	scheduled	VBN	O	schedule	prep_as	19	SENT_52	[p5l825t1277r1197b1340],
22	.	.	O	.	_	0	SENT_52	[p5l825t1277r1197b1340],

1	Study	NNP	O	Study	_	0	SENT_53	[p5l9t1500r213b1581],
2	protocol	NN	O	protocol	dep	1	SENT_53	[p5l245t1500r544b1581],
3	and	CC	O	and	_	0	SENT_53	[p5l579t1500r705b1563],
4	quantiﬁcation	NN	O	quantiﬁcation	dep	1	SENT_53	[p5l737t1500r1230b1581],
5	of	IN	O	of	_	0	SENT_53	[p5l1264t1500r1341b1563],
6	drugs	NNS	O	drug	prep_of	2	SENT_53	[p5l1369t1500r1562b1581],

1	A	DT	O	a	det	5	SENT_54	[p5l7t1724r70b1786],
2	one	CD	NUMBER	one	num	5	SENT_54	[p5l101t1743r587b1805],
3	—	NN	O	—	nn	5	SENT_54	[p5l101t1743r587b1805],
4	sequence	NN	O	sequence	nn	5	SENT_54	[p5l101t1743r587b1805],
5	study	NN	O	study	nn	6	SENT_54	[p5l621t1724r810b1805],
6	design	NN	O	design	nsubjpass	13	SENT_54	[p5l842t1724r1073b1805],
7	with	IN	O	with	_	0	SENT_54	[p5l1104t1724r1261b1787],
8	a	DT	O	a	det	11	SENT_54	[p5l1293t1743r1330b1786],
9	3-day	JJ	DURATION	3-day	amod	11	SENT_54	[p5l1362t1724r1561b1805],
10	washout	NN	O	washout	nn	11	SENT_54	[p5l1593t1724r1891b1787],
11	period	NN	O	period	prep_with	6	SENT_54	[p5l1919t1724r2148b1805],
12	was	VBD	O	be	auxpass	13	SENT_54	[p5l8t1854r142b1898],
13	conducted	VBN	O	conduct	_	0	SENT_54	[p5l183t1835r568b1897],
14	.	.	O	.	_	0	SENT_54	[p5l183t1835r568b1897],

1	This	DT	O	this	det	3	SENT_55	[p5l610t1835r765b1897],
2	study	NN	O	study	nn	3	SENT_55	[p5l808t1835r996b1916],
3	protocol	NN	O	protocol	nsubjpass	5	SENT_55	[p5l1034t1835r1331b1916],
4	was	VBD	O	be	auxpass	5	SENT_55	[p5l1371t1854r1505b1898],
5	approved	VBN	O	approve	_	0	SENT_55	[p5l1547t1835r1878b1916],
6	by	IN	O	by	_	0	SENT_55	[p5l1914t1835r2002b1916],
7	the	DT	O	the	det	10	SENT_55	[p5l2040t1835r2147b1897],
8	Ethics	NNP	ORGANIZATION	Ethics	nn	10	SENT_55	[p5l7t1945r228b2007],
9	Review	NNP	ORGANIZATION	Review	nn	10	SENT_55	[p5l268t1945r539b2007],
10	Boards	NNS	ORGANIZATION	board	agent	5	SENT_55	[p5l578t1945r828b2007],
11	of	IN	ORGANIZATION	of	_	0	SENT_55	[p5l869t1945r946b2007],
12	Kyushu	NNP	ORGANIZATION	Kyushu	nn	13	SENT_55	[p5l979t1945r1253b2026],
13	University	NNP	ORGANIZATION	University	prep_of	10	SENT_55	[p5l1291t1944r1668b2026],
14	and	CC	O	and	_	0	SENT_55	[p5l1708t1945r1835b2007],
15	Kyushu	NNP	ORGANIZATION	Kyushu	prep_of	10	SENT_55	[p5l1872t1945r2147b2026],
16	Clinical	JJ	ORGANIZATION	clinical	amod	23	SENT_55	[p5l8t2057r290b2120],
17	Pharmacology	NNP	ORGANIZATION	Pharmacology	nn	23	SENT_55	[p5l333t2057r850b2138],
18	Research	NNP	ORGANIZATION	Research	nn	23	SENT_55	[p5l893t2057r1221b2120],
19	Clinic	NNP	ORGANIZATION	Clinic	nn	23	SENT_55	[p5l1264t2057r1500b2131],
20	,	,	O	,	_	0	SENT_55	[p5l1264t2057r1500b2131],
21	Fukuoka	NNP	LOCATION	Fukuoka	appos	23	SENT_55	[p5l1546t2057r1877b2131],
22	,	,	O	,	_	0	SENT_55	[p5l1546t2057r1877b2131],
23	Japan	NNP	LOCATION	Japan	nsubjpass	30	SENT_55	[p5l1922t2059r2144b2138],
24	,	,	O	,	_	0	SENT_55	[p5l1922t2059r2144b2138],
25	and	CC	O	and	_	0	SENT_55	[p5l9t2168r135b2231],
26	written	VBN	O	write	amod	28	SENT_55	[p5l200t2168r453b2231],
27	informed	JJ	O	informed	amod	28	SENT_55	[p5l518t2168r845b2231],
28	consent	NN	O	consent	nsubjpass	30	SENT_55	[p5l911t2178r1183b2231],
29	was	VBD	O	be	auxpass	30	SENT_55	[p5l1248t2188r1382b2231],
30	obtained	VBN	O	obtain	rcmod	10	SENT_55	[p5l1450t2168r1758b2231],
31	from	IN	O	from	_	0	SENT_55	[p5l1822t2168r1995b2231],
32	all	DT	O	all	det	33	SENT_55	[p5l2061t2168r2147b2231],
33	subjects	NNS	O	subject	prep_from	30	SENT_55	[p5l10t2280r313b2361],
34	.	.	O	.	_	0	SENT_55	[p5l10t2280r313b2361],

1	On	IN	O	on	_	0	SENT_56	[p5l382t2280r488b2343],
2	day	NN	DURATION	day	prep_on	7	SENT_56	[p5l552t2280r678b2361],
3	1	CD	NUMBER	1	num	2	SENT_56	[p5l750t2281r803b2354],
4	,	,	O	,	_	0	SENT_56	[p5l750t2281r803b2354],
5	each	DT	O	each	nsubj	7	SENT_56	[p5l871t2280r1033b2343],
6	subject	JJ	O	subject	advmod	7	SENT_56	[p5l1100t2280r1351b2361],
7	received	VBN	O	receive	_	0	SENT_56	[p5l1412t2280r1717b2343],
8	10	CD	NUMBER	10	num	9	SENT_56	[p5l1788t2280r1866b2343],
9	mg	NN	O	mg	tmod	7	SENT_56	[p5l1899t2300r2011b2361],
10	of	IN	O	of	_	0	SENT_56	[p5l2076t2280r2153b2343],
11	pravastatin	NN	O	pravastatin	nn	14	SENT_56	[p5l6t2390r400b2471],
12	(	CD	NUMBER	(	num	14	SENT_56	[p5l436t2372r905b2468],
13	Mevalotin	NNP	O	Mevalotin	nn	14	SENT_56	[p5l436t2372r905b2468],
14	®	NN	O	®	prep_of	9	SENT_56	[p5l436t2372r905b2468],
15	;	:	O	;	_	0	SENT_56	[p5l436t2372r905b2468],
16	Daiichi	NNP	ORGANIZATION	Daiichi	dep	9	SENT_56	[p5l941t2390r1503b2471],
17	.	.	O	.	_	0	SENT_56	[p5l941t2390r1503b2471],

1	—	NN	O	—	_	0	SENT_57	[p5l941t2390r1503b2471],
2	.	.	O	.	_	0	SENT_57	[p5l941t2390r1503b2471],

1	Sankyo	NNP	ORGANIZATION	Sankyo	nn	2	SENT_58	[p5l941t2390r1503b2471],
2	Co.	NNP	ORGANIZATION	Co.	_	0	SENT_58	[p5l1537t2391r1656b2453],
3	.	.	O	.	_	0	SENT_58	[p5l1537t2391r1656b2453],

1	Ltd.	NNP	ORGANIZATION	Ltd.	nn	5	SENT_59	[p5l1693t2391r1857b2464],
2	,	,	O	,	_	0	SENT_59	[p5l1693t2391r1857b2464],
3	Tokyo	NNP	LOCATION	Tokyo	appos	5	SENT_59	[p5l1893t2390r2144b2471],
4	,	,	O	,	_	0	SENT_59	[p5l1893t2390r2144b2471],
5	Japan	NNP	LOCATION	Japan	_	0	SENT_59	[p5l7t2503r237b2583],
6	)	CD	NUMBER	)	num	5	SENT_59	[p5l7t2503r237b2583],
7	with	IN	O	with	_	0	SENT_59	[p5l301t2502r458b2565],
8	150	CD	NUMBER	150	num	9	SENT_59	[p5l527t2502r650b2565],
9	ml	NN	O	ml	prep_with	5	SENT_59	[p5l683t2502r775b2564],
10	of	IN	O	of	_	0	SENT_59	[p5l837t2502r914b2565],
11	water	NN	O	water	prep_of	9	SENT_59	[p5l969t2512r1168b2565],
12	after	IN	O	after	_	0	SENT_59	[p5l1229t2502r1392b2565],
13	an	DT	O	a	det	15	SENT_59	[p5l1453t2522r1534b2565],
14	overnight	JJ	TIME	overnight	amod	15	SENT_59	[p5l1595t2502r1938b2583],
15	fast	JJ	O	fast	prep_after	5	SENT_59	[p5l1998t2502r2142b2565],
16	.	.	O	.	_	0	SENT_59	[p5l1998t2502r2142b2565],

1	Peripheral	JJ	O	peripheral	amod	4	SENT_60	[p5l7t2613r374b2694],
2	venous	JJ	O	venous	amod	4	SENT_60	[p5l420t2633r669b2676],
3	blood	NN	O	blood	nn	4	SENT_60	[p5l715t2613r919b2676],
4	samples	NNS	O	sample	nsubjpass	6	SENT_60	[p5l965t2613r1248b2694],
5	were	VBD	O	be	auxpass	6	SENT_60	[p5l1294t2633r1465b2676],
6	obtained	VBN	O	obtain	_	0	SENT_60	[p5l1512t2613r1820b2676],
7	prior	JJ	O	prior	_	0	SENT_60	[p5l1862t2613r2037b2694],
8	to	TO	O	to	_	0	SENT_60	[p5l2080t2623r2146b2676],
9	dosing	NN	O	dosing	prep_prior_to	6	SENT_60	[p5l8t2723r243b2804],
10	and	CC	O	and	_	0	SENT_60	[p5l284t2723r410b2785],
11	at	IN	O	at	conj_and	6	SENT_60	[p5l450t2732r512b2785],
12	0.25	CD	NUMBER	0.25	pobj	11	SENT_60	[p5l550t2723r723b2797],
13	,	,	O	,	_	0	SENT_60	[p5l550t2723r723b2797],
14	0.5	CD	NUMBER	0.5	pobj	11	SENT_60	[p5l765t2722r894b2797],
15	,	,	O	,	_	0	SENT_60	[p5l765t2722r894b2797],
16	0.75	CD	NUMBER	0.75	pobj	11	SENT_60	[p5l936t2723r1109b2797],
17	,	,	O	,	_	0	SENT_60	[p5l936t2723r1109b2797],
18	1	CD	NUMBER	1	conj_and	12	SENT_60	[p5l1159t2723r1212b2797],
19	,	,	O	,	_	0	SENT_60	[p5l1159t2723r1212b2797],
20	2	CD	NUMBER	2	conj_and	12	SENT_60	[p5l1255t2723r1315b2797],
21	,	,	O	,	_	0	SENT_60	[p5l1255t2723r1315b2797],
22	3	CD	NUMBER	3	conj_and	12	SENT_60	[p5l1359t2723r1418b2797],
23	,	,	O	,	_	0	SENT_60	[p5l1359t2723r1418b2797],
24	4	CD	NUMBER	4	conj_and	12	SENT_60	[p5l1459t2723r1521b2797],
25	,	,	O	,	_	0	SENT_60	[p5l1459t2723r1521b2797],
26	5	CD	NUMBER	5	conj_and	12	SENT_60	[p5l1564t2722r1624b2797],
27	,	,	O	,	_	0	SENT_60	[p5l1564t2722r1624b2797],
28	6	CD	NUMBER	6	conj_and	12	SENT_60	[p5l1668t2723r1727b2797],
29	,	,	O	,	_	0	SENT_60	[p5l1668t2723r1727b2797],
30	8	CD	NUMBER	8	conj_and	12	SENT_60	[p5l1773t2723r1830b2797],
31	,	,	O	,	_	0	SENT_60	[p5l1773t2723r1830b2797],
32	12	CD	NUMBER	12	pobj	11	SENT_60	[p5l1881t2723r1978b2797],
33	,	,	O	,	_	0	SENT_60	[p5l1881t2723r1978b2797],
34	and	CC	NUMBER	and	_	0	SENT_60	[p5l2022t2723r2148b2785],
35	24	CD	NUMBER	24	num	36	SENT_60	[p5l8t2835r94b2897],
36	h	NN	O	h	pobj	11	SENT_60	[p5l126t2835r169b2897],
37	after	IN	O	after	_	0	SENT_60	[p5l203t2835r366b2897],
38	dosing	NN	O	dosing	prep_after	36	SENT_60	[p5l397t2835r632b2916],
39	for	IN	O	for	_	0	SENT_60	[p5l665t2835r768b2897],
40	pravastatin	NN	O	pravastatin	prep_for	38	SENT_60	[p5l797t2835r1192b2916],
41	and	CC	O	and	_	0	SENT_60	[p5l1225t2835r1352b2897],
42	its	PRP$	O	its	poss	43	SENT_60	[p5l1383t2835r1464b2897],
43	metabolite	NN	O	metabolite	prep_after	36	SENT_60	[p5l1497t2835r1896b2909],
44	,	,	O	,	_	0	SENT_60	[p5l1497t2835r1896b2909],
45	RMS	NNP	O	RMS	appos	43	SENT_60	[p5l1931t2835r2145b2898],
46	—	CD	NUMBER	—	num	45	SENT_60	[p5l1931t2835r2145b2898],
47	416	CD	NUMBER	416	num	52	SENT_60	[p5l7t2944r158b3018],
48	,	,	O	,	_	0	SENT_60	[p5l7t2944r158b3018],
49	single	JJ	O	single	amod	52	SENT_60	[p5l217t2945r620b3026],
50	—	NN	O	—	nn	52	SENT_60	[p5l217t2945r620b3026],
51	dose	NN	O	dose	nn	52	SENT_60	[p5l217t2945r620b3026],
52	pharmacokinetics	NNS	O	pharmacokinetic	dep	6	SENT_60	[p5l671t2945r1325b3026],
53	.	.	O	.	_	0	SENT_60	[p5l671t2945r1325b3026],

1	Urine	NN	O	urine	nsubjpass	3	SENT_61	[p5l1381t2945r1582b3008],
2	was	VBD	O	be	auxpass	3	SENT_61	[p5l1635t2964r1770b3007],
3	collected	VBN	O	collect	_	0	SENT_61	[p5l1825t2945r2149b3007],
4	cumulatively	RB	O	cumulatively	advmod	3	SENT_61	[p5l8t3057r475b3138],
5	over	IN	O	over	_	0	SENT_61	[p5l513t3077r672b3120],
6	24	CD	NUMBER	24	num	7	SENT_61	[p5l708t3058r792b3119],
7	h	NN	O	h	prep_over	4	SENT_61	[p5l825t3057r868b3119],
8	after	IN	O	after	_	0	SENT_61	[p5l906t3057r1069b3120],
9	dosing	NN	O	dosing	prep_after	3	SENT_61	[p5l1105t3057r1358b3138],
10	.	.	O	.	_	0	SENT_61	[p5l1105t3057r1358b3138],

1	After	IN	O	after	_	0	SENT_62	[p5l1400t3057r1588b3120],
2	a	DT	O	a	det	5	SENT_62	[p5l1625t3077r1662b3120],
3	3-day	JJ	DURATION	3-day	amod	5	SENT_62	[p5l1699t3057r1898b3138],
4	washout	NN	O	washout	nn	5	SENT_62	[p5l1936t3057r2144b3120, p5l8t3178r121b3231],
5	period	NN	O	period	prep_after	10	SENT_62	[p5l160t3168r408b3249],
6	,	,	O	,	_	0	SENT_62	[p5l160t3168r408b3249],
7	each	DT	O	each	det	8	SENT_62	[p5l453t3168r615b3231],
8	subject	NN	O	subject	nsubjpass	10	SENT_62	[p5l660t3168r910b3249],
9	was	VBD	O	be	auxpass	10	SENT_62	[p5l951t3188r1085b3231],
10	given	VBN	O	give	_	0	SENT_62	[p5l1130t3168r1327b3249],
11	lo	FW	O	lo	iobj	10	SENT_62	[p5l1376t3168r1454b3231],
12	mg	NN	O	mg	dobj	10	SENT_62	[p5l1487t3188r1598b3249],
13	of	IN	O	of	_	0	SENT_62	[p5l1642t3168r1719b3231],
14	olmesartan	NN	O	olmesartan	nn	15	SENT_62	[p5l1755t3168r2148b3231],
15	medoxomil	NN	O	medoxomil	prep_of	12	SENT_62	[p5l7t3280r415b3343],
16	(	CD	NUMBER	(	num	18	SENT_62	[p5l466t3262r871b3357],
17	Olmetec	JJ	O	olmetec	amod	18	SENT_62	[p5l466t3262r871b3357],
18	®	NN	O	®	dep	15	SENT_62	[p5l466t3262r871b3357],
19	;	:	O	;	_	0	SENT_62	[p5l466t3262r871b3357],
20	Daiichi	NNP	ORGANIZATION	Daiichi	dep	15	SENT_62	[p5l924t3280r1514b3361],
21	.	.	O	.	_	0	SENT_62	[p5l924t3280r1514b3361],

1	—	NN	O	—	_	0	SENT_63	[p5l924t3280r1514b3361],
2	.	.	O	.	_	0	SENT_63	[p5l924t3280r1514b3361],

1	Sankyo	NNP	ORGANIZATION	Sankyo	nsubj	17	SENT_64	[p5l924t3280r1514b3361],
2	)	CD	NUMBER	)	num	1	SENT_64	[p5l924t3280r1514b3361],
3	with	IN	O	with	_	0	SENT_64	[p5l1565t3280r1722b3343],
4	150	CD	NUMBER	150	num	5	SENT_64	[p5l1778t3280r1902b3343],
5	ml	NN	O	ml	prep_with	1	SENT_64	[p5l1935t3280r2027b3342],
6	of	IN	O	of	_	0	SENT_64	[p5l2076t3280r2153b3343],
7	water	NN	O	water	prep_of	5	SENT_64	[p5l8t3401r206b3454],
8	once	RB	DATE	once	advmod	1	SENT_64	[p5l245t3411r410b3454],
9	daily	RB	SET	daily	advmod	1	SENT_64	[p5l451t3391r627b3472],
10	at	IN	O	at	amod	1	SENT_64	[p5l668t3401r731b3454],
11	the	DT	O	the	det	13	SENT_64	[p5l768t3391r875b3454],
12	same	JJ	O	same	amod	13	SENT_64	[p5l917t3411r1096b3454],
13	time	NN	O	time	dep	1	SENT_64	[p5l1136t3391r1293b3454],
14	for	IN	O	for	_	0	SENT_64	[p5l1333t3391r1437b3454],
15	3	CD	DURATION	3	num	16	SENT_64	[p5l1476t3392r1511b3454],
16	days	NNS	NUMBER	day	prep_for	13	SENT_64	[p5l1549t3391r1708b3472],
17	(	VBP	O	(	_	0	SENT_64	[p5l1751t3392r1866b3469],
18	on	IN	O	on	_	0	SENT_64	[p5l1751t3392r1866b3469],
19	days	NNS	DURATION	day	prep_on	17	SENT_64	[p5l1906t3391r2065b3472],
20	5	CD	NUMBER	5	num	19	SENT_64	[p5l2107t3391r2143b3454],
21	through	IN	O	through	_	0	SENT_64	[p5l7t3502r285b3583],
22	7	CD	NUMBER	7	num	23	SENT_64	[p5l354t3503r444b3580],
23	)	NN	O	)	prep_through	19	SENT_64	[p5l354t3503r444b3580],
24	.	.	O	.	_	0	SENT_64	[p5l354t3503r444b3580],

1	On	IN	O	on	_	0	SENT_65	[p5l520t3503r625b3565],
2	day	NN	DURATION	day	prep_on	6	SENT_65	[p5l695t3502r820b3583],
3	8	CD	NUMBER	8	num	2	SENT_65	[p5l895t3503r952b3576],
4	,	,	O	,	_	0	SENT_65	[p5l895t3503r952b3576],
5	subjects	NNS	O	subject	nsubj	6	SENT_65	[p5l1028t3502r1310b3583],
6	received	VBD	O	receive	_	0	SENT_65	[p5l1381t3502r1685b3565],
7	olmesartan	NN	O	olmesartan	nn	8	SENT_65	[p5l1755t3502r2148b3565],
8	medoxomil	NN	O	medoxomil	dobj	6	SENT_65	[p5l7t3613r415b3676],
9	(	CD	NUMBER	(	number	10	SENT_65	[p5l485t3614r599b3691],
10	10	CD	NUMBER	10	num	12	SENT_65	[p5l485t3614r599b3691],
11	mg	NN	O	mg	nn	12	SENT_65	[p5l632t3614r771b3694],
12	)	NN	O	)	dep	8	SENT_65	[p5l632t3614r771b3694],
13	and	CC	O	and	_	0	SENT_65	[p5l843t3613r969b3676],
14	pravastatin	NN	O	pravastatin	conj_and	8	SENT_65	[p5l1034t3613r1428b3694],
15	(	CD	NUMBER	(	number	16	SENT_65	[p5l1498t3614r1612b3691],
16	10	CD	NUMBER	10	num	18	SENT_65	[p5l1498t3614r1612b3691],
17	mg	NN	O	mg	nn	18	SENT_65	[p5l1645t3614r1785b3694],
18	)	NN	O	)	dep	14	SENT_65	[p5l1645t3614r1785b3694],
19	simultaneously	RB	O	simultaneously	advmod	6	SENT_65	[p5l1857t3613r2145b3676, p5l7t3724r302b3805],
20	.	.	O	.	_	0	SENT_65	[p5l1857t3613r2145b3676, p5l7t3724r302b3805],

1	Plasma	NN	O	plasma	nn	4	SENT_66	[p5l342t3724r600b3786],
2	and	CC	O	and	_	0	SENT_66	[p5l635t3724r761b3786],
3	urine	NN	O	urine	nn	4	SENT_66	[p5l794t3724r977b3786],
4	samples	NNS	O	sample	nsubjpass	6	SENT_66	[p5l1015t3724r1298b3805],
5	were	VBD	O	be	auxpass	6	SENT_66	[p5l1334t3743r1505b3787],
6	collected	VBN	O	collect	_	0	SENT_66	[p5l1541t3724r1866b3786],
7	on	IN	O	on	_	0	SENT_66	[p5l1900t3743r1986b3786],
8	day	NN	DURATION	day	prep_on	6	SENT_66	[p5l2021t3724r2147b3805],

1	5	CD	NUMBER	5	num	2	SENT_67	[p6l9t22r45b85],
2	(	NN	O	(	nsubj	8	SENT_67	[p6l101t22r231b99],
3	for	IN	O	for	_	0	SENT_67	[p6l101t22r231b99],
4	olmesartan	NN	O	olmesartan	prep_for	2	SENT_67	[p6l278t22r670b84],
5	single	JJ	O	single	amod	8	SENT_67	[p6l722t22r1124b103],
6	—	NN	O	—	nn	8	SENT_67	[p6l722t22r1124b103],
7	dose	NN	O	dose	nn	8	SENT_67	[p6l722t22r1124b103],
8	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_67	[p6l1172t22r1834b103],
9	)	NN	O	)	nn	14	SENT_67	[p6l1172t22r1834b103],
10	and	CC	O	and	_	0	SENT_67	[p6l1887t22r2013b84],
11	on	IN	O	on	nn	14	SENT_67	[p6l2061t41r2148b84],
12	day	NN	DURATION	day	pobj	11	SENT_67	[p6l8t132r134b213],
13	8	CD	NUMBER	8	num	12	SENT_67	[p6l182t132r218b195],
14	(	NN	O	(	dobj	8	SENT_67	[p6l267t131r398b209],
15	for	IN	O	for	_	0	SENT_67	[p6l267t131r398b209],
16	the	DT	O	the	det	20	SENT_67	[p6l440t132r547b194],
17	pharmacokinetic	JJ	O	pharmacokinetic	amod	20	SENT_67	[p6l591t132r1190b213],
18	interaction	NN	O	interaction	nn	20	SENT_67	[p6l1235t132r1619b194],
19	study	NN	O	study	nn	20	SENT_67	[p6l1666t132r1882b213],
20	)	NN	O	)	prep_for	14	SENT_67	[p6l1666t132r1882b213],
21	in	IN	O	in	_	0	SENT_67	[p6l1928t132r1996b193],
22	the	DT	O	the	det	24	SENT_67	[p6l2040t132r2147b194],
23	same	JJ	O	same	amod	24	SENT_67	[p6l10t264r189b307],
24	manner	NN	O	manner	prep_in	20	SENT_67	[p6l229t264r499b307],
25	as	IN	O	as	prep	8	SENT_67	[p6l538t264r607b307],
26	on	IN	O	on	pcomp	25	SENT_67	[p6l649t264r735b307],
27	day	NN	DURATION	day	pobj	26	SENT_67	[p6l776t244r901b325],
28	1	CD	NUMBER	1	num	27	SENT_67	[p6l950t245r1002b307],
29	.	.	O	.	_	0	SENT_67	[p6l950t245r1002b307],

1	The	DT	O	the	det	2	SENT_68	[p6l1046t244r1183b307],
2	concentrations	NNS	O	concentration	nsubjpass	12	SENT_68	[p6l1224t244r1744b307],
3	of	IN	O	of	_	0	SENT_68	[p6l1787t244r1864b307],
4	all	DT	O	all	det	6	SENT_68	[p6l1899t244r1985b307],
5	test	NN	O	test	nn	6	SENT_68	[p6l2024t254r2149b307],
6	compounds	NNS	O	compound	prep_of	2	SENT_68	[p6l8t355r418b436],
7	in	IN	O	in	_	0	SENT_68	[p6l448t355r515b417],
8	plasma	NN	O	plasma	prep_in	6	SENT_68	[p6l543t355r797b436],
9	and	CC	O	and	_	0	SENT_68	[p6l827t355r953b418],
10	urine	NN	O	urine	prep_in	6	SENT_68	[p6l980t355r1163b418],
11	were	VBD	O	be	auxpass	12	SENT_68	[p6l1192t375r1363b418],
12	determined	VBN	O	determine	_	0	SENT_68	[p6l1393t355r1796b418],
13	by	IN	O	by	_	0	SENT_68	[p6l1823t355r1911b436],
14	liquid	JJ	O	liquid	amod	16	SENT_68	[p6l1940t355r2148b436],
15	chromatography	NN	O	chromatography	nn	16	SENT_68	[p6l8t466r906b547],
16	—	NN	O	—	agent	12	SENT_68	[p6l8t466r906b547],
17	tandem	JJ	O	tandem	amod	19	SENT_68	[p6l8t466r906b547],
18	mass	NN	O	mass	nn	19	SENT_68	[p6l938t486r1113b529],
19	spectrometry	NN	O	spectrometry	tmod	12	SENT_68	[p6l1150t475r1613b547],
20	(	CD	NUMBER	(	num	21	SENT_68	[p6l1650t466r2145b543],
21	LC	NN	O	lc	dep	19	SENT_68	[p6l1650t466r2145b543],
22	.	.	O	.	_	0	SENT_68	[p6l1650t466r2145b543],

1	—	NN	O	—	_	0	SENT_69	[p6l1650t466r2145b543],
2	.	.	O	.	_	0	SENT_69	[p6l1650t466r2145b543],

1	MS/MS	NN	O	ms/ms	_	0	SENT_70	[p6l1650t466r2145b543],
2	)	CD	NUMBER	)	npadvmod	3	SENT_70	[p6l1650t466r2145b543],
3	as	IN	O	as	advmod	4	SENT_70	[p6l9t597r78b640],
4	described	VBN	O	describe	partmod	1	SENT_70	[p6l136t577r478b640],
5	in	IN	O	in	_	0	SENT_70	[p6l533t577r601b639],
6	earlier	JJR	O	earlier	amod	7	SENT_70	[p6l657t577r886b640],
7	reports	NNS	O	report	prep_in	4	SENT_70	[p6l939t587r1186b658],
8	(	CD	NUMBER	(	num	9	SENT_70	[p6l1246t577r1632b655],
9	Kawabata	NNP	O	Kawabata	dep	1	SENT_70	[p6l1246t577r1632b655],
10	et	FW	O	et	nn	11	SENT_70	[p6l1686t587r1750b640],
11	al.	FW	O	al.	dep	9	SENT_70	[p6l1806t577r1885b640],
12	2005	CD	DATE	2005	dep	9	SENT_70	[p6l1947t577r2143b651],
13	;	:	O	;	_	0	SENT_70	[p6l1947t577r2143b651],
14	Nishizato	NNP	O	Nishizato	dep	1	SENT_70	[p6l7t688r349b751],
15	et	FW	O	et	nn	16	SENT_70	[p6l387t698r450b751],
16	al.	FW	O	al.	dep	14	SENT_70	[p6l486t688r565b751],
17	2003	CD	DATE	2003	num	18	SENT_70	[p6l607t689r830b766],
18	)	CD	NUMBER	)	dep	14	SENT_70	[p6l607t689r830b766],
19	.	.	O	.	_	0	SENT_70	[p6l607t689r830b766],

1	Pharmacokinetic	JJ	O	pharmacokinetic	_	0	SENT_71	[p6l7t912r609b975],
2	and	CC	O	and	_	0	SENT_71	[p6l645t912r772b975],
3	statistical	JJ	O	statistical	amod	4	SENT_71	[p6l807t912r1141b975],
4	analysis	NN	O	analysis	conj_and	1	SENT_71	[p6l1177t912r1460b993],

1	Peak	JJ	O	peak	amod	3	SENT_72	[p6l7t1136r181b1198],
2	plasma	NN	O	plasma	nn	3	SENT_72	[p6l224t1136r479b1217],
3	concentration	NN	O	concentration	nsubjpass	8	SENT_72	[p6l525t1136r1013b1198],
4	(	CD	NUMBER	(	num	6	SENT_72	[p6l1061t1136r1289b1213],
5	Cmax	NN	O	cmax	nn	6	SENT_72	[p6l1061t1136r1289b1213],
6	)	NN	O	)	dep	3	SENT_72	[p6l1061t1136r1289b1213],
7	was	VBD	O	be	auxpass	8	SENT_72	[p6l1338t1155r1473b1199],
8	obtained	VBN	O	obtain	_	0	SENT_72	[p6l1521t1136r1829b1198],
9	directly	RB	O	directly	advmod	8	SENT_72	[p6l1875t1136r2146b1217],
10	from	IN	O	from	_	0	SENT_72	[p6l8t1246r180b1309],
11	the	DT	O	the	det	12	SENT_72	[p6l218t1247r325b1309],
12	data	NNS	O	datum	prep_from	8	SENT_72	[p6l365t1247r530b1309],
13	.	.	O	.	_	0	SENT_72	[p6l365t1247r530b1309],

1	The	DT	O	the	det	2	SENT_73	[p6l573t1247r710b1309],
2	area	NN	O	area	nsubj	7	SENT_73	[p6l751t1266r898b1309],
3	under	IN	O	under	_	0	SENT_73	[p6l935t1247r1140b1309],
4	the	DT	O	the	det	6	SENT_73	[p6l1177t1247r1284b1309],
5	plasma	NN	O	plasma	nn	6	SENT_73	[p6l1321t1247r1577b1328],
6	concentrationtime	NN	O	concentrationtime	prep_under	2	SENT_73	[p6l1615t1247r2149b1309, p6l7t1359r165b1422],
7	curve	NN	O	curve	_	0	SENT_73	[p6l195t1379r391b1422],
8	from	IN	O	from	_	0	SENT_73	[p6l422t1359r595b1422],
9	time	NN	O	time	nn	11	SENT_73	[p6l623t1359r780b1422],
10	0-24	CD	NUMBER	0-24	num	11	SENT_73	[p6l811t1360r986b1422],
11	h	NN	O	h	prep_from	7	SENT_73	[p6l1019t1359r1062b1421],
12	(	CD	NUMBER	(	num	14	SENT_73	[p6l1094t1360r1469b1437],
13	AUC0_24	NN	O	auc0_24	nn	14	SENT_73	[p6l1094t1360r1469b1437],
14	)	NN	O	)	nsubjpass	16	SENT_73	[p6l1094t1360r1469b1437],
15	was	VBD	O	be	auxpass	16	SENT_73	[p6l1502t1379r1636b1422],
16	calculated	VBN	O	calculate	rcmod	11	SENT_73	[p6l1668t1359r2032b1422],
17	by	IN	O	by	_	0	SENT_73	[p6l2059t1359r2147b1440],
18	the	DT	O	the	det	21	SENT_73	[p6l7t1470r114b1533],
19	linear	JJ	O	linear	amod	21	SENT_73	[p6l164t1470r368b1533],
20	trapezoidal	JJ	O	trapezoidal	amod	21	SENT_73	[p6l415t1470r813b1551],
21	rule	NN	O	rule	agent	16	SENT_73	[p6l861t1470r1018b1544],
22	,	,	O	,	_	0	SENT_73	[p6l861t1470r1018b1544],
23	and	CC	O	and	_	0	SENT_73	[p6l1072t1470r1198b1533],
24	apparent	JJ	O	apparent	amod	26	SENT_73	[p6l1247t1479r1555b1551],
25	total	JJ	O	total	amod	26	SENT_73	[p6l1602t1470r1760b1533],
26	clearance	NN	O	clearance	conj_and	11	SENT_73	[p6l1809t1470r2146b1533],
27	(	CD	NUMBER	(	num	29	SENT_73	[p6l10t1581r276b1658],
28	CL/F	NN	O	cl/f	nn	29	SENT_73	[p6l10t1581r276b1658],
29	)	NN	O	)	nsubjpass	31	SENT_73	[p6l10t1581r276b1658],
30	was	VBD	O	be	auxpass	31	SENT_73	[p6l305t1601r439b1644],
31	calculated	VBN	O	calculate	rcmod	26	SENT_73	[p6l467t1581r831b1644],
32	as	IN	O	as	mark	33	SENT_73	[p6l858t1601r926b1644],
33	follows	VBZ	O	follow	advcl	31	SENT_73	[p6l953t1581r1238b1644],
34	:	:	O	:	_	0	SENT_73	[p6l953t1581r1238b1644],
35	CLt/F	NN	O	clt/f	nn	37	SENT_73	[p6l1271t1581r1487b1658],
36	=	JJ	O	=	amod	37	SENT_73	[p6l1518t1610r1579b1633],
37	dose/AUC0	NN	O	dose/auc0	dep	26	SENT_73	[p6l1615t1581r2143b1658],
38	_	NN	O	_	dep	37	SENT_73	[p6l1615t1581r2143b1658],
39	24	CD	NUMBER	24	num	38	SENT_73	[p6l1615t1581r2143b1658],
40	.	.	O	.	_	0	SENT_73	[p6l1615t1581r2143b1658],

1	The	DT	O	the	det	2	SENT_74	[p6l7t1693r144b1756],
2	kg	NN	O	kg	nsubjpass	4	SENT_74	[p6l185t1693r252b1771],
3	was	VBD	O	be	auxpass	4	SENT_74	[p6l294t1713r428b1756],
4	determined	VBN	O	determine	_	0	SENT_74	[p6l471t1693r875b1756],
5	by	IN	O	by	_	0	SENT_74	[p6l913t1693r1001b1774],
6	log	NN	O	log	nn	10	SENT_74	[p6l1042t1693r1392b1774],
7	—	CD	NUMBER	—	num	10	SENT_74	[p6l1042t1693r1392b1774],
8	linear	JJ	O	linear	amod	10	SENT_74	[p6l1042t1693r1392b1774],
9	regression	NN	O	regression	nn	10	SENT_74	[p6l1429t1693r1797b1774],
10	analysis	NN	O	analysis	agent	4	SENT_74	[p6l1840t1693r2143b1774],
11	.	.	O	.	_	0	SENT_74	[p6l1840t1693r2143b1774],

1	Renal	JJ	O	renal	amod	5	SENT_75	[p6l7t1804r214b1867],
2	clearance	NN	O	clearance	nn	5	SENT_75	[p6l281t1804r618b1867],
3	(	CD	NUMBER	(	num	5	SENT_75	[p6l687t1805r1019b1882],
4	CLr0_24	NN	O	clr0_24	nn	5	SENT_75	[p6l687t1805r1019b1882],
5	)	NN	O	)	nsubjpass	7	SENT_75	[p6l687t1805r1019b1882],
6	was	VBD	O	be	auxpass	7	SENT_75	[p6l1087t1824r1221b1867],
7	estimated	VBN	O	estimate	_	0	SENT_75	[p6l1289t1804r1633b1867],
8	by	IN	O	by	_	0	SENT_75	[p6l1696t1804r1784b1885],
9	dividing	VBG	O	divide	agent	7	SENT_75	[p6l1850t1804r2147b1885],
10	Ae0_24	NN	O	ae0_24	dobj	9	SENT_75	[p6l7t1916r244b1993],
11	with	IN	O	with	_	0	SENT_75	[p6l276t1915r433b1978],
12	AUC0_24	NN	O	auc0_24	prep_with	9	SENT_75	[p6l464t1916r804b1993],
13	,	,	O	,	_	0	SENT_75	[p6l464t1916r804b1993],
14	where	WRB	O	where	advmod	19	SENT_75	[p6l840t1915r1056b1978],
15	Ae	NN	O	ae	nsubj	19	SENT_75	[p6l1088t1916r1189b1978],
16	is	VBZ	O	be	cop	19	SENT_75	[p6l1221t1915r1277b1978],
17	the	DT	O	the	det	19	SENT_75	[p6l1310t1915r1418b1978],
18	cumulative	JJ	O	cumulative	amod	19	SENT_75	[p6l1450t1915r1848b1978],
19	amount	NN	O	amount	rcmod	12	SENT_75	[p6l1882t1925r2149b1978],
20	excreted	VBN	O	excrete	partmod	19	SENT_75	[p6l8t2027r312b2089],
21	in	IN	O	in	_	0	SENT_75	[p6l343t2027r410b2089],
22	urine	NN	O	urine	prep_in	20	SENT_75	[p6l442t2027r642b2089],
23	.	.	O	.	_	0	SENT_75	[p6l442t2027r642b2089],

1	The	DT	O	the	det	3	SENT_76	[p6l679t2027r816b2089],
2	statistical	JJ	O	statistical	amod	3	SENT_76	[p6l852t2027r1187b2089],
3	differences	NNS	O	difference	nsubjpass	9	SENT_76	[p6l1221t2027r1616b2089],
4	of	IN	O	of	_	0	SENT_76	[p6l1652t2027r1728b2089],
5	parameters	NNS	O	parameter	prep_of	3	SENT_76	[p6l1753t2036r2145b2108],
6	among	IN	O	among	_	0	SENT_76	[p6l9t2157r248b2219],
7	groups	NNS	O	group	prep_among	5	SENT_76	[p6l287t2157r526b2219],
8	were	VBD	O	be	auxpass	9	SENT_76	[p6l563t2157r734b2200],
9	determined	VBN	O	determine	_	0	SENT_76	[p6l772t2138r1176b2200],
10	by	IN	O	by	_	0	SENT_76	[p6l1209t2138r1297b2219],
11	the	DT	O	the	det	12	SENT_76	[p6l1333t2138r1440b2200],
12	Kruskal	NNP	PERSON	Kruskal	agent	9	SENT_76	[p6l1479t2138r2038b2200],
13	.	.	O	.	_	0	SENT_76	[p6l1479t2138r2038b2200],

1	—	NN	O	—	_	0	SENT_77	[p6l1479t2138r2038b2200],
2	.	.	O	.	_	0	SENT_77	[p6l1479t2138r2038b2200],

1	Wallis	NNP	PERSON	Wallis	_	0	SENT_78	[p6l1479t2138r2038b2200],
2	or	CC	O	or	_	0	SENT_78	[p6l2076t2157r2149b2200],
3	Mann	NNP	PERSON	Mann	conj_or	1	SENT_78	[p6l7t2248r570b2329],
4	.	.	O	.	_	0	SENT_78	[p6l7t2248r570b2329],

1	—	NN	O	—	_	0	SENT_79	[p6l7t2248r570b2329],
2	.	.	O	.	_	0	SENT_79	[p6l7t2248r570b2329],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_80	[p6l7t2248r570b2329],
2	U	NNP	O	U	_	0	SENT_80	[p6l633t2250r693b2311],
3	tests	NNS	O	test	dep	2	SENT_80	[p6l743t2257r918b2310],
4	.	.	O	.	_	0	SENT_80	[p6l743t2257r918b2310],

1	To	TO	O	to	aux	2	SENT_81	[p6l978t2249r1074b2310],
2	evaluate	VB	O	evaluate	_	0	SENT_81	[p6l1132t2248r1428b2310],
3	the	DT	O	the	det	4	SENT_81	[p6l1485t2248r1592b2310],
4	effect	NN	O	effect	dobj	2	SENT_81	[p6l1650t2248r1852b2310],
5	of	IN	O	of	_	0	SENT_81	[p6l1909t2247r1986b2310],
6	coadministration	NN	O	coadministration	prep_of	4	SENT_81	[p6l2036t2267r2145b2310, p6l9t2360r544b2434],
7	,	,	O	,	_	0	SENT_81	[p6l2036t2267r2145b2310, p6l9t2360r544b2434],
8	within	IN	O	within	_	0	SENT_81	[p6l583t2360r1097b2441],
9	—	CD	NUMBER	—	num	11	SENT_81	[p6l583t2360r1097b2441],
10	subject	JJ	O	subject	amod	11	SENT_81	[p6l583t2360r1097b2441],
11	differences	NNS	O	difference	prep_within	2	SENT_81	[p6l1130t2360r1526b2423],
12	of	IN	O	of	_	0	SENT_81	[p6l1562t2360r1640b2423],
13	data	NNS	O	datum	prep_of	11	SENT_81	[p6l1668t2360r1816b2423],
14	between	IN	O	between	_	0	SENT_81	[p6l1848t2360r2148b2423],
15	single	JJ	O	single	amod	17	SENT_81	[p6l10t2471r414b2552],
16	—	NN	O	—	nn	17	SENT_81	[p6l10t2471r414b2552],
17	dose	NN	O	dose	prep_between	13	SENT_81	[p6l10t2471r414b2552],
18	and	CC	O	and	_	0	SENT_81	[p6l442t2471r569b2534],
19	co	NN	O	co	nn	20	SENT_81	[p6l595t2471r1228b2534],
20	—	NN	O	—	prep_between	13	SENT_81	[p6l595t2471r1228b2534],
21	administration	NN	O	administration	nn	22	SENT_81	[p6l595t2471r1228b2534],
22	phases	NNS	O	phase	nsubjpass	24	SENT_81	[p6l1253t2471r1490b2552],
23	were	VBD	O	be	auxpass	24	SENT_81	[p6l1518t2491r1689b2534],
24	analyzed	VBN	O	analyze	rcmod	17	SENT_81	[p6l1718t2471r2034b2552],
25	by	IN	O	by	_	0	SENT_81	[p6l2059t2471r2147b2552],
26	J	NN	PERSON	j	nn	28	SENT_81	[p6l52t2628r65b2653],
27	Hum	NNP	PERSON	Hum	nn	28	SENT_81	[p6l78t2628r148b2652],
28	Genet	NNP	PERSON	Genet	agent	24	SENT_81	[p6l161t2627r244b2653],
29	(	CD	NUMBER	(	num	28	SENT_81	[p6l258t2627r349b2658],
30	2008	CD	DATE	2008	num	31	SENT_81	[p6l258t2627r349b2658],
31	)	CD	NUMBER	)	tmod	24	SENT_81	[p6l258t2627r349b2658],
32	532899-904	CD	NUMBER	532899-904	num	33	SENT_81	[p6l363t2627r530b2653],
33	901	CD	NUMBER	901	dep	31	SENT_81	[p6l2056t2627r2104b2653],

1	the	DT	O	the	det	2	SENT_82	[p6l13t2796r120b2859],
2	Wilcoxon	NNP	PERSON	Wilcoxon	nsubj	3	SENT_82	[p6l158t2796r510b2859],
3	signed	VBD	O	sign	_	0	SENT_82	[p6l551t2796r1001b2877],
4	—	CD	NUMBER	—	num	5	SENT_82	[p6l551t2796r1001b2877],
5	ranks	NNS	O	rank	dobj	3	SENT_82	[p6l551t2796r1001b2877],
6	test	NN	O	test	dep	5	SENT_82	[p6l1040t2806r1180b2859],
7	.	.	O	.	_	0	SENT_82	[p6l1040t2806r1180b2859],

1	P	NN	O	p	npadvmod	2	SENT_83	[p6l1221t2799r1276b2858],
2	<	JJR	O	<	dep	5	SENT_83	[p6l1308t2811r1365b2859],
3	0.05	CD	NUMBER	0.05	nsubjpass	5	SENT_83	[p6l1397t2796r1546b2859],
4	was	VBD	O	be	auxpass	5	SENT_83	[p6l1588t2816r1722b2859],
5	considered	VBN	O	consider	_	0	SENT_83	[p6l1762t2796r2148b2859],
6	statistically	RB	O	statistically	advmod	7	SENT_83	[p6l17t2906r421b2987],
7	signiﬁcant	JJ	O	signiﬁcant	acomp	5	SENT_83	[p6l457t2906r844b2987],
8	.	.	O	.	_	0	SENT_83	[p6l457t2906r844b2987],

1	Results	NNS	O	result	_	0	SENT_84	[p6l14t3150r289b3213],
2	and	CC	O	and	_	0	SENT_84	[p6l322t3150r462b3213],
3	discussion	NN	O	discussion	conj_and	1	SENT_84	[p6l496t3149r880b3213],

1	All	DT	O	all	det	3	SENT_85	[p6l13t3373r125b3435],
2	ten	CD	NUMBER	ten	num	3	SENT_85	[p6l163t3382r271b3436],
3	participants	NNS	O	participant	nsubj	4	SENT_85	[p6l307t3373r724b3454],
4	completed	VBD	O	complete	conj_and	4	SENT_85	[p6l764t3373r1136b3454],
5	the	DT	O	the	det	6	SENT_85	[p6l1172t3373r1279b3436],
6	study	NN	O	study	dobj	4	SENT_85	[p6l1321t3373r1508b3454],
7	according	VBG	O	accord	_	0	SENT_85	[p6l1548t3373r1897b3454],
8	to	TO	O	to	prepc_according_to	4	SENT_85	[p6l1935t3383r2002b3436],
9	the	DT	O	the	det	10	SENT_85	[p6l2040t3373r2147b3436],
10	protocol	NN	O	protocol	pobj	4	SENT_85	[p6l12t3484r309b3565],
11	without	IN	O	without	_	0	SENT_85	[p6l358t3484r630b3547],
12	the	DT	O	the	det	16	SENT_85	[p6l675t3484r782b3547],
13	clinically	RB	O	clinically	advmod	14	SENT_85	[p6l830t3484r1162b3565],
14	important	JJ	O	important	amod	16	SENT_85	[p6l1209t3484r1557b3565],
15	adverse	JJ	O	adverse	amod	16	SENT_85	[p6l1604t3484r1873b3547],
16	events	NNS	O	event	prep_without	10	SENT_85	[p6l1921t3494r2146b3547],
17	probably	RB	O	probably	advmod	18	SENT_85	[p6l12t3595r329b3676],
18	due	JJ	O	due	amod	16	SENT_85	[p6l397t3595r522b3658],
19	to	TO	O	to	_	0	SENT_85	[p6l589t3605r656b3658],
20	the	DT	O	the	det	21	SENT_85	[p6l723t3595r830b3658],
21	administration	NN	O	administration	prep_to	4	SENT_85	[p6l898t3595r1413b3658],
22	of	IN	O	of	_	0	SENT_85	[p6l1480t3595r1557b3658],
23	pravastatin	NN	O	pravastatin	nn	26	SENT_85	[p6l1616t3595r2010b3676],
24	or	CC	O	or	_	0	SENT_85	[p6l2076t3615r2149b3658],
25	olmesartan	NN	O	olmesartan	nn	26	SENT_85	[p6l15t3706r406b3769],
26	medoxomil	NN	O	medoxomil	prep_of	21	SENT_85	[p6l438t3706r844b3769],
27	in	IN	O	in	_	0	SENT_85	[p6l877t3706r945b3768],
28	the	DT	O	the	det	32	SENT_85	[p6l976t3706r1083b3769],
29	single	JJ	O	single	amod	32	SENT_85	[p6l1119t3706r1521b3787],
30	—	NN	O	—	nn	32	SENT_85	[p6l1119t3706r1521b3787],
31	dose	NN	O	dose	nn	32	SENT_85	[p6l1119t3706r1521b3787],
32	phase	NN	O	phase	prep_in	26	SENT_85	[p6l1552t3706r1754b3787],
33	as	RB	O	as	_	0	SENT_85	[p6l1789t3726r1858b3769],
34	well	RB	O	well	_	0	SENT_85	[p6l1891t3706r2042b3769],
35	as	IN	O	as	_	0	SENT_85	[p6l2077t3726r2146b3769],
36	in	IN	O	in	_	0	SENT_85	[p7l14t22r81b84],
37	the	DT	O	the	det	41	SENT_85	[p7l113t22r220b84],
38	co	NN	O	co	nn	41	SENT_85	[p7l254t22r885b84],
39	—	NN	O	—	nn	41	SENT_85	[p7l254t22r885b84],
40	administration	NN	O	administration	nn	41	SENT_85	[p7l254t22r885b84],
41	phase	NN	O	phase	prep_in	4	SENT_85	[p7l917t22r1138b103],
42	.	.	O	.	_	0	SENT_85	[p7l917t22r1138b103],

1	In	IN	O	in	dep	24	SENT_86	[p7l116t134r188b195],
2	the	DT	O	the	det	6	SENT_86	[p7l225t133r332b195],
3	single	JJ	O	single	amod	6	SENT_86	[p7l373t133r775b214],
4	—	NN	O	—	nn	6	SENT_86	[p7l373t133r775b214],
5	dose	NN	O	dose	nn	6	SENT_86	[p7l373t133r775b214],
6	phase	NN	O	phase	pobj	1	SENT_86	[p7l813t133r1035b214],
7	,	,	O	,	_	0	SENT_86	[p7l813t133r1035b214],
8	the	DT	O	the	det	10	SENT_86	[p7l1076t133r1183b195],
9	mean	NN	O	mean	nn	10	SENT_86	[p7l1221t152r1414b195],
10	Cmax	NN	O	cmax	pobj	1	SENT_86	[p7l1456t134r1624b210],
11	and	CC	O	and	_	0	SENT_86	[p7l1665t133r1791b195],
12	AUC0_24	NN	O	auc0_24	nn	13	SENT_86	[p7l1828t133r2147b210],
13	values	NNS	O	value	pobj	1	SENT_86	[p7l14t244r238b307],
14	of	IN	O	of	_	0	SENT_86	[p7l275t244r352b306],
15	olmesartan	NN	O	olmesartan	prep_of	13	SENT_86	[p7l379t244r771b306],
16	in	IN	O	in	_	0	SENT_86	[p7l804t244r871b306],
17	SLC01BI	NN	O	slc01bus	nn	19	SENT_86	[p7l904t244r1559b307],
18	*	CD	NUMBER	*	num	19	SENT_86	[p7l904t244r1559b307],
19	I5	NN	O	i5	prep_in	15	SENT_86	[p7l904t244r1559b307],
20	/	:	O	/	punct	24	SENT_86	[p7l904t244r1559b307],
21	*	CD	NUMBER	*	number	22	SENT_86	[p7l904t244r1559b307],
22	15	CD	NUMBER	15	num	23	SENT_86	[p7l904t244r1559b307],
23	subjects	NNS	O	subject	nsubj	24	SENT_86	[p7l1594t244r1875b325],
24	tended	VBD	O	tend	_	0	SENT_86	[p7l1911t244r2148b306],
25	to	TO	O	to	aux	27	SENT_86	[p7l13t365r80b418],
26	be	VB	O	be	cop	27	SENT_86	[p7l116t355r199b418],
27	higher	JJR	O	higher	xcomp	24	SENT_86	[p7l235t355r481b436],
28	,	,	O	,	_	0	SENT_86	[p7l235t355r481b436],
29	and	CC	O	and	_	0	SENT_86	[p7l523t355r649b418],
30	the	DT	O	the	det	32	SENT_86	[p7l684t355r791b418],
31	mean	NN	O	mean	nn	32	SENT_86	[p7l829t375r1021b418],
32	CL	NN	MISC	cl	xcomp	24	SENT_86	[p7l1058t356r1273b433],
33	,	,	O	,	_	0	SENT_86	[p7l1058t356r1273b433],
34	/	:	O	/	punct	39	SENT_86	[p7l1058t356r1273b433],
35	F	NN	O	f	nn	36	SENT_86	[p7l1058t356r1273b433],
36	value	NN	O	value	nsubj	39	SENT_86	[p7l1305t355r1496b418],
37	was	VBD	O	be	cop	39	SENT_86	[p7l1534t375r1668b418],
38	signiﬁcantly	RB	O	signiﬁcantly	advmod	39	SENT_86	[p7l1709t355r2147b436],
39	lower	JJR	O	lower	parataxis	27	SENT_86	[p7l14t466r217b529],
40	than	IN	O	than	_	0	SENT_86	[p7l253t466r406b529],
41	those	DT	O	those	prep_than	39	SENT_86	[p7l443t466r629b529],
42	in	IN	O	in	_	0	SENT_86	[p7l667t466r735b528],
43	SLC01BI	NN	O	slc01bus	nn	45	SENT_86	[p7l773t466r1426b530],
44	*	CD	NUMBER	*	num	45	SENT_86	[p7l773t466r1426b530],
45	Ib	NN	O	ib	prep_in	41	SENT_86	[p7l773t466r1426b530],
46	/	:	O	/	punct	39	SENT_86	[p7l773t466r1426b530],
47	*	CD	NUMBER	*	num	49	SENT_86	[p7l773t466r1426b530],
48	1	CD	NUMBER	1	num	49	SENT_86	[p7l773t466r1426b530],
49	]	NN	O	]	dobj	27	SENT_86	[p7l773t466r1426b530],
50	?	.	O	?	_	0	SENT_86	[p7l773t466r1426b530],

1	subjects	NNS	O	subject	_	0	SENT_87	[p7l1467t466r1749b547],
2	(	CD	NUMBER	(	num	3	SENT_87	[p7l1791t466r2020b544],
3	Table	NNP	O	Table	dep	1	SENT_87	[p7l1791t466r2020b544],
4	1	CD	NUMBER	1	number	5	SENT_87	[p7l2062t467r2143b543],
5	)	CD	NUMBER	)	dep	3	SENT_87	[p7l2062t467r2143b543],
6	.	.	O	.	_	0	SENT_87	[p7l2062t467r2143b543],

1	Recent	JJ	O	recent	nsubj	12	SENT_88	[p7l14t579r262b640],
2	in	FW	O	in	nn	4	SENT_88	[p7l296t577r364b639],
3	vitro	FW	O	vitro	dep	4	SENT_88	[p7l399t577r564b640],
4	studies	NNS	O	study	advmod	5	SENT_88	[p7l603t577r845b640],
5	using	VBG	O	use	partmod	1	SENT_88	[p7l881t577r1072b658],
6	OATPlBl	NN	O	oatplbl	nn	7	SENT_88	[p7l1109t577r1899b658],
7	—	NN	O	—	dobj	5	SENT_88	[p7l1109t577r1899b658],
8	expressing	VBG	O	express	xcomp	5	SENT_88	[p7l1109t577r1899b658],
9	Xenopus	NN	MISC	xenopus	nn	11	SENT_88	[p7l1932t579r2144b640, p7l6t708r135b767],
10	laevis	NN	O	laevi	nn	11	SENT_88	[p7l179t687r384b750],
11	oocytes	NNS	O	oocyte	dobj	8	SENT_88	[p7l427t696r696b768],
12	(	VBP	O	(	_	0	SENT_88	[p7l742t687r1501b768],
13	Nakagomi	NNP	PERSON	Nakagomi	dobj	12	SENT_88	[p7l742t687r1501b768],
14	.	.	O	.	_	0	SENT_88	[p7l742t687r1501b768],

1	—	NN	O	—	_	0	SENT_89	[p7l742t687r1501b768],
2	.	.	O	.	_	0	SENT_89	[p7l742t687r1501b768],

1	Hagihara	NNP	O	Hagihara	nsubj	16	SENT_90	[p7l742t687r1501b768],
2	et	FW	O	et	nn	3	SENT_90	[p7l1542t696r1605b749],
3	al.	FW	O	al.	nsubj	9	SENT_90	[p7l1647t687r1726b749],
4	2006	CD	DATE	2006	num	5	SENT_90	[p7l1774t687r1976b764],
5	)	NN	O	)	dep	3	SENT_90	[p7l1774t687r1976b764],
6	and	CC	O	and	_	0	SENT_90	[p7l2022t687r2148b749],
7	HEK293	NN	O	hek293	nn	8	SENT_90	[p7l14t800r324b863],
8	cells	NNS	O	cell	dep	3	SENT_90	[p7l374t799r534b862],
9	(	VBP	O	(	rcmod	1	SENT_90	[p7l582t799r906b877],
10	Yamada	NNP	PERSON	Yamada	nsubj	12	SENT_90	[p7l582t799r906b877],
11	et	FW	O	et	nn	12	SENT_90	[p7l949t809r1013b862],
12	al.	FW	O	al.	xcomp	9	SENT_90	[p7l1057t799r1135b862],
13	2007	CD	DATE	2007	num	14	SENT_90	[p7l1185t800r1388b877],
14	)	CD	NUMBER	)	dep	12	SENT_90	[p7l1185t800r1388b877],
15	have	VBP	O	have	aux	16	SENT_90	[p7l1433t799r1600b862],
16	indicated	VBN	O	indicate	_	0	SENT_90	[p7l1644t799r1972b862],
17	that	IN	O	that	complm	21	SENT_90	[p7l2015t799r2148b862],
18	olmesartan	NN	O	olmesartan	nsubj	21	SENT_90	[p7l15t911r406b974],
19	is	VBZ	O	be	cop	21	SENT_90	[p7l461t911r517b974],
20	a	DT	O	a	det	21	SENT_90	[p7l575t931r612b974],
21	substrate	NN	O	substrate	ccomp	16	SENT_90	[p7l669t911r982b974],
22	of	IN	O	of	_	0	SENT_90	[p7l1039t911r1116b974],
23	OAT	NN	O	oat	nn	24	SENT_90	[p7l1168t912r1347b974],
24	P1Bl	NN	O	p1bl	prep_of	21	SENT_90	[p7l1349t912r1564b974],
25	.	.	O	.	_	0	SENT_90	[p7l1349t912r1564b974],

1	Olmesartan	NNP	O	Olmesartan	nsubjpass	3	SENT_91	[p7l1625t911r2036b974],
2	is	VBZ	O	be	auxpass	3	SENT_91	[p7l2090t911r2146b974],
3	eliminated	VBN	O	eliminate	_	0	SENT_91	[p7l15t1023r393b1085],
4	from	IN	O	from	_	0	SENT_91	[p7l423t1023r595b1085],
5	the	DT	O	the	det	6	SENT_91	[p7l624t1023r731b1085],
6	body	NN	O	body	prep_from	3	SENT_91	[p7l762t1023r939b1104],
7	through	IN	O	through	prep	3	SENT_91	[p7l970t1023r1246b1104],
8	hepatic	JJ	O	hepatic	amod	11	SENT_91	[p7l1276t1023r1533b1104],
9	and	CC	O	and	_	0	SENT_91	[p7l1567t1023r1693b1085],
10	renal	JJ	O	renal	amod	11	SENT_91	[p7l1722t1023r1899b1085],
11	routes	NNS	O	route	dep	16	SENT_91	[p7l1930t1032r2146b1085],
12	without	IN	O	without	_	0	SENT_91	[p7l14t1133r287b1195],
13	extensive	JJ	O	extensive	amod	14	SENT_91	[p7l312t1133r647b1195],
14	metabolism	NN	O	metabolism	prep_without	11	SENT_91	[p7l673t1133r1092b1195],
15	(	CD	NUMBER	(	dep	16	SENT_91	[p7l1119t1133r1337b1209],
16	Laeis	NNP	O	Laeis	dep	20	SENT_91	[p7l1119t1133r1337b1209],
17	et	FW	O	et	nn	18	SENT_91	[p7l1365t1142r1428b1195],
18	al.	FW	O	al.	dep	16	SENT_91	[p7l1454t1133r1533b1195],
19	2001	CD	DATE	2001	num	20	SENT_91	[p7l1565t1133r1787b1209],
20	)	CD	NUMBER	)	dep	7	SENT_91	[p7l1565t1133r1787b1209],
21	.	.	O	.	_	0	SENT_91	[p7l1565t1133r1787b1209],

1	Since	IN	O	since	mark	11	SENT_92	[p7l1820t1133r2013b1195],
2	the	DT	O	the	det	3	SENT_92	[p7l2041t1133r2147b1195],
3	uptake	NN	O	uptake	nsubj	11	SENT_92	[p7l13t1244r250b1325],
4	of	IN	O	of	_	0	SENT_92	[p7l292t1244r369b1306],
5	olmesartan	NN	O	olmesartan	prep_of	3	SENT_92	[p7l403t1244r794b1306],
6	into	IN	O	into	_	0	SENT_92	[p7l834t1244r970b1306],
7	hepatocytes	NNS	O	hepatocyte	prep_into	5	SENT_92	[p7l1011t1244r1431b1325],
8	is	VBZ	O	be	cop	11	SENT_92	[p7l1473t1244r1529b1306],
9	the	DT	O	the	det	11	SENT_92	[p7l1570t1244r1677b1306],
10	ﬁrst	JJ	O	ﬁrst	amod	11	SENT_92	[p7l1719t1244r1855b1306],
11	step	NN	O	step	csubj	43	SENT_92	[p7l1897t1253r2035b1325],
12	of	IN	O	of	_	0	SENT_92	[p7l2076t1244r2153b1306],
13	hepatobiliary	JJ	O	hepatobiliary	amod	14	SENT_92	[p7l13t1355r485b1436],
14	excretion	NN	O	excretion	prep_of	11	SENT_92	[p7l539t1355r889b1429],
15	,	,	O	,	_	0	SENT_92	[p7l539t1355r889b1429],
16	which	WDT	O	which	nsubj	29	SENT_92	[p7l945t1355r1161b1418],
17	is	VBZ	O	be	cop	21	SENT_92	[p7l1213t1355r1268b1418],
18	the	DT	O	the	det	21	SENT_92	[p7l1322t1355r1428b1418],
19	major	JJ	O	major	amod	21	SENT_92	[p7l1481t1355r1689b1436],
20	elimination	NN	O	elimination	nn	21	SENT_92	[p7l1740t1355r2148b1418],
21	route	NN	O	route	rcmod	14	SENT_92	[p7l13t1476r195b1529],
22	of	IN	O	of	_	0	SENT_92	[p7l252t1466r329b1529],
23	olmesartan	NN	O	olmesartan	prep_of	21	SENT_92	[p7l380t1466r790b1540],
24	,	,	O	,	_	0	SENT_92	[p7l380t1466r790b1540],
25	increased	VBD	O	increase	conj_and	21	SENT_92	[p7l849t1466r1187b1529],
26	systemic	JJ	O	systemic	amod	27	SENT_92	[p7l1245t1466r1552b1547],
27	exposures	NNS	O	exposure	dobj	25	SENT_92	[p7l1610t1486r1963b1547],
28	and	CC	O	and	_	0	SENT_92	[p7l2022t1466r2148b1529],
29	decreased	VBD	O	decrease	rcmod	14	SENT_92	[p7l15t1577r367b1640],
30	apparent	JJ	O	apparent	amod	32	SENT_92	[p7l400t1586r706b1658],
31	total	JJ	O	total	amod	32	SENT_92	[p7l737t1577r894b1640],
32	clearance	NN	O	clearance	dobj	29	SENT_92	[p7l928t1577r1264b1640],
33	of	IN	O	of	_	0	SENT_92	[p7l1299t1577r1376b1640],
34	olmesartan	NN	O	olmesartan	prep_of	32	SENT_92	[p7l1403t1577r1794b1640],
35	observed	VBN	O	observe	partmod	34	SENT_92	[p7l1828t1577r2148b1640],
36	in	IN	O	in	_	0	SENT_92	[p7l14t1687r81b1748],
37	subjects	NNS	O	subject	prep_in	35	SENT_92	[p7l135t1687r417b1768],
38	with	IN	O	with	_	0	SENT_92	[p7l470t1687r626b1750],
39	*	NN	O	*	nn	41	SENT_92	[p7l681t1686r804b1750],
40	l5	NN	O	l5	nn	41	SENT_92	[p7l681t1686r804b1750],
41	alleles	NNS	O	allele	prep_with	37	SENT_92	[p7l861t1687r1085b1749],
42	might	MD	O	might	aux	43	SENT_92	[p7l1138t1687r1346b1768],
43	result	VB	O	result	_	0	SENT_92	[p7l1394t1687r1593b1749],
44	from	IN	O	from	_	0	SENT_92	[p7l1644t1687r1816b1749],
45	reduced	VBN	O	reduce	amod	47	SENT_92	[p7l1865t1687r2148b1749],
46	hepatic	JJ	O	hepatic	amod	47	SENT_92	[p7l13t1799r269b1880],
47	uptake	NN	O	uptake	prep_from	43	SENT_92	[p7l309t1799r546b1880],
48	of	IN	O	of	_	0	SENT_92	[p7l587t1799r663b1862],
49	olmesartan	NN	O	olmesartan	prep_of	47	SENT_92	[p7l697t1799r1088b1862],
50	via	IN	O	via	_	0	SENT_92	[p7l1127t1799r1235b1862],
51	OATP1Bl	NN	O	oatp1bl	prep_via	49	SENT_92	[p7l1274t1800r1671b1862],
52	.	.	O	.	_	0	SENT_92	[p7l1274t1800r1671b1862],

1	The	DT	O	the	det	2	SENT_93	[p7l1714t1799r1850b1862],
2	lack	NN	O	lack	nsubj	10	SENT_93	[p7l1890t1799r2039b1862],
3	of	IN	O	of	_	0	SENT_93	[p7l2076t1799r2153b1862],
4	intergenotypic	JJ	O	intergenotypic	amod	5	SENT_93	[p7l14t1910r528b1991],
5	differences	NNS	O	difference	prep_of	2	SENT_93	[p7l564t1910r958b1973],
6	in	IN	O	in	_	0	SENT_93	[p7l992t1910r1060b1972],
7	renal	JJ	O	renal	amod	8	SENT_93	[p7l1091t1910r1269b1973],
8	clearance	NN	O	clearance	prep_in	5	SENT_93	[p7l1303t1910r1640b1973],
9	also	RB	O	also	advmod	10	SENT_93	[p7l1675t1910r1813b1973],
10	supports	VBZ	O	support	_	0	SENT_93	[p7l1850t1920r2146b1991],
11	this	DT	O	this	det	12	SENT_93	[p7l14t2021r139b2083],
12	hypothesis	NN	O	hypothesis	dobj	10	SENT_93	[p7l185t2021r565b2102],
13	(	IN	O	(	_	0	SENT_93	[p7l614t2021r842b2098],
14	Table	NNP	O	Table	prep_(	10	SENT_93	[p7l614t2021r842b2098],
15	1	CD	NUMBER	1	number	16	SENT_93	[p7l884t2021r965b2098],
16	)	CD	NUMBER	)	dep	14	SENT_93	[p7l884t2021r965b2098],
17	.	.	O	.	_	0	SENT_93	[p7l884t2021r965b2098],

1	The	DT	O	the	det	2	SENT_94	[p7l1015t2021r1151b2083],
2	SLCOIBI	NNP	O	SLCOIBI	nsubjpass	17	SENT_94	[p7l1197t2021r1550b2084],
3	*	CD	NUMBER	*	num	2	SENT_94	[p7l1569t2021r1692b2083],
4	15	CD	NUMBER	15	num	5	SENT_94	[p7l1569t2021r1692b2083],
5	allele	NN	O	allele	dep	2	SENT_94	[p7l1738t2021r1948b2095],
6	,	,	O	,	_	0	SENT_94	[p7l1738t2021r1948b2095],
7	possessing	VBG	O	possess	partmod	17	SENT_94	[p7l1995t2040r2145b2102, p7l17t2132r268b2213],
8	the	DT	O	the	det	9	SENT_94	[p7l350t2132r456b2194],
9	521T	NN	O	521t	nsubj	12	SENT_94	[p7l540t2132r843b2195],
10	>	JJR	O	>	dep	11	SENT_94	[p7l540t2132r843b2195],
11	C	NN	O	c	amod	9	SENT_94	[p7l540t2132r843b2195],
12	variant	JJ	O	variant	xcomp	7	SENT_94	[p7l926t2132r1191b2206],
13	,	,	O	,	_	0	SENT_94	[p7l926t2132r1191b2206],
14	has	VBZ	O	have	aux	17	SENT_94	[p7l1275t2132r1391b2194],
15	been	VBN	O	be	auxpass	17	SENT_94	[p7l1472t2132r1640b2194],
16	consistently	RB	O	consistently	advmod	17	SENT_94	[p7l1722t2132r2147b2213],
17	associated	VBN	O	associate	_	0	SENT_94	[p7l16t2243r381b2305],
18	with	IN	O	with	_	0	SENT_94	[p7l430t2243r586b2306],
19	reduced	VBN	O	reduce	amod	21	SENT_94	[p7l634t2243r917b2305],
20	transport	NN	O	transport	nn	21	SENT_94	[p7l965t2252r1282b2324],
21	activity	NN	O	activity	prep_with	17	SENT_94	[p7l1332t2243r1598b2324],
22	of	IN	O	of	_	0	SENT_94	[p7l1648t2243r1725b2305],
23	OATPlBl	NN	O	oatplbl	prep_of	21	SENT_94	[p7l1769t2243r2140b2306],
24	both	CC	O	both	prep	23	SENT_94	[p7l13t2354r171b2417],
25	in	FW	O	in	nn	26	SENT_94	[p7l211t2354r278b2416],
26	vitro	FW	O	vitro	dep	31	SENT_94	[p7l318t2354r484b2417],
27	and	CC	O	and	_	0	SENT_94	[p7l527t2354r653b2417],
28	in	FW	O	in	dep	31	SENT_94	[p7l693t2354r760b2416],
29	vivo	FW	O	vivo	nn	30	SENT_94	[p7l800t2354r955b2417],
30	(	FW	O	(	pobj	28	SENT_94	[p7l999t2354r1261b2435],
31	Chung	NNP	PERSON	Chung	dep	24	SENT_94	[p7l999t2354r1261b2435],
32	et	FW	O	et	nn	33	SENT_94	[p7l1303t2364r1367b2417],
33	al.	FW	O	al.	dep	17	SENT_94	[p7l1408t2354r1486b2417],
34	2005	CD	DATE	2005	dep	33	SENT_94	[p7l1532t2354r1728b2428],
35	;	:	O	;	_	0	SENT_94	[p7l1532t2354r1728b2428],
36	Ieiri	NNP	O	Ieiri	dep	33	SENT_94	[p7l1773t2354r1918b2417],
37	et	FW	O	et	nn	38	SENT_94	[p7l1961t2364r2024b2417],
38	al.	FW	O	al.	dep	36	SENT_94	[p7l2065t2354r2143b2417],
39	2007	CD	DATE	2007	dep	36	SENT_94	[p7l15t2466r212b2539],
40	;	:	O	;	_	0	SENT_94	[p7l15t2466r212b2539],
41	Iwai	NNP	O	Iwai	dep	33	SENT_94	[p7l252t2465r408b2528],
42	et	FW	O	et	nn	43	SENT_94	[p7l446t2475r509b2528],
43	al.	FW	O	al.	dep	41	SENT_94	[p7l546t2465r625b2528],
44	2004	CD	DATE	2004	dep	41	SENT_94	[p7l667t2466r863b2539],
45	;	:	O	;	_	0	SENT_94	[p7l667t2466r863b2539],
46	Kameyama	NNP	PERSON	Kameyama	dep	33	SENT_94	[p7l905t2467r1312b2546],
47	et	FW	O	et	nn	48	SENT_94	[p7l1348t2475r1411b2528],
48	al.	FW	O	al.	dep	46	SENT_94	[p7l1448t2465r1527b2528],
49	2005	CD	DATE	2005	dep	46	SENT_94	[p7l1569t2465r1766b2539],
50	;	:	O	;	_	0	SENT_94	[p7l1569t2465r1766b2539],
51	Nishizato	NNP	O	Nishizato	dep	33	SENT_94	[p7l1805t2465r2147b2528],
52	et	FW	O	et	nn	53	SENT_94	[p7l15t2585r77b2639],
53	al.	FW	O	al.	dep	51	SENT_94	[p7l104t2576r183b2639],
54	2003	CD	DATE	2003	num	55	SENT_94	[p7l214t2577r437b2653],
55	)	CD	NUMBER	)	dep	33	SENT_94	[p7l214t2577r437b2653],
56	.	.	O	.	_	0	SENT_94	[p7l214t2577r437b2653],

1	However	RB	O	however	advmod	21	SENT_95	[p7l467t2578r812b2650],
2	,	,	O	,	_	0	SENT_95	[p7l467t2578r812b2650],
3	the	DT	O	the	det	5	SENT_95	[p7l841t2576r947b2639],
4	altered	JJ	O	altered	amod	5	SENT_95	[p7l976t2576r1217b2639],
5	CL	NN	MISC	cl	nsubjpass	21	SENT_95	[p7l1243t2576r1458b2653],
6	,	,	O	,	_	0	SENT_95	[p7l1243t2576r1458b2653],
7	/	:	O	/	punct	9	SENT_95	[p7l1243t2576r1458b2653],
8	F	NN	O	f	dep	9	SENT_95	[p7l1243t2576r1458b2653],
9	due	JJ	O	due	dep	5	SENT_95	[p7l1480t2576r1605b2639],
10	to	TO	O	to	aux	11	SENT_95	[p7l1632t2586r1698b2639],
11	change	VB	O	change	xcomp	9	SENT_95	[p7l1725t2576r1975b2657],
12	in	IN	O	in	_	0	SENT_95	[p7l2002t2576r2070b2638],
13	F	NN	O	f	nn	14	SENT_95	[p7l2095t2579r2152b2638],
14	value	NN	O	value	prep_in	11	SENT_95	[p7l7t2687r199b2750],
15	in	IN	O	in	_	0	SENT_95	[p7l231t2687r299b2749],
16	our	PRP$	O	we	poss	17	SENT_95	[p7l331t2707r449b2750],
17	subjects	NNS	O	subject	prep_in	14	SENT_95	[p7l481t2687r764b2768],
18	can	MD	O	can	aux	21	SENT_95	[p7l798t2697r1036b2750],
19	not	RB	O	not	neg	21	SENT_95	[p7l798t2697r1036b2750],
20	be	VB	O	be	auxpass	21	SENT_95	[p7l1065t2687r1148b2750],
21	denied	VBN	O	deny	_	0	SENT_95	[p7l1181t2687r1419b2750],
22	because	IN	O	because	mark	24	SENT_95	[p7l1448t2687r1731b2750],
23	there	EX	O	there	expl	24	SENT_95	[p7l1763t2687r1940b2750],
24	is	VBZ	O	be	advcl	21	SENT_95	[p7l1972t2687r2028b2750],
25	no	DT	O	no	det	27	SENT_95	[p7l2060t2707r2147b2750],
26	intravenous	JJ	O	intravenous	amod	27	SENT_95	[p7l7t2798r423b2861],
27	data	NNS	O	datum	nsubj	24	SENT_95	[p7l458t2798r606b2861],
28	to	TO	O	to	aux	29	SENT_95	[p7l638t2808r705b2861],
29	estimate	VB	O	estimate	infmod	27	SENT_95	[p7l739t2798r1036b2861],
30	absolute	JJ	O	absolute	amod	31	SENT_95	[p7l1071t2798r1366b2861],
31	bioavailability	NN	O	bioavailability	dobj	29	SENT_95	[p7l1398t2798r1937b2879],
32	.	.	O	.	_	0	SENT_95	[p7l1398t2798r1937b2879],

1	In	IN	O	in	_	0	SENT_96	[p7l109t2910r182b2971],
2	the	DT	O	the	det	6	SENT_96	[p7l222t2909r329b2971],
3	co	NN	O	co	nn	6	SENT_96	[p7l372t2909r1005b2971],
4	—	NN	O	—	nn	6	SENT_96	[p7l372t2909r1005b2971],
5	administration	NN	O	administration	nn	6	SENT_96	[p7l372t2909r1005b2971],
6	phase	NN	O	phase	prep_in	17	SENT_96	[p7l1045t2909r1268b2990],
7	,	,	O	,	_	0	SENT_96	[p7l1045t2909r1268b2990],
8	the	DT	O	the	det	10	SENT_96	[p7l1312t2909r1419b2971],
9	intergenotypic	JJ	O	intergenotypic	amod	10	SENT_96	[p7l1461t2909r1977b2990],
10	differences	NNS	O	difference	nsubj	17	SENT_96	[p7l2021t2909r2145b2971, p7l8t3020r303b3082],
11	in	IN	O	in	_	0	SENT_96	[p7l361t3020r428b3082],
12	the	DT	O	the	det	14	SENT_96	[p7l484t3020r591b3082],
13	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_96	[p7l647t3020r1245b3101],
14	proﬁles	NNS	O	proﬁles	prep_in	10	SENT_96	[p7l1302t3020r1569b3101],
15	of	IN	O	of	_	0	SENT_96	[p7l1627t3020r1704b3082],
16	olmesartan	NN	O	olmesartan	prep_of	14	SENT_96	[p7l1755t3020r2148b3082],
17	disappeared	VBD	O	disappear	_	0	SENT_96	[p7l8t3130r436b3211],
18	(	CD	NUMBER	(	num	19	SENT_96	[p7l475t3130r637b3211],
19	Fig	NN	O	fig	dobj	17	SENT_96	[p7l475t3130r637b3211],
20	.	.	O	.	_	0	SENT_96	[p7l475t3130r637b3211],

1	1	CD	NUMBER	1	_	0	SENT_97	[p7l682t3130r737b3203],
2	;	:	O	;	_	0	SENT_97	[p7l682t3130r737b3203],
3	Table	NNP	O	Table	dep	1	SENT_97	[p7l778t3130r980b3192],
4	1	CD	NUMBER	1	number	5	SENT_97	[p7l1022t3130r1103b3207],
5	)	CD	NUMBER	)	dep	3	SENT_97	[p7l1022t3130r1103b3207],
6	.	.	O	.	_	0	SENT_97	[p7l1022t3130r1103b3207],

1	After	IN	O	after	_	0	SENT_98	[p7l1145t3129r1334b3192],
2	the	DT	O	the	det	5	SENT_98	[p7l1369t3130r1476b3192],
3	co	NN	O	co	nn	5	SENT_98	[p7l1515t3130r2147b3192],
4	—	NN	O	—	nn	5	SENT_98	[p7l1515t3130r2147b3192],
5	administration	NN	O	administration	prep_after	63	SENT_98	[p7l1515t3130r2147b3192],
6	of	IN	O	of	_	0	SENT_98	[p7l8t3242r85b3305],
7	pravastatin	NN	O	pravastatin	prep_of	5	SENT_98	[p7l132t3242r545b3323],
8	,	,	O	,	_	0	SENT_98	[p7l132t3242r545b3323],
9	the	DT	O	the	det	11	SENT_98	[p7l602t3242r709b3305],
10	mean	NN	O	mean	nn	11	SENT_98	[p7l764t3262r958b3305],
11	AUC0_24	NN	O	auc0_24	prep_of	5	SENT_98	[p7l1011t3243r1331b3319],
12	and	CC	O	and	_	0	SENT_98	[p7l1387t3242r1514b3305],
13	Cmax	NN	MISC	cmax	nn	14	SENT_98	[p7l1571t3244r1740b3319],
14	values	NNS	O	value	prep_of	5	SENT_98	[p7l1794t3242r2019b3305],
15	of	IN	O	of	_	0	SENT_98	[p7l2076t3242r2153b3305],
16	olmesartan	NN	O	olmesartan	prep_of	14	SENT_98	[p7l8t3353r400b3416],
17	in	IN	O	in	_	0	SENT_98	[p7l445t3353r513b3415],
18	*	CD	NUMBER	*	num	19	SENT_98	[p7l561t3353r848b3416],
19	lb	NN	O	lb	prep_in	16	SENT_98	[p7l561t3353r848b3416],
20	/	:	O	/	punct	24	SENT_98	[p7l561t3353r848b3416],
21	*	CD	NUMBER	*	num	23	SENT_98	[p7l561t3353r848b3416],
22	lb	NN	O	lb	nn	23	SENT_98	[p7l561t3353r848b3416],
23	subjects	NNS	O	subject	nsubj	24	SENT_98	[p7l897t3353r1179b3434],
24	increased	VBD	O	increase	dep	16	SENT_98	[p7l1226t3353r1582b3427],
25	,	,	O	,	_	0	SENT_98	[p7l1226t3353r1582b3427],
26	and	CC	O	and	_	0	SENT_98	[p7l1632t3353r1759b3416],
27	the	DT	O	the	det	29	SENT_98	[p7l1802t3353r1909b3416],
28	mean	NN	O	mean	nn	29	SENT_98	[p7l1955t3373r2148b3416],
29	CL	NN	MISC	cl	conj_and	14	SENT_98	[p7l8t3464r223b3541],
30	,	,	O	,	_	0	SENT_98	[p7l8t3464r223b3541],
31	/	:	O	/	punct	34	SENT_98	[p7l8t3464r223b3541],
32	F	NN	O	f	nn	33	SENT_98	[p7l8t3464r223b3541],
33	value	NN	O	value	nsubj	34	SENT_98	[p7l269t3464r462b3527],
34	decreased	VBN	O	decrease	parataxis	63	SENT_98	[p7l513t3464r866b3527],
35	by	IN	O	by	_	0	SENT_98	[p7l914t3464r1001b3545],
36	approximately	RB	O	approximately	quantmod	37	SENT_98	[p7l1054t3464r1570b3545],
37	20	CD	PERCENT	20	num	38	SENT_98	[p7l1623t3464r1802b3538],
38	%	NN	PERCENT	%	prep_by	34	SENT_98	[p7l1623t3464r1802b3538],
39	,	,	O	,	_	0	SENT_98	[p7l1623t3464r1802b3538],
40	whereas	IN	O	whereas	mark	42	SENT_98	[p7l1856t3464r2146b3527],
41	there	EX	O	there	expl	42	SENT_98	[p7l7t3575r184b3638],
42	were	VBD	O	be	dep	38	SENT_98	[p7l254t3595r425b3638],
43	only	RB	O	only	advmod	45	SENT_98	[p7l495t3575r651b3656],
44	slight	JJ	O	slight	amod	45	SENT_98	[p7l723t3575r919b3656],
45	changes	NNS	O	change	nsubj	42	SENT_98	[p7l987t3575r1271b3656],
46	in	IN	O	in	_	0	SENT_98	[p7l1342t3575r1409b3637],
47	*	CD	NUMBER	*	num	48	SENT_98	[p7l1482t3575r1765b3638],
48	l5	NN	O	l5	prep_in	45	SENT_98	[p7l1482t3575r1765b3638],
49	/	:	O	/	punct	34	SENT_98	[p7l1482t3575r1765b3638],
50	*	CD	NUMBER	*	number	51	SENT_98	[p7l1482t3575r1765b3638],
51	15	CD	NUMBER	15	num	52	SENT_98	[p7l1482t3575r1765b3638],
52	subjects	NNS	O	subject	nsubj	63	SENT_98	[p7l1841t3575r2144b3656],
53	,	,	O	,	_	0	SENT_98	[p7l1841t3575r2144b3656],
54	resulting	VBG	O	result	partmod	63	SENT_98	[p7l6t3686r318b3767],
55	in	IN	O	in	_	0	SENT_98	[p7l356t3686r423b3748],
56	comparable	JJ	O	comparable	amod	57	SENT_98	[p7l459t3686r876b3767],
57	values	NNS	O	value	prep_in	54	SENT_98	[p7l913t3686r1138b3749],
58	between	IN	O	between	_	0	SENT_98	[p7l1175t3686r1474b3749],
59	the	DT	O	the	det	62	SENT_98	[p7l1509t3686r1615b3749],
60	two	CD	NUMBER	two	num	62	SENT_98	[p7l1652t3696r1783b3749],
61	genotype	NN	O	genotype	nn	62	SENT_98	[p7l1821t3696r2146b3767],
62	groups	NNS	O	group	prep_between	57	SENT_98	[p8l8t41r247b103],
63	(	VBP	O	(	_	0	SENT_98	[p8l281t22r510b99],
64	Table	NNP	O	Table	nsubj	66	SENT_98	[p8l281t22r510b99],
65	1	CD	NUMBER	1	num	66	SENT_98	[p8l552t22r634b99],
66	)	CD	NUMBER	)	xcomp	63	SENT_98	[p8l552t22r634b99],
67	.	.	O	.	_	0	SENT_98	[p8l552t22r634b99],

1	Although	IN	O	although	mark	6	SENT_99	[p8l667t22r1005b103],
2	the	DT	O	the	det	5	SENT_99	[p8l1034t22r1140b84],
3	small	JJ	O	small	amod	5	SENT_99	[p8l1174t22r1364b84],
4	sample	NN	O	sample	nn	5	SENT_99	[p8l1397t22r1645b103],
5	size	NN	O	size	nsubj	6	SENT_99	[p8l1679t22r1812b84],
6	makes	VBZ	O	make	advcl	19	SENT_99	[p8l1843t22r2069b84],
7	it	PRP	O	it	nsubj	8	SENT_99	[p8l2100t22r2149b84],
8	difﬁcult	NN	O	difﬁcult	xcomp	6	SENT_99	[p8l8t133r291b195],
9	to	TO	O	to	aux	10	SENT_99	[p8l352t142r418b195],
10	address	VB	O	address	infmod	8	SENT_99	[p8l483t133r746b195],
11	the	DT	O	the	det	12	SENT_99	[p8l810t133r917b195],
12	conclusion	NN	O	conclusion	dobj	10	SENT_99	[p8l980t133r1386b206],
13	,	,	O	,	_	0	SENT_99	[p8l980t133r1386b206],
14	these	DT	O	these	det	15	SENT_99	[p8l1451t133r1633b195],
15	observations	NNS	O	observation	nsubj	19	SENT_99	[p8l1697t133r2146b195],
16	might	MD	O	might	aux	19	SENT_99	[p8l7t244r216b325],
17	be	VB	O	be	cop	19	SENT_99	[p8l255t244r338b306],
18	a	DT	O	a	det	19	SENT_99	[p8l382t263r419b306],
19	consequence	NN	O	consequence	_	0	SENT_99	[p8l459t263r915b325],
20	of	IN	O	of	_	0	SENT_99	[p8l959t244r1036b306],
21	the	DT	O	the	det	23	SENT_99	[p8l1072t244r1178b306],
22	competitive	JJ	O	competitive	amod	23	SENT_99	[p8l1222t244r1644b325],
23	inhibition	NN	O	inhibition	prep_of	19	SENT_99	[p8l1686t244r2034b306],
24	of	IN	O	of	_	0	SENT_99	[p8l2076t244r2153b306],
25	olmesartan	NN	O	olmesartan	nn	27	SENT_99	[p8l8t355r400b418],
26	hepatic	JJ	O	hepatic	amod	27	SENT_99	[p8l443t355r701b436],
27	uptake	NN	O	uptake	prep_of	23	SENT_99	[p8l745t355r982b436],
28	via	IN	O	via	_	0	SENT_99	[p8l1026t355r1135b418],
29	OATP1B1	NN	O	oatp1b1	prep_via	27	SENT_99	[p8l1179t356r1550b418],
30	by	IN	O	by	_	0	SENT_99	[p8l1600t355r1688b436],
31	pravastatin	NN	O	pravastatin	prep_by	19	SENT_99	[p8l1731t355r2144b436],
32	,	,	O	,	_	0	SENT_99	[p8l1731t355r2144b436],
33	even	RB	O	even	advmod	19	SENT_99	[p8l8t486r175b529],
34	though	IN	O	though	dep	42	SENT_99	[p8l234t466r482b547],
35	no	DT	O	no	dep	34	SENT_99	[p8l540t486r626b529],
36	in	FW	O	in	nn	37	SENT_99	[p8l686t466r754b528],
37	vitro	FW	O	vitro	dep	34	SENT_99	[p8l813t466r979b529],
38	inhibitory	JJ	O	inhibitory	amod	39	SENT_99	[p8l1039t466r1391b547],
39	data	NNS	O	datum	nsubj	42	SENT_99	[p8l1452t466r1600b529],
40	are	VBP	O	be	cop	42	SENT_99	[p8l1660t486r1764b529],
41	currently	RB	DATE	currently	advmod	42	SENT_99	[p8l1826t466r2146b547],
42	available	JJ	O	available	ccomp	19	SENT_99	[p8l9t577r349b640],
43	.	.	O	.	_	0	SENT_99	[p8l9t577r349b640],

1	Very	RB	O	very	advmod	2	SENT_100	[p8l109t689r285b769],
2	little	JJ	O	little	amod	13	SENT_100	[p8l313t688r475b750],
3	is	VBZ	O	be	auxpass	4	SENT_100	[p8l503t688r558b750],
4	known	VBN	O	know	ccomp	2	SENT_100	[p8l585t688r828b750],
5	about	IN	O	about	_	0	SENT_100	[p8l856t688r1052b750],
6	the	DT	O	the	det	7	SENT_100	[p8l1077t688r1184b750],
7	metabolism	NN	O	metabolism	prep_about	4	SENT_100	[p8l1211t688r1630b750],
8	of	IN	O	of	_	0	SENT_100	[p8l1657t687r1734b750],
9	olmesartan	NN	O	olmesartan	prep_of	7	SENT_100	[p8l1755t688r2148b750],
10	by	IN	O	by	_	0	SENT_100	[p8l6t800r94b881],
11	CYP	NN	O	cyp	nn	12	SENT_100	[p8l117t801r288b863],
12	enzyme	NN	O	enzyme	agent	4	SENT_100	[p8l309t820r586b881],
13	systems	NNS	O	system	_	0	SENT_100	[p8l612t810r911b881],
14	;	:	O	;	_	0	SENT_100	[p8l612t810r911b881],
15	no	DT	O	no	det	17	SENT_100	[p8l937t820r1023b863],
16	literature	NN	O	literature	nn	17	SENT_100	[p8l1046t800r1369b863],
17	reports	NNS	O	report	dep	13	SENT_100	[p8l1390t810r1636b881],
18	in	IN	O	in	_	0	SENT_100	[p8l1660t800r1728b862],
19	this	DT	O	this	det	20	SENT_100	[p8l1749t800r1874b863],
20	regard	NN	O	regard	prep_in	17	SENT_100	[p8l1897t800r2142b881],
21	.	.	O	.	_	0	SENT_100	[p8l1897t800r2142b881],

1	Based	VBN	O	base	_	0	SENT_101	[p8l7t911r225b974],
2	on	IN	O	on	prepc_based_on	8	SENT_101	[p8l271t931r357b974],
3	available	JJ	O	available	amod	4	SENT_101	[p8l404t911r726b974],
4	data	NNS	O	datum	pobj	8	SENT_101	[p8l774t911r939b985],
5	,	,	O	,	_	0	SENT_101	[p8l774t911r939b985],
6	pravastatin	NN	O	pravastatin	nsubj	8	SENT_101	[p8l987t911r1382b992],
7	is	VBZ	O	be	cop	8	SENT_101	[p8l1427t911r1483b974],
8	unlikely	JJ	O	unlikely	ccomp	48	SENT_101	[p8l1530t911r1822b992],
9	to	TO	O	to	aux	12	SENT_101	[p8l1869t921r1935b974],
10	be	VB	O	be	cop	12	SENT_101	[p8l1981t911r2064b974],
11	a	DT	O	a	det	12	SENT_101	[p8l2112t931r2149b974],
12	substrate	NN	O	substrate	xcomp	8	SENT_101	[p8l10t1022r324b1084],
13	of	IN	O	of	_	0	SENT_101	[p8l353t1022r431b1084],
14	CYP3A4	NN	O	cyp3a4	prep_of	12	SENT_101	[p8l453t1022r777b1084],
15	or	CC	O	or	_	0	SENT_101	[p8l806t1041r879b1084],
16	CYP2C9	NN	O	cyp2c9	conj_or	14	SENT_101	[p8l906t1022r1247b1095],
17	;	:	O	;	_	0	SENT_101	[p8l906t1022r1247b1095],
18	the	DT	O	the	det	19	SENT_101	[p8l1279t1022r1385b1084],
19	co-administration	NN	O	co-administration	nsubj	23	SENT_101	[p8l1415t1022r2048b1084],
20	of	IN	O	of	_	0	SENT_101	[p8l2076t1022r2153b1084],
21	CYP3A4	NN	O	cyp3a4	nn	22	SENT_101	[p8l8t1133r332b1196],
22	inhibitors	NNS	O	inhibitor	prep_of	19	SENT_101	[p8l369t1133r709b1195],
23	(	VBP	O	(	parataxis	8	SENT_101	[p8l749t1133r903b1210],
24	i.e.	FW	O	i.e.	dobj	23	SENT_101	[p8l749t1133r903b1210],
25	,	,	O	,	_	0	SENT_101	[p8l749t1133r903b1210],
26	verapamil	NN	O	verapamil	conj_and	24	SENT_101	[p8l942t1133r1319b1214],
27	,	,	O	,	_	0	SENT_101	[p8l942t1133r1319b1214],
28	mibefradil	NN	O	mibefradil	conj_and	24	SENT_101	[p8l1358t1133r1750b1207],
29	,	,	O	,	_	0	SENT_101	[p8l1358t1133r1750b1207],
30	itraconaz	NN	O	itraconaz	nn	32	SENT_101	[p8l1789t1133r2145b1195],
31	—	NN	O	—	nn	32	SENT_101	[p8l1789t1133r2145b1195],
32	ole	NN	O	ole	conj_and	24	SENT_101	[p8l8t1244r134b1318],
33	,	,	O	,	_	0	SENT_101	[p8l8t1244r134b1318],
34	clarithromycin	NN	O	clarithromycin	conj_and	24	SENT_101	[p8l202t1244r749b1325],
35	,	,	O	,	_	0	SENT_101	[p8l202t1244r749b1325],
36	and	CC	O	and	_	0	SENT_101	[p8l818t1244r944b1306],
37	grapefruit	NN	O	grapefruit	nn	38	SENT_101	[p8l1008t1244r1362b1325],
38	juice	NN	O	juice	conj_and	24	SENT_101	[p8l1416t1244r1624b1325],
39	)	CD	NUMBER	)	dep	38	SENT_101	[p8l1416t1244r1624b1325],
40	or	CC	O	or	_	0	SENT_101	[p8l1692t1263r1764b1306],
41	CYP2C9	NN	O	cyp2c9	nn	43	SENT_101	[p8l1827t1244r2146b1307],
42	inhibitor	NN	O	inhibitor	nn	43	SENT_101	[p8l7t1355r317b1418],
43	(	NN	O	(	conj_and	24	SENT_101	[p8l348t1355r503b1433],
44	i.e.	FW	O	i.e.	dep	43	SENT_101	[p8l348t1355r503b1433],
45	,	,	O	,	_	0	SENT_101	[p8l348t1355r503b1433],
46	ﬂuconazole	JJ	O	ﬂuconazole	amod	47	SENT_101	[p8l538t1355r976b1432],
47	)	NN	O	)	nsubj	48	SENT_101	[p8l538t1355r976b1432],
48	had	VBD	O	have	_	0	SENT_101	[p8l1009t1355r1138b1418],
49	no	DT	O	no	det	51	SENT_101	[p8l1167t1375r1254b1418],
50	signiﬁcant	JJ	O	signiﬁcant	amod	51	SENT_101	[p8l1289t1355r1660b1436],
51	effect	NN	O	effect	dobj	48	SENT_101	[p8l1689t1355r1892b1418],
52	on	IN	O	on	_	0	SENT_101	[p8l1923t1375r2009b1418],
53	the	DT	O	the	det	54	SENT_101	[p8l2040t1355r2147b1418],
54	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	51	SENT_101	[p8l6t1466r639b1547],
55	of	IN	O	of	_	0	SENT_101	[p8l692t1466r769b1529],
56	pravastatin	NN	O	pravastatin	nn	58	SENT_101	[p8l812t1466r1205b1547],
57	(	CD	NUMBER	(	num	58	SENT_101	[p8l1259t1466r1649b1543],
58	Fukazawa	NNP	O	Fukazawa	prep_of	54	SENT_101	[p8l1259t1466r1649b1543],
59	et	FW	O	et	nn	60	SENT_101	[p8l1698t1476r1762b1529],
60	al.	FW	O	al.	dep	58	SENT_101	[p8l1812t1466r1891b1529],
61	2003	CD	DATE	2003	dep	60	SENT_101	[p8l1947t1467r2143b1540],
62	;	:	O	;	_	0	SENT_101	[p8l1947t1467r2143b1540],
63	Jacobson	NNP	PERSON	Jacobson	dep	60	SENT_101	[p8l7t1577r334b1640],
64	2004	CD	DATE	2004	dep	63	SENT_101	[p8l365t1577r562b1651],
65	;	:	O	;	_	0	SENT_101	[p8l365t1577r562b1651],
66	Kantola	NNP	O	Kantola	dep	60	SENT_101	[p8l598t1577r880b1640],
67	et	FW	O	et	nn	68	SENT_101	[p8l910t1586r973b1640],
68	al.	FW	O	al.	dep	66	SENT_101	[p8l1004t1577r1083b1640],
69	2000	CD	DATE	2000	num	70	SENT_101	[p8l1119t1578r1342b1654],
70	)	CD	NUMBER	)	dep	66	SENT_101	[p8l1119t1578r1342b1654],
71	.	.	O	.	_	0	SENT_101	[p8l1119t1578r1342b1654],

1	Additionally	RB	O	additionally	advmod	29	SENT_102	[p8l1377t1577r1849b1658],
2	,	,	O	,	_	0	SENT_102	[p8l1377t1577r1849b1658],
3	in	IN	O	in	_	0	SENT_102	[p8l1882t1577r1950b1639],
4	Vitro	NNP	O	Vitro	nn	6	SENT_102	[p8l1980t1577r2146b1640],
5	inhibition	NN	O	inhibition	nn	6	SENT_102	[p8l7t1687r356b1749],
6	proﬁles	NNS	O	proﬁles	nsubj	11	SENT_102	[p8l383t1686r649b1768],
7	of	IN	O	of	_	0	SENT_102	[p8l681t1686r758b1749],
8	major	JJ	O	major	amod	10	SENT_102	[p8l780t1687r990b1768],
9	human	JJ	O	human	amod	10	SENT_102	[p8l1017t1687r1259b1749],
10	drug	NN	O	drug	prep_of	6	SENT_102	[p8l1289t1687r1449b1768],
11	metabolizing	VBG	O	metabolize	prepc_in	29	SENT_102	[p8l1479t1687r1947b1768],
12	CYP	NN	O	cyp	nn	13	SENT_102	[p8l1977t1687r2148b1750],
13	isoenzymes	NNS	O	isoenzyme	nsubj	14	SENT_102	[p8l7t1799r423b1880],
14	(	VBP	O	(	ccomp	11	SENT_102	[p8l460t1799r614b1877],
15	i.e.	FW	O	i.e.	dobj	14	SENT_102	[p8l460t1799r614b1877],
16	,	,	O	,	_	0	SENT_102	[p8l460t1799r614b1877],
17	CYP2C8	NN	O	cyp2c8	nn	26	SENT_102	[p8l651t1800r989b1873],
18	,	,	O	,	_	0	SENT_102	[p8l651t1800r989b1873],
19	CYP2C9	NN	O	cyp2c9	nn	26	SENT_102	[p8l1026t1800r1366b1874],
20	,	,	O	,	_	0	SENT_102	[p8l1026t1800r1366b1874],
21	CYP2C19	NN	O	cyp2c19	nn	26	SENT_102	[p8l1402t1800r1786b1874],
22	,	,	O	,	_	0	SENT_102	[p8l1402t1800r1786b1874],
23	CYP3A4	NN	O	cyp3a4	nn	26	SENT_102	[p8l1822t1800r2147b1862],
24	and	CC	O	and	_	0	SENT_102	[p8l9t1910r136b1973],
25	CYP3A5	NN	O	cyp3a5	nn	26	SENT_102	[p8l178t1910r530b1988],
26	)	NN	O	)	nsubj	29	SENT_102	[p8l178t1910r530b1988],
27	by	IN	O	by	_	0	SENT_102	[p8l574t1910r662b1991],
28	pravastatin	NN	O	pravastatin	prep_by	26	SENT_102	[p8l703t1910r1098b1991],
29	showed	VBD	O	show	_	0	SENT_102	[p8l1144t1910r1413b1973],
30	that	IN	O	that	complm	38	SENT_102	[p8l1454t1910r1588b1973],
31	both	CC	O	both	preconj	32	SENT_102	[p8l1629t1910r1787b1973],
32	acid	NN	O	acid	nsubj	38	SENT_102	[p8l1832t1910r1978b1973],
33	and	CC	O	and	_	0	SENT_102	[p8l2022t1910r2148b1973],
34	lactone	NN	O	lactone	nn	35	SENT_102	[p8l7t2021r264b2083],
35	forms	NNS	O	form	nsubj	38	SENT_102	[p8l293t2021r498b2083],
36	of	IN	O	of	_	0	SENT_102	[p8l529t2021r606b2083],
37	pravastatin	NN	O	pravastatin	prep_of	35	SENT_102	[p8l626t2021r1020b2102],
38	had	VBD	O	have	ccomp	29	SENT_102	[p8l1047t2021r1176b2083],
39	minimal	JJ	O	minimal	amod	41	SENT_102	[p8l1203t2021r1501b2083],
40	inhibitory	JJ	O	inhibitory	amod	41	SENT_102	[p8l1530t2021r1882b2102],
41	effects	NNS	O	effect	dobj	38	SENT_102	[p8l1911t2021r2146b2083],
42	on	IN	O	on	_	0	SENT_102	[p8l8t2151r95b2194],
43	metabolic	JJ	O	metabolic	amod	44	SENT_102	[p8l115t2132r466b2194],
44	activities	NNS	O	activity	prep_on	41	SENT_102	[p8l491t2132r811b2195],
45	of	IN	O	of	_	0	SENT_102	[p8l834t2132r911b2194],
46	all	DT	O	all	det	49	SENT_102	[p8l927t2132r1013b2194],
47	ﬁve	JJ	O	ﬁve	amod	49	SENT_102	[p8l1035t2132r1165b2195],
48	CYP	NN	O	cyp	nn	49	SENT_102	[p8l1187t2132r1358b2195],
49	isoenzymes	NNS	O	isoenzyme	prep_of	44	SENT_102	[p8l1378t2132r1794b2213],
50	with	IN	O	with	prep	38	SENT_102	[p8l1816t2132r1973b2195],
51	IC50	NN	O	ic50	nn	52	SENT_102	[p8l1993t2132r2148b2209],
52	values	NNS	O	value	dep	57	SENT_102	[p8l7t2243r233b2306],
53	>	JJR	O	>	dep	52	SENT_102	[p8l271t2243r462b2306],
54	100	CD	NUMBER	100	dep	57	SENT_102	[p8l271t2243r462b2306],
55	uM	NN	O	um	nn	57	SENT_102	[p8l499t2244r621b2323],
56	(	CD	NUMBER	(	num	57	SENT_102	[p8l659t2243r985b2320],
57	Sakaeda	NNP	PERSON	Sakaeda	dep	61	SENT_102	[p8l659t2243r985b2320],
58	et	FW	O	et	nn	59	SENT_102	[p8l1020t2252r1084b2305],
59	al.	FW	O	al.	dep	57	SENT_102	[p8l1120t2243r1198b2305],
60	2006	CD	DATE	2006	num	61	SENT_102	[p8l1240t2243r1463b2320],
61	)	CD	NUMBER	)	dep	50	SENT_102	[p8l1240t2243r1463b2320],
62	.	.	O	.	_	0	SENT_102	[p8l1240t2243r1463b2320],

1	Taking	VBG	O	take	_	0	SENT_103	[p8l1503t2243r1755b2324],
2	these	DT	O	these	dobj	1	SENT_103	[p8l1791t2243r1974b2305],
3	into	IN	O	into	_	0	SENT_103	[p8l2010t2243r2147b2305],
4	consideration	NN	O	consideration	prep_into	6	SENT_103	[p8l8t2354r509b2428],
5	,	,	O	,	_	0	SENT_103	[p8l8t2354r509b2428],
6	increased	VBD	O	increase	dep	1	SENT_103	[p8l571t2354r908b2417],
7	AUC	NN	O	auc	dobj	6	SENT_103	[p8l966t2355r1151b2417],
8	and	CC	O	and	_	0	SENT_103	[p8l1212t2354r1338b2417],
9	decreased	VBD	O	decrease	dep	1	SENT_103	[p8l1396t2354r1748b2417],
10	CL	NN	MISC	cl	nsubj	21	SENT_103	[p8l1807t2355r2022b2432],
11	,	,	O	,	_	0	SENT_103	[p8l1807t2355r2022b2432],
12	/	:	O	/	punct	13	SENT_103	[p8l1807t2355r2022b2432],
13	F	NN	O	f	dep	10	SENT_103	[p8l1807t2355r2022b2432],
14	of	IN	O	of	_	0	SENT_103	[p8l2076t2354r2153b2417],
15	olmesartan	NN	O	olmesartan	prep_of	13	SENT_103	[p8l8t2466r400b2529],
16	in	IN	O	in	_	0	SENT_103	[p8l439t2466r506b2528],
17	the	DT	O	the	det	19	SENT_103	[p8l545t2466r651b2529],
18	co-administration	NN	O	co-administration	nn	19	SENT_103	[p8l691t2466r1324b2529],
19	phase	NN	O	phase	prep_in	13	SENT_103	[p8l1361t2466r1564b2547],
20	are	VBP	O	be	cop	21	SENT_103	[p8l1604t2486r1709b2529],
21	unlikely	JJ	O	unlikely	ccomp	9	SENT_103	[p8l1748t2466r2042b2547],
22	to	TO	O	to	aux	23	SENT_103	[p8l2080t2476r2146b2529],
23	result	VB	O	result	xcomp	21	SENT_103	[p8l6t2577r206b2640],
24	from	IN	O	from	_	0	SENT_103	[p8l237t2577r410b2640],
25	the	DT	O	the	det	26	SENT_103	[p8l440t2577r547b2640],
26	inhibition	NN	O	inhibition	prep_from	23	SENT_103	[p8l578t2577r927b2640],
27	of	IN	O	of	_	0	SENT_103	[p8l959t2577r1036b2640],
28	CYP	NN	O	cyp	prep_of	26	SENT_103	[p8l1063t2577r1595b2640],
29	—	CD	NUMBER	—	nsubj	1	SENT_103	[p8l1063t2577r1595b2640],
30	mediated	VBN	O	mediate	partmod	29	SENT_103	[p8l1063t2577r1595b2640],
31	metabolism	NN	O	metabolism	dobj	30	SENT_103	[p8l1626t2577r2045b2640],
32	of	IN	O	of	prep	31	SENT_103	[p8l2076t2577r2153b2640],

1	Table	NNP	O	Table	_	0	SENT_104	[p8l53t2715r138b2741],
2	1	CD	NUMBER	1	num	4	SENT_104	[p8l152t2715r166b2740],
3	Pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_104	[p8l189t2715r426b2740],
4	parameters	NNS	O	parameter	dep	1	SENT_104	[p8l439t2719r593b2748],
5	of	IN	O	of	_	0	SENT_104	[p8l607t2715r638b2740],
6	olmesartan	NN	O	olmesartan	prep_of	4	SENT_104	[p8l648t2715r802b2740],
7	in	IN	O	in	_	0	SENT_104	[p8l815t2715r842b2740],
8	each	DT	O	each	det	11	SENT_104	[p8l855t2715r919b2740],
9	SLCOIBI	NNP	O	SLCOIBI	nn	11	SENT_104	[p8l931t2716r1071b2741],
10	genotype	NN	O	genotype	nn	11	SENT_104	[p8l1087t2719r1215b2748],
11	group	NN	O	group	prep_in	6	SENT_104	[p8l1228t2723r1309b2748],
12	in	IN	O	in	_	0	SENT_104	[p8l1322t2715r1349b2740],
13	two	CD	NUMBER	two	num	15	SENT_104	[p8l1361t2719r1413b2740],
14	administration	NN	O	administration	nn	15	SENT_104	[p8l1427t2715r1630b2740],
15	conditions	NNS	O	condition	prep_in	11	SENT_104	[p8l1643t2715r1788b2740],
16	Parameter	NNP	O	Parameter	nn	21	SENT_104	[p8l52t2785r196b2810],
17	Single	JJ	O	single	amod	21	SENT_104	[p8l391t2785r556b2817],
18	—	NN	O	—	nn	21	SENT_104	[p8l391t2785r556b2817],
19	dose	NN	O	dose	nn	21	SENT_104	[p8l391t2785r556b2817],
20	phasea	NN	O	phasea	nn	21	SENT_104	[p8l569t2782r661b2817],
21	Co	NNP	O	Co	dep	4	SENT_104	[p8l1281t2785r1538b2810],
22	—	CD	NUMBER	—	num	24	SENT_104	[p8l1281t2785r1538b2810],
23	adIninistration	NN	O	adininistration	nn	24	SENT_104	[p8l1281t2785r1538b2810],
24	phaseb	NN	O	phaseb	dep	1	SENT_104	[p8l1550t2777r1643b2817],

1	*	RB	O	*	dep	2	SENT_105	[p8l392t2853r504b2879],
2	15	CD	NUMBER	15	_	0	SENT_105	[p8l392t2853r504b2879],
3	/	:	O	/	punct	2	SENT_105	[p8l392t2853r504b2879],
4	*	CD	NUMBER	*	num	6	SENT_105	[p8l392t2853r504b2879],
5	l5	NN	O	l5	nn	6	SENT_105	[p8l392t2853r504b2879],
6	group	NN	O	group	dep	2	SENT_105	[p8l519t2861r599b2886],
7	*	CD	NUMBER	*	num	8	SENT_105	[p8l701t2853r812b2879],
8	1b	NN	O	1b	dep	6	SENT_105	[p8l701t2853r812b2879],
9	/	:	O	/	punct	6	SENT_105	[p8l701t2853r812b2879],
10	*	CD	NUMBER	*	num	12	SENT_105	[p8l701t2853r812b2879],
11	15	CD	NUMBER	15	num	12	SENT_105	[p8l701t2853r812b2879],
12	group	NN	O	group	dep	6	SENT_105	[p8l827t2861r908b2886],
13	*	CD	NUMBER	*	num	14	SENT_105	[p8l974t2853r1087b2879],
14	lb	NN	O	lb	dep	12	SENT_105	[p8l974t2853r1087b2879],
15	/	:	O	/	punct	18	SENT_105	[p8l974t2853r1087b2879],
16	*	CD	NUMBER	*	num	18	SENT_105	[p8l974t2853r1087b2879],
17	lb	NN	O	lb	nn	18	SENT_105	[p8l974t2853r1087b2879],
18	group	NN	O	group	dep	14	SENT_105	[p8l1100t2861r1181b2886],
19	*	CD	NUMBER	*	number	20	SENT_105	[p8l1283t2853r1394b2879],
20	15	CD	NUMBER	15	num	14	SENT_105	[p8l1283t2853r1394b2879],
21	/	:	O	/	punct	6	SENT_105	[p8l1283t2853r1394b2879],
22	*	CD	NUMBER	*	num	24	SENT_105	[p8l1283t2853r1394b2879],
23	15	CD	NUMBER	15	num	24	SENT_105	[p8l1283t2853r1394b2879],
24	group	NN	O	group	dep	6	SENT_105	[p8l1409t2861r1490b2886],
25	*	CD	NUMBER	*	num	26	SENT_105	[p8l1592t2853r1703b2879],
26	1b	NN	O	1b	dep	24	SENT_105	[p8l1592t2853r1703b2879],
27	/	:	O	/	punct	24	SENT_105	[p8l1592t2853r1703b2879],
28	*	CD	NUMBER	*	num	30	SENT_105	[p8l1592t2853r1703b2879],
29	15	CD	NUMBER	15	num	30	SENT_105	[p8l1592t2853r1703b2879],
30	group	NN	O	group	dep	24	SENT_105	[p8l1718t2861r1798b2886],
31	*	CD	NUMBER	*	num	32	SENT_105	[p8l1865t2853r1977b2879],
32	1b	NN	O	1b	dep	30	SENT_105	[p8l1865t2853r1977b2879],
33	/	:	O	/	punct	36	SENT_105	[p8l1865t2853r1977b2879],
34	*	CD	NUMBER	*	num	36	SENT_105	[p8l1865t2853r1977b2879],
35	1b	NN	O	1b	nn	36	SENT_105	[p8l1865t2853r1977b2879],
36	group	NN	O	group	dep	32	SENT_105	[p8l1991t2861r2072b2886],
37	(	CD	NUMBER	(	num	38	SENT_105	[p8l392t2887r498b2917],
38	n	NN	O	n	dep	36	SENT_105	[p8l392t2887r498b2917],
39	=	JJ	O	=	quantmod	41	SENT_105	[p8l392t2887r498b2917],
40	4	CD	NUMBER	4	number	41	SENT_105	[p8l392t2887r498b2917],
41	)	CD	NUMBER	)	num	66	SENT_105	[p8l392t2887r498b2917],
42	(	NN	O	(	nn	66	SENT_105	[p8l700t2887r807b2917],
43	n	NN	O	n	nn	66	SENT_105	[p8l700t2887r807b2917],
44	=	JJ	O	=	amod	66	SENT_105	[p8l700t2887r807b2917],
45	2	CD	NUMBER	2	number	46	SENT_105	[p8l700t2887r807b2917],
46	)	CD	NUMBER	)	num	66	SENT_105	[p8l700t2887r807b2917],
47	(	NN	O	(	nn	66	SENT_105	[p8l974t2887r1080b2917],
48	n	NN	O	n	nn	66	SENT_105	[p8l974t2887r1080b2917],
49	=	JJ	O	=	amod	66	SENT_105	[p8l974t2887r1080b2917],
50	4	CD	NUMBER	4	number	51	SENT_105	[p8l974t2887r1080b2917],
51	)	CD	NUMBER	)	num	66	SENT_105	[p8l974t2887r1080b2917],
52	(	NN	O	(	nn	66	SENT_105	[p8l1282t2887r1389b2917],
53	n	NN	O	n	nn	66	SENT_105	[p8l1282t2887r1389b2917],
54	=	JJ	O	=	amod	66	SENT_105	[p8l1282t2887r1389b2917],
55	4	CD	NUMBER	4	number	56	SENT_105	[p8l1282t2887r1389b2917],
56	)	CD	NUMBER	)	num	66	SENT_105	[p8l1282t2887r1389b2917],
57	(	NN	O	(	nn	66	SENT_105	[p8l1591t2887r1697b2917],
58	n	NN	O	n	nn	66	SENT_105	[p8l1591t2887r1697b2917],
59	=	JJ	O	=	amod	66	SENT_105	[p8l1591t2887r1697b2917],
60	2	CD	NUMBER	2	number	61	SENT_105	[p8l1591t2887r1697b2917],
61	)	CD	NUMBER	)	num	66	SENT_105	[p8l1591t2887r1697b2917],
62	(	NN	O	(	nn	66	SENT_105	[p8l1864t2887r1971b2917],
63	n	NN	O	n	nn	66	SENT_105	[p8l1864t2887r1971b2917],
64	=	JJ	O	=	amod	66	SENT_105	[p8l1864t2887r1971b2917],
65	4	CD	NUMBER	4	num	66	SENT_105	[p8l1864t2887r1971b2917],
66	)	NN	O	)	dep	38	SENT_105	[p8l1864t2887r1971b2917],

1	Cmax	NN	O	cmax	dep	128	SENT_106	[p8l54t2980r121b3010],
2	(	CD	NUMBER	(	dep	128	SENT_106	[p8l135t2980r238b3012],
3	ng/ml	NN	O	ng/ml	dep	128	SENT_106	[p8l135t2980r238b3012],
4	)	NN	O	)	dep	128	SENT_106	[p8l135t2980r238b3012],
5	390	CD	NUMBER	390	dep	128	SENT_106	[p8l436t2980r487b3005],
6	:	:	O	:	_	0	SENT_106	[p8l500t2980r525b3004],
7	t	NN	O	t	dep	128	SENT_106	[p8l500t2980r525b3004],
8	110 370 310	CD	NUMBER	110 370 310	dep	128	SENT_106	[p8l1018t2980r1069b3005],[p8l542t2980r590b3005],
9	i	FW	O	i	dep	128	SENT_106	[p8l1082t2980r1107b3004],
10	59	CD	NUMBER	59	dep	128	SENT_106	[p8l1121t2980r1154b3005],
11	400	CD	NUMBER	400	dep	128	SENT_106	[p8l1325t2980r1377b3005],
12	:	:	O	:	_	0	SENT_106	[p8l1391t2991r1415b3004],
13	:	:	O	:	_	0	SENT_106	[p8l1391t2991r1415b3004],
14	61 380 360	CD	NUMBER	61 380 360	dep	128	SENT_106	[p8l1908t2980r1959b3005],[p8l1430t2980r1460b3005],
15	:	:	O	:	_	0	SENT_106	[p8l1973t2991r1997b3004],
16	:	:	O	:	_	0	SENT_106	[p8l1973t2991r1997b3004],
17	80	CD	NUMBER	80	dep	128	SENT_106	[p8l2012t2980r2045b3005],
18	AUC0_24	NN	O	auc0_24	dep	128	SENT_106	[p8l52t3023r179b3054],
19	(	CD	NUMBER	(	dep	128	SENT_106	[p8l192t3023r237b3055],
20	ng	NN	O	ng	dep	128	SENT_106	[p8l192t3023r237b3055],
21	h/ml	NN	O	h/ml	dep	128	SENT_106	[p8l250t3023r325b3053],
22	)	CD	NUMBER	)	dep	128	SENT_106	[p8l250t3023r325b3053],
23	2,100	CD	NUMBER	2,100	dep	128	SENT_106	[p8l409t3023r486b3052],
24	d	NN	O	d	dep	128	SENT_106	[p8l500t3023r525b3047],
25	:	:	O	:	_	0	SENT_106	[p8l500t3023r525b3047],
26	230	CD	NUMBER	230	dep	128	SENT_106	[p8l539t3023r590b3048],
27	2,300	CD	NUMBER	2,300	dep	128	SENT_106	[p8l700t3023r777b3052],
28	1,900	CD	NUMBER	1,900	dep	128	SENT_106	[p8l994t3023r1069b3052],
29	:1	CD	NUMBER	:1	dep	128	SENT_106	[p8l1082t3023r1107b3047],
30	:	:	O	:	_	0	SENT_106	[p8l1082t3023r1107b3047],
31	550	CD	NUMBER	550	dep	128	SENT_106	[p8l1121t3023r1172b3048],
32	2,300	CD	NUMBER	2,300	dep	128	SENT_106	[p8l1299t3023r1377b3052],
33	:1	CD	NUMBER	:1	dep	128	SENT_106	[p8l1391t3023r1415b3047],
34	:	:	O	:	_	0	SENT_106	[p8l1391t3023r1415b3047],
35	350	CD	NUMBER	350	dep	128	SENT_106	[p8l1430t3023r1481b3048],
36	2,100	CD	NUMBER	2,100	dep	128	SENT_106	[p8l1590t3023r1668b3052],
37	2,300	CD	NUMBER	2,300	dep	128	SENT_106	[p8l1881t3023r1959b3052],
38	:	:	O	:	_	0	SENT_106	[p8l1973t3034r1997b3047],
39	:	:	O	:	_	0	SENT_106	[p8l1973t3034r1997b3047],
40	430	CD	NUMBER	430	dep	128	SENT_106	[p8l2011t3023r2063b3048],
41	kg	NN	O	kg	dep	128	SENT_106	[p8l52t3067r79b3098],
42	(	NN	O	(	dep	128	SENT_106	[p8l93t3068r149b3099],
43	per	IN	O	per	dep	128	SENT_106	[p8l93t3068r149b3099],
44	h	NN	O	h	dep	128	SENT_106	[p8l161t3067r188b3098],
45	)	CD	NUMBER	)	dep	128	SENT_106	[p8l161t3067r188b3098],
46	0.095	CD	NUMBER	0.095	dep	128	SENT_106	[p8l408t3067r485b3092],
47	:1	CD	NUMBER	:1	dep	128	SENT_106	[p8l500t3068r525b3092],
48	:	:	O	:	_	0	SENT_106	[p8l500t3068r525b3092],
49	0.008	CD	NUMBER	0.008	dep	128	SENT_106	[p8l539t3067r616b3092],
50	0.096	CD	NUMBER	0.096	dep	128	SENT_106	[p8l761t3067r839b3092],
51	0.096	CD	NUMBER	0.096	dep	128	SENT_106	[p8l990t3067r1068b3092],
52	:1	CD	NUMBER	:1	dep	128	SENT_106	[p8l1082t3068r1107b3092],
53	:	:	O	:	_	0	SENT_106	[p8l1082t3068r1107b3092],
54	0.017	CD	NUMBER	0.017	dep	128	SENT_106	[p8l1121t3067r1198b3092],
55	0.085	CD	NUMBER	0.085	dep	128	SENT_106	[p8l1299t3067r1376b3092],
56	:	:	O	:	_	0	SENT_106	[p8l1391t3068r1415b3092],
57	t	NN	O	t	dep	128	SENT_106	[p8l1391t3068r1415b3092],
58	0.008	CD	NUMBER	0.008	dep	128	SENT_106	[p8l1429t3067r1506b3092],
59	0.10	CD	NUMBER	0.10	dep	128	SENT_106	[p8l1652t3067r1712b3092],
60	0.096	CD	NUMBER	0.096	dep	128	SENT_106	[p8l1881t3067r1959b3092],
61	:	:	O	:	_	0	SENT_106	[p8l1973t3078r1997b3092],
62	0.010	CD	NUMBER	0.010	dep	128	SENT_106	[p8l2011t3067r2089b3092],
63	CL	NN	O	cl	dep	128	SENT_106	[p8l53t3111r138b3141],
64	,	,	O	,	_	0	SENT_106	[p8l53t3111r138b3141],
65	/	:	O	/	dep	128	SENT_106	[p8l53t3111r138b3141],
66	F	NN	O	f	dep	128	SENT_106	[p8l53t3111r138b3141],
67	(	CD	NUMBER	(	dep	128	SENT_106	[p8l150t3111r253b3143],
68	1/kg/h	JJ	O	1/kg/h	dep	128	SENT_106	[p8l150t3111r253b3143],
69	)	NN	O	)	dep	128	SENT_106	[p8l150t3111r253b3143],
70	0.068	CD	NUMBER	0.068	dep	128	SENT_106	[p8l408t3111r485b3136],
71	:1	CD	NUMBER	:1	dep	128	SENT_106	[p8l500t3111r525b3135],
72	:	:	O	:	_	0	SENT_106	[p8l500t3111r525b3135],
73	0.009	CD	NUMBER	0.009	dep	128	SENT_106	[p8l539t3111r633b3136],
74	*	CD	NUMBER	*	dep	128	SENT_106	[p8l539t3111r633b3136],
75	0.058	CD	NUMBER	0.058	dep	128	SENT_106	[p8l761t3111r838b3136],
76	0.10	CD	NUMBER	0.10	dep	128	SENT_106	[p8l1008t3111r1068b3136],
77	:	:	O	:	_	0	SENT_106	[p8l1083t3122r1107b3135],
78	:	:	O	:	_	0	SENT_106	[p8l1083t3122r1107b3135],
79	0.041	CD	NUMBER	0.041	dep	128	SENT_106	[p8l1121t3111r1196b3136],
80	0.062	CD	NUMBER	0.062	dep	128	SENT_106	[p8l1299t3111r1377b3136],
81	:	:	O	:	_	0	SENT_106	[p8l1391t3122r1415b3135],
82	:	:	O	:	_	0	SENT_106	[p8l1391t3122r1415b3135],
83	0.009	CD	NUMBER	0.009	dep	128	SENT_106	[p8l1429t3111r1507b3136],
84	0.060	CD	NUMBER	0.060	dep	128	SENT_106	[p8l1652t3111r1730b3136],
85	0.080	CD	NUMBER	0.080	dep	128	SENT_106	[p8l1881t3111r1959b3136],
86	:	:	O	:	_	0	SENT_106	[p8l1973t3122r1997b3135],
87	:	:	O	:	_	0	SENT_106	[p8l1973t3122r1997b3135],
88	0.012	CD	NUMBER	0.012	dep	128	SENT_106	[p8l2011t3111r2089b3136],
89	Ae0_24	NN	O	ae0_24	dep	128	SENT_106	[p8l52t3154r146b3185],
90	(	CD	NUMBER	(	dep	128	SENT_106	[p8l159t3154r217b3186],
91	pg	NN	O	pg	dep	128	SENT_106	[p8l159t3154r217b3186],
92	)	NN	O	)	dep	128	SENT_106	[p8l159t3154r217b3186],
93	830	CD	NUMBER	830	dep	128	SENT_106	[p8l436t3154r487b3179],
94	:1	CD	NUMBER	:1	dep	128	SENT_106	[p8l500t3154r525b3178],
95	:	:	O	:	_	0	SENT_106	[p8l500t3154r525b3178],
96	260 750 740	CD	NUMBER	260 750 740	dep	128	SENT_106	[p8l1017t3154r1069b3179],[p8l539t3154r590b3179],
97	:1	CD	NUMBER	:1	dep	128	SENT_106	[p8l1082t3154r1107b3178],
98	:	:	O	:	_	0	SENT_106	[p8l1082t3154r1107b3178],
99	240	CD	NUMBER	240	dep	128	SENT_106	[p8l1121t3154r1172b3179],
100	510	CD	NUMBER	510	dep	128	SENT_106	[p8l1326t3154r1377b3179],
101	:1	NN	O	:1	dep	128	SENT_106	[p8l1391t3154r1415b3178],
102	:	:	O	:	_	0	SENT_106	[p8l1391t3154r1415b3178],
103	130 450 440	CD	NUMBER	130 450 440	dep	128	SENT_106	[p8l1907t3154r1959b3179],[p8l1432t3154r1481b3179],
104	:1	CD	NUMBER	:1	dep	128	SENT_106	[p8l1973t3154r1997b3178],
105	:	:	O	:	_	0	SENT_106	[p8l1973t3154r1997b3178],
106	141	CD	NUMBER	141	dep	128	SENT_106	[p8l2014t3154r2060b3178],
107	CLr0_24	NN	O	clr0_24	dep	128	SENT_106	[p8l53t3198r161b3229],
108	(	CD	NUMBER	(	dep	128	SENT_106	[p8l175t3198r278b3230],
109	l/kg/h	JJ	O	l/kg/h	dep	128	SENT_106	[p8l175t3198r278b3230],
110	)	NN	O	)	dep	128	SENT_106	[p8l175t3198r278b3230],
111	0.0055	CD	NUMBER	0.0055	dep	128	SENT_106	[p8l391t3198r485b3223],
112	:1	CD	NUMBER	:1	dep	128	SENT_106	[p8l500t3198r525b3223],
113	:	:	O	:	_	0	SENT_106	[p8l500t3198r525b3223],
114	0.0011	CD	NUMBER	0.0011	dep	128	SENT_106	[p8l539t3198r631b3223],
115	0.0046	CD	NUMBER	0.0046	dep	128	SENT_106	[p8l761t3198r856b3223],
116	0.0071	CD	NUMBER	0.0071	dep	128	SENT_106	[p8l973t3198r1065b3223],
117	:1	CD	NUMBER	:1	dep	128	SENT_106	[p8l1082t3198r1107b3223],
118	:	:	O	:	_	0	SENT_106	[p8l1082t3198r1107b3223],
119	0.0013	CD	NUMBER	0.0013	dep	128	SENT_106	[p8l1121t3198r1215b3223],
120	0.0032	CD	NUMBER	0.0032	dep	128	SENT_106	[p8l1281t3198r1377b3223],
121	:1	CD	NUMBER	:1	dep	128	SENT_106	[p8l1391t3198r1415b3223],
122	:	:	O	:	_	0	SENT_106	[p8l1391t3198r1415b3223],
123	0.0010	CD	NUMBER	0.0010	dep	128	SENT_106	[p8l1429t3198r1525b3223],
124	0.0027	CD	NUMBER	0.0027	dep	128	SENT_106	[p8l1652t3198r1746b3223],
125	0.0034	CD	NUMBER	0.0034	dep	128	SENT_106	[p8l1863t3198r1959b3223],
126	:1	CD	NUMBER	:1	dep	128	SENT_106	[p8l1973t3198r1997b3223],
127	:	:	O	:	_	0	SENT_106	[p8l1973t3198r1997b3223],
128	0.0009	CD	NUMBER	0.0009	_	0	SENT_106	[p8l2011t3198r2106b3223],

1	Values	NNS	O	value	_	0	SENT_107	[p8l53t3283r149b3308],
2	are	VBP	O	be	auxpass	3	SENT_107	[p8l163t3291r204b3308],
3	presented	VBN	O	present	rcmod	1	SENT_107	[p8l217t3283r353b3315],
4	as	IN	O	as	_	0	SENT_107	[p8l366t3291r393b3308],
5	the	DT	O	the	det	7	SENT_107	[p8l406t3283r448b3308],
6	mean	JJ	O	mean	amod	7	SENT_107	[p8l461t3291r537b3308],
7	:1	NN	O	:1	prep_as	3	SENT_107	[p8l551t3283r575b3308],
8	:	:	O	:	_	0	SENT_107	[p8l551t3283r575b3308],
9	SD	NN	O	sd	dobj	3	SENT_107	[p8l590t3283r633b3308],
10	*	CD	NUMBER	*	num	11	SENT_107	[p8l54t3327r67b3342],
11	P	NN	O	p	npadvmod	12	SENT_107	[p8l81t3328r103b3351],
12	<	JJR	O	<	amod	9	SENT_107	[p8l116t3333r138b3352],
13	0.05	CD	NUMBER	0.05	dep	12	SENT_107	[p8l150t3327r210b3352],
14	versus	CC	O	versus	dep	13	SENT_107	[p8l224t3335r312b3352],
15	values	NNS	O	value	dep	14	SENT_107	[p8l326t3327r415b3352],
16	of	IN	O	of	_	0	SENT_107	[p8l428t3327r459b3352],
17	*	CD	NUMBER	*	num	18	SENT_107	[p8l471t3327r584b3352],
18	1b	NN	O	1b	prep_of	15	SENT_107	[p8l471t3327r584b3352],
19	/	:	O	/	punct	22	SENT_107	[p8l471t3327r584b3352],
20	*	CD	NUMBER	*	num	22	SENT_107	[p8l471t3327r584b3352],
21	1b	NN	O	1b	nn	22	SENT_107	[p8l471t3327r584b3352],
22	group	NN	O	group	dep	9	SENT_107	[p8l597t3335r678b3359],
23	3	CD	NUMBER	3	num	24	SENT_107	[p8l53t3369r64b3381],
24	Ingestion	NN	O	ingestion	dep	35	SENT_107	[p8l82t3371r213b3404],
25	of	IN	O	of	_	0	SENT_107	[p8l226t3371r256b3397],
26	a	DT	O	a	det	28	SENT_107	[p8l267t3379r282b3397],
27	single	JJ	O	single	amod	28	SENT_107	[p8l295t3371r378b3404],
28	dose	NN	O	dose	prep_of	24	SENT_107	[p8l391t3371r454b3397],
29	of	IN	O	of	_	0	SENT_107	[p8l467t3371r498b3397],
30	10	CD	NUMBER	10	prep_of	28	SENT_107	[p8l512t3372r542b3397],
31	mg	NN	O	mg	nn	32	SENT_107	[p8l555t3379r599b3404],
32	olmesartan	NN	O	olmesartan	dep	35	SENT_107	[p8l612t3371r767b3397],
33	medoxomil	NN	O	medoxomil	nn	35	SENT_107	[p8l779t3371r939b3397],
34	b	NN	O	b	nn	35	SENT_107	[p8l52t3408r65b3425],
35	Ingestion	NN	O	ingestion	dep	41	SENT_107	[p8l83t3416r214b3448],
36	of	IN	O	of	_	0	SENT_107	[p8l229t3415r259b3441],
37	10	CD	NUMBER	10	num	40	SENT_107	[p8l275t3416r305b3441],
38	mg	NN	O	mg	nn	40	SENT_107	[p8l318t3423r362b3448],
39	olmesartan	NN	O	olmesartan	nn	40	SENT_107	[p8l377t3416r531b3441],
40	medoxomil	NN	O	medoxomil	prep_of	35	SENT_107	[p8l546t3415r706b3441],
41	concomitant	JJ	O	concomitant	dep	1	SENT_107	[p8l721t3416r895b3441],
42	with	IN	O	with	_	0	SENT_107	[p8l910t3416r971b3441],
43	10	CD	NUMBER	10	num	45	SENT_107	[p8l989t3416r1020b3441],
44	mg	NN	O	mg	nn	45	SENT_107	[p8l1033t3423r1077b3448],
45	pravastatin	NN	O	pravastatin	prep_with	41	SENT_107	[p8l1091t3416r1246b3448],
46	following	VBG	O	follow	_	0	SENT_107	[p8l1260t3415r1396b3448],
47	administration	NN	O	administration	prep_following	45	SENT_107	[p8l1412t3415r1615b3441],
48	of	IN	O	of	_	0	SENT_107	[p8l1630t3415r1660b3441],
49	10	CD	NUMBER	10	num	52	SENT_107	[p8l1676t3416r1706b3441],
50	mg	NN	O	mg	nn	52	SENT_107	[p8l1719t3423r1763b3448],
51	olmesartan	NN	O	olmesartan	nn	52	SENT_107	[p8l1778t3416r1932b3441],
52	medoxomil	NN	O	medoxomil	prep_of	47	SENT_107	[p8l1947t3415r2107b3441],
53	alone	RB	O	alone	advmod	55	SENT_107	[p8l53t3457r128b3482],
54	once	RB	DATE	once	advmod	55	SENT_107	[p8l141t3465r207b3482],
55	daily	JJ	SET	daily	advmod	52	SENT_107	[p8l220t3457r289b3489],
56	for	IN	O	for	_	0	SENT_107	[p8l303t3457r343b3482],
57	3	CD	DURATION	3	num	58	SENT_107	[p8l356t3457r370b3482],
58	days	NNS	NUMBER	day	prep_for	55	SENT_107	[p8l385t3457r448b3489],

1	@	IN	O	@	_	0	SENT_108	[p8l1936t3564r1972b3609],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_108	[p8l1986t3575r2107b3610],

1	902	CD	NUMBER	902	num	2	SENT_109	[p8l53t3685r104b3711],
2	J	NN	O	j	_	0	SENT_109	[p8l1629t3686r1642b3711],
3	Hum	NNP	PERSON	Hum	nn	4	SENT_109	[p8l1655t3686r1725b3710],
4	Genet	NNP	PERSON	Genet	dep	2	SENT_109	[p8l1738t3685r1821b3711],
5	(	CD	NUMBER	(	num	6	SENT_109	[p8l1835t3685r1926b3716],
6	2008	CD	DATE	2008	dep	4	SENT_109	[p8l1835t3685r1926b3716],
7	)	CD	NUMBER	)	num	8	SENT_109	[p8l1835t3685r1926b3716],
8	532899-904	CD	NUMBER	532899-904	dep	2	SENT_109	[p8l1940t3685r2107b3711],

1	450	CD	NUMBER	450	num	4	SENT_110	[p9l158t144r258b190],
2	45CD	NN	O	45cd	nn	4	SENT_110	[p9l158t280r189b327, p9l194t280r223b327],
3	o	NN	O	o	nn	4	SENT_110	[p9l230t280r258b327],
4	U3	NN	O	u3	_	0	SENT_110	[p9l158t420r185b466],
5	U	NNP	O	U	nn	6	SENT_110	[p9l196t420r220b466],
6	‘	NNP	O	‘	dep	4	SENT_110	[p9l196t420r220b466],
7	!	.	O	!	_	0	SENT_110	[p9l196t420r220b466],

1	G	NN	O	g	nn	3	SENT_111	[p9l230t420r258b466],
2	U	NNP	O	U	nn	3	SENT_111	[p9l158t558r185b605],
3	)	NNP	O	)	_	0	SENT_111	[p9l158t558r185b605],
4	o	NN	O	o	dep	3	SENT_111	[p9l194t558r223b605],
5	Q	NNP	O	Q	dep	3	SENT_111	[p9l230t558r258b605],
6	250 200 150 100	CD	NUMBER	250 200 150 100	num	5	SENT_111	[p9l164t1110r258b1157],[p9l158t696r258b742],

1	w	NN	O	w	_	0	SENT_112	[p9l47t1820r102b1882],
2	Olmesa	JJ	PERSON	olmesa	amod	4	SENT_112	[p9l31t1124r80b1361],
3	rtan	NN	O	rtan	nn	4	SENT_112	[p9l34t989r80b1118],
4	concentration	NN	O	concentration	dep	1	SENT_112	[p9l31t552r80b974],
5	(	CD	NUMBER	(	num	7	SENT_112	[p9l31t288r96b537],
6	ng/mL	NN	O	ng/ml	nn	7	SENT_112	[p9l31t288r96b537],
7	)	NN	O	)	dep	1	SENT_112	[p9l31t288r96b537],

1	U	NNP	O	U	nn	2	SENT_113	[p9l197t1249r223b1296],
2	‘	NNP	O	‘	_	0	SENT_113	[p9l197t1249r223b1296],
3	:	:	O	:	_	0	SENT_113	[p9l197t1249r223b1296],
4	C	NN	O	c	dep	2	SENT_113	[p9l232t1249r260b1296],

1	Olmesartan	JJ	O	olmesartan	amod	2	SENT_114	[p9l36t2740r85b3114],
2	concentration	NN	O	concentration	_	0	SENT_114	[p9l36t2303r85b2725],
3	(	NN	O	(	nn	4	SENT_114	[p9l36t2038r100b2288],
4	ng/mL	NN	O	ng/ml	dep	2	SENT_114	[p9l36t2038r100b2288],
5	)	CD	NUMBER	)	number	6	SENT_114	[p9l36t2038r100b2288],
6	50	CD	NUMBER	50	dep	4	SENT_114	[p9l207t3034r269b3081],

1	‘	NN	O	‘	nn	2	SENT_115	[p9l1445t213r1582b261],
2	O	NN	O	o	nsubj	5	SENT_115	[p9l1445t213r1582b261],
3	’	CD	NUMBER	’	number	4	SENT_115	[p9l1445t213r1582b261],
4	*	CD	NUMBER	*	num	5	SENT_115	[p9l1644t221r1856b266],
5	l5	NN	O	l5	_	0	SENT_115	[p9l1644t221r1856b266],
6	/	:	O	/	punct	8	SENT_115	[p9l1644t221r1856b266],
7	*	CD	NUMBER	*	number	8	SENT_115	[p9l1644t221r1856b266],
8	15	CD	NUMBER	15	dep	5	SENT_115	[p9l1644t221r1856b266],
9	-	:	O	-	_	0	SENT_115	[p9l1445t320r1582b365],
10	I	PRP	O	I	nsubj	11	SENT_115	[p9l1445t320r1582b365],
11	—	VBP	O	—	rcmod	5	SENT_115	[p9l1445t320r1582b365],
12	*	CD	NUMBER	*	nsubj	13	SENT_115	[p9l1644t325r1856b368],
13	1b	JJ	O	1b	xcomp	11	SENT_115	[p9l1644t325r1856b368],
14	/	:	O	/	punct	15	SENT_115	[p9l1644t325r1856b368],
15	*	CD	NUMBER	*	dep	5	SENT_115	[p9l1644t325r1856b368],
16	15	CD	NUMBER	15	dep	15	SENT_115	[p9l1644t325r1856b368],
17	.	.	O	.	_	0	SENT_115	[p9l1442t423r1578b468],

1	—	NN	O	—	_	0	SENT_116	[p9l1442t423r1578b468],
2	.	.	O	.	_	0	SENT_116	[p9l1442t423r1578b468],

1	L	NN	O	l	_	0	SENT_117	[p9l1442t423r1578b468],
2	*	CD	NUMBER	*	num	3	SENT_117	[p9l1644t427r1860b472],
3	1b	NN	O	1b	dep	1	SENT_117	[p9l1644t427r1860b472],
4	/	:	O	/	punct	1	SENT_117	[p9l1644t427r1860b472],
5	*	CD	NUMBER	*	num	6	SENT_117	[p9l1644t427r1860b472],
6	1b	NN	O	1b	dep	1	SENT_117	[p9l1644t427r1860b472],
7	a	DT	O	a	det	8	SENT_117	[p9l771t1061r1185b1279],
8	\	NN	O	\	dep	6	SENT_117	[p9l771t1061r1185b1279],

1	Time	NNP	O	Time	_	0	SENT_118	[p9l1058t1574r1217b1626],
2	(	CD	NUMBER	(	num	4	SENT_118	[p9l1235t1574r1355b1641],
3	hr	NN	DURATION	hr	nn	4	SENT_118	[p9l1235t1574r1355b1641],
4	)	NN	O	)	dep	1	SENT_118	[p9l1235t1574r1355b1641],

1	Co	NNP	O	Co	_	0	SENT_119	[p9l743t1778r1343b1830],
2	—	CD	NUMBER	—	num	4	SENT_119	[p9l743t1778r1343b1830],
3	administration	NN	O	administration	nn	4	SENT_119	[p9l743t1778r1343b1830],
4	phase	NN	O	phase	dep	1	SENT_119	[p9l1358t1778r1536b1846],

1	-	:	O	-	_	0	SENT_120	[p9l1445t1973r1582b2024],
2	o	NN	O	o	dep	24	SENT_120	[p9l1445t1973r1582b2024],
3	-	:	O	-	_	0	SENT_120	[p9l1445t1973r1582b2024],
4	*	CD	NUMBER	*	number	5	SENT_120	[p9l1644t1982r1856b2026],
5	15	CD	NUMBER	15	dep	2	SENT_120	[p9l1644t1982r1856b2026],
6	/	:	O	/	punct	5	SENT_120	[p9l1644t1982r1856b2026],
7	*	CD	NUMBER	*	number	8	SENT_120	[p9l1644t1982r1856b2026],
8	15	CD	NUMBER	15	num	2	SENT_120	[p9l1644t1982r1856b2026],
9	-	:	O	-	_	0	SENT_120	[p9l1445t2081r1582b2126],
10	I	PRP	O	I	dep	2	SENT_120	[p9l1445t2081r1582b2126],
11	-	:	O	-	_	0	SENT_120	[p9l1445t2081r1582b2126],
12	*	NN	O	*	nn	13	SENT_120	[p9l1644t2085r1856b2130],
13	1b	NN	O	1b	dep	10	SENT_120	[p9l1644t2085r1856b2130],
14	/	:	O	/	punct	10	SENT_120	[p9l1644t2085r1856b2130],
15	*	CD	NUMBER	*	number	16	SENT_120	[p9l1644t2085r1856b2130],
16	15	CD	NUMBER	15	amod	2	SENT_120	[p9l1644t2085r1856b2130],
17	-	:	O	-	_	0	SENT_120	[p9l1442t2185r1578b2231],
18	ﬁ	SYM	O	ﬁ	dep	21	SENT_120	[p9l1442t2185r1578b2231],
19	-	:	O	-	_	0	SENT_120	[p9l1442t2185r1578b2231],
20	*	NN	O	*	nn	21	SENT_120	[p9l1644t2188r1860b2233],
21	1b	NN	O	1b	dep	16	SENT_120	[p9l1644t2188r1860b2233],
22	/	:	O	/	punct	21	SENT_120	[p9l1644t2188r1860b2233],
23	*	CD	NUMBER	*	num	24	SENT_120	[p9l1644t2188r1860b2233],
24	1b	NN	O	1b	_	0	SENT_120	[p9l1644t2188r1860b2233],

1	T1	NN	O	t1	_	0	SENT_121	[p9l1174t3043r1755b3128],
2	12	CD	NUMBER	12	number	3	SENT_121	[p9l1135t3247r1195b3294],
3	16	CD	NUMBER	16	dep	1	SENT_121	[p9l1416t3247r1475b3294],
4	20	CD	NUMBER	20	dep	3	SENT_121	[p9l1692t3247r1756b3294],

1	Single	JJ	O	single	amod	3	SENT_122	[p9l744t73r940b140],
2	dose	NN	O	dose	nn	3	SENT_122	[p9l956t73r1095b124],
3	phase	NN	O	phase	_	0	SENT_122	[p9l1120t73r1298b140],

1	Time	NNP	O	Time	_	0	SENT_123	[p9l1012t3346r1171b3397],
2	(	CD	NUMBER	(	num	4	SENT_123	[p9l1189t3346r1308b3411],
3	hr	NN	DURATION	hr	nn	4	SENT_123	[p9l1189t3346r1308b3411],
4	)	NN	O	)	dep	1	SENT_123	[p9l1189t3346r1308b3411],

1	Fig	NN	O	fig	_	0	SENT_124	[p10l7t60r129b129],
2	.	.	O	.	_	0	SENT_124	[p10l7t60r129b129],

1	1	CD	NUMBER	1	num	3	SENT_125	[p10l162t60r191b113],
2	Plasma	NN	O	plasma	nn	3	SENT_125	[p10l242t61r462b114],
3	concentrations	NNS	O	concentration	nsubj	4	SENT_125	[p10l508t61r950b114],
4	(	VBP	O	(	_	0	SENT_125	[p10l1000t61r1187b126],
5	mean	NN	O	mean	dobj	4	SENT_125	[p10l1000t61r1187b126],
6	:	:	O	:	_	0	SENT_125	[p10l1217t62r1269b113],
7	I	PRP	O	I	dobj	4	SENT_125	[p10l1217t62r1269b113],
8	:	:	O	:	_	0	SENT_125	[p10l1217t62r1269b113],
9	SEM	NN	O	sem	nn	10	SENT_125	[p10l1301t61r1477b126],
10	)	NN	O	)	nsubj	22	SENT_125	[p10l1301t61r1477b126],
11	of	IN	O	of	_	0	SENT_125	[p10l1526t61r1592b114],
12	olmesartan	NN	O	olmesartan	prep_of	10	SENT_125	[p10l1634t61r1967b114],
13	after	IN	O	after	_	0	SENT_125	[p10l2014t61r2153b114],
14	oral	JJ	O	oral	amod	15	SENT_125	[p10l8t149r124b202],
15	administration	NN	O	administration	prep_after	12	SENT_125	[p10l162t149r601b202],
16	of	IN	O	of	_	0	SENT_125	[p10l638t149r703b202],
17	10	CD	NUMBER	10	num	20	SENT_125	[p10l742t149r808b202],
18	mg	NN	O	mg	nn	20	SENT_125	[p10l835t166r930b218],
19	olmesartan	NN	O	olmesartan	nn	20	SENT_125	[p10l968t149r1302b202],
20	medoxomil	NN	O	medoxomil	prep_of	15	SENT_125	[p10l1337t149r1684b202],
21	alone	RB	O	alone	advmod	22	SENT_125	[p10l1721t149r1883b202],
22	(	VBD	O	(	parataxis	4	SENT_125	[p10l1922t150r2005b214],
23	a	DT	O	a	det	24	SENT_125	[p10l1922t150r2005b214],
24	)	NN	O	)	dobj	22	SENT_125	[p10l1922t150r2005b214],
25	and	CC	O	and	_	0	SENT_125	[p10l2044t149r2152b202],
26	with	IN	O	with	_	0	SENT_125	[p10l7t236r141b290],
27	10	CD	NUMBER	10	num	28	SENT_125	[p10l188t237r254b290],
28	mg	NN	O	mg	prep_with	32	SENT_125	[p10l282t253r376b305],
29	pravastatin	NN	O	pravastatin	nn	32	SENT_125	[p10l416t236r750b305],
30	(	CD	NUMBER	(	num	32	SENT_125	[p10l792t237r878b302],
31	b	NN	O	b	nn	32	SENT_125	[p10l792t237r878b302],
32	)	NN	O	)	conj_and	22	SENT_125	[p10l792t237r878b302],
33	in	IN	O	in	_	0	SENT_125	[p10l920t236r977b289],
34	SLC01B1	NN	O	slc01b1	nn	36	SENT_125	[p10l1016t237r1575b290],
35	*	CD	NUMBER	*	num	36	SENT_125	[p10l1016t237r1575b290],
36	I5	NN	O	i5	prep_in	32	SENT_125	[p10l1016t237r1575b290],
37	/	:	O	/	punct	40	SENT_125	[p10l1016t237r1575b290],
38	*	CD	NUMBER	*	num	40	SENT_125	[p10l1016t237r1575b290],
39	I5	NN	O	i5	nn	40	SENT_125	[p10l1016t237r1575b290],
40	subjects	NNS	O	subject	dep	32	SENT_125	[p10l1616t236r1856b305],
41	(	JJ	O	(	amod	42	SENT_125	[p10l1899t237r1957b302],
42	n	NN	O	n	dep	40	SENT_125	[p10l1899t237r1957b302],
43	=	JJ	O	=	amod	42	SENT_125	[p10l1988t261r2040b281],
44	4	CD	NUMBER	4	num	45	SENT_125	[p10l2070t237r2148b302],
45	)	CD	NUMBER	)	tmod	43	SENT_125	[p10l2070t237r2148b302],
46	,	,	O	,	_	0	SENT_125	[p10l2070t237r2148b302],
47	*	CD	NUMBER	*	num	48	SENT_125	[p10l11t325r252b378],
48	1b	NN	O	1b	appos	45	SENT_125	[p10l11t325r252b378],
49	/	:	O	/	punct	40	SENT_125	[p10l11t325r252b378],
50	*	CD	NUMBER	*	num	54	SENT_125	[p10l11t325r252b378],
51	15	CD	NUMBER	15	num	52	SENT_125	[p10l11t325r252b378],
52	subjects	NNS	O	subject	npadvmod	53	SENT_125	[p10l286t325r526b393],
53	(	JJ	O	(	amod	54	SENT_125	[p10l557t325r616b390],
54	n	NN	O	n	dep	32	SENT_125	[p10l557t325r616b390],
55	=	JJ	O	=	amod	54	SENT_125	[p10l647t349r698b369],
56	2	CD	NUMBER	2	number	57	SENT_125	[p10l729t325r806b390],
57	)	CD	NUMBER	)	dep	55	SENT_125	[p10l729t325r806b390],
58	,	,	O	,	_	0	SENT_125	[p10l729t325r806b390],
59	and	CC	O	and	_	0	SENT_125	[p10l839t325r946b378],
60	*	NN	O	*	nn	61	SENT_125	[p10l977t325r1220b378],
61	1b	NN	O	1b	dep	32	SENT_125	[p10l977t325r1220b378],
62	/	:	O	/	punct	68	SENT_125	[p10l977t325r1220b378],
63	*	CD	NUMBER	*	num	65	SENT_125	[p10l977t325r1220b378],
64	1b	JJ	O	1b	amod	65	SENT_125	[p10l977t325r1220b378],
65	subjects	NNS	O	subject	dep	68	SENT_125	[p10l1252t325r1491b393],
66	(	JJ	O	(	amod	67	SENT_125	[p10l1523t325r1581b390],
67	n	NN	O	n	dep	65	SENT_125	[p10l1523t325r1581b390],
68	=	JJ	O	=	dep	61	SENT_125	[p10l1612t349r1664b369],
69	4	CD	NUMBER	4	num	70	SENT_125	[p10l1694t325r1754b390],
70	)	NN	O	)	dep	61	SENT_125	[p10l1694t325r1754b390],

1	olmesartan	NN	O	olmesartan	_	0	SENT_126	[p10l8t540r401b603],
2	by	IN	O	by	_	0	SENT_126	[p10l418t540r506b621],
3	pravastatin	NN	O	pravastatin	prep_by	1	SENT_126	[p10l524t540r937b621],
4	.	.	O	.	_	0	SENT_126	[p10l524t540r937b621],

1	However	RB	O	however	advmod	24	SENT_127	[p10l961t542r1307b614],
2	,	,	O	,	_	0	SENT_127	[p10l961t542r1307b614],
3	possible	JJ	O	possible	amod	4	SENT_127	[p10l1328t540r1621b621],
4	interaction	NN	O	interaction	nsubj	24	SENT_127	[p10l1640t540r2024b603],
5	via	IN	O	via	_	0	SENT_127	[p10l2043t540r2152b603],
6	other	JJ	O	other	amod	7	SENT_127	[p10l8t651r192b714],
7	transporters	NNS	O	transporter	prep_via	4	SENT_127	[p10l212t660r655b732],
8	,	,	O	,	_	0	SENT_127	[p10l212t660r655b732],
9	multidrug	JJ	O	multidrug	amod	11	SENT_127	[p10l680t651r1033b732],
10	resistance	NN	O	resistance	nn	11	SENT_127	[p10l1055t651r1811b714],
11	—	NN	O	—	appos	4	SENT_127	[p10l1055t651r1811b714],
12	associated	VBN	O	associate	partmod	11	SENT_127	[p10l1055t651r1811b714],
13	protein	NN	O	protein	nsubj	17	SENT_127	[p10l1832t651r2086b732],
14	2	CD	NUMBER	2	number	15	SENT_127	[p10l2110t651r2150b713],
15	(	CD	NUMBER	(	num	17	SENT_127	[p10l10t762r296b839],
16	MRP2	NN	O	mrp2	nn	17	SENT_127	[p10l10t762r296b839],
17	)	NN	O	)	xcomp	12	SENT_127	[p10l10t762r296b839],
18	in	IN	O	in	_	0	SENT_127	[p10l328t762r396b824],
19	particular	JJ	O	particular	prep_in	17	SENT_127	[p10l423t762r788b843],
20	,	,	O	,	_	0	SENT_127	[p10l423t762r788b843],
21	can	MD	O	can	aux	24	SENT_127	[p10l821t772r1060b825],
22	not	RB	O	not	neg	24	SENT_127	[p10l821t772r1060b825],
23	be	VB	O	be	cop	24	SENT_127	[p10l1087t762r1170b825],
24	negligible	JJ	O	negligible	_	0	SENT_127	[p10l1200t762r1578b843],
25	,	,	O	,	_	0	SENT_127	[p10l1200t762r1578b843],
26	because	IN	O	because	mark	33	SENT_127	[p10l1610t762r1892b825],
27	pravastatin	NN	O	pravastatin	nsubj	33	SENT_127	[p10l1922t782r2148b843, p10l10t873r201b936],
28	and	CC	O	and	_	0	SENT_127	[p10l226t873r353b936],
29	olmesartan	NN	O	olmesartan	nsubj	33	SENT_127	[p10l377t873r770b936],
30	are	VBP	O	be	cop	33	SENT_127	[p10l796t893r901b936],
31	also	RB	O	also	advmod	33	SENT_127	[p10l928t873r1068b936],
32	a	DT	O	a	det	33	SENT_127	[p10l1095t893r1132b936],
33	substrate	NN	O	substrate	advcl	24	SENT_127	[p10l1158t873r1472b936],
34	of	IN	O	of	_	0	SENT_127	[p10l1498t873r1575b936],
35	MRP2	NN	O	mrp2	prep_of	33	SENT_127	[p10l1593t874r1844b948],
36	,	,	O	,	_	0	SENT_127	[p10l1593t874r1844b948],
37	and	CC	O	and	_	0	SENT_127	[p10l1873t873r2000b936],
38	this	DT	O	this	det	39	SENT_127	[p10l2023t873r2149b936],
39	transporter	NN	O	transporter	nsubjpass	41	SENT_127	[p10l7t995r397b1066],
40	is	VBZ	O	be	auxpass	41	SENT_127	[p10l423t985r479b1048],
41	reported	VBN	O	report	conj_and	24	SENT_127	[p10l507t985r807b1066],
42	to	TO	O	to	aux	44	SENT_127	[p10l834t995r901b1048],
43	be	VB	O	be	auxpass	44	SENT_127	[p10l928t985r1011b1048],
44	involved	VBN	O	involve	xcomp	41	SENT_127	[p10l1040t985r1353b1048],
45	in	IN	O	in	_	0	SENT_127	[p10l1381t985r1448b1047],
46	their	PRP$	O	they	poss	48	SENT_127	[p10l1475t985r1640b1048],
47	biliary	JJ	O	biliary	amod	48	SENT_127	[p10l1665t985r1899b1066],
48	excretion	NN	O	excretion	prep_in	44	SENT_127	[p10l1928t1005r2148b1048, p10l7t1096r145b1159],
49	(	CD	NUMBER	(	num	50	SENT_127	[p10l175t1096r463b1173],
50	Kivisto	NNP	PERSON	Kivisto	dobj	44	SENT_127	[p10l175t1096r463b1173],
51	et	FW	O	et	nn	52	SENT_127	[p10l493t1106r556b1159],
52	al.	FW	O	al.	dep	50	SENT_127	[p10l583t1096r663b1159],
53	2005	CD	DATE	2005	dep	50	SENT_127	[p10l695t1096r893b1170],
54	;	:	O	;	_	0	SENT_127	[p10l695t1096r893b1170],
55	Nakagomi	NNP	PERSON	Nakagomi	dep	50	SENT_127	[p10l923t1096r1659b1177],
56	.	.	O	.	_	0	SENT_127	[p10l923t1096r1659b1177],

1	—	NN	O	—	_	0	SENT_128	[p10l923t1096r1659b1177],
2	.	.	O	.	_	0	SENT_128	[p10l923t1096r1659b1177],

1	Hagihara	NNP	O	Hagihara	_	0	SENT_129	[p10l923t1096r1659b1177],
2	et	FW	O	et	nn	3	SENT_129	[p10l1685t1106r1749b1159],
3	al.	FW	O	al.	dep	1	SENT_129	[p10l1776t1096r1855b1159],
4	2006	CD	DATE	2006	num	5	SENT_129	[p10l1888t1096r2111b1173],
5	)	CD	NUMBER	)	dep	3	SENT_129	[p10l1888t1096r2111b1173],
6	.	.	O	.	_	0	SENT_129	[p10l1888t1096r2111b1173],

1	No	DT	O	no	det	4	SENT_130	[p10l109t1207r215b1268],
2	signiﬁcant	NN	O	signiﬁcant	nn	4	SENT_130	[p10l265t1206r637b1287],
3	intergenotypic	JJ	O	intergenotypic	amod	4	SENT_130	[p10l681t1206r1198b1287],
4	differences	NNS	O	difference	nsubjpass	15	SENT_130	[p10l1247t1205r1643b1268],
5	in	IN	O	in	_	0	SENT_130	[p10l1691t1206r1758b1267],
6	the	DT	O	the	det	8	SENT_130	[p10l1804t1206r1911b1268],
7	mean	NN	O	mean	nn	8	SENT_130	[p10l1958t1225r2151b1268],
8	Ae0_24	NN	O	ae0_24	prep_in	4	SENT_130	[p10l7t1318r244b1395],
9	and	CC	O	and	_	0	SENT_130	[p10l277t1318r403b1380],
10	CLr0_24	NN	O	clr0_24	nn	11	SENT_130	[p10l434t1318r710b1395],
11	values	NNS	O	value	conj_and	4	SENT_130	[p10l741t1318r968b1381],
12	of	IN	O	of	_	0	SENT_130	[p10l1001t1317r1078b1380],
13	olmesartan	NN	O	olmesartan	prep_of	11	SENT_130	[p10l1104t1318r1497b1380],
14	were	VBD	O	be	auxpass	15	SENT_130	[p10l1528t1337r1698b1381],
15	observed	VBN	O	observe	_	0	SENT_130	[p10l1731t1317r2053b1380],
16	in	IN	O	in	_	0	SENT_130	[p10l2083t1318r2151b1380],
17	both	CC	O	both	preconj	21	SENT_130	[p10l6t1429r165b1491],
18	the	DT	O	the	det	21	SENT_130	[p10l208t1429r316b1491],
19	single	JJ	O	single	amod	21	SENT_130	[p10l364t1429r767b1510],
20	—	NN	O	—	nn	21	SENT_130	[p10l364t1429r767b1510],
21	dose	NN	O	dose	prep_in	15	SENT_130	[p10l364t1429r767b1510],
22	and	CC	O	and	_	0	SENT_130	[p10l814t1428r941b1491],
23	co	NN	O	co	nn	26	SENT_130	[p10l985t1429r1619b1491],
24	—	NN	O	—	nn	26	SENT_130	[p10l985t1429r1619b1491],
25	administration	NN	O	administration	nn	26	SENT_130	[p10l985t1429r1619b1491],
26	phases	NNS	O	phase	prep_in	15	SENT_130	[p10l1662t1429r1921b1510],
27	;	:	O	;	_	0	SENT_130	[p10l1662t1429r1921b1510],
28	however	RB	O	however	advmod	39	SENT_130	[p10l1968t1429r2148b1491, p10l8t1561r179b1615],
29	,	,	O	,	_	0	SENT_130	[p10l1968t1429r2148b1491, p10l8t1561r179b1615],
30	these	DT	O	these	det	31	SENT_130	[p10l213t1541r396b1604],
31	values	NNS	O	value	nsubjpass	39	SENT_130	[p10l427t1541r653b1604],
32	in	IN	O	in	_	0	SENT_130	[p10l685t1541r753b1603],
33	the	DT	O	the	det	37	SENT_130	[p10l784t1541r891b1604],
34	single	JJ	O	single	amod	37	SENT_130	[p10l925t1541r1329b1622],
35	—	NN	O	—	nn	37	SENT_130	[p10l925t1541r1329b1622],
36	dose	NN	O	dose	nn	37	SENT_130	[p10l925t1541r1329b1622],
37	phase	NN	O	phase	prep_in	31	SENT_130	[p10l1360t1541r1562b1622],
38	were	VBD	O	be	auxpass	39	SENT_130	[p10l1595t1561r1765b1604],
39	decreased	VBN	O	decrease	parataxis	15	SENT_130	[p10l1798t1541r2151b1604],
40	after	IN	O	after	_	0	SENT_130	[p10l9t1652r172b1715],
41	co	NN	O	co	nn	43	SENT_130	[p10l245t1652r879b1715],
42	—	CD	NUMBER	—	num	43	SENT_130	[p10l245t1652r879b1715],
43	administration	NN	O	administration	prep_after	39	SENT_130	[p10l245t1652r879b1715],
44	of	IN	O	of	_	0	SENT_130	[p10l954t1652r1031b1715],
45	pravastatin	NN	O	pravastatin	prep_of	43	SENT_130	[p10l1099t1652r1513b1733],
46	,	,	O	,	_	0	SENT_130	[p10l1099t1652r1513b1733],
47	irrespective	RB	O	irrespective	advmod	43	SENT_130	[p10l1590t1652r2008b1733],
48	to	TO	O	to	_	0	SENT_130	[p10l2083t1662r2150b1715],
49	SLCOIBI	NNP	O	SLCOIBI	prep_to	47	SENT_130	[p10l8t1764r362b1826],
50	status	NN	O	status	nn	52	SENT_130	[p10l406t1773r603b1826],
51	(	CD	NUMBER	(	num	52	SENT_130	[p10l643t1763r873b1840],
52	Table	NNP	O	Table	dep	43	SENT_130	[p10l643t1763r873b1840],
53	1	CD	NUMBER	1	number	54	SENT_130	[p10l915t1764r996b1840],
54	)	CD	NUMBER	)	dep	52	SENT_130	[p10l915t1764r996b1840],
55	.	.	O	.	_	0	SENT_130	[p10l915t1764r996b1840],

1	The	DT	O	the	det	2	SENT_131	[p10l1035t1763r1172b1826],
2	mechanism	NN	O	mechanism	nsubj	22	SENT_131	[p10l1207t1763r1617b1826],
3	by	IN	O	by	_	0	SENT_131	[p10l1649t1763r1737b1844],
4	which	WDT	O	which	agent	10	SENT_131	[p10l1772t1763r1989b1826],
5	urinary	JJ	O	urinary	amod	6	SENT_131	[p10l2023t1763r2148b1826, p10l7t1894r164b1955],
6	excretion	NN	O	excretion	nsubjpass	10	SENT_131	[p10l236t1874r569b1937],
7	of	IN	O	of	_	0	SENT_131	[p10l641t1874r718b1937],
8	olmesartan	NN	O	olmesartan	prep_of	6	SENT_131	[p10l784t1874r1177b1937],
9	was	VBD	O	be	auxpass	10	SENT_131	[p10l1248t1894r1382b1937],
10	reduced	VBN	O	reduce	rcmod	2	SENT_131	[p10l1454t1874r1739b1937],
11	after	IN	O	after	_	0	SENT_131	[p10l1811t1874r1974b1937],
12	the	DT	O	the	det	15	SENT_131	[p10l2043t1874r2150b1937],
13	co	NN	O	co	nn	15	SENT_131	[p10l8t1985r642b2048],
14	—	NN	O	—	nn	15	SENT_131	[p10l8t1985r642b2048],
15	administration	NN	O	administration	prep_after	10	SENT_131	[p10l8t1985r642b2048],
16	of	IN	O	of	_	0	SENT_131	[p10l667t1985r744b2048],
17	pravastatin	NN	O	pravastatin	prep_of	15	SENT_131	[p10l761t1985r1156b2066],
18	is	VBZ	O	be	cop	19	SENT_131	[p10l1179t1985r1235b2048],
19	unclear	JJ	O	unclear	_	0	SENT_131	[p10l1260t1985r1526b2048],
20	and	CC	O	and	_	0	SENT_131	[p10l1550t1985r1676b2048],
21	still	RB	O	still	advmod	19	SENT_131	[p10l1703t1985r1832b2048],
22	needs	VBZ	O	need	conj_and	19	SENT_131	[p10l1856t1985r2057b2048],
23	to	TO	O	to	aux	25	SENT_131	[p10l2083t1995r2150b2048],
24	be	VB	O	be	auxpass	25	SENT_131	[p10l6t2096r89b2159],
25	clariﬁed	VBN	O	clariﬁed	xcomp	22	SENT_131	[p10l126t2096r437b2159],
26	.	.	O	.	_	0	SENT_131	[p10l126t2096r437b2159],

1	Recent	JJ	O	recent	nsubj	5	SENT_132	[p10l476t2098r726b2159],
2	in	FW	O	in	nn	4	SENT_132	[p10l761t2096r828b2158],
3	vitro	FW	O	vitro	dep	4	SENT_132	[p10l864t2096r1030b2159],
4	studies	NNS	O	study	advmod	5	SENT_132	[p10l1070t2096r1313b2159],
5	indicated	VBD	O	indicate	_	0	SENT_132	[p10l1350t2096r1679b2159],
6	that	IN	O	that	complm	27	SENT_132	[p10l1714t2096r1848b2159],
7	organic	JJ	O	organic	amod	12	SENT_132	[p10l1884t2096r2149b2177],
8	anion	NN	O	anion	nn	12	SENT_132	[p10l9t2207r205b2269],
9	transporter	NN	O	transporter	nn	12	SENT_132	[p10l250t2216r641b2288],
10	3	CD	NUMBER	3	num	12	SENT_132	[p10l686t2207r721b2270],
11	(	NN	O	(	nn	12	SENT_132	[p10l774t2207r1055b2284],
12	OAT3	NN	O	oat3	nsubjpass	27	SENT_132	[p10l774t2207r1055b2284],
13	)	CD	NUMBER	)	dep	12	SENT_132	[p10l774t2207r1055b2284],
14	expressed	VBN	O	express	partmod	12	SENT_132	[p10l1104t2207r1457b2288],
15	at	IN	O	at	_	0	SENT_132	[p10l1502t2216r1565b2269],
16	the	DT	O	the	det	18	SENT_132	[p10l1609t2207r1716b2269],
17	basolateral	JJ	O	basolateral	amod	18	SENT_132	[p10l1760t2207r2150b2269],
18	membrane	NN	O	membrane	prep_at	14	SENT_132	[p10l7t2317r385b2379],
19	of	IN	O	of	_	0	SENT_132	[p10l421t2317r498b2379],
20	renal	JJ	O	renal	amod	24	SENT_132	[p10l525t2317r703b2379],
21	proximal	JJ	O	proximal	amod	24	SENT_132	[p10l736t2317r1061b2398],
22	tubule	JJ	O	tubule	amod	24	SENT_132	[p10l1095t2317r1317b2379],
23	epithelial	JJ	O	epithelial	amod	24	SENT_132	[p10l1352t2317r1686b2398],
24	cells	NNS	O	cell	prep_of	18	SENT_132	[p10l1721t2317r1881b2379],
25	is	VBZ	O	be	auxpass	27	SENT_132	[p10l1917t2316r1973b2379],
26	predominantly	RB	O	predominantly	advmod	27	SENT_132	[p10l2007t2336r2148b2398, p10l8t2428r415b2509],
27	involved	VBN	O	involve	ccomp	5	SENT_132	[p10l461t2428r774b2490],
28	in	IN	O	in	_	0	SENT_132	[p10l819t2428r887b2489],
29	renal	JJ	O	renal	amod	30	SENT_132	[p10l930t2428r1109b2490],
30	uptake	NN	O	uptake	prep_in	27	SENT_132	[p10l1154t2428r1391b2509],
31	of	IN	O	of	_	0	SENT_132	[p10l1439t2427r1516b2490],
32	both	DT	O	both	det	33	SENT_132	[p10l1554t2428r1712b2490],
33	pravastatin	NN	O	pravastatin	prep_of	30	SENT_132	[p10l1756t2428r2151b2509],

1	@	IN	O	@	amod	2	SENT_133	[p10l6t2671r83b2766],
2	Springer	NNP	PERSON	Springer	_	0	SENT_133	[p10l113t2694r375b2769],
3	and	CC	O	and	_	0	SENT_133	[p10l10t2796r136b2859],
4	olmesartan	NN	O	olmesartan	nn	6	SENT_133	[p10l190t2796r580b2859],
5	(	CD	NUMBER	(	num	6	SENT_133	[p10l637t2797r1030b2877],
6	Hasegawa	NNP	PERSON	Hasegawa	conj_and	2	SENT_133	[p10l637t2797r1030b2877],
7	et	FW	O	et	nn	8	SENT_133	[p10l1083t2806r1146b2859],
8	al.	FW	O	al.	dep	6	SENT_133	[p10l1200t2796r1279b2859],
9	2002	CD	DATE	2002	dep	6	SENT_133	[p10l1338t2797r1534b2870],
10	;	:	O	;	_	0	SENT_133	[p10l1338t2797r1534b2870],
11	Yamada	NNP	PERSON	Yamada	dep	2	SENT_133	[p10l1592t2796r1889b2859],
12	et	FW	O	et	nn	13	SENT_133	[p10l1942t2806r2005b2859],
13	al.	FW	O	al.	dep	11	SENT_133	[p10l2059t2796r2138b2859],
14	2007	CD	DATE	2007	num	15	SENT_133	[p10l9t2908r232b2985],
15	)	CD	NUMBER	)	dep	11	SENT_133	[p10l9t2908r232b2985],
16	.	.	O	.	_	0	SENT_133	[p10l9t2908r232b2985],

1	The	DT	O	the	det	5	SENT_134	[p10l301t2907r438b2970],
2	drug	NN	O	drug	nn	5	SENT_134	[p10l503t2907r872b2988],
3	—	NN	O	—	nn	5	SENT_134	[p10l503t2907r872b2988],
4	drug	NN	O	drug	nn	5	SENT_134	[p10l503t2907r872b2988],
5	interaction	NN	O	interaction	nsubj	13	SENT_134	[p10l937t2907r1320b2970],
6	via	IN	O	via	_	0	SENT_134	[p10l1384t2907r1492b2970],
7	OAT3	NN	O	oat3	prep_via	5	SENT_134	[p10l1557t2908r1776b2970],
8	between	IN	O	between	_	0	SENT_134	[p10l1844t2907r2142b2970],
9	pravastatin	NN	O	pravastatin	prep_between	7	SENT_134	[p10l7t3018r400b3099],
10	and	CC	O	and	_	0	SENT_134	[p10l438t3018r564b3080],
11	olmesartan	NN	O	olmesartan	conj_and	9	SENT_134	[p10l599t3018r990b3080],
12	may	MD	O	may	aux	13	SENT_134	[p10l1025t3037r1176b3099],
13	account	VB	O	account	_	0	SENT_134	[p10l1215t3027r1491b3080],
14	for	IN	O	for	_	0	SENT_134	[p10l1525t3018r1629b3080],
15	the	DT	O	the	det	16	SENT_134	[p10l1662t3018r1769b3080],
16	reduction	NN	O	reduction	prep_for	13	SENT_134	[p10l1804t3018r2142b3080],
17	of	IN	O	of	_	0	SENT_134	[p10l9t3128r86b3190],
18	olmesartan	NN	O	olmesartan	nn	20	SENT_134	[p10l140t3128r531b3190],
19	renal	JJ	O	renal	amod	20	SENT_134	[p10l589t3128r767b3190],
20	excretion	NN	O	excretion	prep_of	16	SENT_134	[p10l827t3128r1159b3190],
21	in	IN	O	in	_	0	SENT_134	[p10l1218t3128r1285b3189],
22	the	DT	O	the	det	26	SENT_134	[p10l1344t3128r1451b3190],
23	co	NN	O	co	nn	26	SENT_134	[p10l1511t3128r2142b3190],
24	—	NN	O	—	nn	26	SENT_134	[p10l1511t3128r2142b3190],
25	administration	NN	O	administration	nn	26	SENT_134	[p10l1511t3128r2142b3190],
26	phase	NN	O	phase	prep_in	20	SENT_134	[p10l7t3238r231b3319],
27	;	:	O	;	_	0	SENT_134	[p10l7t3238r231b3319],
28	however	RB	O	however	advmod	46	SENT_134	[p10l274t3238r600b3311],
29	,	,	O	,	_	0	SENT_134	[p10l274t3238r600b3311],
30	the	DT	O	the	det	31	SENT_134	[p10l641t3238r748b3300],
31	interaction	NN	O	interaction	nsubjpass	46	SENT_134	[p10l788t3238r1171b3300],
32	via	IN	O	via	_	0	SENT_134	[p10l1210t3238r1318b3300],
33	MRP2	NN	O	mrp2	prep_via	31	SENT_134	[p10l1356t3238r1606b3311],
34	,	,	O	,	_	0	SENT_134	[p10l1356t3238r1606b3311],
35	which	WDT	O	which	nsubjpass	38	SENT_134	[p10l1649t3238r1865b3301],
36	also	RB	O	also	advmod	38	SENT_134	[p10l1906t3238r2045b3300],
37	is	VBZ	O	be	auxpass	38	SENT_134	[p10l2085t3238r2140b3300],
38	expressed	VBN	O	express	rcmod	31	SENT_134	[p10l9t3350r360b3431],
39	in	IN	O	in	_	0	SENT_134	[p10l388t3350r456b3412],
40	the	DT	O	the	det	41	SENT_134	[p10l485t3350r592b3413],
41	kidney	NN	O	kidney	prep_in	38	SENT_134	[p10l621t3350r883b3431],
42	,	,	O	,	_	0	SENT_134	[p10l621t3350r883b3431],
43	can	MD	O	can	aux	46	SENT_134	[p10l916t3360r1153b3413],
44	not	RB	O	not	neg	46	SENT_134	[p10l916t3360r1153b3413],
45	be	VB	O	be	auxpass	46	SENT_134	[p10l1179t3350r1262b3413],
46	ruled	VBN	O	rule	parataxis	13	SENT_134	[p10l1291t3350r1475b3413],
47	out	RP	O	out	prt	46	SENT_134	[p10l1505t3360r1617b3413],
48	(	RB	O	(	advmod	46	SENT_134	[p10l1648t3350r1935b3427],
49	Kivisto	NNP	PERSON	Kivisto	dep	51	SENT_134	[p10l1648t3350r1935b3427],
50	et	FW	O	et	nn	51	SENT_134	[p10l1966t3360r2029b3413],
51	a1	FW	O	a1	advmod	46	SENT_134	[p10l2059t3350r2138b3413],
52	.	.	O	.	_	0	SENT_134	[p10l2059t3350r2138b3413],

1	2005	CD	DATE	2005	_	0	SENT_135	[p10l9t3461r206b3535],
2	;	:	O	;	_	0	SENT_135	[p10l9t3461r206b3535],
3	Nakagomi	NNP	PERSON	Nakagomi	dep	1	SENT_135	[p10l242t3461r974b3542],
4	.	.	O	.	_	0	SENT_135	[p10l242t3461r974b3542],

1	—	NN	O	—	_	0	SENT_136	[p10l242t3461r974b3542],
2	.	.	O	.	_	0	SENT_136	[p10l242t3461r974b3542],

1	Hagihara	NNP	O	Hagihara	_	0	SENT_137	[p10l242t3461r974b3542],
2	et	FW	O	et	nn	3	SENT_137	[p10l1006t3470r1069b3524],
3	al.	FW	O	al.	dep	1	SENT_137	[p10l1102t3461r1181b3524],
4	2006	CD	DATE	2006	num	5	SENT_137	[p10l1219t3461r1442b3538],
5	)	CD	NUMBER	)	dep	3	SENT_137	[p10l1219t3461r1442b3538],
6	.	.	O	.	_	0	SENT_137	[p10l1219t3461r1442b3538],

1	There	EX	O	there	expl	2	SENT_138	[p10l110t3572r316b3635],
2	were	VBD	O	be	_	0	SENT_138	[p10l362t3592r532b3635],
3	no	DT	O	no	det	5	SENT_138	[p10l577t3592r663b3635],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_138	[p10l711t3572r1080b3653],
5	differences	NNS	O	difference	nsubj	2	SENT_138	[p10l1124t3572r1518b3635],
6	in	IN	O	in	_	0	SENT_138	[p10l1564t3572r1631b3634],
7	any	DT	O	any	det	9	SENT_138	[p10l1676t3592r1801b3653],
8	pharmacokinetic	JJ	O	pharmacokinetic	amod	9	SENT_138	[p10l1844t3572r2139b3653, p10l9t3683r334b3746],
9	parameters	NNS	O	parameter	prep_in	5	SENT_138	[p10l404t3693r795b3764],
10	of	IN	O	of	_	0	SENT_138	[p10l868t3683r945b3746],
11	pravastatin	NN	O	pravastatin	prep_of	9	SENT_138	[p10l1008t3683r1401b3764],
12	among	IN	O	among	_	0	SENT_138	[p10l1472t3703r1711b3764],
13	SLCOIBI	NNP	O	SLCOIBI	prep_among	11	SENT_138	[p10l1782t3684r2135b3747],

1	genotypes	NNS	O	genotype	nsubj	6	SENT_139	[p11l9t32r368b103],
2	for	IN	O	for	_	0	SENT_139	[p11l414t22r517b85],
3	both	DT	O	both	det	5	SENT_139	[p11l557t22r716b85],
4	dosing	NN	O	dosing	nn	5	SENT_139	[p11l761t22r995b103],
5	phases	NNS	O	phase	prep_for	1	SENT_139	[p11l1038t22r1274b103],
6	(	VBP	O	(	_	0	SENT_139	[p11l1322t22r1551b100],
7	Table	NNP	O	Table	nsubj	9	SENT_139	[p11l1322t22r1551b100],
8	2	CD	NUMBER	2	num	9	SENT_139	[p11l1586t23r1674b100],
9	)	CD	NUMBER	)	xcomp	6	SENT_139	[p11l1586t23r1674b100],
10	.	.	O	.	_	0	SENT_139	[p11l1586t23r1674b100],

1	In	IN	O	in	_	0	SENT_140	[p11l1722t24r1794b84],
2	contrast	NN	O	contrast	prep_in	12	SENT_140	[p11l1839t32r2138b96],
3	,	,	O	,	_	0	SENT_140	[p11l1839t32r2138b96],
4	mean	VB	O	mean	csubj	12	SENT_140	[p11l8t152r201b195],
5	Cmax	NN	O	cmax	dobj	4	SENT_140	[p11l242t134r411b210],
6	and	CC	O	and	_	0	SENT_140	[p11l449t133r575b195],
7	AUC0_24	NN	O	auc0_24	conj_and	5	SENT_140	[p11l611t133r931b211],
8	of	IN	O	of	_	0	SENT_140	[p11l969t133r1046b195],
9	RMS	NNP	O	RMS	nn	10	SENT_140	[p11l1076t133r1424b196],
10	—	NN	O	—	prep_of	5	SENT_140	[p11l1076t133r1424b196],
11	416	CD	NUMBER	416	advmod	12	SENT_140	[p11l1076t133r1424b196],
12	showed	VBD	O	show	dep	27	SENT_140	[p11l1466t133r1735b196],
13	signiﬁcant	JJ	O	signiﬁcant	amod	14	SENT_140	[p11l1774t133r2143b214],
14	differences	NNS	O	difference	dobj	12	SENT_140	[p11l9t244r403b306],
15	among	IN	O	among	_	0	SENT_140	[p11l450t263r689b325],
16	SLCOIBI	NNP	O	SLCOIBI	prep_among	12	SENT_140	[p11l734t244r1086b307],
17	genotyping	VBG	O	genotype	xcomp	12	SENT_140	[p11l1138t244r1537b325],
18	groups	NNS	O	group	dobj	17	SENT_140	[p11l1582t263r1843b325],
19	;	:	O	;	_	0	SENT_140	[p11l1582t263r1843b325],
20	plasma	NN	O	plasma	nn	21	SENT_140	[p11l1889t244r2144b325],
21	concentrations	NNS	O	concentration	dep	18	SENT_140	[p11l9t355r528b417],
22	of	IN	O	of	_	0	SENT_140	[p11l565t355r642b417],
23	RMS	NNP	O	RMS	nn	24	SENT_140	[p11l670t355r1018b418],
24	—	NN	O	—	prep_of	21	SENT_140	[p11l670t355r1018b418],
25	416	CD	NUMBER	416	advmod	17	SENT_140	[p11l670t355r1018b418],
26	were	VBD	O	be	cop	27	SENT_140	[p11l1055t374r1225b418],
27	higher	JJR	O	higher	_	0	SENT_140	[p11l1260t355r1489b436],
28	in	IN	O	in	_	0	SENT_140	[p11l1521t355r1589b417],
29	SLCOIBI	NNP	O	SLCOIBI	prep_in	27	SENT_140	[p11l1623t355r1975b418],
30	*	CD	NUMBER	*	number	31	SENT_140	[p11l1995t355r2153b418],
31	15	CD	NUMBER	15	dep	27	SENT_140	[p11l1995t355r2153b418],
32	/	:	O	/	punct	41	SENT_140	[p11l1995t355r2153b418],
33	*	CD	NUMBER	*	number	34	SENT_140	[p11l18t467r141b529],
34	15	CD	NUMBER	15	num	35	SENT_140	[p11l18t467r141b529],
35	subjects	NNS	O	subject	npadvmod	36	SENT_140	[p11l174t466r456b547],
36	than	IN	O	than	advmod	41	SENT_140	[p11l489t466r641b529],
37	in	IN	O	in	_	0	SENT_140	[p11l672t466r740b528],
38	SLCOIBI	NNP	O	SLCOIBI	prep_in	36	SENT_140	[p11l771t467r1124b529],
39	*	CD	NUMBER	*	number	40	SENT_140	[p11l1143t467r1215b528],
40	1	CD	NUMBER	1	num	41	SENT_140	[p11l1143t467r1215b528],
41	b	NN	O	b	dep	31	SENT_140	[p11l1225t466r1374b530],
42	/	:	O	/	punct	41	SENT_140	[p11l1225t466r1374b530],
43	*	CD	NUMBER	*	nsubj	27	SENT_140	[p11l1225t466r1374b530],
44	I	PRP	O	I	dep	43	SENT_140	[p11l1225t466r1374b530],
45	b	NN	O	b	nn	46	SENT_140	[p11l1384t466r1424b529],
46	subjects	NNS	O	subject	dep	44	SENT_140	[p11l1460t466r1761b547],
47	.	.	O	.	_	0	SENT_140	[p11l1460t466r1761b547],

1	When	WRB	O	when	advmod	3	SENT_141	[p11l1796t466r2009b529],
2	we	PRP	O	we	nsubj	3	SENT_141	[p11l2041t486r2141b529],
3	introduced	VBD	O	introduce	advcl	16	SENT_141	[p11l8t577r390b640],
4	the	DT	O	the	det	5	SENT_141	[p11l419t577r526b640],
5	sum	NN	O	sum	dobj	3	SENT_141	[p11l559t597r704b640],
6	of	IN	O	of	_	0	SENT_141	[p11l733t577r810b640],
7	pravastatin	NN	O	pravastatin	nn	10	SENT_141	[p11l832t577r1226b658],
8	and	CC	O	and	_	0	SENT_141	[p11l1257t577r1383b640],
9	RMS	NNP	O	RMS	nn	10	SENT_141	[p11l1411t577r1780b651],
10	—	NN	O	—	prep_of	5	SENT_141	[p11l1411t577r1780b651],
11	416	CD	NUMBER	416	advmod	3	SENT_141	[p11l1411t577r1780b651],
12	,	,	O	,	_	0	SENT_141	[p11l1411t577r1780b651],
13	the	DT	O	the	det	15	SENT_141	[p11l1813t577r1920b640],
14	mean	NN	O	mean	nn	15	SENT_141	[p11l1950t597r2142b640],
15	AUC0_24	NN	O	auc0_24	nsubj	16	SENT_141	[p11l8t688r328b765],
16	value	NN	O	value	_	0	SENT_141	[p11l366t688r557b751],
17	in	IN	O	in	_	0	SENT_141	[p11l596t688r663b750],
18	SLCOIBI	NNP	O	SLCOIBI	prep_in	16	SENT_141	[p11l701t689r1054b751],
19	*	CD	NUMBER	*	num	20	SENT_141	[p11l1073t688r1356b751],
20	15	CD	NUMBER	15	dep	18	SENT_141	[p11l1073t688r1356b751],
21	/	:	O	/	punct	20	SENT_141	[p11l1073t688r1356b751],
22	*	CD	NUMBER	*	number	23	SENT_141	[p11l1073t688r1356b751],
23	15	CD	NUMBER	15	num	24	SENT_141	[p11l1073t688r1356b751],
24	subjects	NNS	O	subject	nsubj	27	SENT_141	[p11l1396t688r1677b769],
25	was	VBD	O	be	cop	27	SENT_141	[p11l1718t708r1852b751],
26	signiﬁcantly	RB	O	signiﬁcantly	advmod	27	SENT_141	[p11l1894t688r2139b769, p11l9t798r225b879],
27	higher	JJR	O	higher	dep	20	SENT_141	[p11l264t798r493b879],
28	than	IN	O	than	prep	27	SENT_141	[p11l530t798r682b860],
29	in	IN	O	in	pcomp	28	SENT_141	[p11l721t798r788b859],
30	SLCOIBI	NNP	O	SLCOIBI	dep	29	SENT_141	[p11l827t798r1180b861],
31	*	CD	NUMBER	*	num	30	SENT_141	[p11l1199t798r1270b859],
32	1	CD	NUMBER	1	num	33	SENT_141	[p11l1199t798r1270b859],
33	b	NN	O	b	dep	30	SENT_141	[p11l1280t798r1480b861],
34	/	:	O	/	punct	30	SENT_141	[p11l1280t798r1480b861],
35	*	CD	NUMBER	*	num	37	SENT_141	[p11l1280t798r1480b861],
36	Ib	NN	O	ib	nn	37	SENT_141	[p11l1280t798r1480b861],
37	subjects	NNS	O	subject	dep	30	SENT_141	[p11l1523t798r1805b879],
38	for	IN	O	for	_	0	SENT_141	[p11l1845t798r1948b860],
39	both	DT	O	both	det	41	SENT_141	[p11l1984t798r2142b860],
40	dosing	NN	O	dosing	nn	41	SENT_141	[p11l9t910r243b991],
41	phases	NNS	O	phase	prep_for	37	SENT_141	[p11l297t910r552b991],
42	.	.	O	.	_	0	SENT_141	[p11l297t910r552b991],

1	For	IN	O	for	_	0	SENT_142	[p11l610t912r733b973],
2	urinary	JJ	O	urinary	amod	3	SENT_142	[p11l784t910r1041b991],
3	data	NNS	O	datum	prep_for	25	SENT_142	[p11l1096t910r1262b984],
4	,	,	O	,	_	0	SENT_142	[p11l1096t910r1262b984],
5	the	DT	O	the	det	6	SENT_142	[p11l1318t910r1425b973],
6	mean	NN	O	mean	nsubj	25	SENT_142	[p11l1480t930r1673b973],
7	Ae0_24	NN	O	ae0_24	nn	10	SENT_142	[p11l1725t911r1961b988],
8	and	CC	O	and	_	0	SENT_142	[p11l2017t910r2143b973],
9	CLr0_24	NN	O	clr0_24	nn	10	SENT_142	[p11l9t1022r284b1099],
10	values	NNS	O	value	nsubj	21	SENT_142	[p11l316t1021r541b1084],
11	of	IN	O	of	_	0	SENT_142	[p11l574t1021r651b1084],
12	both	DT	O	both	det	13	SENT_142	[p11l676t1021r834b1084],
13	pravastatin	NN	O	pravastatin	prep_of	10	SENT_142	[p11l864t1021r1256b1102],
14	and	CC	O	and	_	0	SENT_142	[p11l1289t1021r1415b1084],
15	RMS	NNP	O	RMS	nn	16	SENT_142	[p11l1446t1021r1795b1084],
16	—	NN	O	—	prep_of	10	SENT_142	[p11l1446t1021r1795b1084],
17	416	CD	NUMBER	416	num	16	SENT_142	[p11l1446t1021r1795b1084],
18	were	VBD	O	be	cop	21	SENT_142	[p11l1827t1041r1998b1084],
19	not	RB	O	not	neg	21	SENT_142	[p11l2030t1031r2143b1084],
20	markedly	RB	O	markedly	advmod	21	SENT_142	[p11l8t1132r345b1213],
21	different	JJ	O	different	rcmod	6	SENT_142	[p11l374t1132r681b1194],
22	between	IN	O	between	_	0	SENT_142	[p11l708t1132r1006b1195],
23	these	DT	O	these	det	24	SENT_142	[p11l1034t1132r1215b1194],
24	groups	NNS	O	group	prep_between	21	SENT_142	[p11l1245t1151r1483b1213],
25	(	VBP	O	(	_	0	SENT_142	[p11l1516t1132r1692b1209],
26	data	NNS	O	datum	dobj	25	SENT_142	[p11l1516t1132r1692b1209],
27	not	RB	O	not	neg	28	SENT_142	[p11l1719t1141r1832b1194],
28	shown	VBN	O	show	rcmod	26	SENT_142	[p11l1862t1132r2137b1209],
29	)	NN	O	)	dobj	28	SENT_142	[p11l1862t1132r2137b1209],
30	.	.	O	.	_	0	SENT_142	[p11l1862t1132r2137b1209],

1	It	PRP	O	it	nsubj	4	SENT_143	[p11l8t1244r62b1305],
2	was	VBD	O	be	cop	4	SENT_143	[p11l91t1262r225b1306],
3	somewhat	RB	O	somewhat	advmod	4	SENT_143	[p11l259t1243r618b1306],
4	unexpected	JJ	O	unexpected	_	0	SENT_143	[p11l647t1243r1055b1324],
5	that	IN	O	that	complm	7	SENT_143	[p11l1084t1243r1217b1305],
6	there	EX	O	there	expl	7	SENT_143	[p11l1246t1243r1422b1305],
7	were	VBD	O	be	ccomp	4	SENT_143	[p11l1453t1262r1624b1306],
8	no	DT	O	no	det	10	SENT_143	[p11l1654t1262r1740b1305],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_143	[p11l1774t1243r2144b1324],
10	differences	NNS	O	difference	nsubj	7	SENT_143	[p11l9t1354r403b1416],
11	in	IN	O	in	_	0	SENT_143	[p11l447t1354r515b1416],
12	any	DT	O	any	det	14	SENT_143	[p11l559t1373r683b1435],
13	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_143	[p11l725t1354r1322b1435],
14	parameters	NNS	O	parameter	prep_in	10	SENT_143	[p11l1365t1363r1757b1435],
15	of	IN	O	of	_	0	SENT_143	[p11l1802t1354r1879b1416],
16	pravastatin	NN	O	pravastatin	prep_of	14	SENT_143	[p11l1914t1373r2139b1435, p11l11t1465r201b1528],
17	among	IN	O	among	_	0	SENT_143	[p11l276t1485r515b1546],
18	SLCOIBI	NNP	O	SLCOIBI	nn	19	SENT_143	[p11l590t1466r943b1528],
19	genotypes	NNS	O	genotype	prep_among	7	SENT_143	[p11l1024t1475r1404b1546],
20	,	,	O	,	_	0	SENT_143	[p11l1024t1475r1404b1546],
21	because	IN	O	because	mark	24	SENT_143	[p11l1479t1465r1762b1528],
22	previous	JJ	O	previous	amod	23	SENT_143	[p11l1835t1465r2140b1546],
23	studies	NNS	O	study	nsubj	24	SENT_143	[p11l11t1576r253b1639],
24	provided	VBD	O	provide	advcl	7	SENT_143	[p11l290t1576r609b1657],
25	accordant	JJ	O	accordant	amod	26	SENT_143	[p11l647t1576r993b1639],
26	evidence	NN	O	evidence	dobj	24	SENT_143	[p11l1030t1576r1346b1639],
27	that	IN	O	that	complm	32	SENT_143	[p11l1384t1576r1517b1639],
28	SLCOIB1	NN	O	slcoib1	nsubjpass	32	SENT_143	[p11l1553t1577r2049b1639],
29	*	CD	NUMBER	*	num	30	SENT_143	[p11l1553t1577r2049b1639],
30	15	CD	NUMBER	15	dep	28	SENT_143	[p11l1553t1577r2049b1639],
31	is	VBZ	O	be	auxpass	32	SENT_143	[p11l2085t1576r2140b1639],
32	associated	VBN	O	associate	ccomp	24	SENT_143	[p11l10t1687r376b1750],
33	with	IN	O	with	_	0	SENT_143	[p11l438t1687r595b1750],
34	remarkably	RB	O	remarkably	advmod	35	SENT_143	[p11l656t1687r1063b1768],
35	elevated	JJ	O	elevated	amod	37	SENT_143	[p11l1127t1687r1424b1750],
36	plasma	NN	O	plasma	nn	37	SENT_143	[p11l1485t1687r1739b1768],
37	levels	NNS	O	level	prep_with	32	SENT_143	[p11l1801t1687r2006b1750],
38	of	IN	O	of	_	0	SENT_143	[p11l2071t1687r2148b1750],
39	pravastatin	NN	O	pravastatin	nn	41	SENT_143	[p11l7t1797r400b1878],
40	(	CD	NUMBER	(	num	41	SENT_143	[p11l456t1797r704b1874],
41	Niemi	NNP	PERSON	Niemi	prep_of	37	SENT_143	[p11l456t1797r704b1874],
42	et	FW	O	et	nn	43	SENT_143	[p11l759t1806r822b1859],
43	al.	FW	O	al.	dep	41	SENT_143	[p11l875t1797r954b1859],
44	2004	CD	DATE	2004	dep	43	SENT_143	[p11l1013t1797r1209b1871],
45	;	:	O	;	_	0	SENT_143	[p11l1013t1797r1209b1871],
46	Nishizato	NNP	O	Nishizato	dep	43	SENT_143	[p11l1266t1797r1606b1859],
47	et	FW	O	et	nn	48	SENT_143	[p11l1661t1806r1724b1859],
48	al.	FW	O	al.	dep	46	SENT_143	[p11l1777t1797r1856b1859],
49	2003	CD	DATE	2003	num	50	SENT_143	[p11l1915t1797r2138b1874],
50	)	CD	NUMBER	)	dep	46	SENT_143	[p11l1915t1797r2138b1874],
51	.	.	O	.	_	0	SENT_143	[p11l1915t1797r2138b1874],

1	Because	IN	O	because	_	0	SENT_144	[p11l8t1911r304b1972],
2	of	IN	O	of	prepc_because_of	10	SENT_144	[p11l349t1909r426b1972],
3	the	DT	O	the	det	4	SENT_144	[p11l462t1909r569b1972],
4	instability	NN	O	instability	pobj	10	SENT_144	[p11l613t1909r970b1990],
5	in	IN	O	in	_	0	SENT_144	[p11l1013t1909r1080b1971],
6	acid	NN	O	acid	nn	7	SENT_144	[p11l1125t1909r1271b1972],
7	conditions	NNS	O	condition	prep_in	4	SENT_144	[p11l1314t1909r1703b1983],
8	,	,	O	,	_	0	SENT_144	[p11l1314t1909r1703b1983],
9	pravastatin	NN	O	pravastatin	nsubj	10	SENT_144	[p11l1749t1909r2142b1990],
10	underwent	VBD	O	undergo	_	0	SENT_144	[p11l8t2020r385b2083],
11	acid	NN	O	acid	nn	12	SENT_144	[p11l438t2020r955b2101],
12	—	NN	O	—	nsubj	13	SENT_144	[p11l438t2020r955b2101],
13	catalyzed	VBD	O	catalyze	ccomp	10	SENT_144	[p11l438t2020r955b2101],
14	conversion	NN	O	conversion	dobj	13	SENT_144	[p11l1007t2020r1397b2083],
15	to	TO	O	to	aux	16	SENT_144	[p11l1449t2030r1516b2083],
16	form	VB	O	form	xcomp	13	SENT_144	[p11l1569t2020r1741b2083],
17	RMS	NNP	O	RMS	nn	18	SENT_144	[p11l1792t2020r2140b2083],
18	—	NN	O	—	dobj	16	SENT_144	[p11l1792t2020r2140b2083],
19	416	CD	NUMBER	416	advmod	16	SENT_144	[p11l1792t2020r2140b2083],
20	(	NN	O	(	nn	23	SENT_144	[p11l11t2124r702b2211],
21	3	CD	NUMBER	3	num	23	SENT_144	[p11l11t2124r702b2211],
22	’	NN	O	’	nn	23	SENT_144	[p11l11t2124r702b2211],
23	oc	NN	O	oc	tmod	13	SENT_144	[p11l11t2124r702b2211],
24	—	NN	O	—	nn	26	SENT_144	[p11l11t2124r702b2211],
25	isopravastatin	NN	O	isopravastatin	nn	26	SENT_144	[p11l11t2124r702b2211],
26	)	NN	O	)	nsubj	43	SENT_144	[p11l11t2124r702b2211],
27	in	IN	O	in	_	0	SENT_144	[p11l749t2130r816b2192],
28	the	DT	O	the	det	29	SENT_144	[p11l859t2130r965b2192],
29	stomach	NN	O	stomach	prep_in	26	SENT_144	[p11l1012t2130r1307b2192],
30	after	IN	O	after	_	0	SENT_144	[p11l1351t2130r1513b2192],
31	oral	JJ	O	oral	amod	32	SENT_144	[p11l1556t2130r1691b2192],
32	administration	NN	O	administration	prep_after	29	SENT_144	[p11l1737t2130r2139b2192, p11l8t2242r164b2315],
33	,	,	O	,	_	0	SENT_144	[p11l1737t2130r2139b2192, p11l8t2242r164b2315],
34	and	CC	O	and	_	0	SENT_144	[p11l246t2242r371b2304],
35	a	DT	O	a	det	37	SENT_144	[p11l449t2261r486b2304],
36	considerable	JJ	O	considerable	amod	37	SENT_144	[p11l561t2242r1012b2304],
37	amount	NN	O	amount	conj_and	29	SENT_144	[p11l1091t2251r1356b2304],
38	of	IN	O	of	_	0	SENT_144	[p11l1433t2242r1509b2304],
39	RMS	NNP	O	RMS	prep_of	37	SENT_144	[p11l1580t2242r1928b2304],
40	—	NN	O	—	dep	37	SENT_144	[p11l1580t2242r1928b2304],
41	416	CD	NUMBER	416	num	40	SENT_144	[p11l1580t2242r1928b2304],
42	was	VBD	O	be	cop	43	SENT_144	[p11l2006t2261r2140b2304],
43	detectable	JJ	O	detectable	rcmod	23	SENT_144	[p11l9t2353r370b2415],
44	in	IN	O	in	prep	43	SENT_144	[p11l400t2353r467b2415],
45	plasma	NN	O	plasma	dep	52	SENT_144	[p11l493t2353r766b2434],
46	,	,	O	,	_	0	SENT_144	[p11l493t2353r766b2434],
47	urine	NN	O	urine	dep	52	SENT_144	[p11l796t2353r998b2427],
48	,	,	O	,	_	0	SENT_144	[p11l796t2353r998b2427],
49	and	CC	O	and	_	0	SENT_144	[p11l1031t2353r1157b2415],
50	feces	NNS	O	fece	dep	52	SENT_144	[p11l1185t2353r1364b2415],
51	(	CD	NUMBER	(	dep	52	SENT_144	[p11l1397t2354r1684b2430],
52	Everett	NNP	PERSON	Everett	dep	56	SENT_144	[p11l1397t2354r1684b2430],
53	et	FW	O	et	nn	54	SENT_144	[p11l1711t2362r1773b2415],
54	al.	FW	O	al.	dep	52	SENT_144	[p11l1802t2353r1881b2415],
55	1991	CD	DATE	1991	num	56	SENT_144	[p11l1922t2353r2138b2430],
56	)	CD	NUMBER	)	dep	44	SENT_144	[p11l1922t2353r2138b2430],
57	.	.	O	.	_	0	SENT_144	[p11l1922t2353r2138b2430],

1	In	IN	O	in	_	0	SENT_145	[p11l8t2466r80b2526],
2	this	DT	O	this	det	3	SENT_145	[p11l119t2464r244b2527],
3	study	NN	O	study	prep_in	6	SENT_145	[p11l287t2464r495b2545],
4	,	,	O	,	_	0	SENT_145	[p11l287t2464r495b2545],
5	we	PRP	O	we	nsubj	6	SENT_145	[p11l537t2484r637b2527],
6	interpreted	VBD	O	interpret	_	0	SENT_145	[p11l676t2464r1064b2545],
7	data	NNS	O	datum	dobj	6	SENT_145	[p11l1103t2464r1251b2527],
8	in	IN	O	in	_	0	SENT_145	[p11l1288t2464r1356b2526],
9	terms	NNS	O	term	prep_in	6	SENT_145	[p11l1394t2474r1588b2527],
10	of	IN	O	of	_	0	SENT_145	[p11l1630t2464r1707b2527],
11	the	DT	O	the	det	12	SENT_145	[p11l1739t2464r1846b2527],
12	sum	NN	O	sum	prep_of	9	SENT_145	[p11l1888t2484r2033b2527],
13	of	IN	O	of	_	0	SENT_145	[p11l2071t2464r2148b2527],
14	pravastatin	NN	O	pravastatin	nn	17	SENT_145	[p11l7t2575r400b2656],
15	and	CC	O	and	_	0	SENT_145	[p11l428t2575r554b2638],
16	RMS	NNP	O	RMS	conj_and	14	SENT_145	[p11l580t2575r947b2638],
17	—	NN	O	—	prep_of	12	SENT_145	[p11l580t2575r947b2638],
18	416	CD	NUMBER	416	advmod	6	SENT_145	[p11l580t2575r947b2638],
19	.	.	O	.	_	0	SENT_145	[p11l580t2575r947b2638],

1	This	DT	O	this	det	2	SENT_146	[p11l978t2575r1133b2638],
2	method	NN	O	method	nsubjpass	30	SENT_146	[p11l1161t2575r1429b2638],
3	has	VBZ	O	have	aux	5	SENT_146	[p11l1454t2575r1570b2638],
4	been	VBN	O	be	auxpass	5	SENT_146	[p11l1597t2575r1765b2638],
5	suggested	VBN	O	suggest	_	0	SENT_146	[p11l1794t2575r2143b2656],
6	previously	RB	DATE	previously	advmod	5	SENT_146	[p11l7t2686r384b2767],
7	in	IN	O	in	_	0	SENT_146	[p11l417t2686r485b2748],
8	a	DT	O	a	det	9	SENT_146	[p11l519t2706r556b2749],
9	study	NN	O	study	prep_in	5	SENT_146	[p11l590t2686r778b2767],
10	by	IN	O	by	_	0	SENT_146	[p11l810t2686r897b2767],
11	Maeda	NNP	PERSON	Maeda	dep	14	SENT_146	[p11l930t2686r1174b2749],
12	et	FW	O	et	nn	14	SENT_146	[p11l1205t2695r1269b2749],
13	al.	FW	O	al.	nn	14	SENT_146	[p11l1302t2686r1381b2749],
14	(	FW	O	(	agent	5	SENT_146	[p11l1421t2686r1651b2763],
15	2006	CD	DATE	2006	num	16	SENT_146	[p11l1421t2686r1651b2763],
16	)	NN	O	)	xcomp	5	SENT_146	[p11l1421t2686r1651b2763],
17	who	WP	O	who	nsubj	18	SENT_146	[p11l1687t2686r1837b2749],
18	demonstrated	VBD	O	demonstrate	rcmod	16	SENT_146	[p11l1872t2686r2139b2749, p11l11t2797r245b2859],
19	that	IN	O	that	complm	26	SENT_146	[p11l277t2797r410b2859],
20	RMS	NNP	O	RMS	nsubj	26	SENT_146	[p11l441t2797r790b2860],
21	—	CD	NUMBER	—	num	22	SENT_146	[p11l441t2797r790b2860],
22	4l6	NN	O	4l6	dep	20	SENT_146	[p11l441t2797r790b2860],
23	is	VBZ	O	be	cop	26	SENT_146	[p11l822t2797r877b2859],
24	also	RB	O	also	advmod	26	SENT_146	[p11l912t2797r1051b2859],
25	a	DT	O	a	det	26	SENT_146	[p11l1086t2816r1123b2859],
26	substrate	NN	O	substrate	ccomp	18	SENT_146	[p11l1156t2797r1469b2859],
27	of	IN	O	of	_	0	SENT_146	[p11l1501t2797r1579b2859],
28	OATPlBl	NN	O	oatplbl	prep_of	26	SENT_146	[p11l1606t2797r1976b2860],
29	and	CC	O	and	_	0	SENT_146	[p11l2017t2797r2142b2859],
30	assumed	VBD	O	assume	conj_and	5	SENT_146	[p11l10t2909r314b2972],
31	that	IN	O	that	complm	35	SENT_146	[p11l362t2909r496b2972],
32	SLCOIBI	NNP	O	SLCOIBI	nn	33	SENT_146	[p11l543t2910r896b2973],
33	variants	NNS	O	variant	nsubj	35	SENT_146	[p11l951t2909r1230b2972],
34	would	MD	O	would	aux	35	SENT_146	[p11l1281t2909r1502b2972],
35	affect	VB	O	affect	ccomp	30	SENT_146	[p11l1551t2909r1753b2972],
36	the	DT	O	the	det	37	SENT_146	[p11l1800t2909r1907b2972],
37	pharmacokinetics	NNS	O	pharmacokinetic	dobj	35	SENT_146	[p11l1955t2909r2139b2990, p11l8t3020r478b3083],
38	of	IN	O	of	_	0	SENT_146	[p11l509t3020r585b3083],
39	the	DT	O	the	det	40	SENT_146	[p11l605t3020r712b3083],
40	sum	NN	O	sum	prep_of	37	SENT_146	[p11l743t3040r887b3083],
41	of	IN	O	of	_	0	SENT_146	[p11l914t3020r991b3083],
42	pravastatin	NN	O	pravastatin	nn	45	SENT_146	[p11l1010t3020r1404b3101],
43	and	CC	O	and	_	0	SENT_146	[p11l1432t3020r1558b3083],
44	RMS	NNP	O	RMS	nn	45	SENT_146	[p11l1584t3020r1932b3083],
45	—	NN	O	—	prep_of	40	SENT_146	[p11l1584t3020r1932b3083],
46	416	CD	NUMBER	416	npadvmod	47	SENT_146	[p11l1584t3020r1932b3083],
47	more	JJR	O	more	advmod	35	SENT_146	[p11l1960t3040r2141b3083],
48	markedly	RB	O	markedly	advmod	47	SENT_146	[p11l8t3131r345b3212],
49	than	IN	O	than	_	0	SENT_146	[p11l423t3131r575b3193],
50	that	DT	O	that	prep_than	35	SENT_146	[p11l653t3131r787b3193],
51	of	IN	O	of	_	0	SENT_146	[p11l864t3131r942b3193],
52	pravastatin	NN	O	pravastatin	prep_of	50	SENT_146	[p11l1012t3131r1405b3212],
53	itself	PRP	O	itself	dobj	5	SENT_146	[p11l1482t3131r1677b3193],
54	.	.	O	.	_	0	SENT_146	[p11l1482t3131r1677b3193],

1	With	IN	O	with	_	0	SENT_147	[p11l1759t3131r1938b3194],
2	this	DT	O	this	det	3	SENT_147	[p11l2015t3131r2140b3193],
3	assumption	NN	O	assumption	prep_with	7	SENT_147	[p11l10t3242r434b3323],
4	,	,	O	,	_	0	SENT_147	[p11l10t3242r434b3323],
5	they	PRP	O	they	nsubj	7	SENT_147	[p11l461t3242r612b3323],
6	could	MD	O	could	aux	7	SENT_147	[p11l639t3242r835b3304],
7	observe	VB	O	observe	_	0	SENT_147	[p11l861t3242r1134b3305],
8	an	DT	O	a	det	10	SENT_147	[p11l1162t3261r1242b3304],
9	increasing	VBG	O	increase	amod	10	SENT_147	[p11l1267t3242r1633b3323],
10	trend	NN	O	trend	dobj	7	SENT_147	[p11l1658t3242r1841b3304],
11	in	IN	O	in	_	0	SENT_147	[p11l1864t3242r1932b3304],
12	AUC	NN	O	auc	prep_in	7	SENT_147	[p11l1957t3242r2140b3305],
13	of	IN	O	of	_	0	SENT_147	[p11l9t3353r86b3415],
14	the	DT	O	the	det	15	SENT_147	[p11l105t3353r212b3415],
15	sum	NN	O	sum	prep_of	12	SENT_147	[p11l240t3372r385b3415],
16	of	IN	O	of	_	0	SENT_147	[p11l410t3353r487b3415],
17	pravastatin	NN	O	pravastatin	prep_of	15	SENT_147	[p11l505t3353r898b3434],
18	and	CC	O	and	_	0	SENT_147	[p11l924t3353r1050b3415],
19	RMS	NNP	O	RMS	nn	20	SENT_147	[p11l1075t3353r1423b3416],
20	—	NN	O	—	prep_of	12	SENT_147	[p11l1075t3353r1423b3416],
21	416	CD	NUMBER	416	num	20	SENT_147	[p11l1075t3353r1423b3416],
22	in	IN	O	in	_	0	SENT_147	[p11l1450t3353r1517b3415],
23	subjects	NNS	O	subject	prep_in	20	SENT_147	[p11l1545t3353r1826b3434],
24	with	IN	O	with	_	0	SENT_147	[p11l1853t3353r2010b3416],
25	the	DT	O	the	det	28	SENT_147	[p11l2035t3353r2141b3415],
26	*	CD	NUMBER	*	num	28	SENT_147	[p11l13t3464r136b3527],
27	l5	NN	O	l5	nn	28	SENT_147	[p11l13t3464r136b3527],
28	allele	NN	O	allele	prep_with	23	SENT_147	[p11l168t3464r358b3527],
29	as	IN	O	as	_	0	SENT_147	[p11l388t3484r456b3527],
30	compared	VBN	O	compare	prepc_as	7	SENT_147	[p11l485t3464r837b3545],
31	with	IN	O	with	pcomp	30	SENT_147	[p11l863t3464r1020b3527],
32	subjects	NNS	O	subject	dep	39	SENT_147	[p11l1049t3464r1331b3545],
33	without	IN	O	without	_	0	SENT_147	[p11l1359t3464r1632b3527],
34	the	DT	O	the	det	36	SENT_147	[p11l1657t3464r1763b3527],
35	*	CD	NUMBER	*	num	36	SENT_147	[p11l1795t3464r1918b3527],
36	l5	NN	O	l5	prep_without	32	SENT_147	[p11l1795t3464r1918b3527],
37	allele	NN	O	allele	dep	39	SENT_147	[p11l1951t3464r2141b3527],
38	(	CD	NUMBER	(	num	37	SENT_147	[p11l11t3575r281b3652],
39	Maeda	NNP	PERSON	Maeda	dep	43	SENT_147	[p11l11t3575r281b3652],
40	et	FW	O	et	nn	41	SENT_147	[p11l315t3585r378b3638],
41	al.	FW	O	al.	dep	39	SENT_147	[p11l413t3575r492b3638],
42	2006	CD	DATE	2006	num	43	SENT_147	[p11l532t3575r755b3652],
43	)	CD	NUMBER	)	dep	31	SENT_147	[p11l532t3575r755b3652],
44	.	.	O	.	_	0	SENT_147	[p11l532t3575r755b3652],

1	Our	PRP$	O	we	poss	3	SENT_148	[p11l795t3576r932b3638],
2	present	JJ	DATE	present	amod	3	SENT_148	[p11l963t3585r1222b3656],
3	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_148	[p11l1256t3575r1539b3656],
4	are	VBP	O	be	_	0	SENT_148	[p11l1577t3595r1682b3638],
5	in	IN	O	in	_	0	SENT_148	[p11l1717t3575r1785b3637],
6	line	NN	O	line	prep_in	4	SENT_148	[p11l1818t3575r1950b3638],
7	with	IN	O	with	_	0	SENT_148	[p11l1986t3575r2142b3638],
8	their	PRP$	O	they	poss	9	SENT_148	[p11l8t3686r172b3749],
9	results	NNS	O	result	prep_with	6	SENT_148	[p11l206t3686r436b3749],
10	that	IN	O	that	dep	13	SENT_148	[p11l474t3686r608b3749],
11	the	DT	O	the	det	13	SENT_148	[p11l642t3686r749b3749],
12	mean	NN	O	mean	nn	13	SENT_148	[p11l786t3706r978b3749],
13	AUC0_24	NN	O	auc0_24	dep	6	SENT_148	[p11l1014t3686r1334b3763],
14	values	NNS	O	value	dep	4	SENT_148	[p11l1370t3686r1595b3749],
15	in	IN	O	in	_	0	SENT_148	[p11l1633t3686r1701b3748],
16	single	JJ	O	single	amod	18	SENT_148	[p11l1739t3686r2141b3767],
17	—	NN	O	—	nn	18	SENT_148	[p11l1739t3686r2141b3767],
18	dose	NN	O	dose	prep_in	14	SENT_148	[p11l1739t3686r2141b3767],
19	and	CC	O	and	_	0	SENT_148	[p12l10t22r136b84],
20	co	NN	O	co	nn	23	SENT_148	[p12l180t22r811b84],
21	—	NN	O	—	nn	23	SENT_148	[p12l180t22r811b84],
22	administration	NN	O	administration	nn	23	SENT_148	[p12l180t22r811b84],
23	phases	NNS	O	phase	conj_and	18	SENT_148	[p12l854t22r1090b103],
24	of	IN	O	of	_	0	SENT_148	[p12l1138t22r1214b84],
25	*	CD	NUMBER	*	num	26	SENT_148	[p12l1257t21r1540b85],
26	15	CD	NUMBER	15	prep_of	14	SENT_148	[p12l1257t21r1540b85],
27	/	:	O	/	punct	30	SENT_148	[p12l1257t21r1540b85],
28	*	CD	NUMBER	*	number	29	SENT_148	[p12l1257t21r1540b85],
29	15	CD	NUMBER	15	num	30	SENT_148	[p12l1257t21r1540b85],
30	group	NN	O	group	dep	14	SENT_148	[p12l1589t41r1793b103],
31	were	VBD	O	be	cop	36	SENT_148	[p12l1840t41r2010b84],
32	96	CD	NUMBER	96	num	35	SENT_148	[p12l2057t21r2141b85],
33	and	CC	O	and	_	0	SENT_148	[p12l10t133r136b195],
34	98	CD	PERCENT	98	num	35	SENT_148	[p12l172t133r328b196],
35	%	NN	PERCENT	%	npadvmod	36	SENT_148	[p12l172t133r328b196],
36	higher	JJR	O	higher	rcmod	30	SENT_148	[p12l368t133r597b214],
37	than	IN	O	than	_	0	SENT_148	[p12l631t133r784b195],
38	those	DT	O	those	prep_than	36	SENT_148	[p12l820t133r1005b195],
39	of	IN	O	of	_	0	SENT_148	[p12l1044t133r1120b195],
40	the	DT	O	the	det	42	SENT_148	[p12l1150t133r1257b195],
41	*	CD	NUMBER	*	num	42	SENT_148	[p12l1299t133r1583b196],
42	1b	NN	O	1b	prep_of	30	SENT_148	[p12l1299t133r1583b196],
43	/	:	O	/	punct	30	SENT_148	[p12l1299t133r1583b196],
44	*	CD	NUMBER	*	num	46	SENT_148	[p12l1299t133r1583b196],
45	1b	NN	O	1b	nn	46	SENT_148	[p12l1299t133r1583b196],
46	group	NN	O	group	dep	14	SENT_148	[p12l1622t152r1846b214],
47	,	,	O	,	_	0	SENT_148	[p12l1622t152r1846b214],
48	respectively	RB	O	respectively	advmod	4	SENT_148	[p12l1885t152r2139b214, p12l8t245r230b326],
49	,	,	O	,	_	0	SENT_148	[p12l1885t152r2139b214, p12l8t245r230b326],
50	when	WRB	O	when	advmod	51	SENT_148	[p12l268t245r460b308],
51	compared	VBN	O	compare	advcl	4	SENT_148	[p12l495t245r846b326],
52	in	IN	O	in	_	0	SENT_148	[p12l880t245r948b307],
53	terms	NNS	O	term	prep_in	51	SENT_148	[p12l982t255r1178b308],
54	of	IN	O	of	_	0	SENT_148	[p12l1215t245r1292b308],
55	the	DT	O	the	det	56	SENT_148	[p12l1320t245r1427b308],
56	sum	NN	O	sum	prep_of	53	SENT_148	[p12l1465t265r1609b308],
57	of	IN	O	of	_	0	SENT_148	[p12l1645t245r1722b308],
58	pravastatin	NN	O	pravastatin	prep_of	56	SENT_148	[p12l1749t245r2142b326],
59	and	CC	O	and	_	0	SENT_148	[p12l10t355r136b417],
60	RMS-416	NN	O	rms-416	prep_of	56	SENT_148	[p12l168t355r536b417],
61	.	.	O	.	_	0	SENT_148	[p12l168t355r536b417],

1	As	IN	O	as	mark	2	SENT_149	[p12l110t466r204b528],
2	shown	VBN	O	show	advcl	12	SENT_149	[p12l244t466r472b529],
3	in	IN	O	in	_	0	SENT_149	[p12l507t466r574b528],
4	Table	NNP	O	Table	prep_in	2	SENT_149	[p12l610t466r811b528],
5	2	CD	NUMBER	2	num	4	SENT_149	[p12l846t466r905b540],
6	,	,	O	,	_	0	SENT_149	[p12l846t466r905b540],
7	no	DT	O	no	det	10	SENT_149	[p12l944t485r1030b528],
8	statistically	RB	O	statistically	advmod	9	SENT_149	[p12l1069t466r1473b547],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_149	[p12l1512t466r1882b547],
10	differences	NNS	O	difference	nsubjpass	12	SENT_149	[p12l1916t466r2139b528, p12l9t597r203b640],
11	were	VBD	O	be	auxpass	12	SENT_149	[p12l249t597r420b640],
12	observed	VBN	O	observe	_	0	SENT_149	[p12l465t578r786b641],
13	in	IN	O	in	_	0	SENT_149	[p12l828t578r896b640],
14	any	DT	O	any	det	16	SENT_149	[p12l941t597r1065b659],
15	pharmacokinetic	JJ	O	pharmacokinetic	amod	16	SENT_149	[p12l1108t578r1704b659],
16	parameters	NNS	O	parameter	prep_in	12	SENT_149	[p12l1749t587r2140b659],
17	between	IN	O	between	_	0	SENT_149	[p12l7t689r305b752],
18	single	JJ	O	single	amod	20	SENT_149	[p12l338t689r739b770],
19	—	NN	O	—	nn	20	SENT_149	[p12l338t689r739b770],
20	dose	NN	O	dose	prep_between	16	SENT_149	[p12l338t689r739b770],
21	and	CC	O	and	_	0	SENT_149	[p12l772t689r898b752],
22	co	NN	O	co	nn	25	SENT_149	[p12l928t689r1558b752],
23	—	NN	O	—	nn	25	SENT_149	[p12l928t689r1558b752],
24	administration	NN	O	administration	nn	25	SENT_149	[p12l928t689r1558b752],
25	phases	NNS	O	phase	conj_and	20	SENT_149	[p12l1587t689r1822b770],
26	for	IN	O	for	_	0	SENT_149	[p12l1854t689r1957b752],
27	both	DT	O	both	det	28	SENT_149	[p12l1984t689r2142b752],
28	pravastatin	NN	O	pravastatin	prep_for	12	SENT_149	[p12l7t800r400b881],
29	and	CC	O	and	_	0	SENT_149	[p12l466t800r592b863],
30	RMS	NNP	O	RMS	nn	31	SENT_149	[p12l655t800r1023b863],
31	—	NN	O	—	prep_for	12	SENT_149	[p12l655t800r1023b863],
32	416	CD	NUMBER	416	num	31	SENT_149	[p12l655t800r1023b863],
33	.	.	O	.	_	0	SENT_149	[p12l655t800r1023b863],

1	Our	PRP$	O	we	poss	2	SENT_150	[p12l1093t801r1229b863],
2	results	NNS	O	result	nsubj	3	SENT_150	[p12l1291t800r1522b863],
3	show	VBP	O	show	_	0	SENT_150	[p12l1591t800r1773b863],
4	that	IN	O	that	complm	13	SENT_150	[p12l1838t800r1972b863],
5	the	DT	O	the	det	8	SENT_150	[p12l2035t800r2141b863],
6	co	NN	O	co	nn	8	SENT_150	[p12l9t911r640b974],
7	—	NN	O	—	nn	8	SENT_150	[p12l9t911r640b974],
8	administration	NN	O	administration	nsubj	13	SENT_150	[p12l9t911r640b974],
9	of	IN	O	of	_	0	SENT_150	[p12l679t911r756b974],
10	olmesartan	NN	O	olmesartan	prep_of	8	SENT_150	[p12l790t911r1181b974],
11	does	VBZ	O	do	aux	13	SENT_150	[p12l1220t911r1379b974],
12	not	RB	O	not	neg	13	SENT_150	[p12l1418t921r1532b974],
13	affect	VB	O	affect	ccomp	3	SENT_150	[p12l1571t911r1772b974],
14	the	DT	O	the	det	15	SENT_150	[p12l1809t911r1916b974],
15	pharmacokinetics	NNS	O	pharmacokinetic	dobj	13	SENT_150	[p12l1955t911r2139b992, p12l8t1021r478b1083],
16	of	IN	O	of	_	0	SENT_150	[p12l514t1020r591b1083],
17	pravastatin	NN	O	pravastatin	prep_of	15	SENT_150	[p12l616t1021r1009b1102],
18	or	CC	O	or	_	0	SENT_150	[p12l1043t1040r1116b1083],
19	its	PRP$	O	its	poss	20	SENT_150	[p12l1146t1021r1227b1083],
20	metabolite	NN	O	metabolite	dobj	13	SENT_150	[p12l1261t1021r1658b1095],
21	,	,	O	,	_	0	SENT_150	[p12l1261t1021r1658b1095],
22	RMS	NNP	O	RMS	appos	20	SENT_150	[p12l1693t1020r2062b1084],
23	—	CD	NUMBER	—	num	22	SENT_150	[p12l1693t1020r2062b1084],
24	416	CD	NUMBER	416	advmod	13	SENT_150	[p12l1693t1020r2062b1084],
25	.	.	O	.	_	0	SENT_150	[p12l1693t1020r2062b1084],

1	J	NNP	O	J	nn	3	SENT_151	[p12l52t1178r65b1203],
2	Hum	NNP	PERSON	Hum	nn	3	SENT_151	[p12l78t1178r148b1202],
3	Genet	NNP	PERSON	Genet	_	0	SENT_151	[p12l161t1177r244b1203],
4	(	CD	NUMBER	(	num	3	SENT_151	[p12l258t1177r349b1208],
5	2008	CD	DATE	2008	num	6	SENT_151	[p12l258t1177r349b1208],
6	)	CD	NUMBER	)	dep	3	SENT_151	[p12l258t1177r349b1208],
7	532899-904	CD	NUMBER	532899-904	num	8	SENT_151	[p12l363t1177r530b1203],
8	903	CD	NUMBER	903	dep	3	SENT_151	[p12l2056t1177r2105b1203],

1	Table	NNP	O	Table	dep	23	SENT_152	[p12l53t1289r138b1315],
2	2	CD	NUMBER	2	num	4	SENT_152	[p12l150t1289r167b1314],
3	Pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_152	[p12l189t1289r426b1314],
4	parameters	NNS	O	parameter	dep	1	SENT_152	[p12l439t1293r593b1322],
5	of	IN	O	of	_	0	SENT_152	[p12l607t1289r638b1314],
6	pravastatin	NN	O	pravastatin	prep_of	4	SENT_152	[p12l647t1289r802b1322],
7	and	CC	O	and	_	0	SENT_152	[p12l816t1289r866b1314],
8	RMS-416	NN	O	rms-416	prep_of	4	SENT_152	[p12l878t1289r1016b1315],
9	in	IN	O	in	_	0	SENT_152	[p12l1029t1289r1056b1314],
10	each	DT	O	each	det	14	SENT_152	[p12l1069t1289r1133b1314],
11	SLCOI	NNP	O	SLCOI	nn	14	SENT_152	[p12l1145t1290r1245b1315],
12	B1	NN	O	b1	nn	14	SENT_152	[p12l1248t1290r1284b1314],
13	genotype	NN	O	genotype	nn	14	SENT_152	[p12l1300t1293r1428b1322],
14	group	NN	O	group	prep_in	4	SENT_152	[p12l1442t1297r1522b1322],
15	in	IN	O	in	_	0	SENT_152	[p12l1536t1289r1562b1314],
16	two	CD	NUMBER	two	num	18	SENT_152	[p12l1575t1293r1626b1314],
17	administration	NN	O	administration	nn	18	SENT_152	[p12l1640t1289r1843b1314],
18	conditions	NNS	O	condition	prep_in	14	SENT_152	[p12l1857t1289r2002b1314],
19	Parameter	NNP	O	Parameter	nn	20	SENT_152	[p12l52t1361r196b1386],
20	Sing1e	NNP	O	Sing1e	dep	23	SENT_152	[p12l485t1360r650b1393],
21	—	CD	NUMBER	—	num	23	SENT_152	[p12l485t1360r650b1393],
22	dose	NN	O	dose	nn	23	SENT_152	[p12l485t1360r650b1393],
23	phase	NN	O	phase	dep	28	SENT_152	[p12l662t1358r755b1393],
24	“	CD	NUMBER	“	num	25	SENT_152	[p12l662t1358r755b1393],
25	Co	NNP	O	Co	dep	23	SENT_152	[p12l1333t1361r1589b1386],
26	—	CD	NUMBER	—	num	25	SENT_152	[p12l1333t1361r1589b1386],
27	administration	NN	O	administration	nn	28	SENT_152	[p12l1333t1361r1589b1386],
28	phaseb	NN	O	phaseb	_	0	SENT_152	[p12l1602t1353r1695b1393],

1	*	RB	O	*	dep	2	SENT_153	[p12l486t1434r597b1459],
2	15	CD	NUMBER	15	_	0	SENT_153	[p12l486t1434r597b1459],
3	/	:	O	/	punct	2	SENT_153	[p12l486t1434r597b1459],
4	*	CD	NUMBER	*	num	6	SENT_153	[p12l486t1434r597b1459],
5	15	CD	NUMBER	15	num	6	SENT_153	[p12l486t1434r597b1459],
6	group	NN	O	group	dep	2	SENT_153	[p12l612t1442r693b1466],
7	*	CD	NUMBER	*	num	8	SENT_153	[p12l769t1434r880b1459],
8	lb	NN	O	lb	dep	6	SENT_153	[p12l769t1434r880b1459],
9	/	:	O	/	punct	6	SENT_153	[p12l769t1434r880b1459],
10	*	CD	NUMBER	*	num	12	SENT_153	[p12l769t1434r880b1459],
11	l5	NN	O	l5	nn	12	SENT_153	[p12l769t1434r880b1459],
12	group	NN	O	group	dep	6	SENT_153	[p12l895t1442r976b1466],
13	*	CD	NUMBER	*	num	14	SENT_153	[p12l1052t1434r1164b1459],
14	lb	NN	O	lb	dep	12	SENT_153	[p12l1052t1434r1164b1459],
15	/	:	O	/	punct	18	SENT_153	[p12l1052t1434r1164b1459],
16	*	CD	NUMBER	*	num	18	SENT_153	[p12l1052t1434r1164b1459],
17	1b	NN	O	1b	nn	18	SENT_153	[p12l1052t1434r1164b1459],
18	group	NN	O	group	dep	14	SENT_153	[p12l1178t1442r1258b1466],
19	*	CD	NUMBER	*	number	20	SENT_153	[p12l1334t1434r1446b1459],
20	15	CD	NUMBER	15	num	14	SENT_153	[p12l1334t1434r1446b1459],
21	/	:	O	/	punct	6	SENT_153	[p12l1334t1434r1446b1459],
22	*	CD	NUMBER	*	num	24	SENT_153	[p12l1334t1434r1446b1459],
23	15	CD	NUMBER	15	num	24	SENT_153	[p12l1334t1434r1446b1459],
24	group	NN	O	group	dep	6	SENT_153	[p12l1461t1442r1541b1466],
25	*	CD	NUMBER	*	num	26	SENT_153	[p12l1617t1434r1729b1459],
26	1b	NN	O	1b	dep	24	SENT_153	[p12l1617t1434r1729b1459],
27	/	:	O	/	punct	24	SENT_153	[p12l1617t1434r1729b1459],
28	*	CD	NUMBER	*	num	30	SENT_153	[p12l1617t1434r1729b1459],
29	15	CD	NUMBER	15	num	30	SENT_153	[p12l1617t1434r1729b1459],
30	group	NN	O	group	dep	24	SENT_153	[p12l1743t1442r1824b1466],
31	*	CD	NUMBER	*	num	32	SENT_153	[p12l1900t1434r2012b1459],
32	1b	NN	O	1b	dep	30	SENT_153	[p12l1900t1434r2012b1459],
33	/	:	O	/	punct	36	SENT_153	[p12l1900t1434r2012b1459],
34	*	CD	NUMBER	*	num	36	SENT_153	[p12l1900t1434r2012b1459],
35	lb	NN	O	lb	nn	36	SENT_153	[p12l1900t1434r2012b1459],
36	group	NN	O	group	dep	32	SENT_153	[p12l2026t1442r2107b1466],
37	(	CD	NUMBER	(	num	38	SENT_153	[p12l485t1473r592b1503],
38	n	NN	O	n	dep	36	SENT_153	[p12l485t1473r592b1503],
39	=	JJ	O	=	quantmod	41	SENT_153	[p12l485t1473r592b1503],
40	4	CD	NUMBER	4	number	41	SENT_153	[p12l485t1473r592b1503],
41	)	CD	NUMBER	)	num	66	SENT_153	[p12l485t1473r592b1503],
42	(	NN	O	(	nn	66	SENT_153	[p12l768t1473r875b1503],
43	n	NN	O	n	nn	66	SENT_153	[p12l768t1473r875b1503],
44	=	JJ	O	=	amod	66	SENT_153	[p12l768t1473r875b1503],
45	2	CD	NUMBER	2	number	46	SENT_153	[p12l768t1473r875b1503],
46	)	CD	NUMBER	)	num	66	SENT_153	[p12l768t1473r875b1503],
47	(	NN	O	(	nn	66	SENT_153	[p12l1051t1473r1158b1503],
48	n	NN	O	n	nn	66	SENT_153	[p12l1051t1473r1158b1503],
49	=	JJ	O	=	amod	66	SENT_153	[p12l1051t1473r1158b1503],
50	4	CD	NUMBER	4	number	51	SENT_153	[p12l1051t1473r1158b1503],
51	)	CD	NUMBER	)	num	66	SENT_153	[p12l1051t1473r1158b1503],
52	(	NN	O	(	nn	66	SENT_153	[p12l1334t1473r1440b1503],
53	n	NN	O	n	nn	66	SENT_153	[p12l1334t1473r1440b1503],
54	=	JJ	O	=	amod	66	SENT_153	[p12l1334t1473r1440b1503],
55	4	CD	NUMBER	4	number	56	SENT_153	[p12l1334t1473r1440b1503],
56	)	CD	NUMBER	)	num	66	SENT_153	[p12l1334t1473r1440b1503],
57	(	NN	O	(	nn	66	SENT_153	[p12l1616t1473r1723b1503],
58	n	NN	O	n	nn	66	SENT_153	[p12l1616t1473r1723b1503],
59	=	JJ	O	=	amod	66	SENT_153	[p12l1616t1473r1723b1503],
60	2	CD	NUMBER	2	number	61	SENT_153	[p12l1616t1473r1723b1503],
61	)	CD	NUMBER	)	num	66	SENT_153	[p12l1616t1473r1723b1503],
62	(	NN	O	(	nn	66	SENT_153	[p12l1899t1473r2006b1503],
63	n	NN	O	n	nn	66	SENT_153	[p12l1899t1473r2006b1503],
64	=	JJ	O	=	amod	66	SENT_153	[p12l1899t1473r2006b1503],
65	4	CD	NUMBER	4	num	66	SENT_153	[p12l1899t1473r2006b1503],
66	)	NN	O	)	dep	38	SENT_153	[p12l1899t1473r2006b1503],

1	Cmax	NN	O	cmax	nn	3	SENT_154	[p12l10t1606r192b1688],
2	(	CD	NUMBER	(	num	3	SENT_154	[p12l228t1605r508b1692],
3	ng/ml	NN	O	ng/ml	_	0	SENT_154	[p12l228t1605r508b1692],
4	)	CD	NUMBER	)	num	5	SENT_154	[p12l228t1605r508b1692],
5	Pravastatin	NN	O	pravastatin	dep	3	SENT_154	[p12l37t1749r461b1816],
6	19	CD	NUMBER	19	num	8	SENT_154	[p12l1257t1750r1338b1817],
7	:	:	O	:	_	0	SENT_154	[p12l1379t1750r1443b1815],
8	|	CD	NUMBER	|	dep	5	SENT_154	[p12l1379t1750r1443b1815],
9	:	:	O	:	_	0	SENT_154	[p12l1379t1750r1443b1815],
10	16	CD	NUMBER	16	number	11	SENT_154	[p12l1490t1749r1573b1817],
11	14	CD	NUMBER	14	dep	5	SENT_154	[p12l1951t1749r2034b1816],
12	RMS-416	NN	O	rms-416	dep	11	SENT_154	[p12l37t1873r410b1941],
13	29	CD	NUMBER	29	num	12	SENT_154	[p12l1249t1874r1338b1941],
14	:	:	O	:	_	0	SENT_154	[p12l1379t1875r1443b1940],
15	|	CD	NUMBER	|	dep	5	SENT_154	[p12l1379t1875r1443b1940],
16	:	:	O	:	_	0	SENT_154	[p12l1379t1875r1443b1940],
17	4.1	CD	NUMBER	4.1	number	18	SENT_154	[p12l1480t1874r1641b1941],
18	*	CD	NUMBER	*	dep	15	SENT_154	[p12l1480t1874r1641b1941],
19	31	CD	NUMBER	31	num	20	SENT_154	[p12l1945t1874r2027b1941],
20	AUC0_24	NN	O	auc0_24	dep	25	SENT_154	[p12l6t1998r348b2081],
21	(	CD	NUMBER	(	num	22	SENT_154	[p12l385t1998r506b2085],
22	ng	NN	O	ng	dep	20	SENT_154	[p12l385t1998r506b2085],
23	h/ml	NN	O	h/ml	dep	25	SENT_154	[p12l541t1998r745b2080],
24	)	CD	NUMBER	)	num	23	SENT_154	[p12l541t1998r745b2080],
25	Pravastatin	NN	O	pravastatin	dep	15	SENT_154	[p12l37t2121r461b2188],
26	56	CD	NUMBER	56	num	28	SENT_154	[p12l1249t2121r1339b2189],
27	:	:	O	:	_	0	SENT_154	[p12l1379t2122r1443b2187],
28	|	CD	NUMBER	|	dep	25	SENT_154	[p12l1379t2122r1443b2187],
29	:	:	O	:	_	0	SENT_154	[p12l1379t2122r1443b2187],
30	43	CD	NUMBER	43	number	31	SENT_154	[p12l1480t2121r1569b2188],
31	38	CD	NUMBER	38	num	32	SENT_154	[p12l1945t2121r2032b2189],
32	RMS-416	NN	O	rms-416	dep	25	SENT_154	[p12l37t2245r410b2313],
33	70	CD	NUMBER	70	num	35	SENT_154	[p12l1248t2246r1340b2313],
34	:	:	O	:	_	0	SENT_154	[p12l1379t2246r1443b2312],
35	|	CD	NUMBER	|	dep	32	SENT_154	[p12l1379t2246r1443b2312],
36	:	:	O	:	_	0	SENT_154	[p12l1379t2246r1443b2312],
37	15	CD	NUMBER	15	number	38	SENT_154	[p12l1490t2245r1617b2313],
38	*	CD	NUMBER	*	dep	25	SENT_154	[p12l1490t2245r1617b2313],
39	60	CD	NUMBER	60	num	40	SENT_154	[p12l1944t2245r2035b2313],
40	Pravastatin	NN	O	pravastatin	dep	38	SENT_154	[p12l37t2368r460b2435],
41	+	CC	O	+	_	0	SENT_154	[p12l499t2377r564b2441],
42	RMS-416	NN	O	rms-416	conj_+	38	SENT_154	[p12l602t2368r975b2435],
43	130	CD	NUMBER	130	num	45	SENT_154	[p12l1208t2368r1340b2435],
44	:	:	O	:	_	0	SENT_154	[p12l1379t2369r1444b2434],
45	|	CD	NUMBER	|	dep	42	SENT_154	[p12l1379t2369r1444b2434],
46	:	:	O	:	_	0	SENT_154	[p12l1379t2369r1444b2434],
47	41	CD	NUMBER	41	number	48	SENT_154	[p12l1480t2368r1617b2434],
48	*	CD	NUMBER	*	dep	25	SENT_154	[p12l1480t2368r1617b2434],
49	98	CD	NUMBER	98	num	51	SENT_154	[p12l1944t2368r2032b2436],
50	ke	NN	O	ke	nn	51	SENT_154	[p12l6t2493r78b2574],
51	(	NN	O	(	dep	48	SENT_154	[p12l116t2493r266b2578],
52	per	IN	O	per	_	0	SENT_154	[p12l116t2493r266b2578],
53	h	NN	O	h	nn	55	SENT_154	[p12l299t2493r373b2574],
54	)	CD	NUMBER	)	num	55	SENT_154	[p12l299t2493r373b2574],
55	Pravastatin	NN	O	pravastatin	prep_per	25	SENT_154	[p12l37t2616r461b2682],
56	0.31	CD	NUMBER	0.31	num	58	SENT_154	[p12l1177t2616r1332b2682],
57	:	:	O	:	_	0	SENT_154	[p12l1379t2617r1444b2681],
58	|	CD	NUMBER	|	dep	15	SENT_154	[p12l1379t2617r1444b2681],
59	:	:	O	:	_	0	SENT_154	[p12l1379t2617r1444b2681],
60	0.16	CD	NUMBER	0.16	num	61	SENT_154	[p12l1482t2616r1645b2682],
61	0.24	CD	NUMBER	0.24	dep	5	SENT_154	[p12l1991t2616r2154b2682],
62	RMS-416	NN	O	rms-416	dep	61	SENT_154	[p12l37t2738r410b2806],
63	0.55	CD	NUMBER	0.55	num	62	SENT_154	[p12l1177t2738r1336b2806],
64	:	:	O	:	_	0	SENT_154	[p12l1379t2739r1443b2805],
65	|	CD	NUMBER	|	num	67	SENT_154	[p12l1379t2739r1443b2805],
66	:	:	O	:	_	0	SENT_154	[p12l1379t2739r1443b2805],
67	0.24	CD	NUMBER	0.24	dep	5	SENT_154	[p12l1482t2738r1645b2805],
68	0.17	CD	NUMBER	0.17	num	69	SENT_154	[p12l1991t2739r2152b2806],
69	CL	NN	MISC	cl	dep	67	SENT_154	[p12l7t2863r236b2945],
70	,	,	O	,	_	0	SENT_154	[p12l7t2863r236b2945],
71	/	:	O	/	punct	72	SENT_154	[p12l7t2863r236b2945],
72	F	NN	O	f	dep	67	SENT_154	[p12l7t2863r236b2945],
73	[	CD	NUMBER	[	num	74	SENT_154	[p12l273t2862r476b2949],
74	l	NN	O	l	dep	72	SENT_154	[p12l273t2862r476b2949],
75	/	:	O	/	punct	72	SENT_154	[p12l273t2862r476b2949],
76	(	CD	NUMBER	(	num	78	SENT_154	[p12l273t2862r476b2949],
77	kg	NN	O	kg	nn	78	SENT_154	[p12l273t2862r476b2949],
78	h	NN	O	h	dep	72	SENT_154	[p12l510t2862r613b2945],
79	)	CD	NUMBER	)	number	80	SENT_154	[p12l510t2862r613b2945],
80	]	CD	NUMBER	]	num	81	SENT_154	[p12l510t2862r613b2945],
81	Pravastatin	NN	O	pravastatin	dep	78	SENT_154	[p12l37t2987r461b3054],
82	3.9	CD	NUMBER	3.9	dep	67	SENT_154	[p12l1227t2987r1338b3055],
83	:	:	O	:	_	0	SENT_154	[p12l1379t2988r1444b3053],
84	|	CD	NUMBER	|	dep	5	SENT_154	[p12l1379t2988r1444b3053],
85	:	:	O	:	_	0	SENT_154	[p12l1379t2988r1444b3053],
86	2.5	CD	NUMBER	2.5	number	87	SENT_154	[p12l1482t2987r1594b3054],
87	3.7	CD	NUMBER	3.7	dep	84	SENT_154	[p12l1993t2987r2104b3054],

1	48	CD	NUMBER	48	_	0	SENT_155	[p12l60t3530r130b3582],
2	:	:	O	:	_	0	SENT_155	[p12l163t3531r213b3582],
3	|	CD	NUMBER	|	dep	1	SENT_155	[p12l163t3531r213b3582],
4	:	:	O	:	_	0	SENT_155	[p12l163t3531r213b3582],
5	32	CD	NUMBER	32	number	6	SENT_155	[p12l244t3531r313b3582],
6	64	CD	NUMBER	64	dep	3	SENT_155	[p12l657t3530r727b3583],
7	:	:	O	:	_	0	SENT_155	[p12l757t3531r807b3582],
8	|	CD	NUMBER	|	num	10	SENT_155	[p12l757t3531r807b3582],
9	:	:	O	:	_	0	SENT_155	[p12l757t3531r807b3582],
10	47	CD	NUMBER	47	dep	3	SENT_155	[p12l836t3530r907b3582],
11	37	CD	NUMBER	37	number	12	SENT_155	[p12l1233t3531r1301b3583],
12	43	CD	NUMBER	43	dep	10	SENT_155	[p12l1845t3530r1913b3582],
13	:	:	O	:	_	0	SENT_155	[p12l1947t3531r1997b3582],
14	|	CD	NUMBER	|	dep	3	SENT_155	[p12l1947t3531r1997b3582],
15	:	:	O	:	_	0	SENT_155	[p12l1947t3531r1997b3582],
16	14	CD	NUMBER	14	number	17	SENT_155	[p12l2033t3530r2098b3582],
17	16	CD	NUMBER	16	dep	14	SENT_155	[p12l68t3631r132b3684],
18	i	FW	O	i	dep	24	SENT_155	[p12l163t3632r213b3683],
19	12	CD	NUMBER	12	number	20	SENT_155	[p12l249t3632r313b3683],
20	56	CD	NUMBER	56	dep	18	SENT_155	[p12l657t3631r727b3684],
21	i	FW	O	i	dep	20	SENT_155	[p12l757t3632r807b3683],
22	33	CD	NUMBER	33	dep	24	SENT_155	[p12l839t3632r905b3684],
23	64	CD	NUMBER	64	num	24	SENT_155	[p12l1233t3631r1303b3684],
24	18	CD	NUMBER	18	dep	14	SENT_155	[p12l1852t3632r1914b3684],
25	i	FW	O	i	dep	24	SENT_155	[p12l1947t3632r1997b3683],
26	16	CD	NUMBER	16	num	27	SENT_155	[p12l2033t3631r2097b3684],
27	64	CD	NUMBER	64	dep	14	SENT_155	[p12l62t3732r132b3784],
28	:	:	O	:	_	0	SENT_155	[p12l163t3733r213b3784],
29	|	CD	NUMBER	|	dep	3	SENT_155	[p12l163t3733r213b3784],
30	:	:	O	:	_	0	SENT_155	[p12l163t3733r213b3784],
31	26	CD	NUMBER	26	number	32	SENT_155	[p12l243t3732r313b3784],
32	120	CD	NUMBER	120	dep	29	SENT_155	[p12l625t3733r727b3784],
33	:	:	O	:	_	0	SENT_155	[p12l757t3733r807b3784],
34	|	CD	NUMBER	|	dep	3	SENT_155	[p12l757t3733r807b3784],
35	:	:	O	:	_	0	SENT_155	[p12l757t3733r807b3784],
36	33	CD	NUMBER	33	num	37	SENT_155	[p12l839t3732r942b3785],
37	*	NN	O	*	dep	34	SENT_155	[p12l839t3732r942b3785],
38	100	CD	NUMBER	100	number	39	SENT_155	[p12l1202t3733r1304b3784],
39	61	CD	NUMBER	61	dep	37	SENT_155	[p12l1846t3732r1910b3784],
40	:	:	O	:	_	0	SENT_155	[p12l1947t3733r1997b3784],
41	|	CD	NUMBER	|	dep	3	SENT_155	[p12l1947t3733r1997b3784],
42	:	:	O	:	_	0	SENT_155	[p12l1947t3733r1997b3784],
43	20	CD	NUMBER	20	dep	41	SENT_155	[p12l2027t3733r2098b3784],

1	6.3	CD	NUMBER	6.3	number	2	SENT_156	[p13l44t457r129b509],
2	:1	CD	NUMBER	:1	_	0	SENT_156	[p13l163t458r213b508],
3	:	:	O	:	_	0	SENT_156	[p13l163t458r213b508],
4	6.0	CD	NUMBER	6.0	dep	2	SENT_156	[p13l244t457r332b509],
5	3.2	CD	NUMBER	3.2	dep	4	SENT_156	[p13l639t457r727b509],
6	:	:	O	:	_	0	SENT_156	[p13l757t458r807b508],
7	|	CD	NUMBER	|	dep	4	SENT_156	[p13l757t458r807b508],
8	:	:	O	:	_	0	SENT_156	[p13l757t458r807b508],
9	1.8	CD	NUMBER	1.8	number	10	SENT_156	[p13l844t457r925b509],
10	3.6	CD	NUMBER	3.6	dep	7	SENT_156	[p13l1271t457r1359b509],
11	4.7	CD	NUMBER	4.7	dep	10	SENT_156	[p13l1826t457r1915b509],
12	:	:	O	:	_	0	SENT_156	[p13l1947t458r1997b508],
13	|	CD	NUMBER	|	dep	7	SENT_156	[p13l1947t458r1997b508],
14	:	:	O	:	_	0	SENT_156	[p13l1947t458r1997b508],
15	2.6	CD	NUMBER	2.6	num	16	SENT_156	[p13l2027t457r2116b509],
16	Values	NNS	O	value	nsubjpass	18	SENT_156	[p13l52t553r149b578],
17	are	VBP	O	be	auxpass	18	SENT_156	[p13l163t561r204b578],
18	presented	VBN	O	present	dep	2	SENT_156	[p13l217t553r353b585],
19	as	IN	O	as	_	0	SENT_156	[p13l366t561r393b578],
20	the	DT	O	the	det	22	SENT_156	[p13l406t553r448b578],
21	mean	JJ	O	mean	amod	22	SENT_156	[p13l461t561r537b578],
22	:1	NN	O	:1	prep_as	18	SENT_156	[p13l551t553r575b577],
23	:	:	O	:	_	0	SENT_156	[p13l551t553r575b577],
24	SD	NN	O	sd	dobj	18	SENT_156	[p13l590t553r633b578],
25	*	CD	NUMBER	*	num	26	SENT_156	[p13l54t597r67b612],
26	P	NN	O	p	npadvmod	27	SENT_156	[p13l81t598r103b622],
27	<	JJR	O	<	amod	24	SENT_156	[p13l116t603r138b622],
28	0.05	CD	NUMBER	0.05	dep	27	SENT_156	[p13l150t597r210b622],
29	versus	CC	O	versus	dep	28	SENT_156	[p13l224t605r312b622],
30	values	NNS	O	value	dep	29	SENT_156	[p13l326t597r415b622],
31	of	IN	O	of	_	0	SENT_156	[p13l428t597r459b622],
32	*	CD	NUMBER	*	num	33	SENT_156	[p13l471t597r584b622],
33	lb	NN	O	lb	prep_of	30	SENT_156	[p13l471t597r584b622],
34	/	:	O	/	punct	37	SENT_156	[p13l471t597r584b622],
35	*	CD	NUMBER	*	num	37	SENT_156	[p13l471t597r584b622],
36	lb	NN	O	lb	nn	37	SENT_156	[p13l471t597r584b622],
37	group	NN	O	group	dep	24	SENT_156	[p13l597t605r678b629],
38	3	CD	NUMBER	3	num	39	SENT_156	[p13l53t638r64b650],
39	Ingestion	NN	O	ingestion	dep	51	SENT_156	[p13l82t641r213b673],
40	of	IN	O	of	_	0	SENT_156	[p13l226t641r256b666],
41	a	DT	O	a	det	43	SENT_156	[p13l267t649r282b666],
42	single	JJ	O	single	amod	43	SENT_156	[p13l295t641r378b673],
43	dose	NN	O	dose	prep_of	39	SENT_156	[p13l391t641r454b666],
44	of	IN	O	of	_	0	SENT_156	[p13l467t641r498b666],
45	10	CD	NUMBER	10	num	47	SENT_156	[p13l511t641r542b666],
46	mg	NN	O	mg	nn	47	SENT_156	[p13l555t649r599b673],
47	olmesartan	NN	O	olmesartan	prep_of	43	SENT_156	[p13l612t641r767b666],
48	medoxomil	NN	O	medoxomil	dep	51	SENT_156	[p13l779t641r939b666],
49	1	CD	NUMBER	1	num	48	SENT_156	[p13l52t677r65b694],
50	’	CD	NUMBER	’	num	51	SENT_156	[p13l52t677r65b694],
51	Ingestion	NN	O	ingestion	dep	57	SENT_156	[p13l83t685r214b717],
52	of	IN	O	of	_	0	SENT_156	[p13l229t685r259b710],
53	10	CD	NUMBER	10	num	56	SENT_156	[p13l275t685r305b710],
54	mg	NN	O	mg	nn	56	SENT_156	[p13l318t693r362b717],
55	olmesartan	NN	O	olmesartan	nn	56	SENT_156	[p13l377t685r531b710],
56	medoxomil	NN	O	medoxomil	prep_of	51	SENT_156	[p13l546t685r706b710],
57	concomitant	JJ	O	concomitant	dep	2	SENT_156	[p13l721t685r895b710],
58	with	IN	O	with	_	0	SENT_156	[p13l910t685r972b710],
59	10	CD	NUMBER	10	num	61	SENT_156	[p13l989t685r1020b710],
60	mg	NN	O	mg	nn	61	SENT_156	[p13l1033t693r1077b717],
61	pravastatin	NN	O	pravastatin	prep_with	57	SENT_156	[p13l1091t685r1246b717],
62	following	VBG	O	follow	_	0	SENT_156	[p13l1260t685r1396b717],
63	administration	NN	O	administration	prep_following	61	SENT_156	[p13l1412t685r1615b710],
64	of	IN	O	of	_	0	SENT_156	[p13l1630t685r1660b710],
65	10	CD	NUMBER	10	num	68	SENT_156	[p13l1675t685r1706b710],
66	mg	NN	O	mg	nn	68	SENT_156	[p13l1719t693r1763b717],
67	olmesartan	NN	O	olmesartan	nn	68	SENT_156	[p13l1778t685r1932b710],
68	medoxomil	NN	O	medoxomil	prep_of	63	SENT_156	[p13l1947t685r2107b710],
69	alone	RB	O	alone	advmod	71	SENT_156	[p13l8t737r170b790],
70	once	RB	DATE	once	advmod	71	SENT_156	[p13l199t753r340b790],
71	daily	JJ	SET	daily	advmod	68	SENT_156	[p13l369t736r519b805],
72	for	IN	O	for	_	0	SENT_156	[p13l547t736r635b790],
73	3	CD	DURATION	3	num	74	SENT_156	[p13l663t737r693b790],
74	days	NNS	NUMBER	day	prep_for	71	SENT_156	[p13l725t737r860b805],

1	In	IN	O	in	_	0	SENT_157	[p13l109t969r182b1029],
2	this	DT	O	this	det	3	SENT_157	[p13l216t968r342b1030],
3	study	NN	O	study	prep_in	6	SENT_157	[p13l382t968r590b1049],
4	,	,	O	,	_	0	SENT_157	[p13l382t968r590b1049],
5	OATPlB1	NN	O	oatplb1	nsubj	6	SENT_157	[p13l630t968r1002b1031],
6	appeared	VBD	O	appear	_	0	SENT_157	[p13l1046t968r1368b1049],
7	to	TO	O	to	aux	8	SENT_157	[p13l1402t977r1468b1030],
8	play	VB	O	play	xcomp	6	SENT_157	[p13l1504t968r1656b1049],
9	a	DT	O	a	det	10	SENT_157	[p13l1694t987r1731b1030],
10	role	NN	O	role	dobj	8	SENT_157	[p13l1764t968r1902b1030],
11	in	IN	O	in	_	0	SENT_157	[p13l1938t968r2005b1029],
12	the	DT	O	the	det	13	SENT_157	[p13l2040t968r2147b1030],
13	clearance	NN	O	clearance	prep_in	8	SENT_157	[p13l8t1079r345b1142],
14	of	IN	O	of	_	0	SENT_157	[p13l395t1079r472b1142],
15	both	CC	O	both	preconj	16	SENT_157	[p13l513t1079r671b1142],
16	olmesartan	NN	O	olmesartan	prep_of	13	SENT_157	[p13l720t1079r1112b1142],
17	and	CC	O	and	_	0	SENT_157	[p13l1162t1079r1288b1142],
18	pravastatin	NN	O	pravastatin	prep_of	13	SENT_157	[p13l1334t1079r1746b1160],
19	.	.	O	.	_	0	SENT_157	[p13l1334t1079r1746b1160],

1	However	RB	O	however	advmod	25	SENT_158	[p13l1799t1081r2144b1153],
2	,	,	O	,	_	0	SENT_158	[p13l1799t1081r2144b1153],
3	SLCOIBI	NN	O	slcoibus	nn	4	SENT_158	[p13l7t1191r361b1253],
4	variants	NNS	O	variant	nsubj	7	SENT_158	[p13l419t1190r700b1253],
5	did	VBD	O	do	aux	7	SENT_158	[p13l752t1190r865b1253],
6	not	RB	O	not	neg	7	SENT_158	[p13l914t1200r1028b1253],
7	have	VB	O	have	parataxis	25	SENT_158	[p13l1075t1190r1243b1253],
8	a	DT	O	a	det	10	SENT_158	[p13l1295t1210r1332b1253],
9	great	JJ	O	great	amod	10	SENT_158	[p13l1383t1200r1560b1271],
10	impact	NN	O	impact	dobj	7	SENT_158	[p13l1610t1190r1854b1271],
11	on	IN	O	on	_	0	SENT_158	[p13l1904t1210r1990b1253],
12	the	DT	O	the	det	13	SENT_158	[p13l2040t1190r2147b1253],
13	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	10	SENT_158	[p13l6t1301r639b1382],
14	of	IN	O	of	_	0	SENT_158	[p13l672t1301r749b1364],
15	olmesartan	NN	O	olmesartan	prep_of	13	SENT_158	[p13l773t1301r1184b1375],
16	,	,	O	,	_	0	SENT_158	[p13l773t1301r1184b1375],
17	different	JJ	O	different	amod	24	SENT_158	[p13l1218t1301r1526b1364],
18	from	IN	O	from	_	0	SENT_158	[p13l1555t1301r1727b1364],
19	the	DT	O	the	det	20	SENT_158	[p13l1756t1301r1863b1364],
20	case	NN	O	case	prep_from	17	SENT_158	[p13l1894t1321r2044b1364],
21	of	IN	O	of	_	0	SENT_158	[p13l2076t1301r2153b1364],
22	previous	JJ	O	previous	amod	23	SENT_158	[p13l6t1412r312b1493],
23	pravastatin	NN	O	pravastatin	prep_of	20	SENT_158	[p13l341t1412r734b1493],
24	studies	NNS	O	study	nsubj	25	SENT_158	[p13l764t1412r1006b1475],
25	(	VBP	O	(	_	0	SENT_158	[p13l1038t1412r1407b1490],
26	Nishizato	NNP	O	Nishizato	nsubj	28	SENT_158	[p13l1038t1412r1407b1490],
27	et	FW	O	et	nn	28	SENT_158	[p13l1436t1422r1499b1475],
28	al.	FW	O	al.	xcomp	25	SENT_158	[p13l1526t1412r1605b1475],
29	2003	CD	DATE	2003	dep	28	SENT_158	[p13l1638t1413r1835b1487],
30	;	:	O	;	_	0	SENT_158	[p13l1638t1413r1835b1487],
31	Mwinyi	NNP	PERSON	Mwinyi	dep	28	SENT_158	[p13l1865t1412r2147b1493],
32	et	FW	O	et	nn	33	SENT_158	[p13l8t1533r71b1586],
33	al.	FW	O	al.	dep	31	SENT_158	[p13l99t1523r177b1586],
34	2004	CD	DATE	2004	num	35	SENT_158	[p13l210t1524r433b1600],
35	)	CD	NUMBER	)	dep	28	SENT_158	[p13l210t1524r433b1600],
36	.	.	O	.	_	0	SENT_158	[p13l210t1524r433b1600],

1	It	PRP	O	it	nsubj	3	SENT_159	[p13l464t1525r518b1586],
2	is	VBZ	O	be	cop	3	SENT_159	[p13l543t1523r598b1586],
3	obvious	JJ	O	obvious	_	0	SENT_159	[p13l628t1523r907b1586],
4	that	IN	O	that	complm	15	SENT_159	[p13l935t1523r1069b1586],
5	the	DT	O	the	det	8	SENT_159	[p13l1094t1523r1201b1586],
6	small	JJ	O	small	amod	8	SENT_159	[p13l1231t1523r1420b1586],
7	sample	NN	O	sample	nn	8	SENT_159	[p13l1451t1523r1699b1604],
8	size	NN	O	size	nsubj	15	SENT_159	[p13l1730t1523r1864b1586],
9	in	IN	O	in	_	0	SENT_159	[p13l1890t1523r1958b1585],
10	each	DT	O	each	det	12	SENT_159	[p13l1985t1523r2148b1586],
11	genotype	NN	O	genotype	nn	12	SENT_159	[p13l8t1644r334b1715],
12	group	NN	O	group	prep_in	8	SENT_159	[p13l366t1654r571b1715],
13	is	VBZ	O	be	cop	15	SENT_159	[p13l602t1634r657b1697],
14	a	DT	O	a	det	15	SENT_159	[p13l691t1654r728b1697],
15	limitation	NN	O	limitation	ccomp	3	SENT_159	[p13l757t1634r1106b1697],
16	of	IN	O	of	_	0	SENT_159	[p13l1137t1634r1214b1697],
17	our	PRP$	O	we	poss	18	SENT_159	[p13l1239t1654r1357b1697],
18	study	NN	O	study	prep_of	15	SENT_159	[p13l1388t1634r1596b1715],
19	,	,	O	,	_	0	SENT_159	[p13l1388t1634r1596b1715],
20	which	WDT	O	which	nsubj	21	SENT_159	[p13l1630t1634r1847b1697],
21	made	VBD	O	make	rcmod	18	SENT_159	[p13l1877t1634r2069b1697],
22	it	PRP	O	it	iobj	21	SENT_159	[p13l2100t1634r2149b1697],
23	difﬁcult	NN	O	difﬁcult	dobj	21	SENT_159	[p13l8t1745r291b1807],
24	to	TO	O	to	aux	25	SENT_159	[p13l340t1754r407b1807],
25	elucidate	VB	O	elucidate	xcomp	21	SENT_159	[p13l459t1745r782b1807],
26	the	DT	O	the	det	27	SENT_159	[p13l833t1745r940b1807],
27	effects	NNS	O	effect	dobj	25	SENT_159	[p13l993t1745r1228b1807],
28	of	IN	O	of	_	0	SENT_159	[p13l1281t1745r1358b1807],
29	SLCOIBI	NNP	O	SLCOIBI	nn	30	SENT_159	[p13l1403t1745r1757b1808],
30	polymorphism	NN	O	polymorphism	prep_of	27	SENT_159	[p13l1814t1745r2145b1826, p13l6t1855r245b1936],
31	;	:	O	;	_	0	SENT_159	[p13l1814t1745r2145b1826, p13l6t1855r245b1936],
32	however	RB	O	however	advmod	37	SENT_159	[p13l296t1855r623b1929],
33	,	,	O	,	_	0	SENT_159	[p13l296t1855r623b1929],
34	this	DT	DATE	this	nsubjpass	37	SENT_159	[p13l674t1855r800b1917],
35	may	MD	DATE	may	aux	37	SENT_159	[p13l849t1874r1001b1936],
36	be	VB	O	be	auxpass	37	SENT_159	[p13l1048t1855r1131b1917],
37	explained	VBN	O	explain	parataxis	3	SENT_159	[p13l1180t1855r1528b1936],
38	by	IN	O	by	_	0	SENT_159	[p13l1574t1855r1662b1936],
39	the	DT	O	the	agent	37	SENT_159	[p13l1710t1855r1817b1917],
40	in	FW	O	in	nn	41	SENT_159	[p13l1865t1855r1933b1916],
41	vitro	FW	O	vitro	advmod	42	SENT_159	[p13l1980t1855r2146b1917],
42	ﬁndings	NNS	O	ﬁndings	dep	39	SENT_159	[p13l9t1965r292b2047],
43	indicating	VBG	O	indicate	partmod	39	SENT_159	[p13l362t1966r719b2047],
44	that	IN	O	that	complm	63	SENT_159	[p13l789t1966r922b2028],
45	OATPlBl	NN	O	oatplbl	nn	46	SENT_159	[p13l992t1966r1363b2029],
46	accounts	NNS	O	account	dep	59	SENT_159	[p13l1441t1975r1750b2028],
47	for	IN	O	for	_	0	SENT_159	[p13l1820t1966r1924b2028],
48	only	RB	O	only	quantmod	50	SENT_159	[p13l1991t1966r2147b2047],
49	approximately	RB	O	approximately	quantmod	50	SENT_159	[p13l9t2078r526b2159],
50	40-60	CD	PERCENT	40-60	num	51	SENT_159	[p13l596t2078r889b2141],
51	%	NN	PERCENT	%	prep_for	46	SENT_159	[p13l596t2078r889b2141],
52	of	IN	O	of	_	0	SENT_159	[p13l966t2078r1043b2141],
53	total	JJ	O	total	amod	55	SENT_159	[p13l1107t2078r1265b2141],
54	hepatic	JJ	O	hepatic	amod	55	SENT_159	[p13l1336t2078r1592b2159],
55	clearance	NN	O	clearance	prep_of	51	SENT_159	[p13l1667t2078r2003b2141],
56	of	IN	O	of	_	0	SENT_159	[p13l2076t2078r2153b2141],
57	olmesartan	NN	O	olmesartan	prep_of	55	SENT_159	[p13l8t2189r400b2252],
58	(	CD	NUMBER	(	dep	59	SENT_159	[p13l431t2189r758b2266],
59	Yamada	NNP	PERSON	Yamada	dep	63	SENT_159	[p13l431t2189r758b2266],
60	et	FW	O	et	nn	61	SENT_159	[p13l786t2199r849b2252],
61	al.	FW	O	al.	dep	59	SENT_159	[p13l877t2189r956b2252],
62	2007	CD	DATE	2007	num	63	SENT_159	[p13l991t2190r1214b2266],
63	)	CD	NUMBER	)	dep	43	SENT_159	[p13l991t2190r1214b2266],
64	.	.	O	.	_	0	SENT_159	[p13l991t2190r1214b2266],

1	In	IN	O	in	_	0	SENT_160	[p13l1247t2191r1319b2251],
2	contrast	NN	O	contrast	prep_in	6	SENT_160	[p13l1348t2198r1650b2263],
3	,	,	O	,	_	0	SENT_160	[p13l1348t2198r1650b2263],
4	OATPlBl	NN	O	oatplbl	nsubjpass	6	SENT_160	[p13l1682t2189r2054b2252],
5	is	VBZ	O	be	auxpass	6	SENT_160	[p13l2090t2189r2146b2252],
6	found	VBN	O	find	_	0	SENT_160	[p13l8t2301r215b2364],
7	to	TO	O	to	aux	11	SENT_160	[p13l270t2311r337b2364],
8	be	VB	O	be	cop	11	SENT_160	[p13l394t2301r477b2364],
9	a	DT	O	a	det	11	SENT_160	[p13l536t2321r573b2364],
10	predominant	JJ	O	predominant	amod	11	SENT_160	[p13l627t2301r1082b2382],
11	transporter	NN	O	transporter	xcomp	6	SENT_160	[p13l1137t2311r1527b2382],
12	responsible	JJ	O	responsible	amod	11	SENT_160	[p13l1581t2301r1988b2382],
13	for	IN	O	for	_	0	SENT_160	[p13l2046t2301r2149b2364],
14	hepatic	JJ	O	hepatic	amod	15	SENT_160	[p13l7t2412r263b2493],
15	uptake	NN	O	uptake	prep_for	12	SENT_160	[p13l318t2412r555b2493],
16	of	IN	O	of	_	0	SENT_160	[p13l610t2412r687b2475],
17	pravastatin	NN	O	pravastatin	nn	19	SENT_160	[p13l732t2412r1127b2493],
18	(	CD	NUMBER	(	num	19	SENT_160	[p13l1182t2412r1420b2490],
19	Nakai	NNP	PERSON	Nakai	prep_of	15	SENT_160	[p13l1182t2412r1420b2490],
20	et	FW	O	et	nn	21	SENT_160	[p13l1476t2422r1539b2475],
21	al.	FW	O	al.	dep	19	SENT_160	[p13l1592t2412r1670b2475],
22	2001	CD	DATE	2001	num	23	SENT_160	[p13l1729t2413r1952b2490],
23	)	CD	NUMBER	)	dep	21	SENT_160	[p13l1729t2413r1952b2490],
24	.	.	O	.	_	0	SENT_160	[p13l1729t2413r1952b2490],

1	The	DT	O	the	det	2	SENT_161	[p13l2010t2413r2147b2475],
2	relationship	NN	O	relationship	nsubjpass	18	SENT_161	[p13l6t2523r429b2604],
3	between	IN	O	between	_	0	SENT_161	[p13l455t2523r755b2586],
4	the	DT	O	the	det	6	SENT_161	[p13l780t2523r887b2586],
5	AUC	NN	O	auc	nn	6	SENT_161	[p13l913t2524r1098b2586],
6	value	NN	O	value	prep_between	2	SENT_161	[p13l1126t2523r1317b2586],
7	of	IN	O	of	dep	6	SENT_161	[p13l1345t2523r1422b2586],
8	olmesartan	NN	O	olmesartan	pobj	7	SENT_161	[p13l1443t2523r1835b2586],
9	and	CC	O	and	_	0	SENT_161	[p13l1863t2523r1990b2586],
10	that	IN	O	that	dep	16	SENT_161	[p13l2014t2523r2149b2586],
11	of	IN	O	of	dep	16	SENT_161	[p13l8t2634r85b2696],
12	pravastatin	NN	O	pravastatin	pobj	11	SENT_161	[p13l112t2634r506b2715],
13	plus	CC	O	plus	_	0	SENT_161	[p13l539t2634r685b2715],
14	RMS	NNP	O	RMS	nn	15	SENT_161	[p13l721t2634r1070b2697],
15	—	NN	O	—	pobj	11	SENT_161	[p13l721t2634r1070b2697],
16	416	CD	NUMBER	416	dep	6	SENT_161	[p13l721t2634r1070b2697],
17	is	VBZ	O	be	auxpass	18	SENT_161	[p13l1105t2634r1161b2696],
18	shown	VBN	O	show	_	0	SENT_161	[p13l1199t2634r1427b2697],
19	in	IN	O	in	_	0	SENT_161	[p13l1461t2634r1529b2696],
20	Fig	NN	O	fig	prep_in	18	SENT_161	[p13l1561t2634r1697b2715],
21	.	.	O	.	_	0	SENT_161	[p13l1561t2634r1697b2715],

1	2	CD	NUMBER	2	_	0	SENT_162	[p13l1735t2634r1798b2708],
2	;	:	O	;	_	0	SENT_162	[p13l1735t2634r1798b2708],
3	although	IN	O	although	mark	12	SENT_162	[p13l1837t2634r2148b2715],
4	not	RB	O	not	advcl	12	SENT_162	[p13l7t2754r121b2807],
5	statistically	RB	O	statistically	advmod	6	SENT_162	[p13l155t2745r560b2826],
6	signiﬁcant	JJ	O	signiﬁcant	pobj	4	SENT_162	[p13l597t2745r985b2826],
7	,	,	O	,	_	0	SENT_162	[p13l597t2745r985b2826],
8	the	DT	O	the	det	9	SENT_162	[p13l1021t2745r1128b2807],
9	AUC	NN	O	auc	nsubj	12	SENT_162	[p13l1161t2745r1345b2808],
10	of	IN	O	of	_	0	SENT_162	[p13l1381t2745r1458b2807],
11	olmesartan	NN	O	olmesartan	prep_of	9	SENT_162	[p13l1485t2745r1878b2807],
12	tended	VBD	O	tend	dep	1	SENT_162	[p13l1910t2745r2148b2807],
13	to	TO	O	to	aux	14	SENT_162	[p13l7t2864r74b2917],
14	correlate	VB	O	correlate	xcomp	12	SENT_162	[p13l148t2855r459b2917],
15	with	IN	O	with	_	0	SENT_162	[p13l533t2855r690b2917],
16	that	DT	O	that	prep_with	14	SENT_162	[p13l763t2855r896b2917],
17	of	IN	O	of	_	0	SENT_162	[p13l968t2855r1046b2917],
18	pravastatin	NN	O	pravastatin	prep_of	16	SENT_162	[p13l1111t2855r1505b2936],
19	plus	CC	O	plus	prep	18	SENT_162	[p13l1576t2855r1722b2936],
20	RMS	NNP	O	RMS	dep	19	SENT_162	[p13l1797t2854r2146b2918],
21	—	CD	NUMBER	—	num	20	SENT_162	[p13l1797t2854r2146b2918],
22	416	CD	NUMBER	416	num	24	SENT_162	[p13l1797t2854r2146b2918],
23	(	NN	O	(	nn	24	SENT_162	[p13l10t2968r89b3045],
24	R	NN	O	r	dobj	14	SENT_162	[p13l10t2968r89b3045],
25	=	JJ	O	=	amod	24	SENT_162	[p13l126t2996r186b3020],
26	0.534	CD	NUMBER	0.534	tmod	25	SENT_162	[p13l222t2967r443b3041],
27	;	:	O	;	_	0	SENT_162	[p13l222t2967r443b3041],
28	P	NN	O	p	dep	1	SENT_162	[p13l480t2970r534b3029],
29	=	JJ	O	=	amod	31	SENT_162	[p13l567t2994r613b3018],
30	0.112	CD	NUMBER	0.112	tmod	29	SENT_162	[p13l647t2968r894b3044],
31	)	NN	O	)	dep	28	SENT_162	[p13l647t2968r894b3044],
32	.	.	O	.	_	0	SENT_162	[p13l647t2968r894b3044],

1	Since	IN	O	since	mark	6	SENT_163	[p13l935t2967r1129b3030],
2	pravastatin	NN	O	pravastatin	nsubjpass	6	SENT_163	[p13l1163t2967r1558b3048],
3	and	CC	O	and	_	0	SENT_163	[p13l1594t2967r1721b3030],
4	olmesartan	NN	O	olmesartan	conj_and	2	SENT_163	[p13l1755t2967r2148b3030],
5	are	VBP	O	be	auxpass	6	SENT_163	[p13l9t3098r114b3141],
6	cleared	VBN	O	clear	advcl	31	SENT_163	[p13l144t3078r402b3141],
7	from	IN	O	from	_	0	SENT_163	[p13l430t3078r603b3141],
8	the	DT	O	the	det	9	SENT_163	[p13l630t3078r737b3141],
9	body	NN	O	body	prep_from	6	SENT_163	[p13l765t3078r942b3159],
10	by	IN	O	by	_	0	SENT_163	[p13l970t3078r1058b3159],
11	the	DT	O	the	det	12	SENT_163	[p13l1087t3078r1194b3141],
12	liver	NN	O	liver	agent	6	SENT_163	[p13l1223t3078r1387b3141],
13	and	CC	O	and	_	0	SENT_163	[p13l1416t3078r1542b3141],
14	kidneys	NNS	O	kidney	conj_and	12	SENT_163	[p13l1569t3078r1845b3159],
15	without	IN	O	without	_	0	SENT_163	[p13l1876t3078r2148b3141],
16	further	JJ	O	further	amod	17	SENT_163	[p13l7t3189r251b3251],
17	metabolism	NN	O	metabolism	prep_without	6	SENT_163	[p13l274t3189r711b3262],
18	,	,	O	,	_	0	SENT_163	[p13l274t3189r711b3262],
19	the	DT	O	the	det	20	SENT_163	[p13l738t3189r845b3251],
20	correlation	NN	O	correlation	nsubjpass	31	SENT_163	[p13l870t3189r1258b3251],
21	between	IN	O	between	_	0	SENT_163	[p13l1280t3189r1580b3251],
22	olmesartan	NN	O	olmesartan	prep_between	20	SENT_163	[p13l1604t3189r1997b3251],
23	and	CC	O	and	_	0	SENT_163	[p13l2022t3189r2148b3251],
24	pravastatin	NN	O	pravastatin	prep_between	20	SENT_163	[p13l6t3300r400b3381],
25	plus	CC	O	plus	_	0	SENT_163	[p13l440t3300r587b3381],
26	RMS	NNP	O	RMS	nn	27	SENT_163	[p13l629t3300r978b3363],
27	—	NN	O	—	conj_plus	22	SENT_163	[p13l629t3300r978b3363],
28	416	CD	NUMBER	416	advmod	31	SENT_163	[p13l629t3300r978b3363],
29	might	MD	O	might	aux	31	SENT_163	[p13l1021t3300r1230b3381],
30	be	VB	O	be	auxpass	31	SENT_163	[p13l1268t3300r1351b3363],
31	attributed	VBN	O	attribute	_	0	SENT_163	[p13l1395t3300r1737b3363],
32	to	TO	O	to	_	0	SENT_163	[p13l1777t3310r1844b3363],
33	sharing	VBG	O	share	prepc_to	31	SENT_163	[p13l1888t3300r2146b3381],
34	transporters	NNS	O	transporter	dobj	33	SENT_163	[p13l7t3421r427b3492],
35	that	WDT	O	that	nsubj	36	SENT_163	[p13l464t3411r598b3474],
36	mediate	VBP	O	mediate	rcmod	34	SENT_163	[p13l632t3411r914b3474],
37	their	PRP$	O	they	poss	39	SENT_163	[p13l950t3411r1114b3474],
38	elimination	NN	O	elimination	nn	39	SENT_163	[p13l1148t3411r1557b3474],
39	pathways	NNS	O	pathway	dobj	36	SENT_163	[p13l1590t3411r1948b3492],
40	,	,	O	,	_	0	SENT_163	[p13l1590t3411r1948b3492],
41	such	JJ	O	such	_	0	SENT_163	[p13l1989t3411r2148b3474],
42	as	IN	O	as	_	0	SENT_163	[p13l9t3542r78b3585],
43	OATPlBl	NN	O	oatplbl	prep_such_as	34	SENT_163	[p13l114t3523r511b3585],
44	.	.	O	.	_	0	SENT_163	[p13l114t3523r511b3585],

1	In	IN	O	in	_	0	SENT_164	[p13l109t3635r182b3696],
2	summary	NN	O	summary	prep_in	7	SENT_164	[p13l218t3653r566b3715],
3	,	,	O	,	_	0	SENT_164	[p13l218t3653r566b3715],
4	SLCOIBI	NNP	O	SLCOIBI	nn	5	SENT_164	[p13l603t3634r957b3697],
5	polymorphism	NN	O	polymorphism	nsubj	7	SENT_164	[p13l996t3634r1521b3715],
6	could	MD	O	could	aux	7	SENT_164	[p13l1554t3634r1752b3696],
7	contribute	VB	O	contribute	_	0	SENT_164	[p13l1785t3634r2147b3696],
8	to	TO	O	to	_	0	SENT_164	[p14l7t31r74b84],
9	the	DT	O	the	det	11	SENT_164	[p14l101t22r208b84],
10	interindividual	JJ	O	interindividual	amod	11	SENT_164	[p14l236t22r764b85],
11	variability	NN	O	variability	prep_to	7	SENT_164	[p14l791t22r1159b103],
12	in	IN	O	in	_	0	SENT_164	[p14l1186t22r1254b84],
13	the	DT	O	the	det	14	SENT_164	[p14l1281t22r1388b84],
14	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	11	SENT_164	[p14l1414t22r2047b103],
15	of	IN	O	of	_	0	SENT_164	[p14l2076t22r2153b84],
16	olmesartan	NN	O	olmesartan	prep_of	14	SENT_164	[p14l8t132r418b194],
17	.	.	O	.	_	0	SENT_164	[p14l8t132r418b194],

1	As	IN	O	as	_	0	SENT_165	[p14l444t132r539b194],
2	pharmacological	JJ	O	pharmacological	amod	3	SENT_165	[p14l561t132r1160b213],
3	effects	NNS	O	effect	prep_as	6	SENT_165	[p14l1184t131r1418b194],
4	of	IN	O	of	_	0	SENT_165	[p14l1443t132r1520b194],
5	olmesartan	NN	O	olmesartan	prep_of	3	SENT_165	[p14l1536t132r1929b194],
6	occur	VBP	O	occur	_	0	SENT_165	[p14l1951t151r2149b194],
7	in	IN	O	in	_	0	SENT_165	[p14l7t244r75b306],
8	a	DT	O	a	det	10	SENT_165	[p14l117t264r154b307],
9	dose	NN	O	dose	nn	10	SENT_165	[p14l194t244r757b325],
10	—	NN	O	—	prep_in	6	SENT_165	[p14l194t244r757b325],
11	dependent	JJ	O	dependent	amod	12	SENT_165	[p14l194t244r757b325],
12	manner	NN	O	manner	nsubj	6	SENT_165	[p14l795t264r1083b318],
13	,	,	O	,	_	0	SENT_165	[p14l795t264r1083b318],
14	subjects	NNS	O	subject	appos	12	SENT_165	[p14l1129t244r1412b325],
15	with	IN	O	with	_	0	SENT_165	[p14l1454t244r1611b307],
16	SLCOIBI	NN	O	slcoibus	prep_with	14	SENT_165	[p14l1651t245r2006b308],
17	*	CD	NUMBER	*	number	18	SENT_165	[p14l2025t245r2148b307],
18	15	CD	NUMBER	15	num	16	SENT_165	[p14l2025t245r2148b307],

1	R	NN	O	r	_	0	SENT_166	[p14l614t749r995b811],
2	=	JJ	O	=	amod	3	SENT_166	[p14l614t749r995b811],
3	0.534	CD	NUMBER	0.534	dep	1	SENT_166	[p14l614t749r995b811],
4	;	:	O	;	_	0	SENT_166	[p14l614t749r995b811],
5	P	NN	O	p	dep	3	SENT_166	[p14l614t749r995b811],
6	=	JJ	O	=	dep	5	SENT_166	[p14l1021t749r1252b800],
7	o.	NN	O	o.	dobj	6	SENT_166	[p14l1021t749r1252b800],
8	112	CD	NUMBER	112	num	7	SENT_166	[p14l1021t749r1252b800],
9	'	''	O	'	_	0	SENT_166	[p14l1697t725r1737b764],

1	40	CD	NUMBER	40	num	2	SENT_167	[p14l192t1732r262b1783],
2	AUCO	NN	O	auco	_	0	SENT_167	[p14l38t1799r96b2111],
3	—	CD	NUMBER	—	number	4	SENT_167	[p14l38t1799r96b2111],
4	24	CD	NUMBER	24	dep	2	SENT_167	[p14l38t1799r96b2111],
5	of	IN	O	of	_	0	SENT_167	[p14l37t1702r96b1776],
6	pravastatin	NN	O	pravastatin	prep_of	4	SENT_167	[p14l37t1341r111b1692],
7	plus	CC	O	plus	prep	6	SENT_167	[p14l37t1190r111b1323],
8	RMS-416	NN	O	rms-416	nn	10	SENT_167	[p14l38t856r96b1168],
9	(	CD	NUMBER	(	num	10	SENT_167	[p14l37t486r111b832],
10	ng	NN	O	ng	dep	7	SENT_167	[p14l37t486r111b832],
11	.	.	O	.	_	0	SENT_167	[p14l37t486r111b832],

1	hr/mL	NN	O	hr/ml	_	0	SENT_168	[p14l37t486r111b832],
2	)	SYM	O	)	dep	1	SENT_168	[p14l37t486r111b832],

1	AUCO-24	NN	O	auco-24	_	0	SENT_169	[p14l691t2213r1003b2269],
2	of	IN	O	of	_	0	SENT_169	[p14l1026t2212r1100b2269],
3	olmesartan	NN	O	olmesartan	nn	5	SENT_169	[p14l1112t2212r1459b2269],
4	(	CD	NUMBER	(	num	5	SENT_169	[p14l1482t2212r1828b2284],
5	ng	NN	O	ng	prep_of	1	SENT_169	[p14l1482t2212r1828b2284],
6	.	.	O	.	_	0	SENT_169	[p14l1482t2212r1828b2284],

1	hr/mL	NN	O	hr/ml	_	0	SENT_170	[p14l1482t2212r1828b2284],
2	)	SYM	O	)	dep	1	SENT_170	[p14l1482t2212r1828b2284],

1	Fig	NN	O	fig	_	0	SENT_171	[p14l13t2390r135b2458],
2	.	.	O	.	_	0	SENT_171	[p14l13t2390r135b2458],

1	2	CD	NUMBER	2	num	2	SENT_172	[p14l163t2390r199b2443],
2	Correlation	NN	O	correlation	_	0	SENT_172	[p14l248t2390r593b2444],
3	between	IN	O	between	_	0	SENT_172	[p14l625t2390r877b2444],
4	AUC0_24	NN	O	auc0_24	prep_between	2	SENT_172	[p14l910t2391r1182b2456],
5	of	IN	O	of	_	0	SENT_172	[p14l1216t2390r1281b2443],
6	olmesartan	NN	O	olmesartan	prep_of	2	SENT_172	[p14l1310t2390r1642b2443],
7	and	CC	O	and	_	0	SENT_172	[p14l1676t2390r1783b2443],
8	pravastatin	NN	O	pravastatin	prep_of	2	SENT_172	[p14l1814t2390r2148b2459],
9	plus	CC	O	plus	prep	2	SENT_172	[p14l13t2478r136b2547],
10	RMS-416	NN	O	rms-416	dep	9	SENT_172	[p14l166t2478r478b2531],
11	.	.	O	.	_	0	SENT_172	[p14l166t2478r478b2531],

1	Each	DT	O	each	det	2	SENT_173	[p14l510t2478r661b2531],
2	point	NN	O	point	nsubj	3	SENT_173	[p14l682t2480r846b2546],
3	represents	VBZ	O	represent	_	0	SENT_173	[p14l870t2486r1176b2547],
4	the	DT	O	the	det	5	SENT_173	[p14l1205t2478r1296b2531],
5	data	NNS	O	datum	dobj	3	SENT_173	[p14l1325t2478r1451b2531],
6	of	IN	O	of	_	0	SENT_173	[p14l1479t2478r1544b2531],
7	each	DT	O	each	det	8	SENT_173	[p14l1567t2478r1704b2531],
8	subject	NN	O	subject	prep_of	5	SENT_173	[p14l1735t2478r1961b2547],
9	.	.	O	.	_	0	SENT_173	[p14l1735t2478r1961b2547],

1	Solid	JJ	O	solid	amod	2	SENT_174	[p14l1993t2478r2151b2532],
2	line	NN	O	line	nsubj	3	SENT_174	[p14l15t2566r125b2619],
3	represents	VBZ	O	represent	_	0	SENT_174	[p14l152t2574r458b2635],
4	least	JJS	O	least	advmod	3	SENT_174	[p14l488t2566r626b2619],
5	square	JJ	O	square	amod	7	SENT_174	[p14l655t2583r849b2635],
6	linear	JJ	O	linear	amod	7	SENT_174	[p14l877t2566r1051b2619],
7	regression	NN	O	regression	dobj	3	SENT_174	[p14l1076t2566r1387b2635],
8	ﬁtting	VBG	O	ﬁtting	amod	10	SENT_174	[p14l1415t2566r1593b2635],
9	line	NN	O	line	nn	10	SENT_174	[p14l1622t2566r1734b2619],
10	haplotypes	NNS	O	haplotype	nsubjpass	12	SENT_174	[p14l13t2797r398b2878],
11	are	VBP	O	be	auxpass	12	SENT_174	[p14l445t2817r550b2860],
12	predicted	VBN	O	predict	rcmod	7	SENT_174	[p14l593t2797r927b2878],
13	to	TO	O	to	aux	14	SENT_174	[p14l969t2807r1035b2860],
14	exhibit	VB	O	exhibit	xcomp	12	SENT_174	[p14l1080t2797r1328b2860],
15	enhanced	VBN	O	enhance	amod	17	SENT_174	[p14l1371t2797r1708b2860],
16	therapeutic	JJ	O	therapeutic	amod	17	SENT_174	[p14l1750t2797r2146b2878],
17	response	NN	O	response	dobj	14	SENT_174	[p14l13t2928r324b2989],
18	to	TO	O	to	_	0	SENT_174	[p14l355t2918r421b2971],
19	olmesartan	NN	O	olmesartan	prep_to	17	SENT_174	[p14l454t2908r863b2982],
20	,	,	O	,	_	0	SENT_174	[p14l454t2908r863b2982],
21	attributed	VBN	O	attribute	partmod	19	SENT_174	[p14l899t2908r1241b2971],
22	to	TO	O	to	_	0	SENT_174	[p14l1270t2918r1337b2971],
23	high	JJ	O	high	amod	25	SENT_174	[p14l1368t2908r1525b2989],
24	plasma	NN	O	plasma	nn	25	SENT_174	[p14l1554t2908r1808b2989],
25	levels	NNS	O	level	prep_to	21	SENT_174	[p14l1838t2908r2043b2971],
26	of	IN	O	of	_	0	SENT_174	[p14l2076t2908r2153b2971],
27	olmesartan	NN	O	olmesartan	prep_of	25	SENT_174	[p14l15t3018r423b3080],
28	.	.	O	.	_	0	SENT_174	[p14l15t3018r423b3080],

1	On	IN	O	on	_	0	SENT_175	[p14l454t3018r559b3081],
2	the	DT	O	the	det	4	SENT_175	[p14l583t3018r690b3080],
3	other	JJ	O	other	amod	4	SENT_175	[p14l715t3018r899b3080],
4	hand	NN	O	hand	prep_on	17	SENT_175	[p14l920t3018r1111b3092],
5	,	,	O	,	_	0	SENT_175	[p14l920t3018r1111b3092],
6	these	DT	O	these	det	7	SENT_175	[p14l1139t3018r1320b3080],
7	patients	NNS	O	patient	nsubj	17	SENT_175	[p14l1344t3018r1621b3099],
8	may	MD	O	may	aux	17	SENT_175	[p14l1647t3037r1798b3099],
9	be	VB	O	be	cop	17	SENT_175	[p14l1821t3018r1904b3080],
10	at	IN	O	at	_	0	SENT_175	[p14l1931t3027r1993b3080],
11	risk	NN	O	risk	prep_at	17	SENT_175	[p14l2015t3018r2150b3080],
12	of	IN	O	of	_	0	SENT_175	[p14l15t3129r92b3191],
13	dose	NN	O	dose	nn	14	SENT_175	[p14l113t3129r674b3210],
14	—	NN	O	—	prep_of	11	SENT_175	[p14l113t3129r674b3210],
15	dependent	JJ	O	dependent	amod	17	SENT_175	[p14l113t3129r674b3210],
16	adverse	JJ	O	adverse	amod	17	SENT_175	[p14l701t3129r970b3191],
17	effects	NNS	O	effect	_	0	SENT_175	[p14l998t3129r1233b3191],
18	of	IN	O	of	_	0	SENT_175	[p14l1261t3129r1338b3191],
19	olmesartan	NN	O	olmesartan	prep_of	17	SENT_175	[p14l1360t3129r1768b3191],
20	.	.	O	.	_	0	SENT_175	[p14l1360t3129r1768b3191],

1	However	RB	O	however	advmod	13	SENT_176	[p14l1800t3130r2144b3203],
2	,	,	O	,	_	0	SENT_176	[p14l1800t3130r2144b3203],
3	further	JJ	O	further	amod	5	SENT_176	[p14l14t3240r257b3302],
4	clinical	JJ	O	clinical	amod	5	SENT_176	[p14l290t3240r551b3302],
5	studies	NNS	O	study	nsubjpass	13	SENT_176	[p14l588t3240r830b3302],
6	including	VBG	O	include	_	0	SENT_176	[p14l865t3240r1201b3321],
7	a	DT	O	a	det	9	SENT_176	[p14l1237t3259r1274b3302],
8	greater	JJR	O	greater	amod	9	SENT_176	[p14l1307t3249r1554b3321],
9	number	NN	O	number	prep_including	5	SENT_176	[p14l1586t3240r1859b3302],
10	of	IN	O	of	_	0	SENT_176	[p14l1892t3240r1969b3302],
11	subjects	NNS	O	subject	prep_of	9	SENT_176	[p14l1999t3240r2145b3302, p14l6t3352r174b3433],
12	are	VBP	O	be	auxpass	13	SENT_176	[p14l205t3372r310b3415],
13	needed	VBN	O	need	_	0	SENT_176	[p14l337t3352r590b3415],
14	to	TO	O	to	aux	15	SENT_176	[p14l616t3361r682b3415],
15	conﬁrm	VB	O	conﬁrm	xcomp	13	SENT_176	[p14l711t3352r987b3415],
16	these	DT	O	these	det	17	SENT_176	[p14l1013t3352r1194b3415],
17	observations	NNS	O	observation	dobj	15	SENT_176	[p14l1224t3352r1691b3415],
18	.	.	O	.	_	0	SENT_176	[p14l1224t3352r1691b3415],

1	@	IN	O	@	_	0	SENT_177	[p14l1780t3595r1857b3690],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_177	[p14l1887t3618r2148b3693],

1	904	CD	NUMBER	904	num	2	SENT_178	[p15l53t44r104b70],
2	J	NN	O	j	_	0	SENT_178	[p15l1629t45r1642b70],
3	Hum	NNP	PERSON	Hum	nn	4	SENT_178	[p15l1655t45r1725b69],
4	Genet	NNP	PERSON	Genet	dep	2	SENT_178	[p15l1738t44r1821b70],
5	(	CD	NUMBER	(	num	6	SENT_178	[p15l1835t44r1926b75],
6	2008	CD	DATE	2008	dep	4	SENT_178	[p15l1835t44r1926b75],
7	)	CD	NUMBER	)	num	8	SENT_178	[p15l1835t44r1926b75],
8	532899-904	CD	NUMBER	532899-904	dep	2	SENT_178	[p15l1940t44r2107b70],

1	Acknowledgments	NNS	O	acknowledgment	nsubjpass	5	SENT_179	[p15l6t210r600b278],
2	This	DT	O	this	det	3	SENT_179	[p15l680t210r812b264],
3	study	NN	O	study	dep	1	SENT_179	[p15l843t211r1003b279],
4	was	VBD	O	be	auxpass	5	SENT_179	[p15l1031t227r1146b264],
5	supported	VBN	O	support	_	0	SENT_179	[p15l1177t211r1474b279],
6	by	IN	O	by	_	0	SENT_179	[p15l1500t211r1574b279],
7	Health	NNP	O	Health	agent	5	SENT_179	[p15l1603t210r1804b264],
8	and	CC	O	and	_	0	SENT_179	[p15l1833t211r1940b264],
9	Labor	NNP	ORGANIZATION	Labor	nn	12	SENT_179	[p15l1967t210r2149b264],
10	Sciences	NNP	ORGANIZATION	Sciences	nn	12	SENT_179	[p15l9t300r271b353],
11	Research	NNP	ORGANIZATION	Research	nn	12	SENT_179	[p15l309t300r587b353],
12	Grants	NNPS	ORGANIZATION	Grants	agent	5	SENT_179	[p15l625t300r823b353],
13	from	IN	O	from	_	0	SENT_179	[p15l861t300r1008b353],
14	the	DT	O	the	det	15	SENT_179	[p15l1043t300r1135b353],
15	Ministry	NNP	ORGANIZATION	Ministry	prep_from	5	SENT_179	[p15l1170t300r1431b368],
16	of	IN	ORGANIZATION	of	_	0	SENT_179	[p15l1469t300r1534b353],
17	Health	NNP	ORGANIZATION	Health	prep_of	15	SENT_179	[p15l1566t300r1784b363],
18	,	,	O	,	_	0	SENT_179	[p15l1566t300r1784b363],
19	Labor	NNP	ORGANIZATION	Labor	conj_and	17	SENT_179	[p15l1822t300r2005b353],
20	and	CC	ORGANIZATION	and	_	0	SENT_179	[p15l2042t300r2149b353],
21	Welfare	NNP	ORGANIZATION	Welfare	prep_of	15	SENT_179	[p15l6t387r268b450],
22	,	,	O	,	_	0	SENT_179	[p15l6t387r268b450],
23	Tokyo	NNP	LOCATION	Tokyo	nn	25	SENT_179	[p15l298t387r512b456],
24	,	,	O	,	_	0	SENT_179	[p15l298t387r512b456],
25	Japan	NNP	LOCATION	Japan	appos	15	SENT_179	[p15l542t389r729b456],
26	.	.	O	.	_	0	SENT_179	[p15l542t389r729b456],

1	References	NNS	O	reference	_	0	SENT_180	[p15l8t618r424b682],

1	Chung	NNP	PERSON	Chung	nn	2	SENT_181	[p15l8t829r207b898],
2	JY	NN	O	jy	_	0	SENT_181	[p15l228t830r327b892],
3	,	,	O	,	_	0	SENT_181	[p15l228t830r327b892],
4	Cho	NNP	O	Cho	nn	5	SENT_181	[p15l351t829r475b882],
5	JY	NN	O	jy	appos	2	SENT_181	[p15l496t830r595b892],
6	,	,	O	,	_	0	SENT_181	[p15l496t830r595b892],
7	Yu	NNP	O	Yu	nn	8	SENT_181	[p15l618t830r708b882],
8	KS	NN	O	k	appos	2	SENT_181	[p15l731t829r840b892],
9	,	,	O	,	_	0	SENT_181	[p15l731t829r840b892],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_181	[p15l865t829r998b882],
11	JR	NNP	O	JR	appos	2	SENT_181	[p15l1018t830r1112b892],
12	,	,	O	,	_	0	SENT_181	[p15l1018t830r1112b892],
13	Oh	UH	O	oh	dep	14	SENT_181	[p15l1138t829r1227b882],
14	DS	NN	O	d	rcmod	11	SENT_181	[p15l1247t830r1358b892],
15	,	,	O	,	_	0	SENT_181	[p15l1247t830r1358b892],
16	Jung	NNP	PERSON	Jung	nn	17	SENT_181	[p15l1382t830r1523b898],
17	HR	NNP	DURATION	HR	appos	2	SENT_181	[p15l1545t830r1664b892],
18	,	,	O	,	_	0	SENT_181	[p15l1545t830r1664b892],
19	Lim	NNP	ORGANIZATION	Lim	nn	20	SENT_181	[p15l1687t829r1814b882],
20	KS	NN	ORGANIZATION	k	appos	2	SENT_181	[p15l1835t829r1945b892],
21	,	,	O	,	_	0	SENT_181	[p15l1835t829r1945b892],
22	Moon	NNP	ORGANIZATION	Moon	nn	23	SENT_181	[p15l1968t830r2148b882],
23	KH	NNP	ORGANIZATION	KH	appos	2	SENT_181	[p15l161t919r284b980],
24	,	,	O	,	_	0	SENT_181	[p15l161t919r284b980],
25	Shin	NNP	ORGANIZATION	Shin	nn	26	SENT_181	[p15l319t917r455b971],
26	SG	NNP	ORGANIZATION	SG	appos	2	SENT_181	[p15l488t918r597b980],
27	,	,	O	,	_	0	SENT_181	[p15l488t918r597b980],
28	Jang	NNP	PERSON	Jang	nn	29	SENT_181	[p15l630t919r767b986],
29	IJ	NNP	PERSON	IJ	appos	2	SENT_181	[p15l800t919r852b971],
30	(	CD	NUMBER	(	dep	29	SENT_181	[p15l885t917r1082b983],
31	2005	CD	DATE	2005	num	33	SENT_181	[p15l885t917r1082b983],
32	)	NN	O	)	nn	33	SENT_181	[p15l885t917r1082b983],
33	Effect	NN	O	effect	dep	2	SENT_181	[p15l1114t917r1301b970],
34	of	IN	O	of	_	0	SENT_181	[p15l1332t917r1398b970],
35	OATP1B1	NN	O	oatp1b1	nn	37	SENT_181	[p15l1425t918r1740b971],
36	(	CD	NUMBER	(	num	37	SENT_181	[p15l1780t918r2145b983],
37	SLCO1B1	NN	O	slco1b1	prep_of	33	SENT_181	[p15l1780t918r2145b983],
38	)	CD	NUMBER	)	num	40	SENT_181	[p15l1780t918r2145b983],
39	variant	JJ	O	variant	amod	40	SENT_181	[p15l160t1005r371b1058],
40	alleles	NNS	O	allele	dep	2	SENT_181	[p15l396t1005r587b1058],
41	on	IN	O	on	_	0	SENT_181	[p15l612t1022r685b1058],
42	the	DT	O	the	det	43	SENT_181	[p15l709t1005r800b1058],
43	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	40	SENT_181	[p15l822t1005r1359b1074],
44	of	IN	O	of	_	0	SENT_181	[p15l1386t1005r1451b1058],
45	pitavastatin	NN	O	pitavastatin	prep_of	43	SENT_181	[p15l1469t1005r1820b1074],
46	in	IN	O	in	_	0	SENT_181	[p15l1844t1005r1902b1058],
47	healthy	JJ	O	healthy	amod	48	SENT_181	[p15l1924t1005r2147b1074],
48	volunteers	NNS	O	volunteer	prep_in	45	SENT_181	[p15l160t1094r491b1147],
49	.	.	O	.	_	0	SENT_181	[p15l160t1094r491b1147],

1	Clin	NNP	O	Clin	nn	3	SENT_182	[p15l524t1094r653b1147],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_182	[p15l680t1094r1004b1147],
3	Ther	NNP	O	Ther	_	0	SENT_182	[p15l1033t1094r1176b1147],
4	78:342	CD	NUMBER	78:342	dep	3	SENT_182	[p15l1203t1094r1565b1148],
5	—	CD	NUMBER	—	number	6	SENT_182	[p15l1203t1094r1565b1148],
6	350	CD	NUMBER	350	dep	4	SENT_182	[p15l1203t1094r1565b1148],

1	Everett	NNP	PERSON	Everett	nn	2	SENT_183	[p15l7t1184r227b1236],
2	DW	NNP	PERSON	DW	nsubj	18	SENT_183	[p15l276t1184r417b1245],
3	,	,	O	,	_	0	SENT_183	[p15l276t1184r417b1245],
4	Chando	NNP	PERSON	Chando	nn	5	SENT_183	[p15l469t1182r703b1236],
5	TJ	NNP	PERSON	TJ	appos	2	SENT_183	[p15l753t1184r844b1245],
6	,	,	O	,	_	0	SENT_183	[p15l753t1184r844b1245],
7	Didonato	NNP	ORGANIZATION	Didonato	nn	8	SENT_183	[p15l896t1182r1177b1235],
8	GC	NN	ORGANIZATION	gc	appos	2	SENT_183	[p15l1229t1183r1347b1245],
9	,	,	O	,	_	0	SENT_183	[p15l1229t1183r1347b1245],
10	Singhvi	NNP	PERSON	Singhvi	nn	11	SENT_183	[p15l1401t1182r1634b1251],
11	SM	NNP	O	SM	appos	2	SENT_183	[p15l1686t1183r1808b1245],
12	,	,	O	,	_	0	SENT_183	[p15l1686t1183r1808b1245],
13	Pan	NNP	ORGANIZATION	Pan	nn	14	SENT_183	[p15l1860t1184r1972b1235],
14	HY	NNP	ORGANIZATION	HY	appos	2	SENT_183	[p15l2021t1184r2145b1245],
15	,	,	O	,	_	0	SENT_183	[p15l2021t1184r2145b1245],
16	Weinstein	NNP	PERSON	Weinstein	nn	17	SENT_183	[p15l159t1270r468b1324],
17	SH	NNP	O	SH	appos	2	SENT_183	[p15l492t1271r585b1324],
18	(	VBD	O	(	_	0	SENT_183	[p15l608t1271r805b1336],
19	1991	CD	DATE	1991	num	21	SENT_183	[p15l608t1271r805b1336],
20	)	CD	NUMBER	)	num	21	SENT_183	[p15l608t1271r805b1336],
21	Biotransformation	NN	O	biotransformation	dobj	18	SENT_183	[p15l829t1270r1387b1324],
22	of	IN	O	of	_	0	SENT_183	[p15l1410t1270r1475b1324],
23	pravastatin	NN	O	pravastatin	nn	24	SENT_183	[p15l1490t1270r1825b1339],
24	sodium	NN	O	sodium	prep_of	21	SENT_183	[p15l1849t1270r2070b1324],
25	in	IN	O	in	_	0	SENT_183	[p15l2090t1270r2148b1323],
26	humans	NNS	O	human	prep_in	18	SENT_183	[p15l159t1358r410b1411],
27	.	.	O	.	_	0	SENT_183	[p15l159t1358r410b1411],

1	Drug	NN	O	drug	nn	3	SENT_184	[p15l442t1359r595b1427],
2	Metab	NNP	O	Metab	nn	3	SENT_184	[p15l624t1358r816b1411],
3	Dispos	NNP	O	Dispos	_	0	SENT_184	[p15l844t1358r1052b1427],
4	l9	NN	O	l9	dep	3	SENT_184	[p15l1088t1358r1440b1412],
5	:740	CD	NUMBER	:740	num	4	SENT_184	[p15l1088t1358r1440b1412],
6	—	NN	O	—	dep	3	SENT_184	[p15l1088t1358r1440b1412],
7	748	CD	NUMBER	748	num	6	SENT_184	[p15l1088t1358r1440b1412],

1	Fukazawa	NN	O	fukazawa	nsubj	12	SENT_185	[p15l7t1447r315b1501],
2	I	CD	NUMBER	i	num	1	SENT_185	[p15l355t1449r395b1510],
3	,	,	O	,	_	0	SENT_185	[p15l355t1449r395b1510],
4	Uchida	NNP	PERSON	Uchida	nn	5	SENT_185	[p15l437t1447r657b1501],
5	N	NNP	O	N	appos	1	SENT_185	[p15l696t1449r765b1510],
6	,	,	O	,	_	0	SENT_185	[p15l696t1449r765b1510],
7	Uchida	NNP	PERSON	Uchida	nn	8	SENT_185	[p15l808t1447r1028b1501],
8	E	NNP	O	E	appos	1	SENT_185	[p15l1066t1449r1128b1510],
9	,	,	O	,	_	0	SENT_185	[p15l1066t1449r1128b1510],
10	Yasuhara	NNP	PERSON	Yasuhara	nn	11	SENT_185	[p15l1171t1447r1458b1500],
11	H	NNP	PERSON	H	appos	1	SENT_185	[p15l1497t1449r1551b1500],
12	(	VBD	O	(	_	0	SENT_185	[p15l1592t1448r1789b1513],
13	2003	CD	DATE	2003	num	15	SENT_185	[p15l1592t1448r1789b1513],
14	)	CD	NUMBER	)	num	15	SENT_185	[p15l1592t1448r1789b1513],
15	Effects	NNS	O	effect	dobj	12	SENT_185	[p15l1831t1447r2045b1500],
16	of	IN	O	of	_	0	SENT_185	[p15l2087t1447r2153b1500],
17	grapefruit	NN	O	grapefruit	nn	18	SENT_185	[p15l161t1535r460b1604],
18	juice	NN	O	juice	prep_of	15	SENT_185	[p15l489t1535r641b1604],
19	on	IN	O	on	_	0	SENT_185	[p15l678t1552r751b1589],
20	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	12	SENT_185	[p15l785t1535r1322b1604],
21	of	IN	O	of	_	0	SENT_185	[p15l1360t1535r1425b1589],
22	atorvastatin	NN	O	atorvastatin	prep_of	20	SENT_185	[p15l1456t1535r1811b1589],
23	and	CC	O	and	_	0	SENT_185	[p15l1847t1535r1954b1589],
24	pravastatin	NN	O	pravastatin	prep_of	20	SENT_185	[p15l1988t1552r2146b1604, p15l162t1623r358b1676],
25	in	IN	O	in	_	0	SENT_185	[p15l386t1623r443b1676],
26	Japanese	JJ	MISC	japanese	prep_in	12	SENT_185	[p15l470t1624r755b1692],
27	.	.	O	.	_	0	SENT_185	[p15l470t1624r755b1692],

1	Br	NN	O	br	nn	4	SENT_186	[p15l787t1624r862b1676],
2	J	NN	O	j	nn	4	SENT_186	[p15l888t1624r916b1676],
3	Clin	NN	O	clin	nn	4	SENT_186	[p15l944t1623r1073b1676],
4	Pharmacol	NN	O	pharmacol	_	0	SENT_186	[p15l1100t1623r1424b1676],
5	57:448	CD	NUMBER	57:448	num	6	SENT_186	[p15l1454t1623r1812b1676],
6	—	NN	O	—	dep	4	SENT_186	[p15l1454t1623r1812b1676],
7	455	CD	NUMBER	455	dep	4	SENT_186	[p15l1454t1623r1812b1676],

1	Hasegawa	NNP	PERSON	Hasegawa	nn	2	SENT_187	[p15l7t1713r319b1780],
2	M	NNP	O	M	_	0	SENT_187	[p15l351t1713r434b1774],
3	,	,	O	,	_	0	SENT_187	[p15l351t1713r434b1774],
4	Kusuhara	NNP	PERSON	Kusuhara	nn	5	SENT_187	[p15l471t1711r761b1764],
5	H	NNP	PERSON	H	appos	2	SENT_187	[p15l793t1713r862b1774],
6	,	,	O	,	_	0	SENT_187	[p15l793t1713r862b1774],
7	Sugiyama	NNP	PERSON	Sugiyama	nn	8	SENT_187	[p15l900t1711r1202b1780],
8	D	NNP	O	D	appos	2	SENT_187	[p15l1235t1713r1303b1774],
9	,	,	O	,	_	0	SENT_187	[p15l1235t1713r1303b1774],
10	Ito	NNP	LOCATION	Ito	nn	11	SENT_187	[p15l1340t1713r1422b1764],
11	K	NNP	LOCATION	K	appos	2	SENT_187	[p15l1457t1713r1525b1774],
12	,	,	O	,	_	0	SENT_187	[p15l1457t1713r1525b1774],
13	Ueda	NNP	PERSON	Ueda	nn	14	SENT_187	[p15l1561t1711r1721b1765],
14	S	NNP	O	S	appos	2	SENT_187	[p15l1755t1712r1810b1774],
15	,	,	O	,	_	0	SENT_187	[p15l1755t1712r1810b1774],
16	Endou	NNP	O	Endou	nn	17	SENT_187	[p15l1845t1711r2043b1764],
17	H	NNP	O	H	appos	2	SENT_187	[p15l2076t1713r2145b1774],
18	,	,	O	,	_	0	SENT_187	[p15l2076t1713r2145b1774],
19	Sugiyama	NNP	PERSON	Sugiyama	nn	20	SENT_187	[p15l162t1799r465b1868],
20	Y	NN	PERSON	y	appos	2	SENT_187	[p15l487t1801r540b1852],
21	(	CD	NUMBER	(	num	22	SENT_187	[p15l566t1800r762b1865],
22	2002	CD	DATE	2002	dep	20	SENT_187	[p15l566t1800r762b1865],
23	)	CD	NUMBER	)	num	25	SENT_187	[p15l566t1800r762b1865],
24	Functional	JJ	O	functional	amod	25	SENT_187	[p15l788t1799r1113b1853],
25	involvement	NN	O	involvement	dep	2	SENT_187	[p15l1137t1799r1518b1853],
26	of	IN	O	of	_	0	SENT_187	[p15l1543t1799r1608b1853],
27	rat	NN	O	rat	prep_of	25	SENT_187	[p15l1626t1808r1706b1853],
28	organic	JJ	O	organic	amod	33	SENT_187	[p15l1730t1799r1955b1868],
29	anion	NN	O	anion	nn	33	SENT_187	[p15l1982t1799r2148b1853],
30	transporter	NN	O	transporter	nn	33	SENT_187	[p15l160t1895r490b1956],
31	3	CD	NUMBER	3	num	33	SENT_187	[p15l534t1888r564b1941],
32	(	NN	O	(	nn	33	SENT_187	[p15l613t1887r1098b1953],
33	rOat3	NN	O	roat3	dep	2	SENT_187	[p15l613t1887r1098b1953],
34	;	:	O	;	_	0	SENT_187	[p15l613t1887r1098b1953],
35	Slc22a8	NN	O	slc22a8	nn	36	SENT_187	[p15l613t1887r1098b1953],
36	)	NN	O	)	dep	33	SENT_187	[p15l613t1887r1098b1953],
37	in	IN	O	in	_	0	SENT_187	[p15l1143t1887r1201b1940],
38	the	DT	O	the	det	40	SENT_187	[p15l1244t1887r1335b1941],
39	renal	JJ	O	renal	amod	40	SENT_187	[p15l1377t1888r1529b1941],
40	uptake	NN	O	uptake	prep_in	36	SENT_187	[p15l1571t1888r1773b1956],
41	of	IN	O	of	_	0	SENT_187	[p15l1817t1887r1883b1941],
42	organic	JJ	O	organic	amod	43	SENT_187	[p15l1922t1887r2146b1956],
43	anions	NNS	O	anion	prep_of	40	SENT_187	[p15l162t1975r372b2028],
44	.	.	O	.	_	0	SENT_187	[p15l162t1975r372b2028],

1	J	NNP	O	J	nn	4	SENT_188	[p15l403t1977r432b2029],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_188	[p15l458t1975r783b2028],
3	Exp	NNP	O	Exp	nn	4	SENT_188	[p15l811t1977r931b2044],
4	Ther	NNP	O	Ther	_	0	SENT_188	[p15l960t1975r1103b2028],
5	300:746	CD	NUMBER	300:746	number	6	SENT_188	[p15l1131t1975r1526b2029],
6	—	CD	NUMBER	—	dep	4	SENT_188	[p15l1131t1975r1526b2029],
7	753	CD	NUMBER	753	dep	6	SENT_188	[p15l1131t1975r1526b2029],

1	Hirano	NNP	PERSON	Hirano	nn	2	SENT_189	[p15l7t2063r216b2116],
2	M	NNP	O	M	nsubj	26	SENT_189	[p15l250t2065r331b2126],
3	,	,	O	,	_	0	SENT_189	[p15l250t2065r331b2126],
4	Maeda	NNP	PERSON	Maeda	nn	5	SENT_189	[p15l367t2063r574b2116],
5	K	NNP	PERSON	K	dep	20	SENT_189	[p15l607t2065r675b2126],
6	,	,	O	,	_	0	SENT_189	[p15l607t2065r675b2126],
7	Hayashi	NNP	PERSON	Hayashi	nn	8	SENT_189	[p15l711t2063r958b2132],
8	H	NNP	O	H	appos	5	SENT_189	[p15l992t2065r1061b2126],
9	,	,	O	,	_	0	SENT_189	[p15l992t2065r1061b2126],
10	Kusuhara	NNP	O	Kusuhara	nn	11	SENT_189	[p15l1098t2063r1388b2116],
11	H	NNP	O	H	appos	5	SENT_189	[p15l1420t2065r1489b2126],
12	,	,	O	,	_	0	SENT_189	[p15l1420t2065r1489b2126],
13	Sugiyama	NNP	PERSON	Sugiyama	appos	5	SENT_189	[p15l1526t2063r1829b2132],
14	Y	NN	PERSON	y	dep	20	SENT_189	[p15l1861t2065r1914b2116],
15	(	CD	NUMBER	(	num	14	SENT_189	[p15l1950t2063r2146b2129],
16	2005	CD	DATE	2005	num	20	SENT_189	[p15l1950t2063r2146b2129],
17	)	NNP	O	)	nn	20	SENT_189	[p15l1950t2063r2146b2129],
18	Bile	NNP	O	Bile	nn	20	SENT_189	[p15l160t2151r285b2205],
19	salt	NN	O	salt	nn	20	SENT_189	[p15l316t2152r419b2205],
20	export	NN	O	export	dep	26	SENT_189	[p15l447t2160r640b2220],
21	pump	NN	O	pump	dep	20	SENT_189	[p15l666t2168r838b2220],
22	(	CD	NUMBER	(	num	24	SENT_189	[p15l870t2152r1400b2217],
23	BSEP/ABCB11	NN	O	bsep/abcb11	nn	24	SENT_189	[p15l870t2152r1400b2217],
24	)	NN	O	)	nsubj	26	SENT_189	[p15l870t2152r1400b2217],
25	can	MD	O	can	aux	26	SENT_189	[p15l1431t2168r1535b2205],
26	transport	VB	O	transport	_	0	SENT_189	[p15l1563t2159r1833b2220],
27	a	DT	O	a	det	30	SENT_189	[p15l1862t2168r1894b2205],
28	nonbile	JJ	O	nonbile	amod	30	SENT_189	[p15l1921t2151r2147b2205],
29	acid	NN	O	acid	nn	30	SENT_189	[p15l162t2241r286b2294],
30	substrate	NN	O	substrate	dobj	26	SENT_189	[p15l316t2241r599b2303],
31	,	,	O	,	_	0	SENT_189	[p15l316t2241r599b2303],
32	pravastatin	NN	O	pravastatin	appos	30	SENT_189	[p15l628t2241r978b2309],
33	.	.	O	.	_	0	SENT_189	[p15l628t2241r978b2309],

1	J	NNP	O	J	nn	4	SENT_190	[p15l1009t2242r1037b2294],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_190	[p15l1064t2241r1389b2294],
3	Exp	NNP	O	Exp	nn	4	SENT_190	[p15l1416t2242r1537b2309],
4	Ther	NNP	O	Ther	_	0	SENT_190	[p15l1565t2241r1709b2294],
5	314:876	CD	NUMBER	314:876	number	6	SENT_190	[p15l1737t2241r2135b2294],
6	—	CD	NUMBER	—	dep	4	SENT_190	[p15l1737t2241r2135b2294],
7	882	CD	NUMBER	882	num	8	SENT_190	[p15l1737t2241r2135b2294],
8	Ieiri	NN	O	ieirus	dep	6	SENT_190	[p15l7t2329r132b2383],
9	I	PRP	O	I	dep	4	SENT_190	[p15l157t2331r197b2392],
10	,	,	O	,	_	0	SENT_190	[p15l157t2331r197b2392],
11	Suwannakul	NNP	O	Suwannakul	nn	12	SENT_190	[p15l227t2329r599b2383],
12	S	NNP	O	S	appos	9	SENT_190	[p15l627t2330r681b2392],
13	,	,	O	,	_	0	SENT_190	[p15l627t2330r681b2392],
14	Maeda	NNP	PERSON	Maeda	nn	15	SENT_190	[p15l709t2329r916b2383],
15	K	NNP	PERSON	K	appos	9	SENT_190	[p15l941t2331r1009b2392],
16	,	,	O	,	_	0	SENT_190	[p15l941t2331r1009b2392],
17	Uchimaru	NNP	O	Uchimaru	nn	18	SENT_190	[p15l1036t2329r1340b2383],
18	H	NNP	O	H	appos	9	SENT_190	[p15l1366t2331r1434b2392],
19	,	,	O	,	_	0	SENT_190	[p15l1366t2331r1434b2392],
20	Hashimoto	NN	PERSON	hashimoto	nn	21	SENT_190	[p15l1462t2329r1794b2383],
21	K	NN	PERSON	k	appos	9	SENT_190	[p15l1821t2331r1889b2392],
22	,	,	O	,	_	0	SENT_190	[p15l1821t2331r1889b2392],
23	Kimura	NNP	PERSON	Kimura	nn	24	SENT_190	[p15l1918t2329r2149b2383],
24	M	NNP	PERSON	M	appos	9	SENT_190	[p15l160t2419r242b2480],
25	,	,	O	,	_	0	SENT_190	[p15l160t2419r242b2480],
26	Fujino	NNP	PERSON	Fujino	nn	27	SENT_190	[p15l295t2417r492b2486],
27	H	NNP	PERSON	H	appos	9	SENT_190	[p15l545t2419r613b2480],
28	,	,	O	,	_	0	SENT_190	[p15l545t2419r613b2480],
29	Hirano	NNP	PERSON	Hirano	nn	30	SENT_190	[p15l668t2417r876b2471],
30	M	NNP	O	M	appos	9	SENT_190	[p15l928t2419r1009b2480],
31	,	,	O	,	_	0	SENT_190	[p15l928t2419r1009b2480],
32	Kusuhara	NNP	PERSON	Kusuhara	nn	33	SENT_190	[p15l1065t2417r1355b2471],
33	H	NNP	PERSON	H	appos	9	SENT_190	[p15l1405t2419r1474b2481],
34	,	,	O	,	_	0	SENT_190	[p15l1405t2419r1474b2481],
35	Irie	NNP	PERSON	Irie	nn	36	SENT_190	[p15l1528t2417r1632b2471],
36	S	NNP	O	S	appos	9	SENT_190	[p15l1686t2418r1740b2481],
37	,	,	O	,	_	0	SENT_190	[p15l1686t2418r1740b2481],
38	Higuchi	NNP	PERSON	Higuchi	nn	39	SENT_190	[p15l1794t2417r2037b2486],
39	S	NNP	O	S	appos	9	SENT_190	[p15l2091t2418r2145b2480],
40	,	,	O	,	_	0	SENT_190	[p15l2091t2418r2145b2480],
41	Sugiyama	NNP	PERSON	Sugiyama	nn	42	SENT_190	[p15l162t2506r465b2574],
42	Y	NN	PERSON	y	appos	9	SENT_190	[p15l507t2507r559b2558],
43	(	CD	NUMBER	(	num	44	SENT_190	[p15l604t2506r801b2571],
44	2007	CD	DATE	2007	dep	4	SENT_190	[p15l604t2506r801b2571],
45	)	CD	NUMBER	)	num	46	SENT_190	[p15l604t2506r801b2571],
46	SLCO1B1	NN	O	slco1b1	dep	44	SENT_190	[p15l848t2506r1159b2559],
47	(	CD	NUMBER	(	num	48	SENT_190	[p15l1210t2506r1573b2571],
48	OATPIB1	NN	O	oatpib1	dep	4	SENT_190	[p15l1210t2506r1573b2571],
49	,	,	O	,	_	0	SENT_190	[p15l1210t2506r1573b2571],
50	an	DT	O	a	det	53	SENT_190	[p15l1620t2522r1689b2559],
51	uptake	NN	O	uptake	nn	53	SENT_190	[p15l1731t2506r1933b2574],
52	transporter	NN	O	transporter	nn	53	SENT_190	[p15l1976t2514r2146b2559, p15l159t2594r364b2662],
53	)	NN	O	)	conj_and	48	SENT_190	[p15l1976t2514r2146b2559, p15l159t2594r364b2662],
54	and	CC	O	and	_	0	SENT_190	[p15l391t2593r498b2646],
55	ABCG2	NN	O	abcg2	conj_and	48	SENT_190	[p15l520t2594r767b2647],
56	(	CD	NUMBER	(	num	57	SENT_190	[p15l793t2594r1025b2659],
57	BCRP	NN	O	bcrp	dep	4	SENT_190	[p15l793t2594r1025b2659],
58	,	,	O	,	_	0	SENT_190	[p15l793t2594r1025b2659],
59	an	DT	O	a	det	61	SENT_190	[p15l1052t2610r1121b2646],
60	efﬂux	NN	O	efﬂux	nn	61	SENT_190	[p15l1144t2593r1319b2646],
61	transporter	NN	O	transporter	appos	57	SENT_190	[p15l1343t2594r1694b2662],
62	)	CD	NUMBER	)	num	64	SENT_190	[p15l1343t2594r1694b2662],
63	variant	JJ	O	variant	amod	64	SENT_190	[p15l1721t2593r1932b2647],
64	alleles	NNS	O	allele	dep	4	SENT_190	[p15l1956t2593r2146b2646],
65	and	CC	O	and	_	0	SENT_190	[p15l161t2682r269b2735],
66	pharmacokinetics	NNS	O	pharmacokinetic	dep	4	SENT_190	[p15l293t2681r831b2750],
67	of	IN	O	of	_	0	SENT_190	[p15l860t2681r925b2735],
68	pitavastatin	NN	O	pitavastatin	prep_of	64	SENT_190	[p15l945t2681r1297b2750],
69	in	IN	O	in	_	0	SENT_190	[p15l1323t2681r1381b2734],
70	healthy	JJ	O	healthy	amod	71	SENT_190	[p15l1407t2682r1630b2750],
71	volunteers	NNS	O	volunteer	prep_in	68	SENT_190	[p15l1657t2682r1988b2735],
72	.	.	O	.	_	0	SENT_190	[p15l1657t2682r1988b2735],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_191	[p15l2019t2681r2148b2735],
2	Pharmacol	NNP	PERSON	Pharmacol	nn	3	SENT_191	[p15l160t2771r485b2824],
3	T	NN	O	t	_	0	SENT_191	[p15l512t2772r557b2823],
4	her	PRP$	O	she	dep	3	SENT_191	[p15l559t2771r656b2824],
5	822541-547	CD	NUMBER	822541-547	dep	3	SENT_191	[p15l685t2770r1043b2824],

1	Iwai	NNP	O	Iwai	nn	2	SENT_192	[p15l7t2859r140b2912],
2	M	NNP	O	M	_	0	SENT_192	[p15l168t2860r250b2922],
3	,	,	O	,	_	0	SENT_192	[p15l168t2860r250b2922],
4	Suzuki	NNP	PERSON	Suzuki	nn	5	SENT_192	[p15l282t2859r489b2912],
5	H	NNP	PERSON	H	appos	2	SENT_192	[p15l518t2860r586b2922],
6	,	,	O	,	_	0	SENT_192	[p15l518t2860r586b2922],
7	Ieiri	NNP	O	Ieiri	nn	11	SENT_192	[p15l616t2859r741b2912],
8	I	PRP	O	I	dep	11	SENT_192	[p15l769t2860r809b2922],
9	,	,	O	,	_	0	SENT_192	[p15l769t2860r809b2922],
10	Otsubo	NNP	PERSON	Otsubo	dep	11	SENT_192	[p15l841t2859r1056b2912],
11	K	NNP	O	K	appos	2	SENT_192	[p15l1086t2860r1153b2922],
12	,	,	O	,	_	0	SENT_192	[p15l1086t2860r1153b2922],
13	Sugiyama	NNP	PERSON	Sugiyama	nn	14	SENT_192	[p15l1185t2859r1488b2928],
14	Y	NN	PERSON	y	appos	2	SENT_192	[p15l1515t2860r1567b2911],
15	(	CD	NUMBER	(	num	16	SENT_192	[p15l1597t2859r1793b2925],
16	2004	CD	DATE	2004	dep	14	SENT_192	[p15l1597t2859r1793b2925],
17	)	CD	NUMBER	)	num	19	SENT_192	[p15l1597t2859r1793b2925],
18	Functional	JJ	O	functional	amod	19	SENT_192	[p15l1823t2859r2148b2912],
19	analysis	NN	O	analysis	dep	2	SENT_192	[p15l162t2946r403b3015],
20	of	IN	O	of	_	0	SENT_192	[p15l434t2946r500b3000],
21	single	JJ	O	single	amod	23	SENT_192	[p15l526t2946r704b3015],
22	nucleotide	NN	O	nucleotide	nn	23	SENT_192	[p15l734t2946r1050b3000],
23	polymorphisms	NNS	O	polymorphism	prep_of	19	SENT_192	[p15l1078t2946r1551b3015],
24	of	IN	O	of	_	0	SENT_192	[p15l1583t2946r1648b3000],
25	hepatic	JJ	O	hepatic	amod	27	SENT_192	[p15l1671t2946r1890b3015],
26	organic	JJ	O	organic	amod	27	SENT_192	[p15l1922t2947r2146b3015],
27	anion	NN	O	anion	prep_of	23	SENT_192	[p15l162t3035r328b3088],
28	transporter	NN	O	transporter	nn	29	SENT_192	[p15l395t3042r725b3103],
29	OATP1B1	NN	O	oatp1b1	dep	2	SENT_192	[p15l794t3035r1109b3088],
30	(	CD	NUMBER	(	num	31	SENT_192	[p15l1185t3035r1521b3100],
31	OATP	NN	O	oatp	dep	29	SENT_192	[p15l1185t3035r1521b3100],
32	.	.	O	.	_	0	SENT_192	[p15l1185t3035r1521b3100],

1	—	NN	O	—	_	0	SENT_193	[p15l1185t3035r1521b3100],
2	.	.	O	.	_	0	SENT_193	[p15l1185t3035r1521b3100],

1	C	NN	O	c	_	0	SENT_194	[p15l1185t3035r1521b3100],
2	)	NN	O	)	dep	1	SENT_194	[p15l1185t3035r1521b3100],
3	.	.	O	.	_	0	SENT_194	[p15l1185t3035r1521b3100],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_195	[p15l1593t3035r2146b3103],
2	14:749	CD	NUMBER	14:749	num	3	SENT_195	[p15l168t3124r520b3178],
3	—	NN	O	—	dep	1	SENT_195	[p15l168t3124r520b3178],
4	757	CD	NUMBER	757	dep	1	SENT_195	[p15l168t3124r520b3178],

1	Jacobson	NNP	PERSON	Jacobson	nn	2	SENT_196	[p15l7t3212r285b3265],
2	TA	NNP	O	TA	nsubj	3	SENT_196	[p15l319t3212r419b3264],
3	(	VBD	O	(	_	0	SENT_196	[p15l456t3212r653b3278],
4	2004	CD	DATE	2004	num	5	SENT_196	[p15l456t3212r653b3278],
5	)	CD	NUMBER	)	dobj	3	SENT_196	[p15l456t3212r653b3278],
6	Comparative	JJ	O	comparative	amod	9	SENT_196	[p15l691t3212r1083b3281],
7	pharmacokinetic	JJ	O	pharmacokinetic	amod	9	SENT_196	[p15l1118t3212r1625b3281],
8	interaction	NN	O	interaction	nn	9	SENT_196	[p15l1662t3212r1988b3265],
9	proﬁles	NNS	O	proﬁles	dep	3	SENT_196	[p15l2022t3229r2146b3281, p15l161t3301r284b3354],
10	of	IN	O	of	_	0	SENT_196	[p15l362t3301r428b3354],
11	pravastatin	NN	O	pravastatin	prep_of	9	SENT_196	[p15l497t3301r848b3369],
12	,	,	O	,	_	0	SENT_196	[p15l497t3301r848b3369],
13	simvastatin	NN	O	simvastatin	conj_and	11	SENT_196	[p15l930t3301r1290b3363],
14	,	,	O	,	_	0	SENT_196	[p15l930t3301r1290b3363],
15	and	CC	O	and	_	0	SENT_196	[p15l1371t3301r1478b3354],
16	atorvastatin	NN	O	atorvastatin	conj_and	11	SENT_196	[p15l1555t3301r1909b3354],
17	when	WRB	O	when	advmod	18	SENT_196	[p15l1985t3301r2148b3354],
18	coadministered	VBN	O	coadminister	dep	11	SENT_196	[p15l161t3389r626b3442],
19	with	IN	O	with	_	0	SENT_196	[p15l655t3389r789b3442],
20	cytochrome	NN	O	cytochrome	nn	22	SENT_196	[p15l818t3389r1176b3457],
21	p450	NN	O	p450	nn	22	SENT_196	[p15l1204t3388r1355b3457],
22	inhibitors	NNS	O	inhibitor	prep_with	18	SENT_196	[p15l1385t3389r1691b3442],
23	.	.	O	.	_	0	SENT_196	[p15l1385t3389r1691b3442],

1	Am	VBP	O	be	dep	3	SENT_197	[p15l1723t3389r1837b3441],
2	J	NN	O	j	nn	3	SENT_197	[p15l1864t3390r1892b3442],
3	Cardiol	NN	O	cardiol	_	0	SENT_197	[p15l1921t3389r2147b3442],
4	94:1140	CD	NUMBER	94:1140	number	5	SENT_197	[p15l161t3478r598b3532],
5	—	CD	NUMBER	—	dep	3	SENT_197	[p15l161t3478r598b3532],
6	1146	CD	DATE	1146	dep	5	SENT_197	[p15l161t3478r598b3532],

1	Kameyama	NNP	PERSON	Kameyama	nn	2	SENT_198	[p15l8t3567r354b3634],
2	Y	NN	PERSON	y	nsubj	15	SENT_198	[p15l387t3567r455b3628],
3	,	,	O	,	_	0	SENT_198	[p15l387t3567r455b3628],
4	Yamashita	NNP	PERSON	Yamashita	nn	5	SENT_198	[p15l491t3565r816b3619],
5	K	NNP	PERSON	K	appos	2	SENT_198	[p15l849t3567r917b3628],
6	,	,	O	,	_	0	SENT_198	[p15l849t3567r917b3628],
7	Kobayashi	NNP	LOCATION	Kobayashi	nn	8	SENT_198	[p15l953t3565r1275b3634],
8	K	NNP	LOCATION	K	appos	2	SENT_198	[p15l1310t3567r1378b3629],
9	,	,	O	,	_	0	SENT_198	[p15l1310t3567r1378b3629],
10	Hosokawa	NNP	PERSON	Hosokawa	nn	11	SENT_198	[p15l1413t3566r1733b3619],
11	M	NNP	O	M	appos	2	SENT_198	[p15l1765t3567r1847b3628],
12	,	,	O	,	_	0	SENT_198	[p15l1765t3567r1847b3628],
13	Chiba	NNP	ORGANIZATION	Chiba	nn	14	SENT_198	[p15l1883t3565r2064b3619],
14	K	NNP	ORGANIZATION	K	appos	2	SENT_198	[p15l2097t3567r2150b3618],
15	(	VBD	O	(	_	0	SENT_198	[p15l162t3654r359b3720],
16	2005	CD	DATE	2005	num	17	SENT_198	[p15l162t3654r359b3720],
17	)	CD	NUMBER	)	nn	19	SENT_198	[p15l162t3654r359b3720],
18	Functional	JJ	O	functional	amod	19	SENT_198	[p15l415t3655r740b3708],
19	characterization	NN	O	characterization	dobj	15	SENT_198	[p15l794t3655r1282b3708],
20	of	IN	O	of	_	0	SENT_198	[p15l1337t3655r1402b3708],
21	SLCO1B1	NN	O	slco1b1	nn	23	SENT_198	[p15l1453t3655r1764b3708],
22	(	CD	NUMBER	(	num	23	SENT_198	[p15l1827t3655r2146b3720],
23	OATP	NN	O	oatp	prep_of	19	SENT_198	[p15l1827t3655r2146b3720],
24	.	.	O	.	_	0	SENT_198	[p15l1827t3655r2146b3720],

1	—	NN	O	—	_	0	SENT_199	[p15l1827t3655r2146b3720],
2	.	.	O	.	_	0	SENT_199	[p15l1827t3655r2146b3720],

1	C	NN	O	c	_	0	SENT_200	[p15l1827t3655r2146b3720],
2	)	CD	NUMBER	)	num	3	SENT_200	[p15l1827t3655r2146b3720],
3	Variants	NNS	O	variant	dep	1	SENT_200	[p15l160t3744r416b3807],
4	,	,	O	,	_	0	SENT_200	[p15l160t3744r416b3807],
5	SLCO1B1	NN	O	slco1b1	appos	3	SENT_200	[p15l484t3744r894b3807],
6	*	CD	NUMBER	*	number	7	SENT_200	[p15l484t3744r894b3807],
7	5	CD	NUMBER	5	dep	5	SENT_200	[p15l484t3744r894b3807],
8	,	,	O	,	_	0	SENT_200	[p15l484t3744r894b3807],
9	SLCO1B1	NN	O	slco1b1	appos	3	SENT_200	[p15l963t3744r1391b3798],
10	*	CD	NUMBER	*	number	11	SENT_200	[p15l963t3744r1391b3798],
11	15	CD	NUMBER	15	dep	9	SENT_200	[p15l963t3744r1391b3798],
12	and	CC	O	and	_	0	SENT_200	[p15l1459t3744r1567b3797],
13	SLCO1B1	NN	O	slco1b1	appos	3	SENT_200	[p15l1631t3744r2059b3797],
14	*	CD	NUMBER	*	number	15	SENT_200	[p15l1631t3744r2059b3797],
15	15	CD	NUMBER	15	dep	13	SENT_200	[p15l1631t3744r2059b3797],
16	+	CC	O	+	cc	15	SENT_200	[p15l2093t3751r2145b3803],

1	Cl007G	NN	O	cl007g	_	0	SENT_201	[p16l161t19r432b82],
2	,	,	O	,	_	0	SENT_201	[p16l161t19r432b82],
3	by	IN	O	by	dep	1	SENT_201	[p16l473t19r548b88],
4	using	VBG	O	use	pcomp	3	SENT_201	[p16l587t19r750b88],
5	transient	JJ	O	transient	amod	7	SENT_201	[p16l790t19r1052b72],
6	expression	NN	O	expression	nn	7	SENT_201	[p16l1091t19r1414b88],
7	systems	NNS	O	system	dobj	4	SENT_201	[p16l1456t27r1691b88],
8	of	IN	O	of	_	0	SENT_201	[p16l1733t19r1799b72],
9	HeLa	NN	O	helum	nn	12	SENT_201	[p16l1833t20r2001b72],
10	and	CC	O	and	_	0	SENT_201	[p16l2041t19r2149b72],
11	HEK293	NN	O	hek293	nn	12	SENT_201	[p16l160t108r425b162],
12	cells	NNS	O	cell	prep_of	7	SENT_201	[p16l452t108r605b161],
13	.	.	O	.	_	0	SENT_201	[p16l452t108r605b161],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_202	[p16l631t108r1101b177],
2	Genomics	NNP	O	Genomics	_	0	SENT_202	[p16l1125t108r1430b161],
3	15:513	CD	NUMBER	15:513	dep	2	SENT_202	[p16l1462t107r1816b161],
4	—	CD	NUMBER	—	number	5	SENT_202	[p16l1462t107r1816b161],
5	522	CD	NUMBER	522	dep	3	SENT_202	[p16l1462t107r1816b161],

1	Kantola	JJ	ORGANIZATION	kantola	amod	2	SENT_203	[p16l8t197r248b250],
2	T	NN	ORGANIZATION	t	dep	18	SENT_203	[p16l273t198r334b260],
3	,	,	O	,	_	0	SENT_203	[p16l273t198r334b260],
4	Backman	NNP	PERSON	Backman	nn	5	SENT_203	[p16l362t197r650b250],
5	JT	NNP	O	JT	appos	2	SENT_203	[p16l675t198r766b260],
6	,	,	O	,	_	0	SENT_203	[p16l675t198r766b260],
7	Niemi	NNP	PERSON	Niemi	nn	8	SENT_203	[p16l794t197r984b250],
8	M	NNP	O	M	appos	2	SENT_203	[p16l1010t198r1092b260],
9	,	,	O	,	_	0	SENT_203	[p16l1010t198r1092b260],
10	Kivisto	NNP	ORGANIZATION	Kivisto	nn	11	SENT_203	[p16l1122t197r1342b250],
11	KT	NNP	ORGANIZATION	KT	appos	2	SENT_203	[p16l1371t198r1485b260],
12	,	,	O	,	_	0	SENT_203	[p16l1371t198r1485b260],
13	Neuvonen	NNP	PERSON	Neuvonen	nn	15	SENT_203	[p16l1513t198r1825b250],
14	PJ	NNP	PERSON	PJ	nn	15	SENT_203	[p16l1851t198r1921b250],
15	(	NNP	O	(	appos	2	SENT_203	[p16l1950t197r2146b263],
16	2000	CD	DATE	2000	num	18	SENT_203	[p16l1950t197r2146b263],
17	)	CD	NUMBER	)	num	18	SENT_203	[p16l1950t197r2146b263],
18	Effect	NN	O	effect	_	0	SENT_203	[p16l159t284r346b337],
19	of	IN	O	of	_	0	SENT_203	[p16l395t284r461b337],
20	ﬂuconazole	NN	O	ﬂuconazole	prep_of	18	SENT_203	[p16l506t284r855b337],
21	on	IN	O	on	_	0	SENT_203	[p16l905t301r979b337],
22	plasma	NN	O	plasma	nn	23	SENT_203	[p16l1027t284r1243b353],
23	ﬂuvastatin	NN	O	ﬂuvastatin	prep_on	20	SENT_203	[p16l1292t284r1608b337],
24	and	CC	O	and	_	0	SENT_203	[p16l1658t284r1765b337],
25	pravastatin	NN	O	pravastatin	nn	26	SENT_203	[p16l1814t284r2148b353],
26	concentrations	NNS	O	concentration	prep_on	20	SENT_203	[p16l161t373r619b426],
27	.	.	O	.	_	0	SENT_203	[p16l161t373r619b426],

1	Eur	NNP	O	Eur	nn	4	SENT_204	[p16l651t374r761b426],
2	J	NNP	O	J	nn	4	SENT_204	[p16l786t374r814b426],
3	Clin	NNP	O	Clin	nn	4	SENT_204	[p16l842t373r971b426],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_204	[p16l998t373r1323b426],
5	562225-229	CD	NUMBER	562225-229	dep	4	SENT_204	[p16l1352t373r1711b427],

1	Kawabata	NNP	PERSON	Kawabata	nn	2	SENT_205	[p16l8t463r311b516],
2	K	NNP	PERSON	K	_	0	SENT_205	[p16l334t464r402b526],
3	,	,	O	,	_	0	SENT_205	[p16l334t464r402b526],
4	Samata	NNP	ORGANIZATION	Samata	nn	5	SENT_205	[p16l429t463r652b516],
5	N	NNP	ORGANIZATION	N	appos	2	SENT_205	[p16l673t464r743b526],
6	,	,	O	,	_	0	SENT_205	[p16l673t464r743b526],
7	Urasaki	NNP	O	Urasaki	nn	8	SENT_205	[p16l768t463r1003b516],
8	Y	NN	O	y	appos	2	SENT_205	[p16l1026t464r1079b515],
9	(	CD	NUMBER	(	num	10	SENT_205	[p16l1104t463r1300b528],
10	2005	CD	DATE	2005	dep	8	SENT_205	[p16l1104t463r1300b528],
11	)	CD	NUMBER	)	num	13	SENT_205	[p16l1104t463r1300b528],
12	Quantitative	JJ	MISC	quantitative	amod	13	SENT_205	[p16l1326t463r1701b529],
13	determination	NN	O	determination	dep	2	SENT_205	[p16l1725t463r2148b516],
14	of	IN	O	of	_	0	SENT_205	[p16l161t550r227b603],
15	pravastatin	NN	O	pravastatin	prep_of	13	SENT_205	[p16l247t550r582b619],
16	and	CC	O	and	_	0	SENT_205	[p16l610t550r717b603],
17	R-416	NN	O	r-416	prep_of	13	SENT_205	[p16l742t550r947b613],
18	,	,	O	,	_	0	SENT_205	[p16l742t550r947b613],
19	its	PRP$	O	its	poss	21	SENT_205	[p16l977t550r1045b603],
20	main	JJ	O	main	amod	21	SENT_205	[p16l1073t550r1224b603],
21	metabolite	NN	O	metabolite	appos	2	SENT_205	[p16l1250t550r1571b603],
22	in	IN	O	in	_	0	SENT_205	[p16l1599t550r1656b603],
23	human	JJ	O	human	amod	24	SENT_205	[p16l1682t550r1888b603],
24	plasma	NN	O	plasma	prep_in	21	SENT_205	[p16l1913t550r2145b619],
25	,	,	O	,	_	0	SENT_205	[p16l1913t550r2145b619],
26	by	IN	O	by	_	0	SENT_205	[p16l159t638r234b707],
27	liquid	JJ	O	liquid	amod	32	SENT_205	[p16l270t638r448b707],
28	chromatography	NN	O	chromatography	nn	32	SENT_205	[p16l484t638r1234b707],
29	—	NN	O	—	nn	32	SENT_205	[p16l484t638r1234b707],
30	tandem	JJ	O	tandem	amod	32	SENT_205	[p16l484t638r1234b707],
31	mass	NN	O	mass	nn	32	SENT_205	[p16l1269t655r1418b691],
32	spectrometry	NN	O	spectrometry	prep_by	2	SENT_205	[p16l1459t646r1868b707],
33	.	.	O	.	_	0	SENT_205	[p16l1459t646r1868b707],

1	J	NN	O	j	nn	3	SENT_206	[p16l1908t639r1936b691],
2	Chromatr	NN	O	chromatr	nn	3	SENT_206	[p16l1973t638r2146b691, p16l160t735r300b780],
3	B	NN	O	b	_	0	SENT_206	[p16l326t729r370b780],
4	8l6	CD	NUMBER	8l6	num	5	SENT_206	[p16l405t727r725b781],
5	:73	CD	NUMBER	:73	dep	3	SENT_206	[p16l405t727r725b781],
6	—	NN	O	—	dep	3	SENT_206	[p16l405t727r725b781],
7	79	CD	NUMBER	79	num	6	SENT_206	[p16l405t727r725b781],

1	Kivisto	NNP	PERSON	Kivisto	nn	2	SENT_207	[p16l8t817r229b871],
2	KT	NNP	O	KT	nsubj	37	SENT_207	[p16l256t818r371b880],
3	,	,	O	,	_	0	SENT_207	[p16l256t818r371b880],
4	Grisk	NNP	PERSON	Grisk	nn	5	SENT_207	[p16l401t817r568b870],
5	O	NNP	PERSON	O	appos	2	SENT_207	[p16l593t817r661b880],
6	,	,	O	,	_	0	SENT_207	[p16l593t817r661b880],
7	Hofmann	NNP	ORGANIZATION	Hofmann	nn	8	SENT_207	[p16l689t817r976b870],
8	U	NNP	ORGANIZATION	U	appos	5	SENT_207	[p16l1001t818r1070b880],
9	,	,	O	,	_	0	SENT_207	[p16l1001t818r1070b880],
10	Meissner	NNP	PERSON	Meissner	nn	11	SENT_207	[p16l1098t817r1377b870],
11	K	NNP	PERSON	K	appos	5	SENT_207	[p16l1402t818r1470b880],
12	,	,	O	,	_	0	SENT_207	[p16l1402t818r1470b880],
13	Moritz	NNP	PERSON	Moritz	nn	14	SENT_207	[p16l1498t817r1703b870],
14	KU	NNP	PERSON	KU	appos	5	SENT_207	[p16l1732t818r1854b880],
15	,	,	O	,	_	0	SENT_207	[p16l1732t818r1854b880],
16	Ritter	NNP	PERSON	Ritter	nn	17	SENT_207	[p16l1882t817r2056b870],
17	C	NNP	O	C	appos	5	SENT_207	[p16l2081t817r2145b880],
18	,	,	O	,	_	0	SENT_207	[p16l2081t817r2145b880],
19	Arnold	NNP	ORGANIZATION	Arnold	nn	20	SENT_207	[p16l160t904r374b957],
20	KA	NN	ORGANIZATION	ka	appos	5	SENT_207	[p16l432t905r554b967],
21	,	,	O	,	_	0	SENT_207	[p16l432t905r554b967],
22	Lutjoohann	NN	PERSON	lutjoohann	nn	23	SENT_207	[p16l613t904r964b973],
23	D	NN	O	d	appos	5	SENT_207	[p16l1020t905r1089b967],
24	,	,	O	,	_	0	SENT_207	[p16l1020t905r1089b967],
25	Von	NNP	PERSON	Von	nn	27	SENT_207	[p16l1149t921r1261b957],
26	Bergmann	NNP	PERSON	Bergmann	nn	27	SENT_207	[p16l1317t905r1633b973],
27	K	NNP	PERSON	K	appos	5	SENT_207	[p16l1691t905r1759b967],
28	,	,	O	,	_	0	SENT_207	[p16l1691t905r1759b967],
29	Kloting	NNP	O	Kloting	nn	33	SENT_207	[p16l1819t904r2048b973],
30	I	PRP	O	I	dep	33	SENT_207	[p16l2105t905r2145b967],
31	,	,	O	,	_	0	SENT_207	[p16l2105t905r2145b967],
32	Eichelbaum	NNP	PERSON	Eichelbaum	dep	33	SENT_207	[p16l160t992r524b1045],
33	M	NNP	O	M	appos	5	SENT_207	[p16l564t994r647b1055],
34	,	,	O	,	_	0	SENT_207	[p16l564t994r647b1055],
35	Kroemer	NNP	PERSON	Kroemer	nn	36	SENT_207	[p16l691t994r960b1045],
36	HK	NNP	O	HK	appos	5	SENT_207	[p16l1000t994r1109b1045],
37	(	VBD	O	(	_	0	SENT_207	[p16l1150t992r1347b1058],
38	2005	CD	DATE	2005	num	39	SENT_207	[p16l1150t992r1347b1058],
39	)	CD	NUMBER	)	dobj	37	SENT_207	[p16l1150t992r1347b1058],
40	Disposition	NNP	O	Disposition	dep	37	SENT_207	[p16l1389t992r1739b1061],
41	of	IN	O	of	_	0	SENT_207	[p16l1781t992r1847b1045],
42	oral	JJ	O	oral	amod	45	SENT_207	[p16l1883t992r1998b1045],
43	and	CC	O	and	_	0	SENT_207	[p16l2041t992r2149b1045],
44	intravenous	JJ	O	intravenous	amod	45	SENT_207	[p16l160t1081r513b1134],
45	pravastatin	NN	O	pravastatin	prep_of	37	SENT_207	[p16l534t1081r868b1150],
46	in	IN	O	in	_	0	SENT_207	[p16l888t1081r947b1133],
47	MRP2-deﬁcient	JJ	O	mrp2-deﬁcient	amod	50	SENT_207	[p16l966t1081r1452b1134],
48	TR	NN	O	tr	nn	50	SENT_207	[p16l1472t1082r1609b1133],
49	‘	NN	O	‘	nn	50	SENT_207	[p16l1472t1082r1609b1133],
50	rats	NNS	O	rat	prep_in	37	SENT_207	[p16l1631t1089r1756b1134],
51	.	.	O	.	_	0	SENT_207	[p16l1631t1089r1756b1134],

1	Drug	NN	MISC	drug	_	0	SENT_208	[p16l1780t1082r1933b1150],
2	Metab	NNP	MISC	Metab	nn	3	SENT_208	[p16l1954t1081r2147b1134],
3	Dispos	NNP	MISC	Dispos	dep	1	SENT_208	[p16l160t1168r368b1237],
4	33:1593	CD	NUMBER	33:1593	number	5	SENT_208	[p16l399t1168r834b1222],
5	—	CD	NUMBER	—	num	6	SENT_208	[p16l399t1168r834b1222],
6	l596	NN	O	l596	dep	3	SENT_208	[p16l399t1168r834b1222],

1	Kobayashi	NNP	PERSON	Kobayashi	nn	2	SENT_209	[p16l8t1256r330b1325],
2	D	NNP	PERSON	D	_	0	SENT_209	[p16l360t1258r429b1319],
3	,	,	O	,	_	0	SENT_209	[p16l360t1258r429b1319],
4	Nozawa	NNP	ORGANIZATION	Nozawa	nn	5	SENT_209	[p16l460t1258r709b1310],
5	T	NN	ORGANIZATION	t	appos	2	SENT_209	[p16l738t1258r799b1319],
6	,	,	O	,	_	0	SENT_209	[p16l738t1258r799b1319],
7	Imai	NNP	LOCATION	Imai	nn	8	SENT_209	[p16l831t1256r968b1309],
8	K	NNP	LOCATION	K	appos	2	SENT_209	[p16l999t1258r1067b1319],
9	,	,	O	,	_	0	SENT_209	[p16l999t1258r1067b1319],
10	Nezu	NNP	PERSON	Nezu	nn	11	SENT_209	[p16l1098t1258r1257b1309],
11	JI	NNP	PERSON	JI	appos	2	SENT_209	[p16l1286t1258r1355b1319],
12	,	,	O	,	_	0	SENT_209	[p16l1286t1258r1355b1319],
13	Tsuji	NNP	PERSON	Tsuji	nn	14	SENT_209	[p16l1387t1256r1541b1325],
14	A	NNP	O	A	appos	2	SENT_209	[p16l1571t1257r1640b1319],
15	,	,	O	,	_	0	SENT_209	[p16l1571t1257r1640b1319],
16	Tamai	NNP	O	Tamai	appos	2	SENT_209	[p16l1671t1256r1865b1309],
17	I	PRP	O	I	nsubj	18	SENT_209	[p16l1895t1258r1918b1309],
18	(	VBP	O	(	rcmod	16	SENT_209	[p16l1950t1257r2146b1322],
19	2003	CD	DATE	2003	num	21	SENT_209	[p16l1950t1257r2146b1322],
20	)	CD	NUMBER	)	num	21	SENT_209	[p16l1950t1257r2146b1322],
21	Involvement	NN	O	involvement	nsubj	26	SENT_209	[p16l160t1344r545b1397],
22	of	IN	O	of	_	0	SENT_209	[p16l582t1344r647b1397],
23	human	JJ	O	human	amod	25	SENT_209	[p16l677t1344r883b1397],
24	organic	JJ	O	organic	amod	25	SENT_209	[p16l920t1344r1145b1413],
25	anion	NN	O	anion	prep_of	21	SENT_209	[p16l1184t1344r1350b1397],
26	transporting	VBG	O	transport	dep	18	SENT_209	[p16l1386t1344r1752b1413],
27	polypeptide	NN	O	polypeptide	nn	28	SENT_209	[p16l1788t1344r2147b1413],
28	OATP-B	NN	O	oatp-b	nsubj	31	SENT_209	[p16l161t1433r428b1485],
29	(	CD	NUMBER	(	num	31	SENT_209	[p16l457t1432r810b1498],
30	SLC21A9	NN	O	slc21a9	nn	31	SENT_209	[p16l457t1432r810b1498],
31	)	NN	O	)	xcomp	26	SENT_209	[p16l457t1432r810b1498],
32	in	IN	O	in	_	0	SENT_209	[p16l835t1432r892b1485],
33	pH-dependent	JJ	O	ph-dependent	amod	34	SENT_209	[p16l913t1432r1345b1501],
34	transport	NN	O	transport	prep_in	31	SENT_209	[p16l1367t1440r1637b1501],
35	across	IN	O	across	_	0	SENT_209	[p16l1660t1449r1845b1485],
36	intestinal	JJ	O	intestinal	amod	38	SENT_209	[p16l1869t1432r2147b1485],
37	apical	JJ	O	apical	amod	38	SENT_209	[p16l162t1520r341b1589],
38	membrane	NN	O	membrane	prep_across	34	SENT_209	[p16l369t1520r705b1573],
39	.	.	O	.	_	0	SENT_209	[p16l369t1520r705b1573],

1	J	NNP	O	J	nn	4	SENT_210	[p16l736t1521r764b1573],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_210	[p16l791t1520r1115b1573],
3	Exp	NNP	O	Exp	nn	4	SENT_210	[p16l1143t1521r1264b1589],
4	Ther	NNP	O	Ther	_	0	SENT_210	[p16l1292t1520r1436b1573],
5	306:703	CD	NUMBER	306:703	number	6	SENT_210	[p16l1465t1520r1860b1573],
6	—	CD	NUMBER	—	dep	4	SENT_210	[p16l1465t1520r1860b1573],
7	708	CD	NUMBER	708	dep	6	SENT_210	[p16l1465t1520r1860b1573],

1	Laeis	NNP	O	Laeis	nn	2	SENT_211	[p16l7t1608r169b1661],
2	P	NN	O	p	nsubj	9	SENT_211	[p16l220t1610r276b1671],
3	,	,	O	,	_	0	SENT_211	[p16l220t1610r276b1671],
4	Puchler	NN	O	puchler	nn	5	SENT_211	[p16l328t1608r560b1661],
5	K	NN	O	k	appos	2	SENT_211	[p16l608t1610r676b1671],
6	,	,	O	,	_	0	SENT_211	[p16l608t1610r676b1671],
7	Kirch	NNP	ORGANIZATION	Kirch	nn	8	SENT_211	[p16l729t1608r899b1661],
8	W	NNP	O	W	appos	5	SENT_211	[p16l947t1610r1018b1661],
9	(	VBD	O	(	_	0	SENT_211	[p16l1069t1609r1266b1674],
10	2001	CD	DATE	2001	num	11	SENT_211	[p16l1069t1609r1266b1674],
11	)	CD	NUMBER	)	dobj	9	SENT_211	[p16l1069t1609r1266b1674],
12	The	DT	O	the	det	16	SENT_211	[p16l1317t1608r1433b1661],
13	pharmacokinetic	JJ	O	pharmacokinetic	amod	16	SENT_211	[p16l1482t1608r1989b1677],
14	and	CC	O	and	_	0	SENT_211	[p16l2042t1608r2149b1661],
15	metabolic	JJ	O	metabolic	conj_and	13	SENT_211	[p16l160t1696r459b1750],
16	proﬁle	NN	O	proﬁle	nsubj	20	SENT_211	[p16l498t1696r696b1765],
17	of	IN	O	of	_	0	SENT_211	[p16l737t1696r802b1750],
18	olmesartan	NN	O	olmesartan	nn	19	SENT_211	[p16l837t1697r1169b1750],
19	medoxomil	NN	O	medoxomil	prep_of	16	SENT_211	[p16l1208t1696r1554b1750],
20	limits	VBZ	O	limit	dep	9	SENT_211	[p16l1594t1696r1764b1750],
21	the	DT	O	the	det	22	SENT_211	[p16l1805t1697r1896b1750],
22	risk	NN	O	risk	dobj	20	SENT_211	[p16l1934t1696r2049b1750],
23	of	IN	O	of	prep	22	SENT_211	[p16l2088t1696r2153b1750],

1	@	IN	O	@	_	0	SENT_212	[p16l6t1927r83b2022],
2	Springer	NNP	PERSON	Springer	nn	6	SENT_212	[p16l113t1950r375b2025],
3	clinically	RB	O	clinically	advmod	4	SENT_212	[p16l161t2037r443b2106],
4	relevant	JJ	O	relevant	amod	6	SENT_212	[p16l506t2037r752b2091],
5	drug	NN	O	drug	nn	6	SENT_212	[p16l815t2038r951b2106],
6	interaction	NN	O	interaction	pobj	1	SENT_212	[p16l1014t2037r1355b2091],
7	.	.	O	.	_	0	SENT_212	[p16l1014t2037r1355b2091],

1	J	NNP	O	J	nn	3	SENT_213	[p16l1422t2039r1449b2091],
2	Hypertens	NNPS	O	Hypertens	nn	3	SENT_213	[p16l1512t2039r1822b2106],
3	l9	NN	O	l9	_	0	SENT_213	[p16l1893t2038r2151b2106],
4	(	CD	NUMBER	(	num	5	SENT_213	[p16l1893t2038r2151b2106],
5	suppl	NN	O	suppl	dep	3	SENT_213	[p16l1893t2038r2151b2106],
6	l	NN	O	l	tmod	5	SENT_213	[p16l167t2126r518b2192],
7	)	CD	NUMBER	)	dep	3	SENT_213	[p16l167t2126r518b2192],
8	:	:	O	:	_	0	SENT_213	[p16l167t2126r518b2192],
9	S2l	NN	O	s2l	dep	7	SENT_213	[p16l167t2126r518b2192],
10	.	.	O	.	_	0	SENT_213	[p16l167t2126r518b2192],

1	—	NN	O	—	_	0	SENT_214	[p16l167t2126r518b2192],
2	.	.	O	.	_	0	SENT_214	[p16l167t2126r518b2192],

1	S32	NN	O	s32	_	0	SENT_215	[p16l167t2126r518b2192],

1	Maeda	NNP	PERSON	Maeda	nn	2	SENT_216	[p16l7t2214r214b2267],
2	K	NNP	PERSON	K	_	0	SENT_216	[p16l239t2216r307b2277],
3	,	,	O	,	_	0	SENT_216	[p16l239t2216r307b2277],
4	Ieiri	NNP	O	Ieiri	nn	8	SENT_216	[p16l333t2214r458b2267],
5	I	PRP	O	I	dep	8	SENT_216	[p16l483t2216r522b2277],
6	,	,	O	,	_	0	SENT_216	[p16l483t2216r522b2277],
7	Yasuda	NNP	ORGANIZATION	Yasuda	dep	8	SENT_216	[p16l550t2214r777b2267],
8	K	NNP	ORGANIZATION	K	appos	2	SENT_216	[p16l802t2216r869b2277],
9	,	,	O	,	_	0	SENT_216	[p16l802t2216r869b2277],
10	Fujino	NNP	PERSON	Fujino	nn	11	SENT_216	[p16l896t2214r1093b2283],
11	A	NNP	O	A	appos	2	SENT_216	[p16l1117t2215r1186b2277],
12	,	,	O	,	_	0	SENT_216	[p16l1117t2215r1186b2277],
13	Fujiwara	NNP	PERSON	Fujiwara	nn	14	SENT_216	[p16l1213t2214r1484b2283],
14	H	NNP	O	H	appos	2	SENT_216	[p16l1507t2216r1576b2277],
15	,	,	O	,	_	0	SENT_216	[p16l1507t2216r1576b2277],
16	Otsubo	NNP	PERSON	Otsubo	nn	17	SENT_216	[p16l1604t2214r1820b2268],
17	K	NNP	PERSON	K	appos	2	SENT_216	[p16l1846t2216r1914b2277],
18	,	,	O	,	_	0	SENT_216	[p16l1846t2216r1914b2277],
19	Hirano	NNP	PERSON	Hirano	nn	20	SENT_216	[p16l1941t2214r2150b2267],
20	M	NNP	O	M	appos	2	SENT_216	[p16l160t2304r242b2366],
21	,	,	O	,	_	0	SENT_216	[p16l160t2304r242b2366],
22	Watanabe	NNP	ORGANIZATION	Watanabe	nn	23	SENT_216	[p16l273t2303r577b2356],
23	T	NN	ORGANIZATION	t	appos	2	SENT_216	[p16l607t2304r668b2365],
24	,	,	O	,	_	0	SENT_216	[p16l607t2304r668b2365],
25	Kitamura	NNP	PERSON	Kitamura	nn	26	SENT_216	[p16l701t2302r987b2356],
26	Y	NN	PERSON	y	appos	2	SENT_216	[p16l1016t2304r1084b2365],
27	,	,	O	,	_	0	SENT_216	[p16l1016t2304r1084b2365],
28	Kusuhara	NN	PERSON	kusuhara	nn	29	SENT_216	[p16l1117t2303r1407b2356],
29	H	NN	PERSON	h	appos	2	SENT_216	[p16l1436t2304r1504b2365],
30	,	,	O	,	_	0	SENT_216	[p16l1436t2304r1504b2365],
31	Sugiyama	NNP	PERSON	Sugiyama	nn	32	SENT_216	[p16l1537t2302r1840b2371],
32	Y	NN	PERSON	y	appos	2	SENT_216	[p16l1868t2304r1921b2355],
33	(	CD	NUMBER	(	num	36	SENT_216	[p16l1953t2302r2149b2368],
34	2006	CD	DATE	2006	num	36	SENT_216	[p16l1953t2302r2149b2368],
35	)	CD	NUMBER	)	num	36	SENT_216	[p16l1953t2302r2149b2368],
36	Effects	NNS	O	effect	dep	32	SENT_216	[p16l160t2390r374b2443],
37	of	IN	O	of	_	0	SENT_216	[p16l400t2390r466b2443],
38	organic	JJ	O	organic	amod	39	SENT_216	[p16l485t2390r710b2459],
39	anion	NN	O	anion	prep_of	2	SENT_216	[p16l737t2390r904b2443],
40	transporting	VBG	O	transport	partmod	2	SENT_216	[p16l927t2390r1294b2459],
41	polypeptide	NN	O	polypeptide	nn	43	SENT_216	[p16l1318t2390r1678b2459],
42	lBl	NN	O	lbl	nn	43	SENT_216	[p16l1709t2391r1820b2443],
43	haplotype	NN	O	haplotype	dobj	40	SENT_216	[p16l1851t2390r2151b2459],
44	on	IN	O	on	_	0	SENT_216	[p16l161t2495r234b2531],
45	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	43	SENT_216	[p16l270t2478r808b2547],
46	of	IN	O	of	_	0	SENT_216	[p16l846t2478r912b2531],
47	pravastatin	NN	O	pravastatin	prep_of	45	SENT_216	[p16l942t2478r1293b2547],
48	,	,	O	,	_	0	SENT_216	[p16l942t2478r1293b2547],
49	valsartan	NN	O	valsartan	prep_of	45	SENT_216	[p16l1332t2478r1622b2541],
50	,	,	O	,	_	0	SENT_216	[p16l1332t2478r1622b2541],
51	and	CC	O	and	_	0	SENT_216	[p16l1663t2478r1770b2531],
52	temocapril	NN	O	temocapril	prep_of	45	SENT_216	[p16l1806t2478r2147b2547],
53	.	.	O	.	_	0	SENT_216	[p16l1806t2478r2147b2547],

1	Clin	NNP	O	Clin	nn	3	SENT_217	[p16l161t2567r290b2621],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_217	[p16l318t2568r642b2621],
3	Ther	NNP	O	Ther	_	0	SENT_217	[p16l671t2568r815b2621],
4	792427-439	CD	NUMBER	792427-439	dep	3	SENT_217	[p16l842t2568r1202b2621],

1	Mwinyi	NNP	PERSON	Mwinyi	nn	2	SENT_218	[p16l7t2656r246b2724],
2	J	NNP	PERSON	J	_	0	SENT_218	[p16l272t2657r300b2709],
3	,	,	O	,	_	0	SENT_218	[p16l305t2700r316b2718],
4	Johne	NNP	O	Johne	nn	5	SENT_218	[p16l345t2656r521b2709],
5	A	NNP	O	A	appos	2	SENT_218	[p16l547t2656r616b2719],
6	,	,	O	,	_	0	SENT_218	[p16l547t2656r616b2719],
7	Bauer	NNP	PERSON	Bauer	nn	8	SENT_218	[p16l645t2657r827b2709],
8	S	NN	O	s	appos	2	SENT_218	[p16l854t2656r908b2718],
9	,	,	O	,	_	0	SENT_218	[p16l854t2656r908b2718],
10	Roots	NNS	O	root	appos	2	SENT_218	[p16l937t2657r1112b2709],
11	I	PRP	O	I	dep	10	SENT_218	[p16l1139t2657r1179b2718],
12	,	,	O	,	_	0	SENT_218	[p16l1139t2657r1179b2718],
13	Gerloff	NNP	PERSON	Gerloff	nn	14	SENT_218	[p16l1209t2656r1435b2709],
14	T	NN	O	t	appos	2	SENT_218	[p16l1456t2657r1501b2708],
15	(	CD	NUMBER	(	num	16	SENT_218	[p16l1530t2656r1726b2721],
16	2004	CD	DATE	2004	dep	14	SENT_218	[p16l1530t2656r1726b2721],
17	)	CD	NUMBER	)	num	18	SENT_218	[p16l1530t2656r1726b2721],
18	Evidence	NN	O	evidence	dep	2	SENT_218	[p16l1754t2656r2037b2709],
19	for	IN	O	for	_	0	SENT_218	[p16l2064t2656r2153b2709],
20	inverse	JJ	O	inverse	amod	21	SENT_218	[p16l160t2743r378b2796],
21	effects	NNS	O	effect	prep_for	18	SENT_218	[p16l411t2743r611b2796],
22	of	IN	O	of	_	0	SENT_218	[p16l646t2743r711b2796],
23	OATP-C	NN	O	oatp-c	prep_of	21	SENT_218	[p16l739t2744r1009b2797],
24	(	CD	NUMBER	(	num	25	SENT_218	[p16l1045t2743r1398b2809],
25	SLC2lA6	NN	O	slc2la6	dep	2	SENT_218	[p16l1045t2743r1398b2809],
26	)	CD	NUMBER	)	num	27	SENT_218	[p16l1045t2743r1398b2809],
27	*	NN	O	*	dep	25	SENT_218	[p16l1436t2743r1503b2797],
28	5	CD	NUMBER	5	nn	32	SENT_218	[p16l1436t2743r1503b2797],
29	and	CC	O	and	_	0	SENT_218	[p16l1539t2743r1646b2796],
30	*	CD	NUMBER	*	conj_and	28	SENT_218	[p16l1681t2743r1789b2796],
31	lb	NN	O	lb	nn	32	SENT_218	[p16l1681t2743r1789b2796],
32	haplotypes	NNS	O	haplotype	dep	2	SENT_218	[p16l1821t2743r2149b2812],
33	on	IN	O	on	_	0	SENT_218	[p16l161t2848r235b2885],
34	pravastatin	NN	O	pravastatin	nn	35	SENT_218	[p16l261t2831r596b2900],
35	kinetics	NNS	O	kinetics	prep_on	32	SENT_218	[p16l623t2831r875b2885],
36	.	.	O	.	_	0	SENT_218	[p16l623t2831r875b2885],

1	Clin	NNP	O	Clin	nn	3	SENT_219	[p16l908t2831r1037b2885],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_219	[p16l1064t2832r1389b2885],
3	Ther	NNP	O	Ther	_	0	SENT_219	[p16l1417t2832r1561b2885],
4	752415-421	CD	NUMBER	752415-421	dep	3	SENT_219	[p16l1588t2831r1943b2885],

1	Nakagomi	NNP	PERSON	Nakagomi	_	0	SENT_220	[p16l7t2919r630b2988],
2	.	.	O	.	_	0	SENT_220	[p16l7t2919r630b2988],

1	—	NN	O	—	_	0	SENT_221	[p16l7t2919r630b2988],
2	.	.	O	.	_	0	SENT_221	[p16l7t2919r630b2988],

1	Hagihara	NN	PERSON	hagihara	nn	2	SENT_222	[p16l7t2919r630b2988],
2	R	NN	PERSON	r	dep	24	SENT_222	[p16l650t2921r715b2982],
3	,	,	O	,	_	0	SENT_222	[p16l650t2921r715b2982],
4	Nakai	NNP	PERSON	Nakai	nn	5	SENT_222	[p16l738t2919r918b2973],
5	D	NNP	PERSON	D	appos	2	SENT_222	[p16l939t2921r1009b2982],
6	,	,	O	,	_	0	SENT_222	[p16l939t2921r1009b2982],
7	Kawai	NNP	PERSON	Kawai	nn	8	SENT_222	[p16l1033t2919r1228b2973],
8	K	NNP	PERSON	K	appos	2	SENT_222	[p16l1251t2921r1318b2982],
9	,	,	O	,	_	0	SENT_222	[p16l1251t2921r1318b2982],
10	Yoshigae	NNP	O	Yoshigae	nn	11	SENT_222	[p16l1342t2919r1627b2988],
11	Y	NN	O	y	appos	2	SENT_222	[p16l1649t2921r1717b2982],
12	,	,	O	,	_	0	SENT_222	[p16l1649t2921r1717b2982],
13	Tokui	NNP	ORGANIZATION	Tokui	nn	14	SENT_222	[p16l1741t2919r1921b2973],
14	T	NN	ORGANIZATION	t	appos	2	SENT_222	[p16l1942t2921r2003b2982],
15	,	,	O	,	_	0	SENT_222	[p16l1942t2921r2003b2982],
16	Abe	NN	ORGANIZATION	abe	nn	17	SENT_222	[p16l2026t2920r2150b2973],
17	T	NN	ORGANIZATION	t	appos	2	SENT_222	[p16l160t3010r221b3072],
18	,	,	O	,	_	0	SENT_222	[p16l160t3010r221b3072],
19	Ikeda	NNP	PERSON	Ikeda	appos	2	SENT_222	[p16l277t3009r447b3062],
20	T	NN	PERSON	t	dep	24	SENT_222	[p16l500t3010r544b3061],
21	(	CD	NUMBER	(	num	20	SENT_222	[p16l601t3009r798b3074],
22	2006	CD	DATE	2006	num	24	SENT_222	[p16l601t3009r798b3074],
23	)	CD	NUMBER	)	num	24	SENT_222	[p16l601t3009r798b3074],
24	OATPlB1	NN	O	oatplb1	dep	31	SENT_222	[p16l855t3009r1193b3072],
25	,	,	O	,	_	0	SENT_222	[p16l855t3009r1193b3072],
26	OATPIB3	NN	O	oatpib3	dep	31	SENT_222	[p16l1252t3009r1591b3072],
27	,	,	O	,	_	0	SENT_222	[p16l1252t3009r1591b3072],
28	and	CC	O	and	_	0	SENT_222	[p16l1649t3009r1756b3062],
29	MRP2	NN	O	mrp2	dep	31	SENT_222	[p16l1809t3009r2005b3061],
30	are	VBP	O	be	auxpass	31	SENT_222	[p16l2061t3025r2150b3062],
31	involved	VBN	O	involve	_	0	SENT_222	[p16l160t3096r427b3150],
32	in	IN	O	in	_	0	SENT_222	[p16l480t3097r538b3149],
33	hepatobiliary	JJ	O	hepatobiliary	amod	34	SENT_222	[p16l591t3096r994b3165],
34	transport	NN	O	transport	prep_in	31	SENT_222	[p16l1049t3105r1319b3165],
35	of	IN	O	of	_	0	SENT_222	[p16l1374t3096r1440b3150],
36	olmesartan	NN	O	olmesartan	prep_of	34	SENT_222	[p16l1490t3097r1839b3159],
37	,	,	O	,	_	0	SENT_222	[p16l1490t3097r1839b3159],
38	a	DT	O	a	det	40	SENT_222	[p16l1898t3113r1930b3150],
39	novel	JJ	O	novel	amod	40	SENT_222	[p16l1983t3097r2151b3150],
40	angiotensin	NN	O	angiotensin	appos	36	SENT_222	[p16l162t3184r511b3253],
41	II	CD	NUMBER	ii	num	42	SENT_222	[p16l539t3186r588b3237],
42	blocker	NN	O	blocker	dep	40	SENT_222	[p16l614t3185r858b3238],
43	.	.	O	.	_	0	SENT_222	[p16l614t3185r858b3238],

1	Drug	NN	O	drug	_	0	SENT_223	[p16l889t3186r1043b3253],
2	Metab	NNP	O	Metab	nn	3	SENT_223	[p16l1071t3185r1264b3238],
3	Dispos	NNP	O	Dispos	dep	1	SENT_223	[p16l1293t3184r1501b3253],
4	342862-869	CD	NUMBER	342862-869	dep	1	SENT_223	[p16l1532t3184r1891b3238],

1	Nakai	NNP	PERSON	Nakai	nn	2	SENT_224	[p16l7t3273r187b3326],
2	D	NNP	PERSON	D	nsubj	21	SENT_224	[p16l209t3274r278b3336],
3	,	,	O	,	_	0	SENT_224	[p16l209t3274r278b3336],
4	Nakagomi	NNP	PERSON	Nakagomi	nn	5	SENT_224	[p16l301t3273r617b3341],
5	R	NNP	PERSON	R	appos	2	SENT_224	[p16l639t3274r704b3336],
6	,	,	O	,	_	0	SENT_224	[p16l639t3274r704b3336],
7	Furuta	NNP	PERSON	Furuta	nn	8	SENT_224	[p16l727t3274r926b3326],
8	Y	NN	PERSON	y	appos	2	SENT_224	[p16l947t3274r1015b3335],
9	,	,	O	,	_	0	SENT_224	[p16l947t3274r1015b3335],
10	Tokui	NNP	ORGANIZATION	Tokui	nn	11	SENT_224	[p16l1039t3273r1219b3326],
11	T	NN	ORGANIZATION	t	appos	2	SENT_224	[p16l1241t3274r1302b3336],
12	,	,	O	,	_	0	SENT_224	[p16l1241t3274r1302b3336],
13	Abe	NN	ORGANIZATION	abe	nn	14	SENT_224	[p16l1326t3273r1450b3326],
14	T	NN	ORGANIZATION	t	appos	2	SENT_224	[p16l1471t3274r1532b3335],
15	,	,	O	,	_	0	SENT_224	[p16l1471t3274r1532b3335],
16	Ikeda	NNP	ORGANIZATION	Ikeda	nn	17	SENT_224	[p16l1557t3273r1725b3326],
17	T	NN	ORGANIZATION	t	appos	2	SENT_224	[p16l1745t3274r1806b3336],
18	,	,	O	,	_	0	SENT_224	[p16l1745t3274r1806b3336],
19	Nishimura	NNP	PERSON	Nishimura	nn	20	SENT_224	[p16l1830t3273r2152b3326],
20	K	NNP	PERSON	K	appos	2	SENT_224	[p16l162t3362r215b3413],
21	(	VBD	O	(	_	0	SENT_224	[p16l238t3361r434b3427],
22	2001	CD	DATE	2001	num	23	SENT_224	[p16l238t3361r434b3427],
23	)	CD	NUMBER	)	dobj	21	SENT_224	[p16l238t3361r434b3427],
24	Human	JJ	O	human	amod	28	SENT_224	[p16l459t3362r682b3414],
25	liver-speciﬁc	NN	O	liver-speciﬁc	nn	28	SENT_224	[p16l704t3361r1100b3430],
26	organic	JJ	O	organic	amod	28	SENT_224	[p16l1125t3361r1350b3430],
27	anion	NN	O	anion	nn	28	SENT_224	[p16l1375t3361r1542b3414],
28	transporter	NN	O	transporter	nsubj	32	SENT_224	[p16l1564t3369r1910b3430],
29	,	,	O	,	_	0	SENT_224	[p16l1564t3369r1910b3430],
30	LST-l	NN	O	lst-l	appos	28	SENT_224	[p16l1934t3361r2148b3424],
31	,	,	O	,	_	0	SENT_224	[p16l1934t3361r2148b3424],
32	mediates	VBZ	O	mediate	dep	21	SENT_224	[p16l160t3448r429b3502],
33	uptake	NN	O	uptake	dobj	32	SENT_224	[p16l464t3449r666b3517],
34	of	IN	O	of	_	0	SENT_224	[p16l702t3448r768b3502],
35	pravastatin	NN	O	pravastatin	prep_of	33	SENT_224	[p16l796t3448r1131b3517],
36	by	IN	O	by	_	0	SENT_224	[p16l1164t3449r1239b3517],
37	human	JJ	O	human	amod	38	SENT_224	[p16l1273t3449r1480b3502],
38	hepatocytes	NNS	O	hepatocyte	prep_by	32	SENT_224	[p16l1513t3449r1888b3517],
39	.	.	O	.	_	0	SENT_224	[p16l1513t3449r1888b3517],

1	J	NNP	O	J	nn	4	SENT_225	[p16l1926t3450r1954b3502],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_225	[p16l1987t3449r2149b3502, p16l160t3538r345b3591],
3	Exp	NNP	O	Exp	nn	4	SENT_225	[p16l373t3539r494b3606],
4	Ther	NNP	O	Ther	_	0	SENT_225	[p16l522t3538r666b3591],
5	297:86	CD	NUMBER	297:86	num	6	SENT_225	[p16l693t3538r1091b3592],
6	l	NN	O	l	dep	4	SENT_225	[p16l693t3538r1091b3592],
7	—	NN	O	—	dep	4	SENT_225	[p16l693t3538r1091b3592],
8	867	CD	NUMBER	867	num	7	SENT_225	[p16l693t3538r1091b3592],

1	Niemi	NNP	PERSON	Niemi	nn	2	SENT_226	[p16l7t3626r195b3679],
2	M	NNP	O	M	_	0	SENT_226	[p16l217t3627r299b3689],
3	,	,	O	,	_	0	SENT_226	[p16l217t3627r299b3689],
4	Schaeffeler	NNP	O	Schaeffeler	nn	5	SENT_226	[p16l324t3626r670b3679],
5	E	NNP	O	E	appos	2	SENT_226	[p16l689t3627r750b3689],
6	,	,	O	,	_	0	SENT_226	[p16l689t3627r750b3689],
7	Lang	NNP	PERSON	Lang	nn	8	SENT_226	[p16l773t3627r928b3695],
8	T	NN	O	t	appos	2	SENT_226	[p16l949t3627r1010b3689],
9	,	,	O	,	_	0	SENT_226	[p16l949t3627r1010b3689],
10	Fromm	NNP	ORGANIZATION	Fromm	nn	11	SENT_226	[p16l1033t3627r1257b3679],
11	MF	NN	ORGANIZATION	mf	appos	2	SENT_226	[p16l1276t3627r1400b3689],
12	,	,	O	,	_	0	SENT_226	[p16l1276t3627r1400b3689],
13	Neuvonen	NN	O	neuvonen	nn	14	SENT_226	[p16l1423t3627r1736b3679],
14	M	NN	O	m	appos	2	SENT_226	[p16l1755t3627r1837b3689],
15	,	,	O	,	_	0	SENT_226	[p16l1755t3627r1837b3689],
16	Kyrklund	NN	O	kyrklund	nn	17	SENT_226	[p16l1862t3626r2152b3695],
17	C	NN	O	c	appos	2	SENT_226	[p16l161t3715r225b3778],
18	,	,	O	,	_	0	SENT_226	[p16l161t3715r225b3778],
19	Backman	NNP	PERSON	Backman	nn	20	SENT_226	[p16l254t3715r542b3768],
20	JT	NNP	O	JT	appos	2	SENT_226	[p16l567t3716r658b3777],
21	,	,	O	,	_	0	SENT_226	[p16l567t3716r658b3777],
22	Kerb	NNP	O	Kerb	nn	23	SENT_226	[p16l688t3715r837b3768],
23	R	NNP	O	R	appos	2	SENT_226	[p16l863t3716r929b3778],
24	,	,	O	,	_	0	SENT_226	[p16l863t3716r929b3778],
25	Schwab	NNP	ORGANIZATION	Schwab	nn	26	SENT_226	[p16l960t3715r1196b3768],
26	M	NNP	ORGANIZATION	M	appos	2	SENT_226	[p16l1223t3716r1305b3778],
27	,	,	O	,	_	0	SENT_226	[p16l1223t3716r1305b3778],
28	Neuvonen	NNP	O	Neuvonen	nn	29	SENT_226	[p16l1334t3716r1646b3768],
29	PJ	NNP	O	PJ	appos	2	SENT_226	[p16l1672t3716r1757b3778],
30	,	,	O	,	_	0	SENT_226	[p16l1672t3716r1757b3778],
31	Eichelbaum	NNP	PERSON	Eichelbaum	appos	2	SENT_226	[p16l1786t3714r2152b3768],

1	M	NN	O	m	nsubjpass	13	SENT_227	[p17l160t20r242b82],
2	,	,	O	,	_	0	SENT_227	[p17l160t20r242b82],
3	Kivisto	NNP	ORGANIZATION	Kivisto	nn	4	SENT_227	[p17l280t19r501b72],
4	KT	NNP	ORGANIZATION	KT	appos	1	SENT_227	[p17l537t20r636b71],
5	(	CD	NUMBER	(	num	11	SENT_227	[p17l672t19r868b84],
6	2004	CD	DATE	2004	num	11	SENT_227	[p17l672t19r868b84],
7	)	NNP	O	)	nn	11	SENT_227	[p17l672t19r868b84],
8	High	NNP	O	High	nn	11	SENT_227	[p17l905t19r1056b87],
9	plasma	NN	O	plasma	nn	11	SENT_227	[p17l1088t19r1305b88],
10	pravastatin	NN	O	pravastatin	nn	11	SENT_227	[p17l1337t19r1673b87],
11	concentrations	NNS	O	concentration	dep	4	SENT_227	[p17l1707t19r2149b72],
12	are	VBP	O	be	auxpass	13	SENT_227	[p17l162t124r252b160],
13	associated	VBN	O	associate	_	0	SENT_227	[p17l316t107r627b160],
14	with	IN	O	with	_	0	SENT_227	[p17l689t107r823b160],
15	single	JJ	O	single	amod	17	SENT_227	[p17l887t107r1065b176],
16	nucleotide	NN	O	nucleotide	nn	17	SENT_227	[p17l1128t107r1445b160],
17	polymorphisms	NNS	O	polymorphism	prep_with	13	SENT_227	[p17l1506t107r1979b176],
18	and	CC	O	and	_	0	SENT_227	[p17l2044t107r2152b160],
19	haplotypes	NNS	O	haplotype	conj_and	17	SENT_227	[p17l159t195r488b264],
20	of	IN	O	of	_	0	SENT_227	[p17l570t195r637b248],
21	organic	JJ	O	organic	amod	22	SENT_227	[p17l712t195r937b264],
22	anion	NN	O	anion	prep_of	17	SENT_227	[p17l1021t195r1187b248],
23	transporting	VBG	O	transport	xcomp	13	SENT_227	[p17l1267t195r1634b264],
24	polypeptide-C	NN	O	polypeptide-c	nsubj	27	SENT_227	[p17l1714t195r2150b264],
25	(	CD	NUMBER	(	num	27	SENT_227	[p17l163t283r340b348],
26	OAT	NN	O	oat	nn	27	SENT_227	[p17l163t283r340b348],
27	P	NN	O	p	xcomp	23	SENT_227	[p17l342t283r475b346],
28	.	.	O	.	_	0	SENT_227	[p17l342t283r475b346],

1	—	NN	O	—	_	0	SENT_228	[p17l342t283r475b346],
2	.	.	O	.	_	0	SENT_228	[p17l342t283r475b346],

1	C	NN	O	c	_	0	SENT_229	[p17l342t283r475b346],
2	,	,	O	,	_	0	SENT_229	[p17l342t283r475b346],
3	SLCO1Bl	NN	O	slco1bl	nn	4	SENT_229	[p17l507t283r866b348],
4	)	NN	O	)	appos	1	SENT_229	[p17l507t283r866b348],
5	.	.	O	.	_	0	SENT_229	[p17l507t283r866b348],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_230	[p17l898t283r1451b351],
2	142429-440	CD	NUMBER	142429-440	dep	1	SENT_230	[p17l1488t283r1843b337],

1	Niemi	NNP	PERSON	Niemi	nn	2	SENT_231	[p17l7t371r195b424],
2	M	NNP	O	M	nsubj	40	SENT_231	[p17l218t372r300b434],
3	,	,	O	,	_	0	SENT_231	[p17l218t372r300b434],
4	Backman	NNP	PERSON	Backman	nn	5	SENT_231	[p17l324t371r611b424],
5	JT	NNP	O	JT	appos	2	SENT_231	[p17l632t372r723b434],
6	,	,	O	,	_	0	SENT_231	[p17l632t372r723b434],
7	Kajosaari	NNP	PERSON	Kajosaari	nn	8	SENT_231	[p17l749t371r1038b440],
8	LI	NNP	PERSON	LI	appos	2	SENT_231	[p17l1060t372r1147b434],
9	,	,	O	,	_	0	SENT_231	[p17l1060t372r1147b434],
10	Leathart	NNP	PERSON	Leathart	nn	12	SENT_231	[p17l1171t371r1425b424],
11	J	NNP	PERSON	J	nn	12	SENT_231	[p17l1446t372r1474b424],
12	B	NNP	PERSON	B	appos	2	SENT_231	[p17l1476t372r1541b434],
13	,	,	O	,	_	0	SENT_231	[p17l1476t372r1541b434],
14	Neuvonen	NNP	O	Neuvonen	nn	15	SENT_231	[p17l1565t372r1877b424],
15	M	NNP	O	M	appos	2	SENT_231	[p17l1898t372r1981b434],
16	,	,	O	,	_	0	SENT_231	[p17l1898t372r1981b434],
17	Daly	NNP	ORGANIZATION	Daly	nn	18	SENT_231	[p17l2005t371r2150b440],
18	AK	NNP	ORGANIZATION	AK	appos	2	SENT_231	[p17l160t459r284b522],
19	,	,	O	,	_	0	SENT_231	[p17l160t459r284b522],
20	Eichelbaum	NNP	PERSON	Eichelbaum	nn	21	SENT_231	[p17l324t459r689b512],
21	M	NNP	O	M	appos	2	SENT_231	[p17l724t460r807b522],
22	,	,	O	,	_	0	SENT_231	[p17l724t460r807b522],
23	Kivisto	NNP	ORGANIZATION	Kivisto	nn	24	SENT_231	[p17l847t459r1068b512],
24	KT	NNP	ORGANIZATION	KT	appos	2	SENT_231	[p17l1107t460r1222b522],
25	,	,	O	,	_	0	SENT_231	[p17l1107t460r1222b522],
26	Neuvonen	NNP	PERSON	Neuvonen	nn	28	SENT_231	[p17l1261t460r1573b512],
27	PJ	NNP	PERSON	PJ	nn	28	SENT_231	[p17l1609t460r1679b512],
28	(	NNP	O	(	nn	29	SENT_231	[p17l1718t459r1949b525],
29	2005a	NN	O	2005a	appos	2	SENT_231	[p17l1718t459r1949b525],
30	)	CD	NUMBER	)	num	33	SENT_231	[p17l1718t459r1949b525],
31	Polymorphic	JJ	MISC	polymorphic	amod	33	SENT_231	[p17l1987t459r2149b528, p17l160t546r412b615],
32	organic	JJ	O	organic	amod	33	SENT_231	[p17l443t546r668b615],
33	anion	NN	O	anion	dep	29	SENT_231	[p17l700t546r867b599],
34	transporting	VBG	O	transport	partmod	2	SENT_231	[p17l896t546r1263b615],
35	polypeptide	NN	O	polypeptide	nn	36	SENT_231	[p17l1292t546r1651b615],
36	1B1	NN	O	1b1	dobj	34	SENT_231	[p17l1689t547r1800b599],
37	is	VBZ	O	be	cop	40	SENT_231	[p17l1835t546r1883b599],
38	a	DT	O	a	det	40	SENT_231	[p17l1915t563r1946b599],
39	major	JJ	O	major	amod	40	SENT_231	[p17l1974t546r2153b615],
40	determinant	NN	O	determinant	_	0	SENT_231	[p17l161t635r525b688],
41	of	IN	O	of	_	0	SENT_231	[p17l567t635r633b688],
42	repaglinide	NN	O	repaglinide	nn	43	SENT_231	[p17l669t635r1012b703],
43	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	40	SENT_231	[p17l1054t635r1608b703],
44	.	.	O	.	_	0	SENT_231	[p17l1054t635r1608b703],

1	Clin	NNP	O	Clin	nn	3	SENT_232	[p17l1655t635r1784b688],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_232	[p17l1825t635r2150b688],
3	Ther	NNP	O	Ther	_	0	SENT_232	[p17l160t724r304b777],
4	772468-478	CD	NUMBER	772468-478	dep	3	SENT_232	[p17l331t724r691b777],

1	Niemi	NNP	PERSON	Niemi	nn	2	SENT_233	[p17l7t812r195b865],
2	M	NNP	O	M	nsubjpass	24	SENT_233	[p17l240t813r322b875],
3	,	,	O	,	_	0	SENT_233	[p17l240t813r322b875],
4	Kivisto	NNP	ORGANIZATION	Kivisto	nn	5	SENT_233	[p17l370t812r591b865],
5	KT	NNP	ORGANIZATION	KT	appos	2	SENT_233	[p17l637t813r752b875],
6	,	,	O	,	_	0	SENT_233	[p17l637t813r752b875],
7	Hofmann	NNP	PERSON	Hofmann	nn	8	SENT_233	[p17l799t812r1086b865],
8	U	NNP	PERSON	U	appos	2	SENT_233	[p17l1129t813r1199b875],
9	,	,	O	,	_	0	SENT_233	[p17l1129t813r1199b875],
10	Schwab	NNP	ORGANIZATION	Schwab	nn	11	SENT_233	[p17l1248t812r1484b866],
11	M	NNP	ORGANIZATION	M	appos	2	SENT_233	[p17l1529t813r1611b875],
12	,	,	O	,	_	0	SENT_233	[p17l1529t813r1611b875],
13	Eichelbaum	NNP	PERSON	Eichelbaum	nn	14	SENT_233	[p17l1658t812r2023b865],
14	M	NNP	O	M	appos	2	SENT_233	[p17l2066t813r2148b875],
15	,	,	O	,	_	0	SENT_233	[p17l2066t813r2148b875],
16	Fromm	NNP	PERSON	Fromm	nn	17	SENT_233	[p17l160t903r384b955],
17	MF	NN	O	mf	appos	2	SENT_233	[p17l410t903r519b954],
18	(	CD	NUMBER	(	num	22	SENT_233	[p17l549t902r784b967],
19	2005b	JJ	O	2005b	amod	22	SENT_233	[p17l549t902r784b967],
20	)	NN	O	)	nn	22	SENT_233	[p17l549t902r784b967],
21	Fexofenadine	NN	O	fexofenadine	nn	22	SENT_233	[p17l813t902r1227b955],
22	pharmacokinetics	NNS	O	pharmacokinetic	dep	17	SENT_233	[p17l1254t902r1792b970],
23	are	VBP	O	be	auxpass	24	SENT_233	[p17l1823t918r1913b955],
24	associated	VBN	O	associate	_	0	SENT_233	[p17l1942t902r2149b955, p17l162t990r287b1043],
25	with	IN	O	with	_	0	SENT_233	[p17l328t990r462b1043],
26	a	DT	O	a	det	27	SENT_233	[p17l505t1007r537b1043],
27	polymorphism	NN	O	polymorphism	prep_with	24	SENT_233	[p17l577t990r1023b1059],
28	of	IN	O	of	_	0	SENT_233	[p17l1065t990r1130b1043],
29	the	DT	O	the	det	32	SENT_233	[p17l1167t990r1258b1043],
30	SLCO1B1	NN	O	slco1b1	nn	32	SENT_233	[p17l1303t990r1614b1043],
31	gene	NN	O	gene	nn	32	SENT_233	[p17l1664t1007r1805b1059],
32	(	NN	O	(	prep_of	27	SENT_233	[p17l1850t990r2150b1059],
33	encoding	VBG	O	encode	xcomp	24	SENT_233	[p17l1850t990r2150b1059],
34	OATPlBl	NN	O	oatplbl	nn	35	SENT_233	[p17l162t1079r524b1144],
35	)	NN	O	)	dobj	33	SENT_233	[p17l162t1079r524b1144],
36	.	.	O	.	_	0	SENT_233	[p17l162t1079r524b1144],

1	Br	NN	O	br	nn	4	SENT_234	[p17l556t1079r632b1131],
2	J	NN	O	j	nn	4	SENT_234	[p17l658t1079r686b1131],
3	Clin	NN	O	clin	nn	4	SENT_234	[p17l714t1078r843b1131],
4	Pharmacol	NN	O	pharmacol	_	0	SENT_234	[p17l870t1078r1195b1131],
5	592602-604	CD	NUMBER	592602-604	dep	4	SENT_234	[p17l1225t1078r1586b1132],

1	Nishizato	NNP	MISC	Nishizato	nn	2	SENT_235	[p17l7t1167r297b1221],
2	Y	NN	O	y	dep	45	SENT_235	[p17l333t1169r402b1230],
3	,	,	O	,	_	0	SENT_235	[p17l333t1169r402b1230],
4	Ieiri	NNP	O	Ieiri	nn	8	SENT_235	[p17l439t1167r564b1221],
5	I	PRP	O	I	dep	8	SENT_235	[p17l600t1169r639b1230],
6	,	,	O	,	_	0	SENT_235	[p17l600t1169r639b1230],
7	Suzuki	NNP	PERSON	Suzuki	dep	8	SENT_235	[p17l679t1167r886b1221],
8	H	NNP	O	H	appos	2	SENT_235	[p17l922t1169r991b1230],
9	,	,	O	,	_	0	SENT_235	[p17l922t1169r991b1230],
10	Kimura	NNP	PERSON	Kimura	nn	11	SENT_235	[p17l1030t1167r1261b1221],
11	M	NNP	PERSON	M	appos	2	SENT_235	[p17l1294t1169r1376b1230],
12	,	,	O	,	_	0	SENT_235	[p17l1294t1169r1376b1230],
13	Kawabata	NNP	ORGANIZATION	Kawabata	nn	14	SENT_235	[p17l1415t1167r1718b1221],
14	K	NNP	ORGANIZATION	K	appos	2	SENT_235	[p17l1754t1169r1822b1230],
15	,	,	O	,	_	0	SENT_235	[p17l1754t1169r1822b1230],
16	Hirota	NNP	ORGANIZATION	Hirota	nn	17	SENT_235	[p17l1859t1167r2054b1221],
17	T	NN	ORGANIZATION	t	appos	2	SENT_235	[p17l2087t1169r2149b1230],
18	,	,	O	,	_	0	SENT_235	[p17l2087t1169r2149b1230],
19	Takane	NN	PERSON	takane	nn	20	SENT_235	[p17l160t1256r384b1309],
20	H	NN	PERSON	h	appos	2	SENT_235	[p17l415t1257r484b1319],
21	,	,	O	,	_	0	SENT_235	[p17l415t1257r484b1319],
22	Irie	NNP	PERSON	Irie	nn	23	SENT_235	[p17l517t1256r621b1309],
23	S	NNP	O	S	appos	2	SENT_235	[p17l655t1256r709b1319],
24	,	,	O	,	_	0	SENT_235	[p17l655t1256r709b1319],
25	Kusuhara	NNP	PERSON	Kusuhara	nn	26	SENT_235	[p17l744t1256r1034b1309],
26	H	NNP	PERSON	H	appos	2	SENT_235	[p17l1065t1257r1133b1319],
27	,	,	O	,	_	0	SENT_235	[p17l1065t1257r1133b1319],
28	Urasaki	NNP	O	Urasaki	nn	29	SENT_235	[p17l1167t1256r1401b1309],
29	Y	NN	O	y	appos	2	SENT_235	[p17l1434t1257r1503b1319],
30	,	,	O	,	_	0	SENT_235	[p17l1434t1257r1503b1319],
31	Urae	NNP	O	Urae	nn	32	SENT_235	[p17l1536t1257r1683b1309],
32	A	NNP	O	A	appos	2	SENT_235	[p17l1714t1256r1783b1319],
33	,	,	O	,	_	0	SENT_235	[p17l1714t1256r1783b1319],
34	Higuchi	NNP	PERSON	Higuchi	nn	35	SENT_235	[p17l1817t1256r2060b1325],
35	S	NNP	O	S	appos	2	SENT_235	[p17l2094t1256r2148b1319],
36	,	,	O	,	_	0	SENT_235	[p17l2094t1256r2148b1319],
37	Otsubo	NNP	PERSON	Otsubo	nn	38	SENT_235	[p17l162t1343r377b1396],
38	K	NNP	PERSON	K	appos	2	SENT_235	[p17l427t1344r494b1406],
39	,	,	O	,	_	0	SENT_235	[p17l427t1344r494b1406],
40	Sugiyama	NNP	PERSON	Sugiyama	nn	41	SENT_235	[p17l547t1343r850b1412],
41	Y	NN	PERSON	y	appos	2	SENT_235	[p17l897t1344r949b1396],
42	(	CD	NUMBER	(	num	45	SENT_235	[p17l998t1344r1195b1409],
43	2003	CD	DATE	2003	num	45	SENT_235	[p17l998t1344r1195b1409],
44	)	CD	NUMBER	)	num	45	SENT_235	[p17l998t1344r1195b1409],
45	Polymorphisms	NNS	O	polymorphism	_	0	SENT_235	[p17l1244t1343r1720b1412],
46	of	IN	O	of	_	0	SENT_235	[p17l1770t1343r1836b1396],
47	OATP-C	NN	O	oatp-c	nn	50	SENT_235	[p17l1880t1344r2150b1396],
48	(	CD	NUMBER	(	num	50	SENT_235	[p17l163t1431r516b1497],
49	SLC2lA6	NN	O	slc2la6	nn	50	SENT_235	[p17l163t1431r516b1497],
50	)	NN	O	)	prep_of	45	SENT_235	[p17l163t1431r516b1497],
51	and	CC	O	and	_	0	SENT_235	[p17l565t1431r673b1484],
52	OAT3	NN	O	oat3	conj_and	45	SENT_235	[p17l720t1432r907b1485],
53	(	CD	NUMBER	(	num	56	SENT_235	[p17l960t1432r1313b1497],
54	SLC22A8	NN	O	slc22a8	nn	56	SENT_235	[p17l960t1432r1313b1497],
55	)	NN	O	)	nn	56	SENT_235	[p17l960t1432r1313b1497],
56	genes	NNS	O	gene	dep	52	SENT_235	[p17l1361t1448r1549b1500],
57	:	:	O	:	_	0	SENT_235	[p17l1361t1448r1549b1500],
58	consequences	NNS	O	consequence	dep	52	SENT_235	[p17l1600t1448r2017b1500],
59	for	IN	O	for	_	0	SENT_235	[p17l2065t1431r2153b1484],
60	pravastatin	NN	O	pravastatin	nn	61	SENT_235	[p17l159t1519r494b1588],
61	pharmacokinetics	NNS	O	pharmacokinetic	prep_for	58	SENT_235	[p17l521t1519r1076b1588],
62	.	.	O	.	_	0	SENT_235	[p17l521t1519r1076b1588],

1	Clin	NNP	O	Clin	nn	6	SENT_236	[p17l1108t1519r1237b1573],
2	Pharmacol	NNP	O	Pharmacol	nn	6	SENT_236	[p17l1265t1519r1590b1572],
3	Ther	NNP	O	Ther	nn	6	SENT_236	[p17l1618t1519r1762b1572],
4	732554-565	CD	NUMBER	732554-565	num	6	SENT_236	[p17l1788t1519r2147b1573],
5	Nozawa	NNP	ORGANIZATION	Nozawa	nn	6	SENT_236	[p17l7t1608r256b1660],
6	T	NN	ORGANIZATION	t	dep	32	SENT_236	[p17l285t1608r346b1670],
7	,	,	O	,	_	0	SENT_236	[p17l285t1608r346b1670],
8	Nakajima	NNP	PERSON	Nakajima	nn	9	SENT_236	[p17l377t1607r674b1676],
9	M	NNP	PERSON	M	appos	6	SENT_236	[p17l702t1608r785b1670],
10	,	,	O	,	_	0	SENT_236	[p17l702t1608r785b1670],
11	Tamai	NNP	PERSON	Tamai	nn	12	SENT_236	[p17l816t1607r1010b1660],
12	I	NNP	O	I	appos	6	SENT_236	[p17l1040t1608r1079b1670],
13	,	,	O	,	_	0	SENT_236	[p17l1040t1608r1079b1670],
14	Noda	NNP	PERSON	Noda	nn	15	SENT_236	[p17l1111t1607r1276b1660],
15	K	NNP	O	K	appos	6	SENT_236	[p17l1305t1608r1373b1670],
16	,	,	O	,	_	0	SENT_236	[p17l1305t1608r1373b1670],
17	Nezu	NNP	PERSON	Nezu	nn	18	SENT_236	[p17l1404t1608r1564b1660],
18	J	NNP	PERSON	J	appos	6	SENT_236	[p17l1593t1608r1621b1660],
19	,	,	O	,	_	0	SENT_236	[p17l1626t1651r1637b1670],
20	Sai	NNP	O	Sai	nn	21	SENT_236	[p17l1671t1607r1764b1660],
21	Y	NN	O	y	appos	6	SENT_236	[p17l1794t1608r1863b1670],
22	,	,	O	,	_	0	SENT_236	[p17l1794t1608r1863b1670],
23	Tsuji	NNP	PERSON	Tsuji	nn	24	SENT_236	[p17l1894t1607r2049b1676],
24	A	NNP	O	A	appos	6	SENT_236	[p17l2079t1608r2148b1670],
25	,	,	O	,	_	0	SENT_236	[p17l2079t1608r2148b1670],
26	Yokoi	NNP	PERSON	Yokoi	appos	6	SENT_236	[p17l160t1695r348b1748],
27	T	NN	O	t	dep	32	SENT_236	[p17l372t1696r416b1748],
28	(	CD	NUMBER	(	num	27	SENT_236	[p17l442t1695r639b1761],
29	2002	CD	DATE	2002	num	32	SENT_236	[p17l442t1695r639b1761],
30	)	NNP	O	)	nn	32	SENT_236	[p17l442t1695r639b1761],
31	Genetic	NNP	O	Genetic	nn	32	SENT_236	[p17l665t1695r898b1748],
32	polymorphisms	NNS	O	polymorphism	dep	41	SENT_236	[p17l922t1695r1395b1764],
33	of	IN	O	of	_	0	SENT_236	[p17l1421t1695r1486b1748],
34	human	JJ	O	human	amod	37	SENT_236	[p17l1503t1695r1710b1748],
35	organic	JJ	O	organic	amod	37	SENT_236	[p17l1734t1695r1959b1764],
36	anion	NN	O	anion	nn	37	SENT_236	[p17l1985t1695r2151b1748],
37	transporters	NNS	O	transporter	prep_of	32	SENT_236	[p17l160t1791r518b1852],
38	OATP-C	NN	O	oatp-c	nn	41	SENT_236	[p17l558t1784r828b1837],
39	(	CD	NUMBER	(	num	41	SENT_236	[p17l868t1783r1222b1849],
40	SLC2lA6	NN	O	slc2la6	nn	41	SENT_236	[p17l868t1783r1222b1849],
41	)	NN	O	)	dep	45	SENT_236	[p17l868t1783r1222b1849],
42	and	CC	O	and	_	0	SENT_236	[p17l1263t1783r1370b1836],
43	OATP-B	NN	O	oatp-b	dep	45	SENT_236	[p17l1408t1784r1675b1837],
44	(	CD	NUMBER	(	num	43	SENT_236	[p17l1719t1784r2146b1849],
45	SLCO2lA9	NN	O	slco2la9	dep	49	SENT_236	[p17l1719t1784r2146b1849],
46	)	CD	NUMBER	)	num	45	SENT_236	[p17l1719t1784r2146b1849],
47	:	:	O	:	_	0	SENT_236	[p17l1719t1784r2146b1849],
48	allele	NN	O	allele	nn	49	SENT_236	[p17l162t1871r324b1925],
49	frequencies	NNS	O	frequency	_	0	SENT_236	[p17l370t1871r719b1940],
50	in	IN	O	in	_	0	SENT_236	[p17l766t1871r824b1924],
51	the	DT	O	the	det	53	SENT_236	[p17l868t1872r959b1925],
52	Japanese	JJ	MISC	japanese	amod	53	SENT_236	[p17l1004t1873r1273b1940],
53	population	NN	O	population	prep_in	49	SENT_236	[p17l1318t1871r1644b1940],
54	and	CC	O	and	_	0	SENT_236	[p17l1691t1871r1798b1925],
55	functional	JJ	O	functional	amod	56	SENT_236	[p17l1843t1871r2151b1925],
56	analysis	NN	O	analysis	prep_in	49	SENT_236	[p17l162t1959r419b2028],
57	.	.	O	.	_	0	SENT_236	[p17l162t1959r419b2028],

1	J	NNP	O	J	nn	4	SENT_237	[p17l451t1960r479b2012],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_237	[p17l506t1959r831b2012],
3	Exp	NNP	O	Exp	nn	4	SENT_237	[p17l859t1960r980b2028],
4	Ther	NNP	O	Ther	_	0	SENT_237	[p17l1008t1959r1152b2012],
5	3022804-813	CD	NUMBER	3022804-813	dep	4	SENT_237	[p17l1180t1959r1575b2012],

1	Sakaeda	FW	ORGANIZATION	sakaeda	nsubj	30	SENT_238	[p17l9t2047r261b2101],
2	T	NN	ORGANIZATION	t	dep	1	SENT_238	[p17l298t2049r359b2110],
3	,	,	O	,	_	0	SENT_238	[p17l298t2049r359b2110],
4	Fujino	NN	PERSON	fujino	nn	5	SENT_238	[p17l399t2047r597b2116],
5	H	NN	PERSON	h	appos	2	SENT_238	[p17l635t2049r704b2110],
6	,	,	O	,	_	0	SENT_238	[p17l635t2049r704b2110],
7	Komoto	NNP	PERSON	Komoto	nn	8	SENT_238	[p17l746t2049r992b2100],
8	C	NNP	O	C	appos	2	SENT_238	[p17l1032t2048r1096b2110],
9	,	,	O	,	_	0	SENT_238	[p17l1032t2048r1096b2110],
10	Kakumoto	NNP	O	Kakumoto	nn	11	SENT_238	[p17l1138t2047r1457b2100],
11	M	NNP	O	M	appos	2	SENT_238	[p17l1495t2049r1578b2110],
12	,	,	O	,	_	0	SENT_238	[p17l1495t2049r1578b2110],
13	Jin	NNP	LOCATION	Jin	nn	14	SENT_238	[p17l1618t2047r1705b2101],
14	JS	NNP	LOCATION	JS	appos	2	SENT_238	[p17l1743t2048r1829b2110],
15	,	,	O	,	_	0	SENT_238	[p17l1743t2048r1829b2110],
16	Iwaki	NNP	ORGANIZATION	Iwaki	nn	17	SENT_238	[p17l1869t2047r2040b2101],
17	K	NNP	ORGANIZATION	K	appos	2	SENT_238	[p17l2080t2049r2148b2110],
18	,	,	O	,	_	0	SENT_238	[p17l2080t2049r2148b2110],
19	Nishiguchi	NNP	ORGANIZATION	Nishiguchi	nn	20	SENT_238	[p17l160t2135r493b2204],
20	K	NNP	ORGANIZATION	K	appos	2	SENT_238	[p17l534t2137r601b2198],
21	,	,	O	,	_	0	SENT_238	[p17l534t2137r601b2198],
22	Nakamura	NNP	ORGANIZATION	Nakamura	nn	23	SENT_238	[p17l643t2136r961b2189],
23	T	NN	ORGANIZATION	t	appos	2	SENT_238	[p17l998t2137r1060b2198],
24	,	,	O	,	_	0	SENT_238	[p17l998t2137r1060b2198],
25	Okamura	NNP	ORGANIZATION	Okamura	nn	26	SENT_238	[p17l1103t2136r1384b2189],
26	N	NNP	ORGANIZATION	N	appos	2	SENT_238	[p17l1422t2137r1491b2198],
27	,	,	O	,	_	0	SENT_238	[p17l1422t2137r1491b2198],
28	Okumura	NNP	PERSON	Okumura	nn	29	SENT_238	[p17l1534t2135r1820b2189],
29	K	NNP	PERSON	K	appos	2	SENT_238	[p17l1860t2137r1913b2188],
30	(	VBD	O	(	_	0	SENT_238	[p17l1953t2135r2149b2201],
31	2006	CD	DATE	2006	num	33	SENT_238	[p17l1953t2135r2149b2201],
32	)	CD	NUMBER	)	num	33	SENT_238	[p17l1953t2135r2149b2201],
33	Effects	NNS	O	effect	dobj	30	SENT_238	[p17l160t2223r374b2276],
34	of	IN	O	of	_	0	SENT_238	[p17l403t2223r469b2276],
35	acid	NN	O	acid	nn	38	SENT_238	[p17l491t2223r616b2276],
36	and	CC	O	and	_	0	SENT_238	[p17l644t2223r751b2276],
37	lactone	NN	O	lactone	nn	38	SENT_238	[p17l778t2223r997b2276],
38	forms	NNS	O	form	prep_of	33	SENT_238	[p17l1024t2223r1198b2276],
39	of	IN	O	of	_	0	SENT_238	[p17l1227t2223r1293b2276],
40	eight	CD	NUMBER	eight	num	43	SENT_238	[p17l1315t2223r1467b2292],
41	HMG-CoA	NN	O	hmg-coa	nn	43	SENT_238	[p17l1493t2223r1837b2276],
42	reductase	NN	O	reductase	nn	43	SENT_238	[p17l1863t2223r2151b2276],
43	inhibitors	NNS	O	inhibitor	prep_of	38	SENT_238	[p17l160t2312r450b2365],
44	on	IN	O	on	_	0	SENT_238	[p17l491t2329r564b2365],
45	CYP-mediated	JJ	MISC	cyp-mediated	amod	46	SENT_238	[p17l604t2312r1056b2366],
46	metabolism	NN	O	metabolism	prep_on	30	SENT_238	[p17l1094t2312r1450b2365],
47	and	CC	O	and	_	0	SENT_238	[p17l1490t2312r1597b2365],
48	MDR1-mediated	JJ	O	mdr1-mediated	amod	49	SENT_238	[p17l1634t2312r2151b2365],
49	transport	NN	O	transport	conj_and	46	SENT_238	[p17l160t2408r445b2469],
50	.	.	O	.	_	0	SENT_238	[p17l160t2408r445b2469],

1	Pharm	NNP	O	Pharm	nn	2	SENT_239	[p17l476t2401r675b2454],
2	Res	NNP	O	Res	_	0	SENT_239	[p17l702t2402r813b2454],
3	232506-512	CD	NUMBER	232506-512	dep	2	SENT_239	[p17l843t2400r1204b2454],

1	Tirona	NNP	O	Tirona	nn	2	SENT_240	[p17l7t2488r210b2542],
2	RG	NNP	O	RG	dep	15	SENT_240	[p17l235t2489r354b2551],
3	,	,	O	,	_	0	SENT_240	[p17l235t2489r354b2551],
4	Leake	NNP	PERSON	Leake	nn	5	SENT_240	[p17l383t2489r568b2542],
5	BF	NNP	O	BF	appos	2	SENT_240	[p17l595t2490r702b2551],
6	,	,	O	,	_	0	SENT_240	[p17l595t2490r702b2551],
7	Merino	NNP	O	Merino	nn	8	SENT_240	[p17l731t2488r953b2542],
8	G	NNP	O	G	appos	2	SENT_240	[p17l981t2489r1049b2552],
9	,	,	O	,	_	0	SENT_240	[p17l981t2489r1049b2552],
10	Kim	NNP	PERSON	Kim	appos	2	SENT_240	[p17l1079t2488r1212b2541],
11	RB	NN	O	rb	dep	15	SENT_240	[p17l1238t2490r1333b2541],
12	(	CD	NUMBER	(	num	11	SENT_240	[p17l1365t2489r1562b2554],
13	2001	CD	DATE	2001	num	15	SENT_240	[p17l1365t2489r1562b2554],
14	)	CD	NUMBER	)	num	15	SENT_240	[p17l1365t2489r1562b2554],
15	Polymorphisms	NNS	O	polymorphism	dep	19	SENT_240	[p17l1590t2488r2066b2557],
16	in	IN	O	in	_	0	SENT_240	[p17l2093t2488r2151b2541],
17	OATP-C	NN	O	oatp-c	prep_in	15	SENT_240	[p17l162t2577r449b2630],
18	:	:	O	:	_	0	SENT_240	[p17l162t2577r449b2630],
19	identiﬁcation	NN	O	identiﬁcation	_	0	SENT_240	[p17l495t2576r897b2629],
20	of	IN	O	of	_	0	SENT_240	[p17l938t2576r1004b2629],
21	multiple	JJ	O	multiple	amod	23	SENT_240	[p17l1038t2576r1291b2645],
22	allelic	JJ	O	allelic	amod	23	SENT_240	[p17l1334t2576r1517b2629],
23	Variants	NNS	O	variant	prep_of	19	SENT_240	[p17l1558t2576r1797b2629],
24	associated	VBN	O	associate	partmod	19	SENT_240	[p17l1840t2576r2152b2629],
25	with	IN	O	with	_	0	SENT_240	[p17l161t2664r295b2718],
26	altered	JJ	O	altered	amod	28	SENT_240	[p17l333t2665r539b2718],
27	transport	NN	O	transport	nn	28	SENT_240	[p17l576t2673r847b2733],
28	activity	NN	O	activity	prep_with	24	SENT_240	[p17l885t2664r1112b2733],
29	among	IN	O	among	_	0	SENT_240	[p17l1151t2681r1355b2733],
30	European	JJ	MISC	european	amod	31	SENT_240	[p17l1393t2666r1708b2733],
31	—	NN	O	—	prep_among	28	SENT_240	[p17l1393t2666r1708b2733],
32	and	CC	O	and	_	0	SENT_240	[p17l1749t2665r1857b2718],
33	AfricanAmericans	NNS	MISC	africanamerican	prep_among	28	SENT_240	[p17l1894t2664r2149b2718, p17l160t2754r505b2807],
34	.	.	O	.	_	0	SENT_240	[p17l1894t2664r2149b2718, p17l160t2754r505b2807],

1	J	NNP	O	J	nn	3	SENT_241	[p17l536t2755r564b2807],
2	Biol	NNP	O	Biol	nn	3	SENT_241	[p17l591t2753r721b2807],
3	Chem	NNP	O	Chem	_	0	SENT_241	[p17l750t2754r931b2807],
4	276235669-35675	CD	NUMBER	276235669-35675	dep	3	SENT_241	[p17l958t2753r1507b2807],

1	Yamada	NNP	PERSON	Yamada	nn	2	SENT_242	[p17l7t2842r261b2895],
2	A	NNP	O	A	dep	47	SENT_242	[p17l315t2842r385b2905],
3	,	,	O	,	_	0	SENT_242	[p17l315t2842r385b2905],
4	Maeda	NNP	PERSON	Maeda	nn	5	SENT_242	[p17l442t2842r649b2895],
5	K	NNP	PERSON	K	appos	2	SENT_242	[p17l705t2843r773b2905],
6	,	,	O	,	_	0	SENT_242	[p17l705t2843r773b2905],
7	Kan1iyama	NN	O	kan1iyama	nn	8	SENT_242	[p17l832t2842r1166b2910],
8	E	NN	O	e	appos	2	SENT_242	[p17l1220t2843r1281b2905],
9	,	,	O	,	_	0	SENT_242	[p17l1220t2843r1281b2905],
10	Sugiyama	NN	ORGANIZATION	sugiyama	nn	11	SENT_242	[p17l1342t2842r1645b2911],
11	D	NN	ORGANIZATION	d	appos	2	SENT_242	[p17l1700t2843r1768b2905],
12	,	,	O	,	_	0	SENT_242	[p17l1700t2843r1768b2905],
13	Kondo	NNP	PERSON	Kondo	nn	14	SENT_242	[p17l1828t2842r2031b2895],
14	T	NN	O	t	appos	2	SENT_242	[p17l2087t2843r2149b2905],
15	,	,	O	,	_	0	SENT_242	[p17l2087t2843r2149b2905],
16	Shiroyanagi	FW	LOCATION	shiroyanagi	appos	2	SENT_242	[p17l162t2929r527b2998],
17	Y	NN	LOCATION	y	dep	16	SENT_242	[p17l556t2931r625b2993],
18	,	,	O	,	_	0	SENT_242	[p17l556t2931r625b2993],
19	Nakazawa	NN	PERSON	nakazawa	nn	20	SENT_242	[p17l656t2930r973b2983],
20	H	NN	O	h	appos	17	SENT_242	[p17l1001t2931r1069b2992],
21	,	,	O	,	_	0	SENT_242	[p17l1001t2931r1069b2992],
22	Okano	NNP	ORGANIZATION	Okano	nn	23	SENT_242	[p17l1102t2930r1301b2983],
23	T	NN	ORGANIZATION	t	appos	17	SENT_242	[p17l1330t2931r1391b2992],
24	,	,	O	,	_	0	SENT_242	[p17l1330t2931r1391b2992],
25	Adachi	NNP	PERSON	Adachi	nn	26	SENT_242	[p17l1422t2929r1640b2983],
26	M	NNP	O	M	appos	17	SENT_242	[p17l1668t2931r1751b2992],
27	,	,	O	,	_	0	SENT_242	[p17l1668t2931r1751b2992],
28	Schuetz	NNP	PERSON	Schuetz	nn	29	SENT_242	[p17l1783t2930r2020b2983],
29	JD	NNP	O	JD	appos	17	SENT_242	[p17l2050t2931r2149b2992],
30	,	,	O	,	_	0	SENT_242	[p17l2050t2931r2149b2992],
31	Adachi	NNP	PERSON	Adachi	nn	32	SENT_242	[p17l160t3017r378b3071],
32	Y	NN	PERSON	y	appos	17	SENT_242	[p17l420t3019r488b3080],
33	,	,	O	,	_	0	SENT_242	[p17l420t3019r488b3080],
34	Hu	NNP	O	Hu	nn	35	SENT_242	[p17l532t3019r622b3071],
35	Z	NNP	O	Z	appos	17	SENT_242	[p17l662t3019r724b3080],
36	,	,	O	,	_	0	SENT_242	[p17l662t3019r724b3080],
37	Kusuhara	NNP	O	Kusuhara	nn	38	SENT_242	[p17l768t3018r1059b3071],
38	H	NNP	O	H	appos	17	SENT_242	[p17l1098t3019r1167b3081],
39	,	,	O	,	_	0	SENT_242	[p17l1098t3019r1167b3081],
40	Sugiyama	NNP	O	Sugiyama	nn	41	SENT_242	[p17l1212t3017r1515b3086],
41	Y	NN	O	y	appos	2	SENT_242	[p17l1555t3019r1607b3070],
42	(	CD	NUMBER	(	num	41	SENT_242	[p17l1650t3018r1846b3083],
43	2007	CD	DATE	2007	dep	47	SENT_242	[p17l1650t3018r1846b3083],
44	)	CD	NUMBER	)	num	47	SENT_242	[p17l1650t3018r1846b3083],
45	Multiple	JJ	O	multiple	amod	47	SENT_242	[p17l1889t3017r2150b3086],
46	human	JJ	O	human	amod	47	SENT_242	[p17l159t3106r367b3159],
47	isoforms	NNS	O	isoform	dep	51	SENT_242	[p17l402t3106r666b3159],
48	of	IN	O	of	_	0	SENT_242	[p17l703t3106r769b3159],
49	drug	NN	O	drug	nn	50	SENT_242	[p17l800t3106r936b3174],
50	transporters	NNS	O	transporter	prep_of	47	SENT_242	[p17l973t3114r1330b3174],
51	contribute	VBP	O	contribute	_	0	SENT_242	[p17l1368t3106r1675b3159],
52	to	TO	O	to	_	0	SENT_242	[p17l1711t3114r1768b3159],
53	the	DT	O	the	det	57	SENT_242	[p17l1804t3106r1896b3159],
54	hepatic	JJ	O	hepatic	amod	57	SENT_242	[p17l1931t3106r2150b3174],
55	and	CC	O	and	_	0	SENT_242	[p17l162t3193r269b3246],
56	renal	JJ	O	renal	amod	57	SENT_242	[p17l292t3193r444b3246],
57	transporter	NN	O	transporter	prep_to	51	SENT_242	[p17l469t3201r800b3262],
58	of	IN	O	of	_	0	SENT_242	[p17l825t3193r890b3246],
59	olmesartan	NN	O	olmesartan	prep_of	57	SENT_242	[p17l911t3193r1260b3256],
60	,	,	O	,	_	0	SENT_242	[p17l911t3193r1260b3256],
61	a	DT	O	a	det	63	SENT_242	[p17l1289t3210r1320b3246],
62	selective	JJ	O	selective	amod	63	SENT_242	[p17l1347t3193r1610b3247],
63	antagonist	NN	O	antagonist	appos	59	SENT_242	[p17l1637t3193r1949b3262],
64	of	IN	O	of	_	0	SENT_242	[p17l1974t3193r2040b3246],
65	the	DT	O	the	det	66	SENT_242	[p17l2059t3193r2150b3246],
66	angiotensin	NN	O	angiotensin	prep_of	63	SENT_242	[p17l162t3281r511b3350],
67	II	CD	NUMBER	ii	num	70	SENT_242	[p17l538t3283r587b3334],
68	AT1	NN	O	at1	nn	70	SENT_242	[p17l614t3282r1043b3350],
69	—	NN	O	—	nn	70	SENT_242	[p17l614t3282r1043b3350],
70	receptor	NN	O	receptor	dep	63	SENT_242	[p17l614t3282r1043b3350],
71	.	.	O	.	_	0	SENT_242	[p17l614t3282r1043b3350],

1	Drug	NN	O	drug	_	0	SENT_243	[p17l1074t3283r1227b3350],
2	Metab	NNP	O	Metab	nn	3	SENT_243	[p17l1255t3282r1448b3335],
3	Dispos	NNP	O	Dispos	dep	1	SENT_243	[p17l1476t3281r1684b3350],
4	3522166-2176	CD	NUMBER	3522166-2176	dep	1	SENT_243	[p17l1714t3281r2150b3335],

